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Abstract 
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain 
stimulation (NIBS) technique capable of inducing neuro-modulatory effects outlasting 
the acute period of stimulation. This capacity to induce long term neuroplastic-like 
changes in the human nervous system has been investigated in a range of 
neurophysiological, cognitive, and clinical applications. Despite 30 years of research, 
the mechanisms underpinning the effects induced by rTMS by are not fully understood. 
Consequently, the neuroplastic-like effects induced by the rTMS can be highly 
heterogenous limiting the potential utility and effectiveness of the technique.  
One approach that may lead to the development of more effective and efficient 
rTMS protocols is through multisite stimulation. Multisite or inter-regional NIBS refers 
to the application of non-invasive neuro-modulatory paradigms over distinct but 
functionally related regions to examine neurological, cognitive, or behavioural 
processes that occur over distributed neural networks. Multisite rTMS can also be used 
to target several neuroanatomical regions within the same session that are implicated in 
different illnesses and disease states. This program of research sought to extend our 
understanding and application of multisite rTMS paradigms by evaluating the safety, 
development, implementation, measurement, and neuro-modulatory effects of multisite 
priming protocols. This thesis is comprised of two broad streams of research.  
The first research stream evaluated the potential of multisite rTMS paradigms 
for clinical applications. Specifically, this thesis evaluated the utility of neuroanatomical 
model of pathology, and clinical rTMS outcomes for obsessive-compulsive disorder 
(OCD) for informing and guiding the development of multisite rTMS protocols. The 
findings of the review revealed that several neuroanatomical regions may be amenable 
to multisite rTMS including the orbitofrontal cortex, (OFC), dorsolateral prefrontal 
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cortex (DLPFC), and supplementary motor area (SMA). Moreover, the clinical rTMS 
OCD literature revealed several rTMS parameters that may have therapeutic potential.  
This led to first empirical study that evaluated the safety, tolerability, and long-
term neurocognitive effects of a multisite rTMS informed by pathophysiological models 
of OCD, and clinical rTMS outcomes. As the study aimed to provide preliminary data 
on the feasibility of multisite rTMS paradigms, a sample of 20 healthy volunteers were 
recruited. Participants in the active condition received low frequency rTMS over the 
OFC and SMA, and high frequency rTMS over the DLPFC. Special care was taken to 
ensure that the protocol was safe and within safety guidelines. The multisite rTMS 
protocol was delivered at reduced stimulus intensities, and short train durations. 
Overall, the findings showed that the multisite protocol was safe and tolerable. As 
expected, those receiving active rTMS reported a higher frequency of side effects 
including headache, neck, and shoulder pain. Long-term data revealed individuals 
receiving active and sham stimulation performed comparably over a 3-month period.  
The second research stream was developed as there was relatively little 
empirical data on the neurophysiological effects of inter-regional priming rTMS 
protocols that could be used to guide the selection of appropriate rTMS parameters for 
multisite designs. Additionally, priming protocols applied intra-regionally have been 
shown to induce robust neuroplastic-like effects. Therefore, the second half of this 
thesis examined the neuro-modulatory effects of inter-regional priming protocols 
administered over the primary motor cortex (M1), and whether more consistent neuro-
plastic effects could be achieved through inter-regional priming protocols. The second 
empirical study evaluated four rTMS protocols administered using a patterned form of 
rTMS referred to as of continuous theta burst stimulation (cTBS) involving the delivery 
of high frequency, low intensity electromagnetic stimuli in the theta range. The first 
protocol was standard cTBS applied over M1. The second was an intra-regional priming 
Page 20 of 414 
 
protocol where cTBS was applied over M1 twice. The last two protocols involved inter-
regional cTBS priming of M1 via the ipsilateral DLPFC, and dorsal premotor cortex 
(dPMC). All protocols were found to be safe and tolerable. Each protocol, however, 
induced highly variable neuroplastic effects on corticospinal excitability.  
To gain further insights into the highly variable neuro-plastic responses, the final 
study utilised a novel multimodal approach involving combined transcranial magnetic 
stimulation and electroencephalography (TMS-EEG) to measure the neuro-modulatory 
effects induced by standard and inter-regional cTBS priming of M1 with transcranial 
magnetic stimulation-evoked potentials (TEPs). An active control condition involving 
TMS applied over the shoulder was included to control for multisensory afferents. The 
findings of the final study revealed that although there was partial overlap between EEG 
responses evoked from the scalp and shoulder, sensory afferents cannot account for the 
entire TEP response. It was also revealed that several TEP components including the 
N45 TEP, and N100 TEP may partially reflect neuroplastic responses to standard and 
inter-regional priming cTBS protocols.  
 The major conclusions stemming from this program of research are (1) 
neurobiological models of neuro-pathophysiology can be used to inform the 
identification of neuroanatomical targets for multisite rTMS, (2) multisite rTMS 
paradigms are generally safe and well-tolerated, (3) intra- and inter-regional cTBS 
priming of M1 induces highly variable neuroplastic effects on corticospinal excitability, 
and (4) multi-modal techniques such as TMS-EEG can be used to measure neuro-
modulatory responses to standard and inter-regional cTBS priming protocols. 




Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation 
(NIBS) technique capable of depolarising nerve cells in the human brain via 
electromagnetic induction (Hallett, 2007). It is a commonly applied paradigm that has 
found increasing application in the areas of neurophysiology (Chen, 2004; Terao & 
Ugawa, 2002), cognitive neuroscience (Guse, Falkai, & Wobrock, 2010; Martin, 
McClintock, Forster, Lo, & Loo, 2017), and neuropsychology (Chang, Lane, & Lin, 
2018; Chung, Hoy, & Fitzgerald, 2015; Jaafari et al., 2012; Slotema, Dirk Blom, Hoek, 
& Sommer, 2010). One group of TMS protocols that can induce profound and long-
lasting neurological effects in the human brain is referred to as repetitive transcranial 
magnetic stimulation (rTMS) (Wassermann et al., 1996). rTMS is of considerable 
interest to the research community as it can induce neuro-modulatory effects, in vivo, 
akin to the neuroplasticity inducing paradigms demonstrated in animal models 
(Abraham & Bear, 1996; Chung, Hill, Rogasch, Hoy, & Fitzgerald, 2016; Fitzgerald, 
Fountain, & Daskalakis, 2006; Karabanov et al., 2015; Malenka & Bear, 2004).  
Despite the wealth of knowledge accrued over the last three decades, the 
neurological mechanisms underpinning the neuro-modulatory effects induced by rTMS 
are not fully understood (Di Lazzaro & Rothwell, 2014b; Huang, Rothwell, Chen, Lu, 
& Chuang, 2011; Pell, Roth, & Zangen, 2011; Ridding & Ziemann, 2010). 
Consequently, the neuro-modulation induced by rTMS can be highly heterogeneous, 
hindering more widespread adoption in investigative studies (Hamada, Murase, Hasan, 
Balaratnam, & Rothwell, 2012; Pell et al., 2011; Ridding & Ziemann, 2010), and limits 
its clinical application (Chang et al., 2018; Jaafari et al., 2012; Slotema et al., 2010). 
Further research is therefore needed to characterise and elucidate the effects of rTMS 
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paradigms and protocols on the human brain to optimise clinical, research, and 
investigative outcomes.   
One relatively novel and unexplored approach is the development, use, and 
administration of multisite priming rTMS paradigms (Karabanov et al., 2015). Multisite 
rTMS involves targeting several functionally related, networked brain regions to 
investigate neurophysiological, cognitive, or behavioural processes. For example 
multisite protocols have led to novel and unique avenues for investigating 
neurocognitive and behavioural processes such as targeting of the inferior frontal gyrus 
and dorsal premotor cortex (dPMC) in language processing  (Murakami, Kell, Restle, 
Ugawa, & Ziemann, 2015), and uncovering basic neurophysiological mechanisms 
operating within the human brain that occur over distributed neural networks (Hamada 
et al., 2009; Potter-Nerger et al., 2009; Ragert, Camus, Vandermeeren, Dimyan, & 
Cohen, 2009). Multisite paradigms may also have potential for improving therapeutic 
outcomes in the areas of neuropsychology and psychiatry (Kang, Kim, Namkoong, Lee, 
& Kim, 2009; Lehner et al., 2013; Ma, Huang, Liao, & Jin, 2014).  
Aims 
This program of research intended to contribute to and extend upon our 
understanding of several important and key aspects of multisite rTMS paradigms and 
applications. The overarching aims of this thesis were to investigate the safety, 
implementation, development, and measurement of the neurological effects induced by 
multisite rTMS paradigms. These objectives were accomplished across two broad 
streams of research. The first research stream investigated the potential of multisite 
rTMS paradigms for clinical applications. Specifically, the first stream of research 
aimed to evaluate the feasibility, safety, and tolerability of a multisite rTMS protocol 
informed by neuroanatomical models of pathophysiology and clinical rTMS treatment 
outcomes. The clinical disorder obsessive compulsive disorder (OCD) was selected 
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because 40 - 60% of individuals diagnosed with the illness do not respond to first line 
treatments (Abramowitz, 2006; Pallanti et al., 2002), and there are promising findings 
that multisite rTMS paradigms may be effective for treating the disorder (Kang et al., 
2009; Ma et al., 2014).  
After some preliminary investigation, it was identified that there was relatively 
little research and empirical data on the basic neurophysiological effects induced by 
inter-regional rTMS paradigms to guide the selection of appropriate rTMS paradigms 
for multisite clinical applications (Hamada et al., 2009; Karabanov et al., 2015; Potter-
Nerger et al., 2009; Ragert et al., 2009). Moreover, repeated bouts of NIBS can induce 
highly complex neurological effects including different forms of neuroplasticity 
(Hamada et al., 2009; Hamada et al., 2008; Karabanov et al., 2015; Potter-Nerger et al., 
2009). These considerations led to the development of the second research stream that 
focused on the basic neurophysiological effects induced by multisite priming protocols. 
Thus, there was shift in focus from clinical applications of multisite rTMS to an 
examination of the neuro-modulatory effects induced by multisite priming protocols. 
The second stream of research aimed to systematically characterise the 
neurophysiological, and neuroplastic effects induced by multisite rTMS paradigms. It 
also sought to evaluate the feasibility and utility of combined multimodal approaches to 
more directly assess and measure the network wide effects induced by multisite rTMS. 
The overall structure of the thesis is presented below.  
Thesis Chapter Outline 
Chapter 1 presents a brief history on the development of TMS as a research tool, 
followed by a description of the basic neurophysiological effects induced by TMS. 
Several TMS paradigms will be introduced including single-pulse and paired-pulse 
transcranial magnetic stimulation protocols that can be used to probe the intricate intra-
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cortical inter-neural networks that subserve inhibitory, and excitatory neurological 
mechanisms within the human central nervous system (CNS).  
Chapter 2 was written with the aim of informing the development of the 
multisite protocols evaluated in Study 2 (Chapter 5), Study 3 (Chapter 7), and Study 4 
(Chapter 9). Chapter 2 introduces the concept of Hebbian plasticity in addition to 
descriptions of two well-known forms of plasticity demonstrated in the animal literature 
referred to as long-term potentiation (LTP), and long-term depression (LTD). These 
forms of plasticity will be used as the conceptual framework for contextualising and 
accounting for the neuro-modulatory effects of conventional rTMS applied to the 
human primary motor cortex (M1). As valid safety, and ethical concerns have been 
raised with the administration of TMS (Rossi, Hallett, Rossini, & Pascual-Leone, 2009; 
Wasserman, 2002), and because there is limited data on the safety of multisite rTMS 
paradigms, the safety profile of inter-regional rTMS was evaluated. Chapter 1 and 
Chapter 2 establish the conceptual groundwork for each subsequent chapter.  
Stream 1 – Clinically Informed Multisite Protocols 
Chapter 3, Chapter 4 (Study 1), and Chapter 5 (Study 2) were included to 
address the first stream of research related to the potential clinical applications of 
multisite rTMS. The findings of Chapter 3 and Chapter 4 (Study 1) were used to inform 
the development of the clinically informed multisite rTMS protocol evaluated in Study 
2 (Chapter 5). As mentioned, the clinical disorder OCD was selected due to poor 
clinical outcomes for a sizable number of individuals seeking treatment (Abramowitz, 
2006; Pallanti et al., 2002), but also promising findings in the rTMS treatment literature 
(Jaafari et al., 2012; Kang et al., 2009; Ma et al., 2014; Trevizol et al., 2016). Chapter 3 
thus characterises the phenomenology and aetiology of OCD including heritability, 
behavioural, cognitive, and neurobiological contributions. An emphasis was made on 
neuroanatomical models of OCD that informed the discussion on the efficacy of rTMS 
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for OCD (Study 1, Chapter 4), and selection of target brain regions in the first empirical 
study (Study 2, Chapter 5). The first study (Chapter 4) presents the results of the 
systematic review that evaluated the efficacy of rTMS for treating OCD. The results 
from the systematic review revealed that while several cortical brain regions have been 
targeted using a variety of rTMS parameters, there is only weak evidence that rTMS is 
effective for treating the symptoms of OCD. However, several neuroanatomical targets 
appear to show therapeutic potential. Further, it was revealed that rTMS exhibits an 
excellent safety profile as a clinical treatment for OCD with low rates of attrition and 
minimal side effects.  
Chapter 5 presents the results of the first published empirical investigation 
(Study 2) related to the first stream of research and evaluated the feasibility, safety, 
tolerability, and long-term neurocognitive effects of a multisite rTMS protocol 
developed from the combined findings of Chapter 2, Chapter 3 and Chapter 4 (Study 1). 
The multisite protocol involved the administration of conventional rTMS over the 
dorsolateral prefrontal cortex (DLPFC), orbitofrontal cortex (OFC), and supplementary 
motor area (SMA) in a single session. As the sample consisted of 20 healthy 
participants, special care was taken to ensure the selected rTMS parameters were well 
within safety guidelines (Rossi et al., 2009; Wasserman, 2002). After receiving sham or 
active multisite rTMS, comprehensive and detailed safety data were obtained (e.g., 
reports of scalp pain, headaches, and shoulder pain). Neurocognitive data were also 
obtained and measured over a three-month period. Overall, the protocol was found to be 
safe and tolerable. Participants receiving active rTMS reported higher frequencies of 
adverse side-effects immediately after stimulation including headache and neck pain, 
however, the long-term neurocognitive data revealed both groups performing 
comparably over the 90-day period. 
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Stream 2 – Characterising the Neuro- and Electro-Physiology of Multisite rTMS 
Although the findings from Study 2 provided preliminary evidence that multisite 
rTMS protocols are safe and tolerable, it was identified that relatively few studies had 
examined the neurological effects induced by multisite priming protocols (Hamada et 
al., 2009; Karabanov et al., 2015; Poetter-Nerger et al., 2009; Ragert et al., 2009). The 
sparse findings regarding the neurological effects induced by multisite NIBS paradigms 
making it difficult to select appropriate rTMS parameters for targeting multiple brain 
regions in clinical applications. This is can be particularly challenging as repeated bouts 
of neuro-modulatory NIBS protocols can induce more complex forms of neuroplasticity 
including homeostatic and non-homeostatic meta-plasticity (Goldsworthy, Pitcher, & 
Ridding, 2012; Hamada et al., 2009; Müller-Dahlhaus & Ziemann, 2015; Murakami, 
Müller‐Dahlhaus, Lu, &  Ziemann, 2012) . The dearth of findings on the 
neurophysiological effects induced by multisite paradigms led to the development of the 
second research stream that aimed to systematically characterise the neuroplastic effects 
of multisite priming protocols. The outcomes of the second research stream are 
presented in the latter half of this thesis in Chapter 6, Chapter 7 (Study 3), Chapter 8, 
and Chapter 9 (Study 4).  
With the change in research focus in mind, Chapter 6 was thus written with 
several aims. The first was to characterise the neurophysiological effects of a patterned 
form of rTMS referred to as theta burst stimulation (TBS). TBS protocols administered 
in humans were inspired by the TBS protocols used to investigate neuroplastic models 
and mechanisms in animal studies (Diamond, Dunwiddie, & Rose, 1988; Huang et al., 
2011; Huang, Edwards, Rounis, Bhatia, & Rothwell, 2005). TBS protocols have gained 
in popularity as they can induce neuroplastic effects comparable to conventional rTMS 
with the benefit of lower stimulation intensities, and shorter administration times 
(Chung et al., 2016; Huang et al., 2005). The second aim was to review the extant 
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literature on the neuroplastic effects of priming paradigms, with the intent of identifying 
gaps in literature regarding the effects of multisite rTMS protocols. It was revealed that 
relatively few studies have examined the neuroplastic effects of inter-regional rTMS 
priming paradigms (Karabanov et al., 2015).  
The findings from Chapter 6 were used to inform the development of several 
priming protocols evaluated in the second empirical study (Study 3, Chapter 7). The 
rationale for the second empirical study was the lack of data regarding the neuroplastic 
effects of multisite rTMS paradigms. Chapter 7 presents the results of the second 
published empirical study that investigated the neuroplastic effects of intra- and inter-
regional priming protocols applied to M1 using continuous theta burst stimulation 
(cTBS). Specifically, the study characterised the neuroplastic effects of priming 
protocols on corticospinal excitability using a single blind, randomised control design. 
Four protocols were evaluated. Two involved inter-regional priming of M1 with cTBS 
via the DLPFC or dorsal premotor cortex (dPMC). One protocol involved intra-regional 
priming with cTBS applied to M1 twice. The fourth was a control condition involving 
sham, then active cTBS applied to M1. All four protocols were found to be safe and 
tolerable with a similar side effect profile to Study 2. In relation to the primary outcome 
measure, it was revealed that intra- and inter-regional priming of M1 induced highly 
variable neuroplastic effects on corticospinal excitability with a large degree of inter-
individual variability observed across all protocols, and post-measurement time points.  
Although neuro-modulatory NIBS techniques are known to induce variable 
neuroplastic effects on corticospinal excitability (Hamada et al., 2012; Ridding & 
Ziemann, 2010; Wiethoff, Hamada, & Rothwell, 2014), the high degree of variability 
observed across each of the four protocols in Study 3 (Chapter 7) had not been 
anticipated. To more fully characterise the neuroplastic effects of inter-regional rTMS 
priming protocols, a novel approach involving combined transcranial magnetic 
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stimulation with electroencephalography (TMS-EEG) was implemented. Chapter 8 was 
thus included to provide an overview of the utility of TMS-EEG for measuring the 
neuro-modulatory effects induced by rTMS protocols directly at the scalp. Basic 
neurophysiological and technical considerations for combining TMS with EEG were 
considered, followed by a narrative review on the insights gleaned with TMS-EEG on 
the neuro-modulatory effects of rTMS protocols. No studies could be identified that 
have characterised the effects of inter-regional priming TBS protocols on M1 using 
TMS-EEG.  
Chapter 9 presents the findings of the third and final empirical study (Study 4). 
As there was some evidence from Study 3 (Chapter 7) that inter-regional cTBS priming 
of M1 via the DLPFC induced group level facilitation of corticospinal excitability 
(albeit, non-significantly), a single-blind, within-subjects randomised control trial was 
used to compare the neuro-modulatory effects of standard cTBS to an inter-regional 
cTBS priming of M1 via the DLPFC using TMS-EEG. Specifically, TMS-EEG was 
implemented to examine the neuro-modulatory effects induced by standard and inter-
regional priming cTBS by comparing changes in a measure of cortical responses to 
TMS referred to as transcranial magnetic stimulation-evoked potentials (TEPs). An 
active control condition involving TMS applied over the shoulder to elicit shoulder-
evoked potentials (SEPs) was included to account for multisensory contamination. The 
major findings were that short TEP latency peaks (< 60 ms) were more prominent 
compared to the equivalent SEP peaks, whereas long latency components (> 60 ms) 
were characteristic across both conditions. Standard cTBS modulated the N45 TEP and 
N45 SEP, however, correlation analyses failed to reveal associations between the two 
components implying partially separable mechanisms. Multisite priming cTBS 
modulated the N100 TEP, but not the N100 SEP. 
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Finally, Chapter 10 summarises the major findings of each of the two streams of 
research presented in this thesis. Both will be presented in the context of the theoretical 
frameworks, and body of research literature presented throughout this thesis. This will 
be followed by a consideration of the implications, limitations, and major conclusions 
stemming from this program of research.  
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Chapter 1 – Brief History, Underlying Physics, and Basic Neurophysiology of 
Transcranial Magnetic Stimulation 
Brief History  
 Although the vast majority of research involving transcranial magnetic 
stimulation (TMS) has accrued over the last three decades, it has been known for over 
100 years that magnetic fields can be used to excite nerves in the human nervous system 
(Barker, 1991; Mills, 1999). One of the earliest records was written by Jacques Arsenne 
d’Arsonval (1896) who reported in 1896 that placing a person’s head within a coil that 
produced a strong, time-varying magnetic field at 42 Hz, could elicit phosphenes 
(perceptions of light) within one’s visual field (Barker, 1991; Mills, 1999). The finding 
that phosphenes could be induced by time-varying magnetic fields was later replicated 
by several others including Thompson (1910), Dunlap (1911), and Barlow, Kohn and 
Walsh (1947). It should be noted, however, that these early effects were likely due to 
stimulation of retinal cells, rather than cortical visual areas (Barlow et al., 1947; 
Lövsund, Öberg, Nilsson, & Reuter, 1980). 
It was during the 1980s that the area of TMS developed into a field of its own 
right. In 1985, a seminal paper published by Barker, Jalinous, and Freeston (1985) 
reported on the development of a new device that could safely and non-invasively 
stimulate the human primary motor cortex (M1). The newly created TMS device was 
capable of storing a large electrical charge within a capacitor that marked a large 
technological advancement over the magnetic stimulators used in the late 1800s and 
early 1900s (Barker, 1991; Mills, 1999; Thompson, 1910). By discharging the stored 
electrical charge through a specialised coil, a powerful time-varying magnetic field 
could be generated. When the discharging coil was held over the human M1, Barker and 
colleagues were able to elicit contractions in the targeted peripheral arm or leg muscles 
non-invasively and painlessly. This was a major advantage over the electrical 
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stimulation methods used by researchers such as Merton, Hill, Morton, and Marsden 
(1982) which was capable of producing similar effects, but was reportedly painful for 
participants. The paper by Barker et al. (1985) was the first modern report of TMS 
applied to the human CNS.  
Principles of Electromagnetism – Michael Faraday’s Law 
Non-invasive stimulation of nerve cells within the human CNS is possible due to 
the fundamental properties of electromagnetism. Although the term magnetic 
stimulation is commonly used to describe the technique, this is technically inaccurate  
as neither magnets (i.e., electrically polarised objects) nor the magnetic field directly 
stimulate nerve cells (Barker, 1991). Rather, it is the electrical current induced by the 
time varying magnetic field that stimulates neurons (Ruohonen, 2003). This property of 
electromagnetic induction is described within Michael Faraday’s Law of 
Electromagnetism and is presented in Equation 1 (Ruohonen, 2003):  
 
∇ × 𝐸𝐸 = −𝜕𝜕 𝐵𝐵
𝑡𝑡




E denotes electrical current 
B refers to magnetic field  
t denotes time  
 
Equation 1 essentially reads that an electrical current (E) is induced by a time-
varying magnetic field (B). The electrical current, therefore, is directly proportional to 
the rate of change of the magnetic field. Thus, whenever an electrical current passes 
through a conductive medium, such as the coils used to deliver TMS, this results in the 
∇
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generation of a magnetic field (Mills, 1999). The generated magnetic field can pass 
relatively unimpeded through air or solid objects, including the human scalp and skull 
(Ruohonen, 2003). If the time-varying magnetic field passes over another conductive 
object, such as nerve cells found within the cortex, this can induce an electrical current 
in the underlying neural tissue (Terao & Ugawa, 2002). Thus, it is the electrical current 
induced by the time varying magnetic field that stimulates nerve cells, rather than the 
magnetic field itself.   
Electrical Stimulation in Animals and Humans  
 To better understand the effects of TMS in the human nervous system, it is 
instructive to examine the findings of electrical stimulation studies conducted in animals 
and humans. When a strong electrical stimulus is applied directly to the motor cortex in 
slightly anaesthetised animals, a series of descending volleys or waves are generated 
along the corticospinal tract (Patton & Amassian, 1954). The first of these waves is 
referred to as the direct wave (D-wave) and is thought to result from direct stimulation 
at or near the cell body of pyramidal neurons (Lemon, 2002; Patton & Amassian, 1954). 
In animals, the D-wave is relatively robust and can be elicited even under heavy 
anaesthesia, cortical degradation induced by cooling or blood loss, or complete removal 
of cortical grey matter (Patton & Amassian, 1954). The second of these waves that 
appear periodically at intervals of approximately 1.5 ms after the D-wave, are referred 
to as indirect waves (I-waves). Numerals are assigned to each deflection to indicate their 
sequence of generation (e.g. I1, I2, and I3) (Terao & Ugawa, 2002). Due to their 
latency, I-waves are thought to result from indirect or trans-synaptic activation of intra-
cortical neuronal circuits (Lemon, 2002; Terao & Ugawa, 2002). As I-waves are 
completely abolished after removal of cortical grey matter, this suggests they are 
cortical in origin (Patton & Amassian, 1954), although the precise neural mechanisms 
that generate I-waves are unknown (Mills, 1999).  
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 In humans, electrical stimulation of the motor cortex can elicit D- and I-waves 
(Terao & Ugawa, 2002). Early studies involving anaesthetised patients showed 
electrical stimulation of the motor cortex resulted in a series of descending volleys of 
which the earliest were interpreted as D-waves measured at the level of the spinal cord 
(Berardelli, Inghilleri, Cruccu, & Manfredi, 1990; Boyd et al., 1986; Burke et al., 1993; 
Nakamura, Kitagawa, Kawaguchi, & Tsuji, 1996). It was also shown that electrical 
stimulation could more readily elicit D-waves, with I-waves appearing at higher 
intensities (Burke et al., 1993). It has been confirmed that similar patterns of D- and I-
waves can be elicited in conscious patients, with D-waves being more readily evoked by 
electrical stimulation (Di Lazzaro et al., 2004).  
Transcranial Magnetic Stimulation of the Human Primary Motor Cortex 
When an electromagnetic stimulus is applied over the human M1, such as those 
generated and delivered with TMS, a series of descending D- and I-waves can be 
measured along the corticospinal tract using epidural recordings (Berardelli et al., 1990; 
Burke et al., 1993; Di Lazzaro et al., 2004; Nakamura et al., 1996). The earliest studies 
comparing responses between electrical and magnetic stimulation showed that magnetic 
stimulation could more readily evoke I-waves, with D-waves being recruited at higher 
intensities (Berardelli et al., 1990; Burke et al., 1993; Nakamura et al., 1996). Nakamura 
et al. (1996) reported that TMS induced electrical currents that flowed in a posterior-to 
anterior direction in M1 preferentially recruited I-waves especially early I-waves (i.e., 
I1), whilst currents induced in a latero-medial direction more readily evoked D-waves. 
This was later confirmed by Di Lazzaro et al. (2004) who reported that TMS induced 
electrical currents following in a posterior-anterior direction more readily evoked I-
waves, with D-waves appearing with increased magnetic stimulus intensities. In an 
earlier study, Di Lazzaro et al. (Di Lazzaro et al., 2001) showed that reversing the TMS 
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induced electrical currents flowing in an anterior-posterior direction within M1 could 
also elicit I-waves especially later I-waves (i.e., I3).  
Although several models have been proposed to account for the observed D- and 
I-wave responses elicited with TMS in humans described above, the precise 
mechanisms and sources contributing to their generation is unknown (Di Lazzaro et al., 
2012; Di Lazzaro & Rothwell, 2014a; Esser, Hill, & Tononi, 2005; Rusu, Murakami, 
Ziemann, & Triesch, 2014; Sakai et al., 1997; Terao & Ugawa, 2002). The available 
evidence from the combined animal and human literature suggest that short latency D-
waves evoked with TMS which induces electrical currents that flow in a latero-medial 
direction in M1 likely results from direct activation at or near the axonal component of 
descending corticospinal pyramidal cells located in layer 5 (Di Lazzaro & Rothwell, 
2014a). In contrast, I-waves elicited with TMS stimuli that induces a current flow in the 
posterior-anterior or anterior-posterior direction, likely results from activation of 
cortical inter-neurons found in layers 2 and 3, which synapse onto layer 5 pyramidal 
cells (Di Lazzaro & Rothwell, 2014a; Jiang, Wang, Lee, Stornetta, & Zhu, 2013; Terao 
& Ugawa, 2002).  
Single Pulse Transcranial Magnetic Stimulation as a Measure of Corticospinal 
Excitability 
The preceding discussion has examined studies evaluating cortical responses to 
electrical or magnetic stimulation recorded at the level of the spinal cord (Di Lazzaro & 
Rothwell, 2014a). Although such studies are essential for understanding the 
neurological effects induced by TMS at the cortical and spinal level, these 
investigations are rare and are often conducted in patient populations undergoing 
treatment for chronic illnesses (Di Lazzaro et al., 2004; Nakamura et al., 1996). 
Responses to magnetic stimulation are more commonly measured in peripheral hand or 
leg muscle using electromyography (EMG), as they are readily accessible and can be 
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measured non-invasively with surface EMG electrodes in healthy individuals (Mills, 
1999).  
When single pulse transcranial magnetic stimulation (spTMS) is delivered with 
sufficient strength over M1, this can elicit a measurable sinusoidal waveform in the 
ongoing EMG trace measured from the target muscle referred to as a motor evoked 
potential (MEP) (Rossini et al., 1994). An example of a MEP is presented in Figure 1. 
The MEP response results from a cascade of neurological events triggered at the cortex 
that travel along the corticospinal pathway to the target muscle (Klomjai, Katz, & 
Lackmy-Vallée, 2015). As described earlier, spTMS applied over M1 likely activates 
intra-cortical inter-neurons located in layers 2 and 3 (Di Lazzaro & Rothwell, 2014a). 
Depolarisation of intra-cortical inter-neurons can then activate descending pyramidal 
cells located in layer 5 (Di Lazzaro et al., 2001; Nakamura et al., 1996). The pyramidal 
cells then activate motor neurons located in the spine that results in a muscle contraction 
in the target muscle that can be measured as a MEP response (Klomjai et al., 2015; 
Tortora & Gabrowski, 2003). 
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Figure 1. A motor evoked potential (MEP) elicited with transcranial magnetic stimulation (TMS) from the primary motor cortex measured 
from the first-dorsal interosseous of the right hand at rest. The peak-to-peak MEP amplitude (difference between the highest peak positive 
peak and lowest trough) is approximately 1 mV.  The latency of the MEP defined as the time interval between the TMS pulse to the first 
deviation from 0 along the y-axis is approximately 34 ms.  
Page 37 of 414 
 
The MEP response comprises several components and can be described in terms of its 
amplitude, latency, duration, and surface area (Mills, 1999). The amplitude refers to the 
peak-to-peak of the sinusoidal waveform (i.e., the difference between the positive peak 
and negative peak), and is conventionally measured in microvolts (µV) (Mills & Nithi, 
1997; Rossini et al., 1994). The latency of the start of the MEP response can be 
measured from the TMS pulse until the first deflection away from zero along the y-axis 
(i.e., the start of the first peak), and can be expressed in milliseconds (Lim & Yiannikas, 
1992). Though less commonly used, the MEP also can be described in terms of its 
duration, and is usually expressed in milliseconds (Mills, 1999). The MEP duration can 
be defined from the onset of the first deflection to the first (Hess, Mills, & Murray, 
1987) or second return to zero (Säisänen et al., 2008). It should be noted that it can be 
difficult to determine precisely when the MEP terminates due to the gradual tapering of 
the MEP response (Mills, 1999). Finally, the size of the MEP can also be expressed as 
the total surface area under the MEP curve (Mills, 1999).  
MEPs can be used to measure corticospinal excitability (CSE) along the 
corticospinal tract (Kiers, Cros, Chiappa, & Fang, 1993a; Lazzaro et al., 2001). Changes 
in the size and latency of the MEP can also be used to index the functional state of the 
corticospinal pathway. For instance, increasing the strength of the TMS stimulus 
induces non-linear changes in the size of the MEP response that is likely due to the 
recruitment of larger neuronal pools (Darling, Wolf, & Butler, 2006; Kiers et al., 
1993a). The latency of the MEP response evoked by TMS can be shortened with 
increasing levels of voluntary muscle contraction in the target muscle (Lim & 
Yiannikas, 1992). MEPs can also be used to measure structural reorganisation of 
cortical regions and corticospinal pathways in conditions such as stroke (Kantak, 
Stinear, Buch, & Cohen, 2012). Another common application is the use of MEPs to 
quantify the neurological effects of neuro-modulatory techniques including repetitive 
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transcranial magnetic stimulation (rTMS) (discussed in Chapter 2), and theta burst 
stimulation (TBS; discussed in Chapter 6). Specifically, changes in size of the MEP 
after administration of neuro-modulatory paradigms are thought to reflect neuroplastic-
like changes induced along the corticospinal pathway (Chung et al., 2016; Fitzgerald et 
al., 2006; Pell et al., 2011).  
The minimum TMS pulse intensity required to evoke a MEP from M1 is 
referred to as the motor threshold (MT) (Rossini et al., 1994). It is typically expressed 
as a percentage of the TMS device’s maximal stimulator output (MSO) capacity 
(Groppa et al., 2012a; Mills & Nithi, 1997; Rossini et al., 1994). The MT provides a 
measure of momentary excitability along the corticospinal pathway (Rossini et al., 
1994). Although the MT can be established by visual monitoring of transient muscle 
contractions in the target muscle, it is more commonly defined according to pre-
specified levels of peak-to-peak MEP size (Groppa et al., 2012a). Although there is 
some variability on what is considered a minimum MEP response (Mills & Nithi, 1997; 
Oberman, Horvath, & Pascual-Leone, 2010; Reid, Chiappa, & Cros, 2002; Rossini et 
al., 1994), the MT is often defined probabilistically as peak-to-peak MEP amplitudes > 
50 µV in at least 50% of a series of consecutive trials (typically 5 or 10) (Groppa et al., 
2012a; Mills, 1999). 
The MT can be established when the target muscle is at rest or during slight 
voluntary contraction (Reid et al., 2002). When the MT is established when the target 
muscle is completely at rest, this is referred to as the resting motor threshold (RMT) 
(Mills & Nithi, 1997). The RMT is commonly defined as peak-to-peak MEP amplitude 
> 50 µV in at least 5 or 10 consecutive trials (Groppa et al., 2012a). The RMT has been 
used to index neuroplastic changes in corticospinal excitability following administration 
of neuro-modulatory techniques such as repetitive transcranial magnetic stimulation 
(discussed in Chapter 2) (Fitzgerald et al., 2006). It is also commonly used to set the 
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stimulus pulse strengths for other TMS paradigms, including paired-pulse transcranial 
magnetic stimulation (ppTMS) protocols (discussed below) (Valls-Solé, Pascual-Leone, 
Wassermann, & Hallett, 1992), rTMS (Chen et al., 1997a; Inghilleri et al., 2006), and 
TBS (Goldsworthy et al., 2012) 
If the MT is established during slight voluntary muscle contraction (usually 
around 5-15% of maximal voluntary force), it is referred to as the active motor 
threshold (AMT) (Oberman et al., 2010; Rossini et al., 1994). To more readily discern 
the target MEP response against the background of on-going muscle activity in the 
EMG trace induced by voluntary contraction, the minimum peak-to-peak MEP 
threshold is often set at a higher value of > 200 µV (Oberman et al., 2010). Similar to 
the RMT, AMT can also be used to set the pulse intensities for different forms of TMS 
including paired-pulse (Kujirai et al., 1993), rTMS (Di Lazzaro et al., 2002; 
Gerschlager, Siebner, & Rothwell, 2001), and TBS (Huang et al., 2005).  
The Cortical Silent Period  
In addition to measures of excitability, spTMS can also be used to measure 
inhibitory mechanisms operating along the corticospinal pathway (Calancie, Nordin, 
Wallin, & Hagbarth, 1987). If a magnetic pulse is delivered to the cortical 
representation of a target muscle during slight voluntary contraction of that muscle, 
there is a transient suppression in ongoing EMG activity immediately following the 
MEP (Terao & Ugawa, 2002). This period of relative inactivity is referred to as the 
cortical silent period (CSP). The duration of the CSP is minimally affected by the level 
of muscle contraction, but is lengthened with increasing magnetic pulse strengths 
(Inghilleri, Berardelli, Cruccu, & Manfredi, 1993). Administration of the gamma-amino 
butyric acid B-receptor (GABARB) agonist baclofen lengthens the CSP when elicited 
with TMS, indicating that the response is mediated through GABAergic transmission 
(Siebner, Dressnandt, Auer, & Conrad, 1998). There is general agreement that the CSP 
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involves inhibition at the level of the cortex and spine (Reid et al., 2002; Säisänen et al., 
2008). The initial CSP component (< 50ms) likely originates in the spinal cord, whilst 
the latter component (> 50ms) is likely to be cortical in origin (Inghilleri et al., 1993; 
Okabe et al., 2003; Reid et al., 2002; Säisänen et al., 2008; Terao & Ugawa, 2002).  
Measuring Inhibitory and Facilitatory Mechanisms with Paired Pulse 
Transcranial Magnetic Stimulation Paradigms  
 The previous sections have described the use of spTMS as a measure of 
corticospinal excitability, and inhibition. Another category of techniques that can 
measure facilitatory and inhibitory neural mechanisms operating at the level of the 
cortex is referred to as ppTMS (Hanajima & Ugawa, 2008). The earliest ppTMS 
paradigms involved the delivery of two TMS pulses in quick succession over M1 
(Kujirai et al., 1993). The aim of ppTMS is to examine the effect of a conditioning 
stimulus (CS; i.e., the first pulse) on a subsequent test stimulus (TS; i.e., the second 
pulse) (Ziemann, 2002). It was discovered that by varying the intensity of the CS or the 
time interval between pulses, researchers could consistently modulate MEP responses 
that are thought to reflect intra-cortical facilitatory, and inhibitory neural mechanisms 
(Chen, 2004). Changes to the MEP response are conventionally quantified as a ratio of 
the conditioned MEP response (i.e., the conditioned TS response) to the unconditioned 
MEP response (i.e., the unconditioned TS). A ratio greater than 1 (or 100%) indicates 
MEP facilitation, whereas values below 1 (or 100%) indicates inhibition (Ni, Müller-
Dahlhaus, Chen, & Ziemann, 2011).   
Short Interval Cortical Inhibition 
Short-interval cortical inhibition (SICI) was first identified by Kujirai et al. 
(1993). The authors showed that a subthreshold CS applied to M1 followed by a 
suprathreshold TS delivered to the same region at intervals of 1 – 5 ms induced a 
reduction in the conditioned MEP response compared to an unconditioned TS response 
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delivered alone. The SICI paradigm could induce suppression of up to 50% in the 
conditioned MEP response, and could only be obtained when the conditioning pulse 
was magnetic and not electrical. Due to these observations, the authors suggested that 
the reduction in the MEP response was likely driven by intra-cortical inhibitory 
mechanisms, possibly mediated by GABAR. Subsequent work by Di Lazzaro et al. 
(2000) has confirmed the role of GABAergic transmission in SICI responses, with 
administration of the GABARA antagonist lorazepam shown to potentiate the SICI 
response.  
Long Interval Cortical Inhibition  
 Long interval cortical inhibition (LICI) was identified by Valls-sole et al. 
(1992). The authors demonstrated that when two suprathreshold magnetic stimuli 
delivered at inter-stimulus intervals between 50 - 200 ms over M1, responses to the 
second suprathreshold TS could be supressed. A subsequent study by Nakamura et al. 
(1997) using epidural electrodes implanted in the spine revealed that I-waves, but not 
D-waves, were supressed following the TS delivered at 100 ms coinciding with the 
inhibition of the conditioned TS MEP response. Pharmacological challenge studies have 
shown that LICI is mediated by GABARB receptors. Werhahn et al. (1999b) 
administered the GABARB antagonist tiagabine and found potentiation of the LICI 
response.  
Intra-Cortical Facilitation (ICF)  
Intra-cortical facilitation (ICF) was also identified by Kujiari et al. (1993). They 
showed that a subthreshold CS followed by a suprathreshold TS at intervals between 10 
– 30 ms induced facilitation of the conditioned TS MEP response (Chen, 2004). As the 
CS was delivered below the MT required to activate the corticospinal pathway, the 
authors suggested that the effect is likely driven by facilitatory mechanisms operating 
intra-cortically (Kujirai et al., 1993; Nakamura et al., 1996). Administration of N-
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methyl-D-aspartate receptor antagonist dextromethorphan reduces the ICF response, 
thus implicating the glutamatergic neural transmission system (Ziemann, Chen, Cohen, 
& Hallett, 1998).  
Conclusions  
 For over 100 years, it has been known that magnetic fields could be used to 
evoke sensory responses (e.g., phosphenes) in the human nervous system. After a period 
of relative inactivity during the early-to-mid 1900s, technological innovation through 
the work of Barker and colleagues (1985) led to the development of the first modern 
TMS device capable of probing superficial layers of the human cerebral cortex, in vivo, 
painlessly and non-invasively. TMS can depolarise cortical neurons due to the 
principles of electromagnetism, whereby a time varying-magnetic field placed over the 
scalp can induce current in the underlying neural tissue. The precise mechanisms 
underpinning the neural effects evoked by TMS are not fully understood. Studies in 
animals and humans reveal that a series of descending volleys can be elicited with 
electrical stimulation of M1. The first of these waves are referred to as D-waves and are 
thought to result from direct activation at or near the axonal component of descending 
pyramidal cells. Later I-waves are thought to result from indirect, trans-synaptic 
activation of pyramidal neurons via intra-cortical interneurons. Epidural studies have 
shown that TMS preferentially recruits I-waves when delivered in a posterior-anterior 
direction. Responses to spTMS are commonly measured through MEPs measured from 
a target periphery muscle. spTMS can be used to measure excitatory and inhibitory 
mechanisms along the corticospinal pathway including RMT, AMT, and the CSP. From 
the initial spTMS paradigms, other protocols have been developed including ppTMS 
that involves the delivery of a conditioning and test stimulus. ppTMS can be used to 
investigate inhibitory and faciliatory mechanisms that operate intra-cortically.  
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Chapter 2 – Conventional Repetitive Transcranial Magnetic Stimulation, and 
Safety Considerations 
Introduction 
As illustrated in Chapter 1, single-pulse transcranial magnetic stimulation 
(spTMS) and paired-pulse transcranial magnetic stimulation (ppTMS) can be used to 
investigate intra-cortical inter-neural networks subserving motor control within the 
human nervous system (Chen, 2004). Another paradigm that involves delivering 
multiple stimuli in rapid succession is referred to as repetitive transcranial magnetic 
stimulation (rTMS) (Green, Pascual-Leone, & Wasserman, 1997). rTMS is of 
considerable interest as it can induce more profound effects on the nervous system 
outlasting the acute period of stimulation (Fitzgerald et al., 2006; Wassermann et al., 
1996). These neuro-modulatory effects can not only be used for the purposes of basic 
and applied neuroscience (Guse et al., 2010; Hallett, 2007), but has far reaching 
therapeutic and clinical potential (Fitzgerald, Brown, & Daskalakis, 2002a; Hallett, 
2000; Hoffman & Cavus, 2014; Jaafari et al., 2012). There are now several variants of 
rTMS including conventional rTMS (reviewed in the current chapter), and patterned 
forms of rTMS including theta burst stimulation (TBS) (reviewed in Chapter 6).  
Although rTMS has been in use for three decades, the neurological mechanisms 
underlying the effects induced by the rTMS are not fully understood (Pell et al., 2011; 
Tang, Thickbroom, & Rodger, 2017). The leading hypothesis is the neuro-modulation 
induced by rTMS may involve similar neurological mechanisms to the plasticity effects 
demonstrated in animal models (Bliss & Gardner-Medwin, 1973; Bliss & Lømo, 1973). 
The aim of this chapter was to therefore characterise the neuroplastic effects of rTMS 
applied to the primary motor cortex (M1). The findings of this chapter will be used to 
inform the development of the multisite protocols used in empirical Study 2 (Chapter 
5), Study 3 (Chapter 7), and Study 4 (Chapter 9). In the first section, the concept of 
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Hebbian plasticity will be introduced, along with two of the most well-known examples 
of plasticity known as long-term potentiation (LTP), and long-term depression (LTD). 
Second, the effects of conventional rTMS on cortical motor excitability, and inhibition 
will be discussed drawing upon findings from the spTMS, and ppTMS literature. 
Finally, the safety of rTMS will be carefully considered and evaluated, as although it 
has been shown to be largely safe, the technique does carry small, non-negligible safety 
risks (Rossi et al., 2009; Wassermann, 1998). The safety of rTMS is important to 
consider when using multi-regional protocols as there is relatively less data on the 
safety of multisite stimulation. For this reason, the safety profile of each multisite 
protocol evaluated in the current program of research was systematically evaluated and 
reported.   
Neuroplasticity  
 Neuroplasticity is an inherent property of the human brain allowing for 
reorganisation of its internal structure in response to environmental demands (Pascual-
Leone, Amedi, Fregni, & Merabet, 2005). A large body of work has been dedicated to 
understanding, and characterising the mechanisms underpinning neuroplasticity as it is 
the leading candidate that can explain our unique ability to learn, form memories, and 
acquire skills (Caporale & Dan, 2008; Green, Bavelier, & aging, 2008; Nicoll & Roche, 
2013) . The concept has also been invoked as the mechanism through which adaptive 
recovery can occur in conditions such as stroke (Murphy & Corbett, 2009), brain trauma 
(Kleim & Jones, 2008), or invasive medical procedures such as hemispherectomies  
(Sebastianelli et al., 2017). It can also lead to unwanted, pathological, and maladaptive 
changes such as the intense pain that can develop in conditions such as phantom limb 
(Flor, 2008). By understanding the mechanisms that induce neuroplastic changes, this 
will allow us to better control, exploit, and translate these processes for neurocognitive, 
and clinical applications.    
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Hebbian Plasticity  
 Formalisation of the concept of plasticity is often credited to Donald E. Hebb 
(1949) who, in his book The Organization of Behavior, argued that lasting 
modifications within the brain occur as a result of changes in the synaptic strength 
between interacting neurons . In addition to the spatial proximity between neighbouring 
neurons, Hebb theorised that such changes in synaptic strength were crucially dependent 
upon timing, requiring both cells to be coactive. According to Hebb, “[w]hen an axon of 
cell A is near enough to excite a cell B and repeatedly or persistently takes part in firing 
it, some growth process or metabolic change takes place in one or both cells such that 
A’s efficiency, as one of the cells firing B, is increased” (p. 62). It was this insight that 
provided the conceptual underpinnings for contextualising the large body of work that 
has since investigated the biological mechanisms that allow for long term plastic 
changes within the central nervous system (CNS) (Malenka & Bear, 2004).  
Long-Term Potentiation 
 One of the most well-known mechanisms of synaptic plasticity is referred to as 
LTP (Malenka & Bear, 2004). Broadly, LTP refers to the increased efficacy of synaptic 
transmission following repeated high frequency stimulation of a target neural 
population (Bliss & Collingridge, 1993). The effects of high frequency stimulation can 
last anywhere for up to several hours (Bliss & Gardner-Medwin, 1973; Thickbroom, 
2007). LTP was first demonstrated experimentally by Bliss and Lomo in 1973 in the 
hippocampus of anaesthetised rabbits (Bliss & Lømo, 1973). The authors recorded 
responses within the dentate gyrus to electrical stimuli applied to the perforant pathway. 
They varied the frequency (10 – 100 Hz), and length (3 s – 15 s) of the delivered 
shocks. By applying conditioning stimuli between 10 – 100 Hz for several seconds, they 
found that they could potentiate granule cell responses within the dentate gyrus lasting 
from 20 min to 10 hr.  Although Bliss and Lomo did not fully comprehend the 
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significance of their findings (Lømo, 2003), the authors suggested that such potentiation 
may underlie aspects of learning, and memory.  
 Subsequently, LTP has been demonstrated in regions other than the 
hippocampus, including the neocortex of the rat (Fox, 2002), rabbit (Voronin, 1984), 
and cat (Tsumoto, 1992). As the mechanisms underlying LTP have been extensively 
investigated within the CA1 region of the hippocampus (Malenka & Bear, 2004), this 
model remains the prototypical exemplar. The model for LTP induction presented here 
is an amalgamation of several review papers by leading authors on the subject (Cooke 
& Bliss, 2006; Lisman, 2003; Malenka & Bear, 2004; Malenka & Nicoll, 1999). 
LTP induction involves changes at both the synaptic, and molecular level 
(Lisman, 2003). Synaptically, several components appear crucial to the induction of 
LTP, including N-methyl-D-aspartate receptors (NMDARs), and α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptors (AMPARs), in addition to glutamate (Glu), 
calcium (Ca2+), and magnesium (Mg2+) (Malenka & Bear, 2004). The process begins 
with the pre-synaptic release of Glu binding with post-synaptic NMDAR, and AMPAR 
(Cooke & Bliss, 2006). Although both receptors are permeable to Ca2+, the intracellular 
influx of Ca2+ only occurs initially through AMPARs due to a voltage dependent Mg2+ 
blockade over the NMDA receptor. With sufficient rise in the intracellular Ca2+ 
gradient, an excitatory post-synaptic potential (EPSP) is generated, removing the Mg2+ 
block allowing for Ca2+ influx via NMDARs. This elicits a cascade of molecular 
mechanisms within the dendritic spine, leading to LTP induction (Caroni, Donato, & 
Muller, 2012). 
Long-Term Depression  
 It has also been proposed in as early as 1973 that an opposing mechanism for 
weakening synaptic strength must also exist (Stent, 1973). Left unabated, prolonged 
LTP would lead to over-saturation of the system, inhibiting neural adaptability 
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(Tsumoto, 1993). This capacity for long term and persistent weakening of synaptic 
strength is now known as long-term depression (LTD). As a form of neuroplasticity, 
LTD is also thought to be involved in memory formation (Bear & Abraham, 1996), 
however, its precise role, and contribution to learning and memory are not fully 
understood (Collingridge, Peineau, Howland, & Wang, 2010). For instance, 
hippocampal LTD  has been implicated in working and episodic memory (Zeng et al., 
2001), behavioural flexibility (Nicholls et al., 2008), and novelty detection (Kemp & 
Manahan-Vaughan, 2004).  
 Several forms of LTD have been identified (Massey & Bashir, 2007). 
Heterosynaptic LTD is a weakening of synaptic strength induced by strong post-
synaptic activity in the absence of pre-synaptic activation (Linden & Connor, 1995). It 
is considered heterosynaptic because the mechanism for weakening connections occurs 
indirectly at neighbouring inputs rather than the weakened synapse itself. This form of 
LTD is anti-Hebbian in nature due to the lack of simultaneous pre- and post-synaptic 
activity (Massey & Bashir, 2007). In contrast, homosynaptic LTD conforms to the 
Hebbian rule, and involves synaptic weakening due to pre-synaptic activation co-
occurring with only moderate post-synaptic activity (Linden & Connor, 1995). A related 
form of homosynaptic LTD known as associative LTD also involves pre-synaptic 
activity, with the difference being that the pre-synaptic activation occurs distinctly out-
of-phase with post-synaptic activation (Linden & Connor, 1995). Both forms are 
homosynaptic because the modification of synaptic strength directly involves the 
activity of the pre-synaptic neuron where the conditioning occurs. One final form of 
LTD, referred to as depotentiation, involves a reversal of a previously potentiated state 
(i.e., LTP) (Kemp & Bashir, 2001). Depotentiation appears to be a distinct form of LTD 
as it involves different molecular induction mechanisms to homosynaptic LTD (Bear, 
2003).  
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 LTD can be induced using a variety of protocols in different brain regions 
(Massey & Bashir, 2007). As with hippocampal LTP, homosynaptic LTD within region 
CA1 is the most extensively researched (Malenka & Bear, 2004). Thus, this model will 
be elaborated upon. Homosynpatic LTD was first demonstrated in a series of 
experiments conducted by Dudek and Bear (1992, 1993) using rat hippocampal slice 
preparations. In their initial study, the authors found that applying 900 conditioning 
pulses delivered at 0.5 – 5 Hz to Schaffer collateral fibres induced strong suppression 
(~20%) of neural responses for greater than 30 min within region CA1. The authors also 
found that application of an NMDAR antagonist (Dl-2-amino-5-phosphonovaleric acid; 
AP5) inhibited LTD expression, thus implicating NMDAR in LTD induction.  
Plasticity as a Framework for Conceptualising the Effects of Repetitive 
Transcranial Magnetic Stimulation  
 As the stimulation parameters, and effects induced by rTMS on M1 share 
similarities with the protocols used to induce LTD, and LTP within hippocampal 
preparations, it has been suggested that similar neurological processes may be occurring 
within the human CNS (Chen et al., 1997a; Malenka & Bear, 2004; Thickbroom, 2007). 
However, there is currently no direct evidence demonstrating that the neurological 
changes induced by rTMS in the human CNS are due to changes in synaptic strength 
(Pell et al., 2011). Moreover, the upper limits of the neuroplastic effects induced by 
rTMS in the human M1 generally last for less than 1 hr (Fitzgerald et al., 2006; Huang 
et al., 2005), whereas the LTP and LTD induced in animal models can last for several 
hours (Bliss & Gardner-Medwin, 1973). Finally, the neuroplastic effects induced by 
rTMS within the human CNS do not always show the same level of consistency, and 
robustness demonstrated in animal models (Fitzgerald et al., 2006; Hamada et al., 2012; 
Pell et al., 2011; Ridding & Ziemann, 2010). Due to these factors, the neuroplastic 
effects of rTMS are often described as “LTD-like” or  “LTP-like” (Hoogendam, 
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Ramakers, & Di Lazzaro, 2010; Pell et al., 2011). Despite these unresolved issues, LTD 
and LTP remain the prime candidates for explaining the biological mechanism induced 
by rTMS.  
Conventional Repetitive Transcranial Magnetic Stimulation Protocols  
Conventional rTMS involves the delivery of multiple pulses (usually several 
hundred) in rapid succession (Green, Pascual-Leone, & Wasserman, 1997). 
Conventional rTMS protocols can be differentiated by the frequency with which the 
pulses are delivered (Wassermann, 1998). The term high frequency rTMS is used to 
describe protocols that deliver pulses at frequencies > 1 Hz (Wassermann, 1998). In 
contrast, the term low frequency rTMS describes protocols involving the delivery of 
TMS stimuli at ≤ 1 Hz (Wassermann, 1998). The differentiation between high and low 
frequency rTMS protocols can be used to demarcate their effects on corticospinal 
excitability (Daskalakis & Chen, 2005; Fitzgerald et al., 2006; Pell et al., 2011), but also 
when considering aspects of safety (discussed further below) (Chen, Gerloff, Classen, 
Wassermann, & Hallett, 1997b; Rossi et al., 2009; Wassermann, 1998).  
Effects of Conventional Low Frequency Repetitive Transcranial Magnetic 
Stimulation on Cortical Motor Excitability  
 Although some inter-individual variability exists (Ridding & Ziemann, 2010), 
low frequency rTMS has been generally shown to suppress corticospinal excitability 
within M1 when quantified using MEP amplitudes (Fitzgerald et al., 2006). One of the 
earliest studies to demonstrate this was conducted by Chen et al. (1997a). The authors 
showed that low frequency stimulation delivered at a rate of 0.9 Hz at 115% RMT for 
15 min (810 pulses) could reduce MEP responses in the abductor pollicis brevis (APB) 
muscle by approximately 20% compared to pre-stimulation levels. Similar results have 
been found by other researcher groups. For example Muellerbacher et al. (2000) 
examined the effect of 1 Hz stimulation at 115% RMT applied for 15 min (900 pulses) 
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over the left M1 hand representation. They found a reduction in MEP input/output 
curves at test pulses delivered at > 140% RMT in the contralateral flexor pollicis brevis 
for up to 30 min. Another study by Fitzgerald et al. (2002b) examined the effects of 1 
Hz stimulation at 85% or 115% RMT for 15 min (900 pulses) applied over the APB M1 
representation on MEP amplitudes. They found that stimulation at 115% RMT 
suppressed MEP responses in the active (but not resting) muscle. Finally, Romero et al. 
(2002) applied 1 Hz stimulation at 90% RMT for 10 min (600 pulses) to the FDI 
representation in M1. The authors found a reduction in MEP amplitudes lasting 
approximately 10 min following rTMS administration.   
Effects of Conventional High Frequency Repetitive Transcranial Magnetic 
Stimulation on the Corticospinal Excitability  
 In contrast, conventional high frequency rTMS can induce facilitation of 
corticospinal excitability within M1. The effects, however, appear to be less robust than 
for those induced by low frequency rTMS (Fitzgerald et al., 2006). One of the earliest 
studies to examine the effect of high frequency rTMS trains on cortical motor 
excitability was conducted by Pascual-Leone et al. (1994). They applied a range of 
pulse frequencies (1 – 25 Hz) and stimulus intensities (100 – 200% RMT) over the APB 
representation in M1. They found that 20 pulses delivered at 5 Hz at 150% RMT 
induced facilitation of the MEP response. Facilitation could also be achieved with 20 
pulses at 10 and 20 Hz at either 110 - 130% RMT. Berardelli et al. (1998) examined the 
effect of 5 trains of 5 Hz rTMS delivered at 120% RMT (100 pulses total) on MEP 
amplitudes within the train (i.e., they measured MEP responses to high frequency 
during the delivery of the train itself). They found a progressive increase in the size of 
the MEP response by up to 284%. The facilitation in MEP responses was observed for 
at least 600 ms following the end of the train. Mudugno et al. (2001) applied different 
pulse frequencies (5 – 20 Hz) at various stimulus strengths (100 – 150% RMT) to the 
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left FDI M1 representation. They found that pulses delivered at 5, 10, and 20 Hz at 
motor threshold (MT) for a total of 13 pulses induced inhibition. However, the authors 
also reported that this could be reversed into facilitation if they increased the number of 
pulses to 20 applied at 5 Hz and 130% MT immediately after the train.  
Effects of Conventional Repetitive Transcranial Magnetic Stimulation on Intra-
Cortical Inhibition and Facilitation 
 The effect of low frequency rTMS on the cortical silent period (CSP) is less 
clear due to inconsistent findings (Fitzgerald et al., 2006). As summarised by Fitzgerald 
et al. (2006), 1 Hz stimulation has been reported to induce no changes (Fitzgerald et al., 
2002b; Modugno et al., 2003), a lengthening (Daskalakis et al., 2006; Stinear & 
Byblow, 2004a) or shortening (Fitzgerald et al., 2004) of the CSP response. The 
findings for high frequency rTMS stimulation are more consistent. Several studies 
report a lengthening of the CSP, albeit within the stimulation train itself (i.e., the CSP is 
measured during simultaneous delivery of the high frequency train and voluntary 
contraction) (Berardelli et al., 1999). Berardelli et al. (1999) applied 11 or 20 pulses at 
different pulse frequencies (3 – 5 Hz) at different stimulus strengths (110 – 120% 
RMT). The authors found both 3 and 5 Hz stimulation resulted in CSP lengthening, 
with the effect being stronger for 3 Hz stimulation at higher intensities. Similar findings 
have been reported by others (Inghilleri et al., 2006; Romeo et al., 2000).  
 Conventional rTMS has also been shown to induce differing effects on cortical 
inhibition, and facilitation when tested using ppTMS techniques (Daskalakis & Chen, 
2005). Although low frequency rTMS at 1 Hz does not appear to significantly affect 
intra-cortical inhibition, it can reduce ICF (Fitzgerald et al., 2006). Romero et al. (2002) 
applied 1 Hz stimulation at 90% RMT for 15 min (900 pulses) and used ppTMS to 
investigate the effects on cortical inhibition and facilitation. They found no changes to 
SICI at inter-stimulus-intervals (ISI) of 2 ms, a finding that has been confirmed in most 
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(Brighina et al., 2005; Daskalakis et al., 2006; Stinear & Byblow, 2004a; Stinear & 
Byblow, 2004b), but not all studies (Modugno et al., 2003; Rizzo et al., 2004). Romero 
et al. (2002) also found a reduction in ICF at ISI of 10 ms, consistent with reports in 
another study (Brighina et al., 2005).  In contrast, several studies have shown that high 
frequency rTMS can reduce SICI (Di Lazzaro et al., 2002; Pascual-Leone et al., 1998; 
Peinemann et al., 2000; Peinemann et al., 2004; Quartarone et al., 2005). One of the 
earliest studies was conducted by Pascual-Leone et al. (1998). They showed that 10 Hz 
rTMS at subthreshold stimulus (1600 pulses) could reduce SICI responses for up to 5 
min after stimulation. High frequency rTMS does not appear to affect ICF, with most 
studies showing no changes to ICF (Di Lazzaro et al., 2002; Pascual-Leone et al., 1998; 
Peinemann et al., 2000; Peinemann et al., 2004).   
Safety of Repetitive Transcranial Magnetic Stimulation 
As reviewed in the preceding sections, rTMS can be used to alter the excitability 
of the corticospinal tract, with varied effects on intra-cortical inhibition and facilitation. 
Techniques such as TMS, and indeed rTMS, can be used to not only probe and 
investigate intra-cortical neural mechanisms operating within the human CNS (Chen, 
2004), they can also be used to induce neuroplastic-like changes in corticospinal 
excitability (Chung et al., 2016; Fitzgerald et al., 2006). However, an important aspect 
of any NIBS paradigm, particularly TMS and rTMS, is the safety of technique. Since its 
introduction, safety concerns have been reasonably raised as TMS can induce 
complications such as syncope, and seizures (Green et al., 1997). Consequently, it is 
essential that all individuals administrating TMS understand the risks associated with 
TMS, and adhere to published safety guidelines developed to mitigate the risks 
associated with TMS exposure (Rossi et al., 2009; Wasserman, 2002). It is worth 
noting, however, that three decades of evidence have shown the risk of seizure is 
extremely low (~1%) (Loo, McFarquhar, & Mitchell, 2008; Machii, Cohen, Ramos-
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Estebanez, & Pascual-Leone, 2006; Rossi et al., 2009). More common but minor 
complications arising from TMS exposure can include headaches, localised pain around 
the area of stimulation, shoulder soreness, and auditory discomfort (Loo et al., 2008; 
Rossi et al., 2009). The following review sections outlines the safety of rTMS in healthy 
populations.  
Proposed Safety Guidelines for Maximal Safe Train Durations  
The earliest standardised safety guidelines developed for rTMS administration 
were developed by Wassermann (2002). The guidelines were derived from laboratories 
at the National Institute of Neurological Disorders and Stroke (NINDS). The safety 
guidelines outlined by Wasserman (1998) describe the maximal safe duration of a single 
rTMS train at different stimulus pulse intensities. The guidelines, as proposed by 
Wasserman (1998) are reproduced in Table 1.  Although the maximum safe duration of 
rTMS trains varies as a function of MEP threshold, three general principles can be 
derived from the guidelines (Wassermann, 1998). Firstly, higher frequencies (i.e., ≥ 5 
Hz) appear to significantly increase the risk of enhanced post-stimulation cortical 
excitability (i.e., increased seizure risk). Second, longer train durations also increase this 
risk. Finally, increasing TMS stimulation intensities (i.e., ≥ 100% MT) also elevates the 
risk of inducing seizure activity, particularly stimulation parameters > 130% of MT. 
These three parameters should be accounted for when developing rTMS protocols to 
minimise the risk of seizure induction.  
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Table 1 
 Originally Proposed Safety Guidelines for Single Trains of Repetitive Transcranial Magnetic Stimulation(Wasserman, 1998, p. 10).  
 
Proposed Safety Guidelines for Inter-Train Intervals 
Another parameter that has been shown to affect the risk of seizure induction is 
the inter-train period (i.e., the intermittent pause between stimulation trains) (Chen et 
al., 1997c). Chen and colleagues (1997c) systematically examined the safety thresholds 
for inter-train intervals by varying both the time interval, and inter-train interval 
between pulses. They used frequencies ranging from 10 – 25 Hz, inter-train intervals 
from 1 to 5 s, and stimulus intensities of 100 – 120% of MT. They defined possible 
seizure activity as the observation of post-EMG activity not due to the acute period of 
rTMS administration. Based on their findings, the authors recommended that inter-train 
periods of at least 5 s ≤ 110% of MT be used in rTMS. They concluded that inter-train 
periods of 1 s or less were unsafe. Their original recommendations are reproduced in 
Table 2.  
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 Table 2 
Original Recommendations for Safe Inter-Train-Intervals for Repetitive Transcranial 
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Seizures 
 The induction of a seizure is the most serious adverse effect that can be induced 
by TMS exposure (Rossi et al., 2009). The incidence of seizures following TMS 
exposure is extremely low. Up until June, 1996, before the safety guidelines proposed 
by Wasserman (1998), there had been seven known seizures induced by high frequency 
rTMS. The seizures occurred in one individual with temporal lobe epilepsy, five healthy 
volunteers, and one individual diagnosed with depression (Wassermann, 1998). The 
updated safety guidelines by Rossi et al. (2009) identified at least nine new reports of 
TMS induced seizures up until December, 2008. Four seizures occurred within the 
safety parameters (Figiel et al., 1998; Haupts, Daum, Ahle, Holinka, & Gehlen, 2004; 
Nowak, Hoffmann, Connemann, & Schönfeldt-Lecuona, 2006; Tharayil, Gangadhar, 
Thirthalli, & Anand, 2005), four fell outside of the safety parameters (Bernabeu, Orient, 
Tormos, & Pascual-Leone, 2004; Conca, König, & Hausmann, 2000; Prikryl & 
Kucerova, 2005; Rosa, Odebrecht, Rigonatti, & Marcolin, 2004), and one occurred 
during patterned rTMS (i.e., theta burst stimulation) (Oberman & Pascual-Leone, 2009). 
Since the 2009 safety guidelines were published, several new seizures have been 
reported (Di Iorio & Rossini, 2017). One was induced in a healthy participant with 
rTMS parameters exceeding safe limits (20 Hz 1.5 s train) (Chiramberro, Lindberg, 
Isometsä, Kähkönen, & Appelberg, 2013). Two occurred in individuals undergoing 
rTMS treatment  (Chiramberro et al., 2013; Hu et al., 2011), four were associated with 
the use of H-coils (Boes et al., 2016; Brainsway, 2013; Cullen et al., 2016; Harel et al., 
2011), one was induced in an individual with anaplastic oligoastrocytoma undergoing 
cortical mapping (Groiss, Trenado, Sabel, Schnitzler, & Wojtecki, 2017), another in an 
individual with epilepsy during ppTMS (Vernet, Walker, Yoo, Pascual-Leone, & 
Chang, 2012). One individual with stroke experienced a seizure 24 hr after receiving 
low frequency rTMS (Agosta et al., 2016). 
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Syncope 
 Syncope is the second major adverse event that can occur as a result of TMS 
exposure. According to a major taskforce created specifically for the diagnosis and 
management of syncope, syncope can be defined as “a T-LOC [transient loss of 
consciousness] due to transient global cerebral hypoperfursion characterized by rapid 
onset, short duration, and spontaneous complete recovery” (Moya et al., 2009, p. 2635). 
Whereas a seizure is caused by abnormal neuronal functioning, syncope, as defined by 
Moya et al. (2009), is caused by a sudden drop in cerebral blood flow. Two features can 
be used to differentiate a seizure from a syncopal episode. Firstly, recovery from a 
syncopal episode is generally spontaneous (i.e., recovery in seconds rather than 
minutes) (Rossi et al., 2009), and the event is acutely time limited (i.e., less than 20 s) 
(Moya et al., 2009).  
Headaches, Muscle Pain and General Discomfort   
 Although TMS is well tolerated by healthy volunteers, and clinical populations, 
both spTMS and rTMS can result in moderate discomfort for some individuals (Rossi et 
al., 2009). Reports of pain are the most common side effect of magnetic stimulation in 
individuals diagnosed with depression (Loo et al., 2008), and stimulation over non-
motor areas of the brain (e.g., frontal regions) (Machii et al., 2006). Following the 
recommendation by Rossi et al. (2009), participants should therefore be informed of the 
possibility of pain and that the procedure itself may be unpleasant or cause general 
discomfort.  
 Headaches and muscle pains are the most common complaint following from 
magnetic stimulation. For instance, a comprehensive review by Loo et al. (2008) 
examined the incidence of adverse effects following rTMS exposure reported by 
individuals diagnosed with depression. They found that for active rTMS, 28% of 
participants reported headaches, whilst 39% reported neck pain. For sham conditions, 
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16% reported headaches, and 15% reported neck pain. Other complaints are possible, 
including migraines (Machii et al., 2006), toothache (Rossi et al., 2009), initial 
discomfort (Anderson et al., 2009), and auditory complications (Wasserman, 2002). 
With respect to migraines, it has been shown that rTMS exposure may actually 
reduce or ameliorate the pain associated with migraines (Brighina et al., 2004). 
Toothache is possible, but generally resolves spontaneously (Rossi et al., 2009). It is 
also worth noting that stimulation over frontal regions may induce initial discomfort 
that generally subsides after several sessions (Anderson et al., 2009). Auditory 
complaints may also arise due to the mechanical ‘clicking’ sound inherent in 
administering magnetic pulses and, as such, the provision of ear plugs should nullify 
this complication (Wasserman, 2002).  
Electrode Burns 
 Electrode burns over the scalp have been reported in the literature (Wasserman, 
2002). One of the earliest reports of an electrode burn was in a study that utilised rTMS 
to investigate hemispheric domination for language. Participants were monitored with 
electroencephalography (EEG) electrodes (silver/silver-chloride), and one participant 
reported a burn under the recording EEG electrode. Pascual-Leone et al. (1990) 
attempted to replicate the electrode burn under controlled conditions by measuring skin 
temperature directly below a metallic electrode and used various magnetic pulse 
strengths and train durations. They found that 40 stimuli at 4 Hz increased skin 
temperature by 3.5 degrees Celsius. Increases in the number of stimuli (i.e., 160 pulses) 
with higher intensities (100%) at 1 Hz led to an increase of 4.4 degrees Celsius.  
Neurocognitive Effects and Safety  
 rTMS can modulate cognitive functioning as measured by various 
neuropsychological tests. Generally, the neuropsychological effects observed after TMS 
administration are transient and can either improve or impair post-exposure 
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performance. Studies examining cognitive functioning tend to report short to 
intermediate effects (Pascual-Leone et al., 1993; Wassermann et al., 1996), with few 
studies examining post stimulation cognitive functioning longitudinally (Wasserman, 
2002). Thus, adverse long-term effects cannot be discounted.  
 An early study that examined the neuropsychological effects of rTMS exposure 
was conducted by Pascual-Leone et al. (1993). Their sample consisted of nine healthy 
volunteers who were screened for possible psychological or physiological health 
impairments in addition to medical histories. The participants were administered a 
battery of neurocognitive tests including the “story recall (revised Wechsler Memory 
Scale, WMS-R), selective reminding, word fluency (letter), Boston naming test, serial 
reaction time test (random blocks), and letter identification task (Posner paradigm)” (p. 
123).  The methodology involved pre- and post-testing (a sham condition was not 
included). They found that rTMS did not induce impaired performance, and with 
showing improvement after rTMS (i.e., the reaction time and verbal memory tasks) 
possible due to practice effects.  
 Wasserman et al. (1996) examined the safety of rTMS at various frequencies (1 
or 20 Hz) at various stimulus intensities (125% and 110%, respectively) and train 
durations. They used a finger tapping performance task and two neurocognitive tests, 
including the Wechsler story recall test (both immediate and delayed) and the verbal 
fluency task. They found facilitation of the finger-tapping task for distal limbs, 
contralateral to the side of rTMS stimulation for both frequencies, with more 
pronounced effects for 1 Hz stimulation. There was a trend towards improved 
performance on the neurocognitive tests, but the results were non-significant.   
 Flitman et al. (1998) employed rTMS to examine language processing. They 
delivered high frequency rTMS at 120% of MT, 15 Hz trains of 750 ms duration with 
inter-train periods of 250 ms, totalling 150 pulses. They reported no adverse 
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psychological effects, although a seizure was induced in one participant.  The 
researchers administered several tests, including the finger tapping test, Grooved 
Pegboard Test, and the Wechsler Memory Scale-Revised Logical Memory subtest. 
Performance for the finger tapping and Grooved Pegboard tests were unremarkable. 
However, they reported an 18% decrease in performance on the Wechsler Memory 
Scale-Revised Story Memory subtest for the total group. The short inter-train durations 
may have led to adverse cumulative effects and subsequent performance impairment.     
Conclusions  
 Neuroplasticity is a property of the CNS, allowing for adaptation, and cognitive 
and behavioural flexibility. rTMS can induce ‘LTD-like’ and ‘LTP-like’ effects on 
corticospinal excitability. Although participants can show some inter-individual 
variability, low frequency rTMS generally suppresses corticospinal excitability, whilst 
high frequency rTMS induces facilitation. The neuro-modulation induced by rTMS can 
be used for neuropsychological, and clinical-therapeutic applications. Thirty years of 
accrued knowledge has shown TMS to be a relatively safe technique. Rare but serious 
side effects include seizures and syncope, with more common side effects including 
headache, and localised pain. These risks can be mitigated by adhering to the safety 
guidelines (Chen et al., 1997b; Rossi et al., 2009; Wassermann, 2002). As there is 
relatively little information on the safety of multisite rTMS protocols, one objective of 
this program of research was to systematically characterise the safety profile of rTMS 
applied to multiple brain regions to help guide the selection of parameters for multi-
regional rTMS applications. Safety data is presented for each empirical study (Chapter 
5, Chapter 7, and Chapter 9).  
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Chapter 3 – Obsessive-Compulsive Disorder: Diagnosis, Phenomenology, 
Aetiology, and Neurobiology 
Introduction 
 As presented in Chapter 2, repetitive transcranial magnetic stimulation (rTMS) 
is a safe technique that can be used to alter the excitability of the human primary motor 
cortex (M1), in vivo. Although it is unclear whether the neuroplastic-like modulation in 
corticospinal excitability are due to changes in synaptic strength per se, the long-lasting 
neuro-modulatory effects induced by rTMS have clear clinical potential. Indeed, there is 
much work evaluating the efficacy of non-invasive techniques (NIBS) such as rTMS for 
treating conditions such as depression (Chung et al., 2015; Daskalakis, 2005), 
schizophrenia (Lee et al., 2005), autism spectrum disorder (Sokhadze et al., 2014), and 
Parkinson’s disease (Boggio et al., 2005).  
One illness that may be amenable to NIBS techniques is obsessive compulsive 
disorder (OCD) (Jaafari et al., 2012; Trevizol et al., 2016). OCD is a debilitating 
psychological illness characterised by unrelenting and persistent thoughts (i.e., 
obsessions), and uncontrollable behavioural or cognitive urges (American Psychological 
Association [APA], 2013). Despite the availability of pharmacological (Math & 
Janardhan Reddy, 2007), and psycho-social interventions (Abramowitz, 1996), an 
estimated 40 - 60% of individuals diagnosed with OCD fail to respond to first-line 
treatments (Abramowitz, Taylor, & McKay, 2005; Pallanti et al., 2002). Consequently, 
there is a need to develop a wider range of effective treatment options. Although NIBS 
techniques such as rTMS have shown promise in treating the disorder, they are 
currently not indicated in the treatment of OCD due to limited clinical improvement.  
This chapter was written as part of the first research stream that evaluated the 
potential of multisite rTMS protocols for clinical applications. Specifically, the aim of 
this chapter was to identify potential therapeutic targets for rTMS based on 
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neurobiological models of OCD. It is contended that several brain regions may be 
suitable treatment targets for rTMS. A brief description of diagnostic and 
phenomenological features of OCD will be presented. This will be followed by a 
summary of the aetiological factors implicated in the disorder including heritable, 
behavioural and cognitive contributions. A neuroanatomical model of OCD referred, to 
as the OCD Circuit Hypothesis, will be described (Saxena & Rauch, 2000). This will be 
followed by a region-by-region overview that will attempt to account for the symptoms 
expressed in OCD. The final section argues that neurobiological models of pathology 
can help guide the selection of therapeutic neuroanatomical targets. The findings from 
this chapter were used to inform the discussion in the systematic review presented in 
Chapter 4 (Study 1), and selection of target regions for the multisite rTMS protocol 
evaluated in the first empirical study (Study 2, Chapter 5).  
Conceptualising Obsessive Compulsive Disorder  
 OCD is a psychiatric illness hallmarked by persistent and unrelenting obsessions 
(e.g., thoughts regarding contamination or of anxiety provoking sexual content), and 
compulsive behavioural or cognitive urges (e.g. ritualistic hand washing or introspective 
counting rituals) (APA, 2013; Swedo & Grant, 2009). The obsessions and compulsions 
are of such severity that they cause marked distress and dysfunction to the individual 
(APA, 2013) . Furthermore, rumination over intrusive thoughts and preoccupation with 
compulsive urges are often time consuming, severely impeding normal daily 
functioning. Although individuals diagnosed with OCD may have insight into their 
disorder and may be aware that their thoughts or compulsions are abnormal or 
excessive, they often feel powerless to stop the intrusive nature of their obsessive 
thoughts or to terminate compulsive behaviours (APA, 2013). Unsurprisingly, OCD 
severely impacts upon an individual’s wellbeing and is considered one of the most 
debilitating forms of psychiatric illness.  
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 Obsessions refer to recurrent, persistent, and intrusive thoughts, images or 
impulses (Goodman et al., 1989). The intrusive thoughts are unwanted and induce 
marked anxiety, distress or impairment to the individual (APA, 2013). Common 
obsessive thoughts include fears regarding contamination (e.g., contamination through 
hand shaking), fear of causing harm to self or others (e.g., harming a family member), 
fixation on symmetry (e.g., experiencing distress when observing perceived 
disorganisation in objects), somatic concerns (e.g., constantly checking for signs of 
cancer or hernia) (Rasmussen & Tsuang, 1986), and/or thoughts of a sexual nature (e.g., 
pornographic imagery) (APA, 2013; Foa et al., 1995). The Diagnostic and Statistical 
Manual of Mental Disorders V (DSM-V) defines obsession as: 
 
1. Recurrent and persistent thoughts, urges, or images that are experienced, at some 
time during the disturbance, as intrusive and unwanted, and that in most 
individuals cause marked anxiety or distress … [and] … 
2. The individual attempts to ignore or suppress such thoughts, urges, or images, or 
to neutralize them with some other thought or action (i.e., by performing a 
compulsion) (APA, 2013, p. 237, p. 237) 
 
The second dimension, compulsions, refers to repetitive, ritualistic behaviours 
(i.e., hand washing), or covert cognitive acts (i.e., silent counting rituals) intended to 
reduce the anxiety or stress borne from an individual’s obsessions (APA, 2013). For 
instance, individuals diagnosed with OCD may engage in elaborate or excessive hand 
washing rituals to reduce the anxiety related to fears of being contaminated (Price & 
Salsman, 2010). One individual reported washing their hands up to 100 times a day due 
to fears of being contaminated by domestic cleaning products (Turk, Marks, & Horder, 
1990). Compulsions are defined in the DSM-V as:  
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1. Repetitive behaviors (e.g., hand washing, ordering, checking), or mental acts 
(e.g., praying, counting, repeating words silently) that the individual feels driven 
to perform in response to an obsession or according to rules that must be applied 
rigidly … [and] … 
2. The behaviours or mental acts are aimed at preventing or reducing anxiety or 
distress, or preventing some dreaded event or situation; however, these 
behaviors or mental acts are not connected in a realistic way with what they are 
designed to neutralize or prevent, or are clearly excessive (APA, 2013, p. 237, p. 
237) 
 
Epidemiology and Prevalence 
   Epidemiological studies reveal that the prevalence rate for OCD varies by 
region. One major survey conducted by Weissman, Bland, Canino and Greenwald 
(1994) examined the lifetime and one-year prevalence rates for OCD across seven 
nations using DSM-III criteria. Except for Taiwan (with a lifetime prevalence of 0.7%), 
the authors estimated the lifetime prevalence of OCD ranges from 1.9% in Korea, to 
2.5% in Puerto Rico. The estimated one-year prevalence rates ranged from 1.1% in New 
Zealand and Korea, to 1.8% in Puerto Rico, and 0.4% for Taiwan. Data from the United 
States reveal that 2.3% of the population meet DSM-IV criteria for OCD (Ruscio, Stein, 
Chiu, & Kessler, 2008). In Australia, Crino, Slade and Andrews (2005) have reported 
that the estimated 12-month prevalence rate differed depending on the applied criteria. 
Using DSM-IV criteria, they estimated that 0.6% of the adult population experienced 
OCD, but up to 2.1% using DSM-III criteria.   
Heritability of Obsessive and Compulsive Traits  
 There is evidence that obsessional and compulsive traits may have a heritable 
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component. The difficulty in obtaining consistent heritability estimates has been due to 
variations in diagnosis, measurement techniques, and available data (i.e., case studies 
versus large cohort studies) (van Grootheest, Cath, Beekman, & Boomsma, 2005). A 
comprehensive review by van Grootheest et al. (2005) examined reports over a 70 year 
period and found literature published before 1965 were largely based on case studies, 
and often failed to include diagnostic OCD criteria making precise estimates difficult 
(Lewis, 1936; Parker, 1964). Studies after 1965, however, utilised improved methods 
such as the inclusion of DSM based criteria increasing internal validity (Andrews, 
Stewart, Allen, & Henderson, 1990; Skre, Onstad, Torgersen, Lygren, & Kringlen, 
1993; Torgersen, 1983). A large-scale study involving 419 twin pairs was conducted by 
Clifford et al. (1984) who examined heritability estimates for obsessional traits and 
symptoms using the Leyton Obsessional Inventory (Cooper, 1970). They estimated that 
the heritability of obsessional traits and symptoms were 44% and 47%, respectively.  
Neurochemistry and Pharmacological Indicators  
 OCD has been shown to be responsive to multiple drug classes, thus implicating 
several neurochemical pathways. The neurochemical pathways implicated in OCD 
include the dopaminergic (Husted, Shapira, & Goodman, 2005), serotonergic 
(Markarian et al., 2010), and norepinergic pathways (Hollander et al., 1991). One class 
of drugs that have been shown to be effective in managing OCD symptomology are 
referred to as serotonin reuptake inhibitors (SRIs). These drugs function by blocking the 
reuptake of serotonin in pre-synaptic cells (Stahl, 1998). As SRIs have been shown to 
be the most effective in ameliorating the symptoms of OCD, they are generally 
recommended as the first line of pharmacological treatment (Fineberg & Gale, 2005; 
Marazziti & Consoli, 2010). SRIs that have been shown to be effective in treating the 
symptoms of OCD include fluvoxamine, fluoxetine, sertraline, paroxetine, citalopram, 
escitalopram, and venlafaxine (Kellner, 2010; Math & Janardhan Reddy, 2007) .  
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Behavioural Theories 
 Behavioural and cognitive theories have been proposed to account for the 
manifestation of OCD. Early theories include Mowrer’s (1956) two factor theory of fear 
learning, that was later expanded to incorporate the development of OCD. According to 
this model, individuals initially develop fear responses to a specific stimulus through 
classical conditioning, that is subsequently maintained through operant conditioning 
(Neziroglu, Henricksen, & Yaryura-Tobias, 2006). For example, in the classical 
conditioning phase, individuals may learn to associate an innocuous object such as a 
blanket (i.e., the neutral stimulus) with a disturbing thought or image (e.g., being 
‘contaminated’ with germs; the unconditioned stimulus) resulting in anxiety (i.e., the 
unconditioned response) (Meyer, 1966). The blanket may develop into a conditioned 
stimulus if subsequent exposures evokes distressing thoughts or imagery eliciting a 
negative emotional response (e.g., fear and anxiety) (Neziroglu et al., 2006). In the 
subsequent maintenance stage, individuals may engage in ritualistic behaviour (i.e., 
compulsions) to reduce the anxiety associated with the trigger and, thus, negatively 
reinforcing those behaviours (e.g., frequent hand washing).  
 The strongest evidence that learning mechanisms are involved in the aetiology 
of OCD is the finding that exposure response-prevention is an effective treatment for 
OCD. In exposure response-prevention, individuals are deliberately exposed to anxiety-
inducing stimuli that provokes compulsive urges to engage in ritualistic behaviour 
(McKay, Taylor, & Abramowitz, 2010). They are then required to refrain from 
engaging in their ritualistic behaviours (Meyer, 1966). The overall aim of exposure 
response-prevention is to habituate individuals to their fears and anxiety such that they 
no longer display compulsive tendencies (McKay et al., 2010). Several meta-analytic 
studies have demonstrated the efficacy of exposure response-prevention in direct 
comparison to other treatment modalities including drug and other cognitively based 
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treatments (Abramowitz, 1996; Kobak, Greist, Jefferson, Katzelnick, & Henk, 1998; 
Rosa-Alcázar, Sánchez-Meca, Gómez-Conesa, & Marín-Martínez, 2008).  
Cognitive Theories 
Cognitive models have been developed to account for the obsessional 
component of OCD. One cognitive model of OCD is Salkovskis’s (1985) cognitive-
behavioural model (Taylor, Abramowitz, & McKay, 2007). It should be noted that other 
cognitive models have been developed (Clark, 2004; Frost et al., 1997; Rachman, 1997; 
Sookman & Pinard, 1999; Taylor et al., 2007). According to Salkovski’s (1985) model, 
external (e.g., seeing a stove top) or internal (e.g., thoughts relating to a stove top) 
precepts may act as triggers for intrusive thoughts (e.g., doubts about turning off one’s 
stove). Intrusive thoughts are experienced as ego dystonic, “that is, the content is 
experienced as inconsistent with the individual’s belief system” (‘I’m sure I turned off 
the stove’; p. 578). The linchpin of Salkovski’s (1985) model is that both clinical (i.e., 
OCD) and non-clinical populations experience intrusive thoughts. If the individual (i.e., 
non-clinical) assigns no value to the intrusive thought, the sequence terminates (‘it’s just 
a thought’). If, however, the intrusive thought is perceived as having serious 
implications, particularly if there are personal ramifications, then automatic thoughts are 
triggered (‘it’s all my fault if the house burns down’) (Abramowitz et al., 2005). The 
automatic thought is experienced as ego syntonic by the individual; that is, the 
automatic thought is congruent with the individual’s belief system (‘burning down the 
house is irresponsible’). In Salkovski’s (1985) model, the trigger and automatic thought 
are maintained by the individual because they are perceived as personally significant. 
This subsequently leads to mood disturbances (e.g., distress, anxiety, or dysphoria). To 
reduce this discomfort, individuals may engage in overt (e.g., checking the stove) or 
covert (e.g., mental counting) neutralising behaviours. Engaging in compulsions 
negatively reinforce the behaviour by reducing state anxiety.  
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 Several meta-analytic studies support the effectiveness of CBT for OCD, either 
in conjunction with behavioural treatment (i.e., exposure response-prevention) or as a 
monotherapy (Eddy, Dutra, Bradley, & Westen, 2004; Rosa-Alcázar et al., 2008; 
Watson & Rees, 2008). Essentially, CBT aims to reduce the symptoms of OCD by 
firstly educating individuals that intrusive thoughts are a part of normal experiences 
(Clark, 2004; Rachman & de Silva, 1978). Second, they are informed that it is not the 
intrusive thought itself that is problematic. Rather, it is the faulty appraisals of the 
intrusive thought that is central to the maintenance of the disorder. The aim of CBT is to 
modify the faulty appraisal to a less threatening appraisal (‘I have lived with my family 
for years without incident’). Neutralising the individual’s perceived threat can lead to a 
reduction in obsessional thoughts and compulsive behaviours (Abramowitz et al., 2005; 
Clark, 2004). A meta-analytic study conducted by Rosa-Alcazar et al. (2008) examined 
placebo-controlled studies that employed exposure response-prevention, cognitive 
restructuring (CR; a variant of CBT) or exposure response-prevention plus CR. The 
authors found that exposure response-prevention (n = 13; Cohen’s D = 1.127) returned 
the strongest effect size followed by CR (n = 3; Cohen’s D = 1.090), followed by 
exposure response-prevention plus CR (n = 8; Cohen’s D = 0.998) although there were 
no significant differences between the three treatment types.  
Summary of the Effectiveness of Pharmacological, Behavioural and Cognitive 
Therapy 
 The evidence presented in the preceding sections indicates that pharmacological 
(Kellner, 2010; Math & Janardhan Reddy, 2007), behavioural (Abramowitz, 1996), and 
cognitive (Rosa-Alcázar et al., 2008) treatments are effective for treating OCD. The 
range of effective treatment modalities for OCD is promising and implies multiple 
therapeutic pathways for treating the disorder. However, despite the effectiveness of 
current treatments, it is estimated that 40 – 60% of individuals diagnosed with OCD fail 
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to respond adequately (Abramowitz et al., 2005; Fineberg & Gale, 2005; Pallanti et al., 
2002). Given the proportion of individuals who do not respond to current treatments, 
with other forms of therapy involving more invasive procedures such as deep brain 
stimulation (Greenberg et al., 2010a), or ablative psychosurgery (Greenberg, Rauch, & 
Haber, 2010b), there is a need to develop a wider range of less invasive therapies that 
are tolerable, safe, and can achieve clinically meaningful outcomes.  
One avenue that may be effective for treating OCD is through the use of NIBS 
techniques such as rTMS that target neuroanatomical regions implicated in the disorder 
(Jaafari et al., 2012; Trevizol et al., 2016). To identify potential therapeutic targets for 
rTMS protocols, a well-accepted neurobiological model of OCD will be described 
below (Saxena & Rauch, 2000). Following from this, a region-by-region overview of 
the evidence implicating key regions in OCD will be presented. Each section will begin 
with an anatomical description of the region, followed by a general overview of its 
functional role, and an explanatory link to OCD. The findings from the following 
sections were used to inform the discussion of the systematic review that evaluated the 
efficacy of rTMS for OCD (Study 1, Chapter 4), and the selection of anatomical targets 
for the multisite rTMS protocol evaluated in the first empirical study (Study 2, Chapter 
5).  
Neuroanatomical Approaches – The Obsessive-Compulsive Disorder Circuit 
Hypothesis  
One influential neuroanatomical model of OCD is referred to as the OCD 
Circuit Hypothesis and was proposed by a group of researchers from the United States 
(Graybiel & Rauch, 2000; Saxena & Rauch, 2000). The model is based primarily on 
neuroimaging data (Saxena & Rauch, 2000), but also neuroanatomical evidence that 
have revealed partially segregated neural circuits connecting cortical and sub-cortical 
regions (particularly the basal ganglia) (Alexander, 1994; Alexander & Crutcher, 1990). 
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In individuals diagnosed with OCD, three regions have been consistently implicated in 
the disorder including the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), 
and striatum (particularly the caudate nucleus) (Graybiel & Rauch, 2000). Other 
regions, such as the dorsolateral prefrontal cortex (DLPFC), and supplementary motor 
area (SMA) have also been implicated in OCD, though to a lesser extent (Van Den 
Heuvel, Van Gorsel, Veltman, & Van Der Werf, 2013; van den Heuvel et al., 2005; 
Yucel et al., 2007). Each region follows a series of parallel neural circuits involved in 
cognitive, behavioural, and affective processes mediated by reciprocal, feedback 
systems (Alexander, 1994; Alexander & Crutcher, 1990). As each anatomical region 
has been shown to be overactive in individuals diagnosed with OCD, this may reflect 
different aspects of the disorder (i.e., obsessions and compulsions). Therefore, it is the 
relative imbalance within these circuits that leads to the manifestation of OCD 
symptoms. The major role each region may contribute to the pathogenesis of OCD is 
described below.  
The Orbitofrontal Cortex  
The human OFC is located on the ventral portion of the prefrontal cortex, and 
includes Brodmann Areas 10, 11, 12, 13, and 37 (Brodmann & Garey, 2007; 
Kringelbach & Rolls, 2004; Petrides & Pandya, 2002; Walker, 1940). It is a highly 
interconnected region, receiving sensory input from all five sense modalities (Rolls, 
2004). It has reciprocal connections with the amygdala, hippocampus, ACC, and the 
DLPFC (Kringelbach & Rolls, 2004), with outputs to the striatum, particularly the 
caudate nucleus (Eblen & Graybiel, 1995; Kringelbach & Rolls, 2004).    
The OFC is involved in emotion processing (Rolls, 2000) especially emotional 
responses triggered by environmental rewards or punishments (Kringelbach & Rolls, 
2004). It is activated by primary (unlearned) reinforcers, including food (Kringelbach, 
O’Doherty, Rolls, & Andrews, 2003) and drink (O'Doherty, Deichmann, Critchley, & 
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Dolan, 2002), and secondary (learned) reinforcers such as money (O'Doherty, 
Kringelbach, Rolls, Hornak, & Andrews, 2001) and human faces (Blair, Morris, Frith, 
Perrett, & Dolan, 1999; Gorno-Tempini et al., 2001). The medial aspects of the OFC are 
involved with representing and monitoring the reward value of reinforcers (De Araujo, 
Rolls, Kringelbach, McGlone, & Phillips, 2003; Kringelbach & Rolls, 2004; O'Doherty 
et al., 2002), whereas the lateral aspects are involved with the evaluation of 
punishments, leading to behaviour change (Kringelbach & Rolls, 2003; O'Doherty et al., 
2001). Rolls (1990) has theorised that the OFC’s role in emotion processing is to 
represent the reward and punishment value of environmental stimuli (Kringelbach & 
Rolls, 2004). Additionally, Rolls (1990) argues that the OFC is prominently involved 
with flexibly generating, monitoring, and updating those representations when the 
reward or punishment values change (Kringelbach & Rolls, 2004).  
The neuroimaging literature provides strong evidence that individuals diagnosed 
with OCD exhibit abnormalities within the OFC, and that these abnormalities can be 
‘normalised’ after treatment (Saxena & Rauch, 2000). Neuroimaging studies reveal 
individuals diagnosed with OCD show higher levels of resting state activity in the OFC 
compared to healthy controls using positron emission tomography (PET)(Baxter et al., 
1987; Baxter et al., 1988), and single-photon emission computed tomography 
(SPECT)(Rubin, Villanueva-Meyer, Ananth, Trajmar, & Mena, 1992). In symptom 
provocation studies, individuals diagnosed with OCD show hyperactivation of the OFC 
(Breiter et al., 1996; Rauch et al., 1994). Finally, imaging studies have shown reduced 
activation in orbitofrontal regions in pre- versus-post treatment designs following 
administration of fluoxetine using PET (Baxter et al., 1992), clomipramine 
(PET)(Benkelfat et al., 1990), and post-operatively after capsulotomy (ablation of the 
anterior region of the internal capsule) with PET (Mindus, Nyman, Mogard, Meyerson, 
& Ericson, 1991) 
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It has also been suggested that the increased metabolism within the OFC in 
individuals diagnosed with OCD at rest may represent an augmented, generalised 
propensity to monitor the external environment for potentially threatening stimuli 
(Saxena & Rauch, 2000). This suggestion is consistent with the OFC’s posited role in 
monitoring and evaluating environmental rewards, and punishments (Kringelbach & 
Rolls, 2004). This can help to explain why individuals diagnosed with OCD more 
readily identify and focus upon OCD relevant stimuli. Additionally, once such 
perceived threats have been identified, this may serve as a feedback loop contributing to 
excessive activation of the OFC as observed during symptom provocation studies 
(Breiter et al., 1996; Rauch et al., 1994). Such hyperactivation may contribute to the 
uncontrolled, recurrent, and intrusive thoughts experienced by individuals diagnosed 
with OCD (Saxena & Rauch, 2000). As the OFC appears to be heavily implicated in 
OCD, it would be an ideal target for neurobiological NIBS techniques such as rTMS 
(Ruffini et al., 2009).  
The Anterior Cingulate Cortex  
The ACC occupies the medial wall of the prefrontal cortex and includes 
Brodmann areas 24, 25, 32, and 33 (Brodmann & Garey, 2007; Bush, Luu, & Posner, 
2000; Nolte, 2008). The ACC can be functionally subdivided into two distinct regions 
(Bush et al., 2000). The dorsal ACC has been shown to be recruited during cognitively 
demanding tasks such as the Stroop task (Bush et al., 1999; Bush et al., 2000; Bush et 
al., 1998) and Go/No-Go task (Kawashima et al., 1996). The ventral ACC has been 
implicated in affective processing and is activated during affective Stroop tasks and in 
symptom provocation studies (OCD, and phobia) (Bush et al., 2000).  
Broadly, the dorsal ACC has been shown to be recruited during concurrent 
conflict monitoring and error detection processes (Botvinick, Braver, Barch, Carter, & 
Cohen, 2001; Bush et al., 2000). One proposal, referred to as conflict monitoring theory, 
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posits that the dorsal ACC achieves these functions by monitoring for conflicts (or 
incongruities) that arise during information processing (Botvinick et al., 2001; Yeung, 
Botvinick, & Cohen, 2004). Essentially, it is thought that the dorsal ACC is involved 
with evaluating the accuracy of selected behavioural responses, and signalling when 
errors have been detected (Botvinick et al., 2001; Gehring, Himle, & Nisenson, 2000; 
Olvet & Hajcak, 2008).   
Conflict monitoring processes can be measured through electrophysiological 
events referred to as event related potentials (ERPs) (Gehring et al., 2000; Verleger, 
1988). More specifically, the error related negativity (a negatively deflecting ERP 
component evoked when individuals commit errors) (Olvet & Hajcak, 2008), is thought 
to reflect error detection processes (Gehring, Goss, Coles, Meyer, & Donchin, 1993; 
Yeung et al., 2004). Studies conducted by Gehring et al. (2000) and Ruchsow et al. 
(2005) have shown that when individuals diagnosed with OCD commit errors on 
neurocognitive tasks (i.e., the Stroop and modified Go/NoGo task, respectively), they 
exhibit larger error related negativity potentials relative to healthy controls. 
Additionally, one functional magnetic resonance imaging (fMRI) study conducted by 
Ursu, Stenger, Shear, Jones and Carter (2003) found greater activation of the ACC in 
individuals diagnosed with OCD compared to controls during high conflict (i.e., 
increased discrimination difficulty), and error trials.  
Based on these findings, it has been suggested that the overactivity observed 
within the ACC in individuals diagnosed with OCD may reflect excessive and 
disproportionate conflict monitoring, and error detection processes (Olvet & Hajcak, 
2008; Ursu et al., 2003). The ACC may be transmitting erroneous ‘error’ signals that 
‘something is wrong’ or that an action has been performed incorrectly (Pitman, 1987; 
Saxena & Rauch, 2000). If this is the case, this would explain why some individuals 
feel constant urges to engage in corrective behaviours (Gehring et al., 2000; Pitman, 
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1987), or to repeat behaviours ritualistically until they feel that they have completed an 
action satisfactorily or ‘”just right” (Leckman et al., 1995, p. 209). Alternatively (or 
concurrently), it is possible that individuals receive signals to ‘check’ or confirm if they 
have completed an action correctly, even if they have just recently completed that action 
(e.g. repeatedly checking if a car door has been locked) (Price & Salsman, 2010). 
Although the ACC would be an ideal target for neurobiological treatments, as it is a 
subcortical structure, it cannot be targeted directly with rTMS (Rudiak & Marg, 1994).  
The Striatum 
 The striatum comprises the caudate nucleus, nucleus accumbens, and putamen 
(Nolte, 2008). It is strongly implicated in goal-directed behaviour, and habit-forming 
processes (Chakravarthy, Joseph, & Bapi, 2010; Redgrave et al., 2010; Robbins & 
Everitt, 1996). Goal-directed behaviour refers to the selection, and implementation of 
behaviours that are associated with predictable outcomes desired by the agent (Cardinal, 
Parkinson, Hall, & Everitt, 2002). In contrast, habitual responding refers to the 
implementation of behavioural responses based on previously acquired stimulus-
response associations but are minimally influenced by the outcomes of those responses 
(Balleine & O'Doherty, 2010). As individuals diagnosed with OCD manifest 
compulsive behaviours that appear to be goal-directed and/or habitual (O'Dwyer & 
Marks, 2000; Price & Salsman, 2010), it has been suggested that abnormalities within 
the striatum could potentially explain two behavioural aspects of the disorder 
(Aouizerate et al., 2004). 
 One possibility is that the overactivity within the striatum may reflect altered or 
aberrant reward-orientated processes, such that individuals diagnosed with OCD may 
engage in compulsive behaviours because of their strong negative reinforcement value 
(Jung et al., 2011; Rachman, 1980; Salkovskis, 1985). This proposal is supported by an 
fMRI study by Jung et al. (2011), who compared cerebral activation in unmedicated 
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individuals diagnosed with OCD and healthy controls during a monetary accruement 
task. The authors found that when OCD participants were required to respond 
accurately to cues to prevent monetary losses, they showed greater activation of the 
ventral striatum during those trials. As individuals in their study had to respond to 
prevent negative outcomes, this can be conceptualised as a form of negative 
reinforcement. Although these findings are preliminary, Jung et al. (2011) suggested 
that the altered activity within the ventral striatum of individuals diagnosed with OCD 
may reflect aberrant reward-orientated processes. That is, individuals diagnosed with 
OCD may have increased sensitivity to punishment or increased motivation to prevent 
punishing outcomes. If either postulate is correct, this may help to explain why those 
with OCD routinely engage in compulsive acts; their compulsive behaviour may serve 
as strong source of negative reinforcement. In the clinical literature, individuals 
diagnosed with OCD have reported that engaging in compulsive behaviours reduces 
their state anxiety (Price & Salsman, 2010; Rachman, 1980).  
A second possibility is that the overactivity within the striatum of individuals 
diagnosed with OCD may reflect excessive release of habitual behaviours when they are 
unnecessary or inappropriate (Aouizerate et al., 2004; Graybiel & Rauch, 2000; Saxena 
& Rauch, 2000). This proposal is based mainly on behavioural research conducted on 
animals (Balleine & O'Doherty, 2010; Graybiel & Rauch, 2000; Jog, Kubota, Connolly, 
Hillegaart, & Graybiel, 1999; Packard & Knowlton, 2002). Jog et al. (1999) have shown 
that when rodents first learn to acquire simple stimulus-response associations (e.g., 
turning left or right in response to auditory cues), the sensorimotor region of the rodent 
striatum is preferentially activated during the ‘turn’ phases. However, as rodents 
become more proficient at the task (in other words, as their turning behaviour become 
more ‘habitual’) the authors found that neural activity within the striatum decreased 
during the ‘turn’ phases but showed increased activity at the ‘start’ and ‘end’ phases of 
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the trial. In humans, fMRI studies have shown that homologous sensorimotor striatal 
regions become more active as healthy individuals achieve greater proficiency at 
performing simple motor tasks (Lehéricy et al., 2005; Redgrave et al., 2010). 
Extrapolating from these findings, the overactivity within the striatum may reflect an 
increased propensity to engage in habitual behaviours when exposed to environmental 
cues (Turk et al., 1990). Although the striatum would be an ideal target for 
neurobiological treatments, as it is a subcortical structure, it cannot be targeted directly 
with rTMS.   
Dorsolateral Prefrontal Cortex  
 The DLPFC has been shown to be recruited in a wide range of cognitive 
processes subsumed under the heuristic of executive functions (Duncan & Owen, 2000). 
Broadly, executive function refers to an agent’s capacity to: (1) dynamically generate, 
and actively maintain, goal-orientated representations, (2) identify and systematically 
manipulate task-relevant information, (3) maintain goal-/task-related representations 
robustly against competing, task-irrelevant goals and/or information, (4) inhibit 
inappropriate behavioural responses, and (5) sequence, plan and cognitively appraise the 
selection, implementation, and likely success of current/future actions (Aron, Robbins, 
& Poldrack, 2004; Banich, 2009; Jurado & Rosselli, 2007; Miller & Cohen, 2001; Stuss 
& Alexander, 2000).  
 A set of neurocognitive assessments that can measure aspects of planning and 
are known to be sensitive indicators of frontal lobe lesions (Owen, Downes, Sahakian, 
Polkey, & Robbins, 1990; Shallice & Shallice, 1982) and, by extension, executive 
functioning (Menzies et al., 2008), are collectively referred to as tower tasks (e.g., The 
Tower of London or Tower of Hanoi). Essentially, tower tasks require participants to 
recreate predefined patterns with the goal of completing the task in as few moves as 
possible. Tower tasks are thought to measure aspects of executive planning  (Menzies et 
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al., 2008), including the ability to plan, evaluate, and execute sequenced plans/responses 
accurately.  
Whether individuals diagnosed with OCD have executive functioning 
impairments is unclear. Some authors have reported mild impairments in executive 
planning (Purcell, Maruff, Kyrios, & Pantelis, 1998; Veale, Sahakian, Owen, & Marks, 
1996), no impairments (Watkins et al., 2005) or moderate impairments (Chamberlain et 
al., 2007; Nielen & Den Boer, 2003). One fMRI study by van den Heuvel et al. (2005) 
found that, in addition to poorer performance on the Tower of London task, individuals 
diagnosed with OCD tended to show differential anatomical recruitment in comparison 
to healthy controls. For instance, during the planning phases, healthy volunteers showed 
greater activation of the right dorsolateral prefrontal cortex, premotor cortex (right), 
cingulate cortex (left), precuneus (bilateral), inferior parietal cortex (left), caudate 
nucleus (right), and putamen (left) when compared with individuals diagnosed with 
OCD (Menzies et al., 2008; van den Heuvel et al., 2005). Or, stated more succinctly, the 
dorsolateral prefrontal-striatal circuit in individuals diagnosed with OCD appeared to be 
less responsive during executive planning processes when compared to healthy 
volunteers.  
 As the DLPFC has been implicated in a range of executive functions (Jurado & 
Rosselli, 2007), it has been difficult to determine precisely how underactivity within 
this region contributes to OCD. van den Heuvel et al. (2005) have posited a more 
central role of dorsolateral-prefrontal circuit dysfunction in OCD (and thus, more 
generalised executive impairments).  Similarly, other authors have suggested that 
decreased activity within the DLPFC may impair several aspects of executive 
functioning, including cognitive processes involved with inhibition or task-switching 
(the ability to flexibly change from one cognitive process to another) (Aouizerate et al., 
2004; Menzies et al., 2008). Executive impairments in either domain could potentially 
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explain why individuals diagnosed with OCD experience difficulties in 
suppressing/disregarding unwanted and pathological thoughts (i.e., obsessions), 
switching over to non-pathological thought processes or the inability to inhibit prepotent 
urges (i.e., compulsions). As the role of the DLPFC in the expression of OCD is less 
established, targeting this region with neurobiological treatments may have less clinical 
benefits. However, as the region is readily accessible with TMS, it has been extensively 
targeted with rTMS treatments, with overall mixed results (Sachdev, Loo, Mitchell, 
McFarquhar, & Malhi, 2007; Sachdev et al., 2001a) 
Supplementary Motor Area 
 The SMA is involved with the generation of sequenced motor movements and 
can be anatomically, and functionally divided into the pre-supplementary motor area 
(pre-SMA), and supplementary motor area proper (SMA-proper) (Nachev, Kennard, & 
Husain, 2008; Picard & Strick, 2001). The pre-SMA corresponds to more rostral regions 
of Brodmann area 6 (BA-6), whilst the SMA-proper corresponds to more caudal regions 
of BA-6 (Brodmann, 1909). Although there are several lines of research suggesting that 
the functions of the pre-SMA and SMA-proper can be partially separated (discussed 
further below). Nachdev et al. (2008) have emphasised that these functional anatomical 
distinctions can be more accurately understood in terms of their relative rather than 
absolute contributions.   
 With respect to functional neuroanatomy, researchers have attempted to 
discriminate between different functions subsumed by the pre-SMA and SMA-proper 
according to several dimensions. One dimension differentiates between self-initiated 
versus externally cued motor behaviours (Nachev et al., 2008). For instance, several 
studies have shown greater activation of the pre-SMA compared to the SMA-proper for 
self-initiated motor movements (Jenkins, Jahanshahi, Jueptner, Passingham, & Brooks, 
2000; Lau, Rogers, & Passingham, 2006; Nachev et al., 2008).  Another dimension 
Page 80 of 414 
 
relates to the initiation of behaviours involving cognitive input (i.e., the pre-SMA) as 
opposed to more ‘basic’ motor patterns (i.e., the SMA-proper) (Abramowitz, 1996; 
Nachev et al., 2008; Petit, Courtney, Ungerleider, & Haxby, 1998; Picard & Strick, 
2001). For instance, greater activation of the pre-SMA has been demonstrated during 
tasks of executive inhibition (Li, Huang, Constable, & Sinha, 2006), involving 
integration of arbitrary associations from different sensory modalities (visual and 
auditory; Kurata, Tsuji, Naraki, Seino, & Abe, 2000; Sakai et al., 2000), and tasks 
involving visual/spatial working memory (Petit et al., 1998; Picard & Strick, 2001). 
There is neuroimaging evidence to suggest that individuals diagnosed with OCD 
may have functional and neuroanatomical abnormalities within the pre-SMA in addition 
to the ACC. For instance, Yucel et al. (2007) compared cerebral activation in 
individuals diagnosed with OCD to a matched control sample on a task of executive 
inhibition referred to as the Multi-Source Interference Task (Bush & Shin, 2006). 
Although there were no differences in terms of task performance, the authors reported 
that individuals diagnosed with OCD tended to show greater relative activation of the 
pre-SMA and lower relative activation of the rostral anterior cingulate during high 
interference conditions. Moreover, Individuals diagnosed with OCD evidenced lower 
concentrations of the neuronal marker N-acetylaspartate acid, a marker of neural 
integrity (and thus, functionality) (Yeo, Brooks, & Jung, 2006) within the dorsal 
anterior cingulate (Yucel et al., 2007). The authors suggested that the greater activation 
observed within the pre-SMA in individuals diagnosed with OCD may reflect 
compensatory neuronal recruitment in response to reduced functionality within the 
dorsal anterior cingulate.  
The significance of these findings in relation to the pathogenesis of OCD, 
however, is not immediately clear. As suggested by Yucel et al. (2007), one possibility 
is that the hyperactivation observed within the pre-SMA may reflect compensation for 
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loss of functionality within the dorsal anterior cingulate. Under this interpretation, 
hyperactivation of the pre-SMA would be a consequence of decreased functionality 
within the dorsal anterior cingulate. Alternatively, it is possible that the overactivity 
observed within the pre-SMA may reflect a more primary deficit (Yucel et al., 2007). 
Or, more specifically, the overactivity within the pre-SMA may be indicative of 
excessive cognitive planning processes associated with the generation of sequenced 
motor movements in OCD. This proposal is plausible given the number of studies that 
have implicated the pre-SMA in self-initiated behaviours or behaviour requiring higher 
levels of cognitive control (Nachev et al., 2008). Much like the DLPFC, the role of the 
SMA in the expression of OCD is less clear. However, there is some evidence that the 
SMA may be an effective TMS treatment target (Mantovani, Simpson, Fallon, Rossi, & 
Lisanby, 2010a) 
Limitations of Neural-Circuitry Models of Obsessive-Compulsive Disorder 
There are several limitations to neuroanatomical models of OCD. Firstly, 
neuroanatomical models do not explain why individuals fixate on a small subset of 
obsessions, or compulsions (Maia, Cooney, & Peterson, 2008). Saxena and Rauch 
(2000) suggest that because the OFC mediates socio-territorial concerns such “danger, 
violence, hygiene, order, and sex” (p. 578) this marks the region as a prime candidate 
for pathological and recurrent cognitive processes (i.e., obsessions). However, the OFC, 
ACC, and motor regions are involved with multiple processes not limited to socio-
territorial concerns (Bush et al., 2000; Kringelbach, 2005; Kringelbach & Rolls, 2004; 
Nachev et al., 2008). On this logic, if these regions mediate multiple processes and the 
neural circuits are indeed dysfunctional such that cognitive, behavioural, and affective 
processes remain trapped, then other processes governed through those regions should 
also remain trapped, not just a smaller subset observed in OCD (Maia et al., 2008).     
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 A second issue is how the putative anatomical abnormalities first develop in 
individuals diagnosed with OCD. Although the OCD circuit hypothesis provides a 
working model that links functional anatomical abnormalities with symptom 
expression, the theory does not provide an explanation as to how and why these 
abnormalities develop from the outset (Maia et al., 2008). That is, the theory can 
explain the maintenance of the disorder, but not how it is caused. A related difficulty is 
how interactions between these regions may result in OCD. For instance, Maia et al. 
(2008) suggest that it is possible that pathological processes begin in one anatomical 
region and subsequently affects others. Alternatively, it could be that multiple brain 
regions are involved initially, but subsequently affect only a few key structures, or 
perhaps some combination of both (Maia et al., 2008).  
Implications for Treatment  
 The preceding sections identified several regions implicated in OCD that may be 
targeted with neurobiological treatments. Specifically, regions such as the OCF, ACC, 
caudate nucleus, and to a lesser extent the DLPFC and SMA. Indeed, invasive 
techniques have often targeted regions or networks connecting the identified regions 
(Greenberg et al., 2010b). For instance, ablative psychosurgical procedures for OCD 
have targeted connecting fibres between frontal regions and the thalamus (Mindus et al., 
1991), regions that connect to the OFC and ACC (Knight, 1973), and the ACC directly 
(Ballantine Jr, Bouckoms, Thomas, & Giriunas, 1987; Whitty, Duffield, Tow, & Cairns, 
1952). In deep brain stimulation, surgical targets for OCD include the internal 
capsule/ventral striatum (Greenberg et al., 2010a), and subthalamic nucleus (Mallet et 
al., 2008). Although these techniques have been shown to be effective for reducing 
OCD symptoms, they carry several serious side effects including incontinence, 
destruction of brain tissue, cyst formation and haemorrhaging (Greenberg et al., 2010b). 
Another neurobiological therapeutic approach that can target some of the regions 
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implicated in OCD but carries far less risk is through the use of NIBS techniques such 
as TMS (Greenberg et al., 1997). Indeed, several efforts have been made to evaluate the 
efficacy of rTMS for treating the primary symptoms of OCD (Jaafari et al., 2012; 
Trevizol et al., 2016). The following chapter presents the outcomes of a systematic 
review that evaluated the efficacy of TMS for treating OCD (Study 1, Chapter 4).  
Conclusions  
OCD is a debilitating illness characterised by unrelenting, intrusive thoughts. 
Individuals diagnosed with OCD often feel compelled to engage in ritualistic, time-
consuming behaviour, severely diminishing quality of life. Although the aetiology of 
OCD is unknown, the available evidence implicates neurochemical, behavioural, and 
cognitive factors in the pathogenesis of the disorder. Although a range of 
pharmacological, behavioural, and psychological treatments have been developed for 
the treatment of OCD, a sizable proportion of individuals do not respond adequately to 
current treatments (Abramowitz et al., 2005; Pallanti et al., 2002). Thus, there is a need 
to develop a wider range of safe, tolerable, and effective treatments for treating the 
illness. Neuroanatomical models of OCD can be used to guide the selection of 
therapeutic targets. One highly influential neuroanatomical model of OCD is the OCD 
Circuit Hypothesis proposed by Saxena and Rauch (2000). The model posits primary 
dysfunction in three regions including the ACC, OFC, and striatum. Other research has 
implicated the DLPFC, and SMA. In line with the first research focus, the following 
chapter will present a systematic review evaluating the efficacy of rTMS for treating 
OCD.  
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Chapter 4 – Study 1: A Systematic Review on the Efficacy of Transcranial 
Magnetic Stimulation for Treating Obsessive Compulsive Disorder 
 
Explanatory note 
The content presented in Chapter 3, Chapter 4 (Study 1) and Chapter 5 (Study 2) form 
part of the first research stream that sought to evaluate the potential of inter-regional 
priming protocols to be applied in the area of neuropsychology. The current chapter 
(Chapter 4) was included to inform the development of the multisite conventional 
repetitive transcranial magnetic stimulation protocol (rTMS) evaluated in Study 2 
(Chapter 5).  
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Study 1: A Systematic Review on the Efficacy of Transcranial Magnetic 
Stimulation for Treating Obsessive Compulsive Disorder 
 
Introduction  
Chapter 3 provided a comprehensive overview of anatomical regions implicated 
in obsessive compulsive disorder (OCD). It was also argued that neuroanatomical 
models of OCD can help guide the selection of treatment targets for neurobiological 
treatments including ablative psychosurgery (Greenberg et al., 2010a), and deep brain 
stimulation (Greenberg et al., 2010b). Another biological treatment approach that 
carries far fewer risk than major surgery is non-invasive brain stimulation (NIBS), 
specifically, repetitive transcranial magnetic stimulation (rTMS) (Wassermann et al., 
1995). Since the first open label trial conducted by Greenberg et al. (1997) revealed 
promising results that rTMS may be effective for treating OCD, other groups have 
evaluated the efficacy of rTMS for treating OCD (Berlim, Van den Eynde, & 
Daskalakis, 2013; Jaafari et al., 2012). Although evidence on the effectiveness of rTMS 
for OCD has been mixed, certain anatomical regions, rTMS parameters, and protocols 
may be effective for treating the illness.  
This systematic review was included as part of the first research stream 
examining the clinical utility of multisite rTMS paradigms. Specifically, this systematic 
review was performed to directly inform the development of the multisite rTMS 
protocol evaluated in the first empirical study of this thesis (Study 2, Chapter 5). This 
chapter had several aims. The first was to systematically evaluate the overall efficacy of 
rTMS for treating OCD. The second was to identify specific rTMS parameters that may 
be effective for reducing the symptoms of OCD. The third aim was to identify 
therapeutic targets to inform the development of multisite rTMS protocols. The final 
objective was to characterise the safety, tolerability, and side effect profile of rTMS.  
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Rationale  
 OCD is a severely debilitating illness hallmarked by unrelenting, persistent and 
intrusive thoughts (i.e., obsessions) that often compels individuals to engage in 
ritualistic or time consuming habitual behaviours (i.e., compulsions) (APA, 2013). 
Although pharmacological (Math & Janardhan Reddy, 2007), and psychosocial 
interventions (Abramowitz, 1996; Kobak et al., 1998) have been developed, between 40 
- 60% of individuals do not respond adequately to current treatments (Fineberg & Gale, 
2005; Pallanti et al., 2002).  Thus, a wider range of novel, safety, and effective 
treatments are needed to treat the condition.  
Inclusion and Exclusion Criteria 
 Given the wide range of potential rTMS parameters, and limited studies in this 
area, all clinical trials involving rTMS were included in this review including double 
blind randomised control trials (RCTs), single blind RCTs, open trials, and case reports. 
Moreover, studies using conventional rTMS or patterned rTMS (i.e., theta burst 
stimulation [TBS]) were included. The inclusion criteria were (1) participants had to 
have a primary diagnosis of OCD with either DSM-III (or higher) or ICD-10 criteria, 
(2) participants were 18-years or older, and (3) investigators used the Yale-Brown 
Obsessive Compulsive Scale (YBOCS) (Goodman et al., 1989) as the primary measure 
of OCD symptom severity. Papers written in a language other than English were 
excluded.  
Outcome Measures  
 The primary outcome measure was pre- and post-YBOCS measures of symptom 
severity (Goodman et al., 1989). Treatment response was defined as the proportion of 
individuals who evidenced a reduction of 25% or more on the YBOCS.  Reductions of 
25% (but less than 35%) on the YBOCS were defined as partial response according to 
the International Treatment Refractory OCD Consortium (Pallanti et al., 2002). 
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Reductions of 35% or higher were considered full response (Pallanti et al., 2002). 
Secondary outcome measures included pre- and post-measures of clinical mood scales 
(e.g. depression and anxiety scales), attrition rates, and adverse side effects experienced 
by participants in either active or sham conditions.   
Information Sources and Search Methodology  
 Articles were identified using electronic database searches and manually 
scanning the reference list of three previous reviews (Berlim et al., 2013; Blom, Figee, 
Vulink, & Denys, 2011; Jaafari et al., 2012; Martin, Barbanoj, Perez, & Sacristan, 
2003). The following databases were searched; Academic Search Complete, Masterfile 
Premier, Medline with Full Text, PsychArticles, PsycExtra, Psychology and 
Behavioural Sciences Collection and PsychINFO.  The following key terms were 
implemented in the search: transcranial magnetic stimulation, TMS, obsessive 
compulsive disorder, OCD, repetitive transcranial magnetic stimulation, rTMS, and 
magnetic stimulation. The electronic database search was conducted in March, 20140F1. 
Time limiters were not applied to maximise the number of identified papers.  
Data Collection Process 
 One investigator (M.D) conducted the literature search. Article titles and 
abstracts were screened for relevance and short-listed for inclusion. Two investigators 
(L.K.B and M.D.) independently applied pre-defined inclusion criteria to the short-
listed articles for inclusion in the final review. The corresponding author of four articles 
                                                 
 
1 I would like to acknowledge that there is a long period between the date the systematic review was 
conducted, and the subsequent submission of the thesis. Although an update was discussed, there were 
several reasons an update was decided against. The first reason was that the multisite rTMS protocol 
evaluated in the first empirical study (Study 3, Chapter 5) was developed as a direct consequence of the 
findings of the systematic review presented in the current chapter. Second, a meta-analytic review has 
since been conducted by Trevizol et al. (2016) and provides a stronger quantitative analysis on the 
treatment strength of rTMS for OCD. The systematic review presented in the current thesis is qualitative, 
and an update would not improve upon the meta-analytic review published by Trevizol et al. (2016).  
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were contacted to confirm whether participants were over the age of 18 at the time of 
study enrolment (Badawy, El Sawy, & El Hay, 2010; Mantovani et al., 2006; Sachdev 
et al., 2001a). Three authors confirmed that participants were 18 years or older during 
the trial (Kang et al., 2009; Mantovani et al., 2006; Sachdev et al., 2001b).  
Data Items 
 Data was extracted for the following variables; (1) participant characteristics 
(age, primary diagnosis, and portion of participants on concurrent medication 
regiments), (2) study design (double blind RCT, single blind RCT, open trials and case 
studies and blinding procedures), (3) number of cortical regions stimulated, (4) region/s 
stimulated, (5) rTMS stimulation protocol (conventional and patterned rTMS), (6) 
rTMS parameters (pulse frequency, inter-train interval, percentage of active or resting 
motor threshold and single session duration), (7) treatment length (hours, days or 
weeks), (8) follow up periods, (9) pre- and post-treatment YBOCS scores, (10) pre- and 
post-treatment mood scale scores, (11) attrition rates, and (12) reported side effects.  
Results 
Study selection  
 Sixteen studies were identified and included in the final review. Figure 2 
presents a flow diagram of the study selection process in accordance with the PRIMSA 
guidelines (Liberati et al., 2009). The electronic database literature search using the 
search terms and strategy outlined above, resulted in the identification of 206 articles 
(duplicate entries were removed by the automated database duplicate removal function). 
All articles were exported to Endnote (version X7.0.2) for secondary duplicate removal 
over two stages. Stage 1 involved the use of the duplicate removal function in Endnote 
with 184 papers retained. Stage two involved manual removal of duplicate items not 
identified in the first phase with 177 articles retained (29 duplicates removed after 
completion of Stage 1 and Stage 2). Article titles and abstracts were screened for 
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relevance. Twenty-four potential articles were retained (153 articles discarded). The 
reference lists of four previous reviews were manually searched for additional articles 
(Arévalo, Baldo, & Dronkers, 2012; Berlim et al., 2013; Blom et al., 2011; Jaafari et al., 
2012; Martin et al., 2003; Ward, Brown, Thompson, & Frackowiak, 2003) with the 
identification of one article . Thus, twenty-five potential papers were identified. Each 
article was read in full and inclusion criteria were applied. One study Greenberg et al. 
did not use the YBOCS and was excluded (Greenberg et al., 1997). One article was a 
conference abstract (Talaei, Morteza-Nia, Jafar-Zadeh, Saghebi, & Ardani, 2009). Three 
studies (Alves Mendes-Filho, Belmonte-de-Abreu, Pedrini, Tosetto Cachoeira, & Maria 
Inês Rodrigues, 2013; Mantovani et al., 2007; Salatino, Momo, Nobili, Berti, & Ricci, 
2014) reported on individuals without a primary diagnosis of OCD. One paper did not 
report diagnostic criteria (Mantovani, Westin, Hirsch, & Lisanby, 2010c). One paper 
(Mantovani et al., 2013a; Mantovani, Shubeck, Gowatsky, Simpson, & Greenberg, 
2013b) reported on follow up findings from a previous study (Mantovani et al., 2010a). 
Two articles (Downar et al., 2013; Mantovani et al., 2013b) were abstracts presented at 
conferences. Finally, the minimum age (> 18 years) of participants in one article could 
not be confirmed (Badawy et al., 2010). Overall, ten studies did not meet pre-specified 
inclusion criteria.  























Figure 2.  Flow diagram of study selection protocol (Liberati et al., 2009).  
Records identified through 
database search  
(n = 206) 
Records after duplicates 
removed  
(n = 177) 
Records screened 
 (n = 177) 
Records excluded  
(n = 153) 
Articles assessed for eligibility  
(n = 25) 
Studies included in qualitative 
synthesis  
(n = 16) 
Excluded Articles (n = 10)  
Primary diagnosis not OCD: 3 
Study did not use YBOCS: 1 
Report on same individual: 1 
Did not report diagnostic criteria: 1 
Additional findings from previous study: 1 
Conference Abstract: 2 
Minimum age not reported: 1 
 
 
Additional records identified through other 
sources  
(n = 1) 
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Study Design, Descriptive Study Characteristics and Tolerability  
 The 16 included studies utilised a range of study designs (summarised in Table 
3). They included eight double blind RCTs (Alonso et al., 2001; Gomes, Brasil-Neto, 
Allam, & Rodrigues de Souza, 2012; Kang et al., 2009; Ma et al., 2014; Mansur et al., 
2011; Mantovani et al., 2010a; Prasko et al., 2006; Sachdev et al., 2007),  two single 
blind RCTs (Ruffini et al., 2009; Sarkhel, Sinha, & Praharaj, 2010), three open trials 
(Kumar & Chadda, 2011; Mantovani et al., 2006; Sachdev et al., 2001b), and three case 
reports (Bishnoi & Jhanwar, 2011; Talaei et al., 2009; Wu et al., 2010). All participants 
were 18 years or older and had a primary diagnosis of OCD according to DSM-III (or 
higher) or ICD-10 criteria.  
 
Table 3 





Total N Age (mean; SD) Diagnosis Treatment 
Length 
Follow Up Attrition Adverse Effects 
(n) 
Dorsolateral Prefrontal cortex 





18 Active: 39.2 (13) DSM-IV 6 weeks 10 weeks None Mild headache 
(1) 
   
   
Sham: 30.3 (9.5)  
     
Sachdev et 
al.  





30 Active: 28.9 (7.7)  ICD-10  2 weeks 2 weeks  3 None reported 
    
   
Sham: 33.4 (8.7) & DSM-
IV 
    
Sachdev 
   et al. 
2007 Double 
blind RCT 
18 Active:29.5 (9.9) 
Sham:35.8 (8.2) 









and weepiness (2) 
Kang et al. 
    
2009 Double 
blind RCT 
20 Active: 28.6 
(12.66) 
Sham: 26.2 
(10.52)     
DSM-IV 2 weeks 2 weeks 1 Transient 
headache (2), 
localised scalp 
pain (1)  
Sarkhel et 
al.  
2010 Single blind  42 Active: 29.38 
(6.55) 
Sham: 31.95 
(7.81)   






27 Active: 42.1 
(11.9) 
Sham: 39.3 
(13.9)     










2011 Case report 1 52 DSM-IV-
TR 
36 weeks Final 
session 
None None reported 
Ma et al. 2014 Double 
blind, RCT 




DSM-IV 2 weeks 1 week 4 Mild headache (5 




Supplementary Motor Area 
       
Mantovani 
et al.  
2006 Open trial 7 33.5 (13.48) DSM-IV-
TR:  
2 weeks Final 
session  
2 None reported 
   




    
Talaei et 
al. 






None None reported 
    
         
Mantovani 





18 Active: 39.6 (8.6) 
Sham: 39.4 
(10.2)  
DSM-IV 4 weeks 2 weeks 3 Headache, neck 








fainting (n = 1) 
Kumar et 
al. 
2011 Open trial  12 33.17 (12.74) ICD-10 Unclear Final 
session 
1 Moderate, 





22 Active: 35.5 (7.5) DSM-IV-
TR 
2 weeks 12 weeks None Headache (3), 
localised scalp 
pain (2)  
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Sham: 37.5 (16)  
     
Orbitofrontal Cortex 
       
Ruffini et 
al. 
2009 Single blind 
RCT 
23 Not reported DSM-IV-
TR 
3 weeks 12 weeks None None reported 
          
Theta Burst Stimulation - Dorsolateral Prefrontal Cortex 
     
Wu et al. 2010 Case report 1 33 DSM-IV Phase 1: 
10 weeks 
24 hours None None reported 
      




Note. DSM-IV – Diagnostic and Statistical Manual of Mental Disorders Version 4; DSM-IV-TR – Diagnostic and Statistical Manual of 
Mental Disorders Version 4 Text Revision; ICD – International Statistical Classification of Diseases; OCD – obsessive compulsive 
disorder; RCT – randomised control trial; TS – Tourette’s syndrome
Eight studies employed treatment lengths of two-weeks (Gomes et al., 2012; 
Kang et al., 2009; Ma et al., 2014; Mantovani et al., 2006; Prasko et al., 2006; Sachdev 
et al., 2007; Sachdev et al., 2001a; Sarkhel et al., 2010), two studies used six-week trials 
(Alonso et al., 2001; Mansur et al., 2011), and four trials with treatment lengths of three 
(Ruffini et al., 2009), four (Mantovani et al., 2010a), 12 (Talaei et al., 2009), and 36 
weeks (Bishnoi & Jhanwar, 2011). The follow up periods ranged from 24 hours (Wu et 
al., 2010) to 12 weeks (Ruffini et al., 2009). 
Study Quality Assessment  
 Study quality was evaluated using an adapted version  of the Downs and Black 
(1998) checklist by one author (M.D). For item 27, the author assessed whether there 
was sufficient power (≥ 0.8) at p > 0.05 to detect changes in YBOCS scores using 
G*Power 3.1 (Cincotta & Ziemann, 2008). Studies with sufficient power were allocated 
a score of 1. Studies with inadequate power (or where power calculations were not 
possible) were allocated a score of 0. The study scores ranged from 9 to 25 (maximum 
of 28) with an average score of 18.5. 
Safety Profile  
Nine studies reported minor, but common side effects, including transient 
headaches, localised scalp pain/discomfort, facial nerve stimulation, feeling faint/dizzy, 
weepiness, cervical pain (i.e. neck and shoulder pain), hearing impairment, impaired 
cognitive performance, and concentration difficulties (Alonso et al., 2001; Gomes et al., 
2012; Kang et al., 2009; Kumar & Chadda, 2011; Ma et al., 2014; Mansur et al., 2011; 
Mantovani et al., 2010a; Sachdev et al., 2007; Sachdev et al., 2001b; Sarkhel et al., 
2010). One participant fainted during threshold determination (Mantovani et al., 2010a). 
No seizures were reported. Regarding attrition, seven studies reported withdrawals 
(Kang et al., 2009; Kumar & Chadda, 2011; Ma et al., 2014; Mansur et al., 2011; 
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Mantovani et al., 2006; Mantovani et al., 2010a; Prasko et al., 2006). Of 298 individuals 
receiving rTMS, only 17 have withdrawn representing an attrition rate of 5.70%. 
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Target Regions, Localisation Methodology and rTMS Protocols   
 Table 4 summarises study design, targeted brain region, localisation methods, 
and rTMS parameters. Few cortical regions have been targeted including the right- and 
left-dorsolateral prefrontal cortex (DLPFC), supplementary motor area (SMA), and left-
orbitofrontal cortex (OFC). Regarding localisation, three studies defined the left- or 
right-DLPFC as 5 cm anterior to the abductor pollicis brevis hotspot (Mansur et al., 
2011; Prasko et al., 2006; Sarkhel et al., 2010), whilst two defined the region as 5 cm 
anterior to the first dorsal interosseous hotspot (Sachdev et al., 2007; Sachdev et al., 
2001b).  One study employed magnetic resonance imaging (MRI)  guided localisation 
techniques (Alonso et al., 2001). Three studies defined the SMA as 15% of the distance 
between the inion and nasion, anterior to Cz according to the 10-20 
electroencephalography (EEG) system (Gomes et al., 2012; Mantovani et al., 2006; 
Mantovani et al., 2010a). One study employing a multisite sequentially applied rTMS 
design targeted the right-DLPFC (5 cm to the abductor pollicis brevis), then SMA (15% 
of the distance between the nasion-inion anterior to Cz) (Kang et al., 2009). One study 
defined the SMA as region Fz using the 10-20 EEG system (Kumar & Chadda, 2011). 
Another study defined the left-OFC as region FP1 using the 10-20 EEG system (Ruffini 
et al., 2009).  One study targeted the right-DLPFC (Bishnoi & Jhanwar, 2011), and 
another targeted the right-SMA (Talaei et al., 2009) but neither reported the localisation 
method.  
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Table 4 









Target Localisation / 
Sham Method 
Coil  HF / 
LF 
rTMS Parameters  No. of 
Sessions 




2001 Active (10) R-DLPFC MRI guided modelling Circular LF 1 Hz, 100% of MT, 20 
min  
18 
    
 








2001 Active (6) R-DLPFC 5cm anterior to right 
DIM 
Figure 8  HF 10 Hz, 5 s train, 25s 
inter-train, 30 trains, 
110% of RMT 
10 
    
 
Active (6) L-DLPFC 5cm anterior to left DIM Figure 8  HF 10 Hz, 5 s train, 25s 
inter-train, 30 trains, 




2006 Active (18) L-DLPFC 5cm anterior to APB  Figure 8  LF 1 Hz, 110% of MT, 30 
min  
10 
   
 







2007 Active (10) L-DLPFC 5cm anterior to DIM  Figure 8  HF 10 Hz, 5 s train, 25 s 
inter-train, 30 trains, 
110% of MT 
10 
     
 
Sham (8) L-DLPFC Active coil discharged at 







2009 Active (10)  Sequential: 
R-DLPFC, 
SMA 
R-DLPFC: 5cm anterior 
to APB; 15%, pre-SMA 
rule 
Figure 8  LF, 
LF 
R-DLPFC: 1 Hz, 110% 
of RMT, 10 min 
duration; SMA: 1 Hz, 
100% of RMT, 10 min  
10 
    
 
Sham (10) Sequential: 
R-DLPFC, 
SMA 









2010 Active (21) R-DLPFC 5cm anterior to APB  Figure 8 HF 10 Hz, 4 s train, 20 
trains, 110% of MT; 
inter-train unspecified  
10 
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al.   
2011 Active (13) R-DLPFC  5cm anterior to APB  Figure 8 HF  10 Hz, 5 s train, 25 s 
inter-train, 40 trains, 
110% of MT  
30 
    
 








Phase 1 (1) 
R-
DFLPFC 
Unspecified Unspecified  ? Unspecified 60 




R-DLPFC Unspecified Unspecified  ? Unspecified 
 




10-20 EEG system 
(Avram et al., 2013) 
Circular   HF 8.1 - 10.9 Hz 
(individualised alpha 
EEG), 4 s train, 20 trains, 
56 s inter-train interval 
80% of MT 
10 




Active coil discharged 
60cm away  
   
10 
Supplementary Motor Area 
 
Mantovani 
et al.  
2006 Active (5) pre-SMA 15%, pre-SMA rule Figure 8 LF 1 Hz, 5 min train, 2 min 
inter-train, 100% of 




2009 Active (1) SMA Vertex Unspecified HF 5 Hz, inter-train not 
specified, 50% of MT, 
10 min  
20 
     
  




et al.  
2010 Active (9) pre-SMA 15%, pre-SMA rule Figure 8 LF 1 Hz, 100% of RMT, 20 
min  
20 
     
 





2011 Active (12) SMA Fz using 10-20 EEG 
system 
Figure 8 LF 1 Hz, 10 s train, 15 s 





2012 Active (12) pre-SMA 15%, pre-SMA rule Figure 8 LF 1 Hz, 100% of RMT, 
20min  
10 
Page 100 of 414 
   
Sham (10) 
  






2009 Active (16) L-OFC FP1, 10-20 EEG  Figure 8 LF 1 Hz, 80% of RMT, 
10min 
15 
   
 






Theta Burst Stimulation - Dorsolateral Prefrontal Cortex  
Wu et al. 2010 Active (1) R-DLPFC Unspecified  Figure 8 cTBS 3 pulses at 50 Hz, 200 
ms interval, 20 s train, 4 
trains, at 80% AMT 
(1,200 pulses/session) 
10 
   
L-DLPFC Unspecified  Figure 8 iTBS  3 pulses at 50hz, 2 s 
train, 10 s inter-train, for 
400 s, at 80% of AMT 
(1,200 pulses/ session) 
10 
Note. 15% pre-SMA rule - 15% of the distance between inion and nasion anterior to Cz; APB - abductor pollicis brevis muscle; cTBS – 
continuous theta burst stimulation; DIM – dorsal interosseous muscle; DLPFC – dorsolateral prefrontal cortex; EEG – 
electroencephalography; HF – high frequency; iTBS – intermittent theta burst stimulation; L – left; LF – low frequency; OFC – orbital 
frontal cortex; R – right; RMT – resting motor threshold; SMA – supplementary motor area.  
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 The most commonly used coil was a figure of 8 coil (n = 12), followed by 
circular coils (n = 2). Two studies did not provide coil information (Bishnoi & Jhanwar, 
2011; Talaei et al., 2009). Generally, high-frequency rTMS was applied at 10 Hz, 5 s 
trains, with 25 s inter-train intervals, with the number of trains ranging from 20 (Sarkhel 
et al., 2010) to 40 trains (Mansur et al., 2011). Researchers using low frequency 
parameters applied 1 Hz rTMS for 10 (Ruffini et al., 2009) - 30 min (Prasko et al., 
2006) with stimulus intensities ranging between 80 (Ruffini et al., 2009) - 110% of 
RMT (Sachdev et al., 2001b). 
 One study used low frequency rTMS applied sequentially to two regions (Kang 
et al., 2009). Kang et al. (2009) used low frequency rTMS parameters of 1 Hz at 110% 
of RMT targeting the right-DLPFC for 10 min, and 100% of RMT targeting the SMA 
for 10 min. One paper has reported using TBS (Wu et al., 2010). In their case report, 
Wu et al. (2010) applied stimulation sequentially using a combination of continuous 
theta burst stimulation (cTBS), and intermittent theta burst stimulation (iTBS). The 
cTBS parameters were 3 pulses at 50 Hz repeated at 5 Hz, at 80% of AMT for 4 20 s 
trains (1,200 pulses total). For iTBS, they applied 3 pulses at 50Hz, 2 s trains, with 10 s 
inter-train intervals, at 80% of AMT, for 400 s (1,200 pulses per session).  One case 
report did not specify their rTMS parameters (Bishnoi & Jhanwar, 2011).  
 Ma et al. (2014) employed individualised high frequency rTMS parameters set 
at individual peak EEG frequencies in the alpha band. They delivered 4 s high 
frequency rTMS trains with pulses delivered between 8.1Hz to 10.9Hz, with an inter-
train interval of 56 s for 20 trains at 80% of motor threshold for two weeks. The total 
number of treatment sessions range between 10 (Prasko et al., 2006) - 60 sessions 
(Bishnoi & Jhanwar, 2011) with two weeks being the most common (n =  9).  
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Study Summaries – The Dorsolateral Prefrontal Cortex 
 Although open label trials targeting the DLPFC were promising (Bishnoi & 
Jhanwar, 2011; Sachdev et al., 2001b), more controlled trials have not provided strong 
evidence supporting the application rTMS over the DLPFC for OCD (Alonso et al., 
2001; Kang et al., 2009; Mansur et al., 2011; Prasko et al., 2006; Sachdev et al., 2007). 
Table 5 summarises the major findings for the primary (i.e., YBOCS), and secondary 
(i.e., negative mood) outcome measures and are presented as a function of target region, 
and year of publication. 
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Table 5 
Summary of the Primary and Secondary Outcomes Measures, Results and Response Rates 


















: n  
Dorsolateral Prefrontal cortex 
Alonso 
et al. 
2001 Active  R-DLPFC 24.0 (5.3) 20.6 (9.1) N.s. main 
effects or 
interaction 





N.s. main effects 
(group or time) 
or interaction 
(group x time) 
Active: 2 
Sham: 1  






2001 Active  R-DLPFC 27.17 
(6.25) 
12 (3.94) N.s. effect of 
group or 
interaction 
(group x time).  
Main effect of 





(18.96)   
N.s. main effect 
of group (group 
or time) or 
interaction 
(group x time) 
for mood 
measures. Main 
effect of time for 
STAI-I            
Right: 2 
Left: 2    
 
  
BDI: 23.2 (12.5)  BDI: 11.60 






(8.81)   
























Main effect of 
group and time.   
N.s. interaction 





N.s. main effect 
of group or 
interaction 
(group x time) 
for mood 
measures. Main 














































2007 Active  L-DLPFC 25.8 (5.7) - N.s. main effect 
of group or 
interaction 
(group x time). 
Main effect of 
time @ 4 weeks 
MADRS: 16.1 
(8.6)  
- N.s. main effect 
of group or 
interaction 
(group x time). 








Open: 6  








17.6 (6.4)  
- 







Sham  L-DLPFC 23.9 (9.9) - MADRS: 16.3 
(11.4)  
- 
   
 
  




16.4 (6.0)  
- 














N.s. main effect 
of group or 
interaction 
(group x time). 






N.s. main effect 
of group or 
interaction 
(group x time) 
for mood 
measures. Main 


















(5.01)   

































    




Main effect of 
group. N.s. main 
effect of time or 
interaction 






(group x time) 
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et al.   
 
2011 Active  R-DLPFC 30.0 (3.7)  25.00 
(8.39) 
Main effect of 
time. N.s. main 
effect group or 
interaction 





N.s. main effect 
of group or 
interaction 
(group x time) 
for all mood 
measures. Main 






















(20.72)   


























2011 Phase 1 R-DLPFC 32 15 No formal 
analyses  
- - - Active: 1  
 
Phase 2 R-DLPFC 
       





(group x time) 
@ week 2 and 3 
HAMD-17: 




(group x time) 
for all mood 
measures 
Active: 13 












(0.58)    





12.00 (6.40)  
HAMD-17: 9.0 




12.14 (3.89)  
HAMA-14: 
9.52 (2.79)     
 
  
CGIS: 5.1 (0.60)  CGIS: 3.71 
(0.64)  
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Supplementary Motor Area 
Mantov
ani et al. 
2006 Active  Pre-SMA 36.4 (7.5) 26 (10.5) YBOCS 
reductions over 
time (7: 5 OCD 
and 2 OCD+TS 
- carry forward 
method) 
CGI: 5.9 (1.1)  CGI: 3 (1.6)  Main effect of 
time for all 
mood measures 
OCD: 3 
          
HAMA: 24.1 
(10.7)  







(10.7)   
 
  




















 et al. 
2009 Active SMA 38 9 - - - - Active: 1 
Mantov
ani et al. 
2010 Active  pre-SMA 26 (5.4) 19.4 (5.6) N.s. main effect 
of group or 
interaction 
(group x time). 








& CGIS. Main 








    
HAMD: 15.3 
(10.6)  
 HAMD: 12.1 


















(6.5)    
 
  
CGIS: 5 (0.7)  CGIS: 4.1 (0.9)    
 
  
PGI: 4.2 (0.9) PGI: 3.5 (1.1)    
Sham  pre-SMA 26.7 (5.5) 23.5 (9) YBOCS-SR: 
27.3 (6.9)  
YBOCS-SR: 

















Page 107 of 414 




35.6 (8.3)  
Zung-SAS: 32.1 
(6.4)     
 
  
CGIS: 5.2 (0.9)  CGIS: 5 (1.3)     
 
  
PGI: 5.2 (0.8) PGI: 4.7 (1.3)  
Kumar 
et al. 







et al.  
    
2012 Active  pre-SMA 36.4 (3.20)  23.7 
(3.89)  
Sig. interaction 
(time x group) 








BAI & CGIS @ 
2 weeks. Sig. 
interaction @ 14 
weeks for CGIS 
Active: 22 
Sham: 10     
BDI-II: 28.6 
(3.70)  
 BDI-II: 22.3 






17.6 (7.2)   
 
  
CGIS: 5.5 (0.43)   CGIS: 2.83 
(0.44)??  
Sham  pre-SMA 31.8 (3.50)  29.8 (4.2)  HAMD-24: 18.7 
(7.70)  
HAMD-24: 
16.2 (6.4)      
BDI-II: 24.9 (4)  BDI-II: 21.7 






25.3 (5.2)     
 
  








Sig.  interaction 
(group x time) at 
3 and 10 weeks, 
but not 12 
weeks 
- - No interactions 
for all mood 
measures 
Active: 12 
Sham: 1   









2010 Active  R-DLPFC 19 8 No formal 
analyses 
HAMD: 49 HAMD: 29  No formal 
analyses 
1  
   
  
L-DLPFC 8 9 
 
HAMD: 29 HAMD: 15 
  
Note. B – bilateral; BAI – Beck Anxiety Inventory; BDI - Beck Depression Inventory;  BDI-II – Beck Depression Inventory II; CGIS – 
Clinical Global Impression Scale; DLPFC – dorsolateral prefrontal cortex; HAMA - Hamilton Rating Scale for Anxiety; HAMD – 
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Hamilton Rating  Scale for Depression ; L – left; MDRS – Montgomery-Asberg Depression Rating Scale; MAUDSLEY-I - Maudsley 
Obsessive-Compulsive Inventory; n.s. – not significant; OFC – orbital frontal cortex; PGI – Patient Global Impression Scale; R – right; 
SAD – Scale for Auto-evaluation for Depression; SASS – Social-Adaptation Self-Evaluation Scale; SCL-90 – Symptoms Check-List-90; 
SF-36 – Medical Outcomes Study 36-item Short-form Health Survey; sig. – significant; SMA – supplementary motor area; STAI-I 
Spielberger State-Trait Anxiety Inventory-State;  YBOCS – Yale-Brown Obsessive Compulsive Scale; YBOCS-SR – Yale-Brown 
Obsessive Compulsive Scale-Self Rated; ZUNG-SAS – Zung Self-Administered Scale. 
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In an early open trial, Sachdev et al. (2001b) applied high frequency rTMS over 
the left- or right-DLPFC and reported reductions in OCD symptoms for up to 1 month. 
Later studies employing both single- and double-blind RCT designs were unable to 
confirm the superiority of active over sham stimulation. Three studies using single and 
double blind RCT designs targeting the left- (Sachdev et al., 2007), and right-DLPFC 
(Mansur et al., 2011; Sarkhel et al., 2010) with high frequency rTMS were unable to 
demonstrate the efficacy of active over sham stimulation. Of note, high frequency rTMS 
of the right-DLPFC may confer antidepressant, and anxiolytic effects as evidenced by 
the interaction effect found in the trial by Sarkhel et al. (2010). Finally, two double 
blind RCTs targeting the left- (Prasko et al., 2006), and right-DLPFC (Alonso et al., 
2001) with low frequency rTMS parameters were ineffective.    
Two double blind RCTs have used relatively novel treatment designs, albeit, 
with mixed findings. Kang et al. (2009) were the first to apply multisite rTMS 
sequentially to the right-DLPFC, then SMA using low frequency rTMS parameters but 
did not find robust differences between the active and sham groups. Ma et al. (2014) 
targeted the left- and right-DLPFC simultaneously (circular coil) using individualised, 
high frequency rTMS parameters. At the end of the two-week trial, the authors found 
significant differences between active and sham stimulation that was maintained at the 
one-week follow up. 
Finally, Bishnoi and Jhanwar (2011) reported a case study on a 52 year old 
female who underwent two phase stimulation of the right-DLPFC. The stimulation 
parameters were not reported. In the first phase, they received 30 sessions over 6 weeks 
(5 sessions per week). In the second, they received an additional 30 sessions over 30 
weeks (1 session per week). They received 60 sessions in total. Over the length of the 
treatment course, their YBOCS score decreased from 32 to 5, representing an 84% 
reduction in symptoms.    
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Study Summaries – Supplementary Motor Area  
 In contrast, there is moderate evidence supporting the administration of low 
frequency rTMS over the SMA for treating OCD. This conclusion is based on two open 
trials (Kumar & Chadda, 2011; Mantovani et al., 2006), one case report (Talaei et al., 
2009), and two double blind RCTs (Gomes et al., 2012; Mantovani et al., 2010a). In the 
open trial by Mantovani et al. (2006), the authors showed low frequency rTMS over the 
SMA can reduce OCD symptoms at two-weeks follow up. The other open trial by 
Kumar and Chadda (2011) used comparable low frequency rTMS parameters and also 
reported reductions in OCD symptoms in their sample of 12 individuals.  
 Two follow up studies using double blind RCT design have provided some 
evidence that active stimulation may be superior to sham. Mantaovani et al. (2010a) 
applied low frequency rTMS parameters of 1Hz for 20 min (100% of MT) for two 
weeks leading to a reduction in participant self-rated YBOCS scores but not for 
clinically rated YBOCS scores two weeks post treatment for the active stimulation 
group. The second trial by Gomes et al. (2012), using identical low frequency rTMS 
parameters, found greater YBOCS reductions in the active stimulation group at the end 
of the two-week trial, and at a three month follow.  
 Finally, Talaei et al. (2009) reported on a 40 year old female participant who 
underwent a two-phase trial targeting the SMA bilaterally, then the right-SMA using 
high and low frequency rTMS, respectively. The authors reported that low frequency 
rTMS decreased their symptoms by 76% (YBOCS reduced from 38 to 9).  
Summaries - Orbitofrontal Cortex 
 Only one trial has targeted the OFC reporting promising results. Ruffini et al. 
(2009) utilised a single blind RCT targeting the left-OFC with low frequency rTMS 
parameters. Their sample comprised 23 participants randomly allocated to active (n = 
16), or sham (n = 7) stimulation. Individuals were administered 15 sessions of 10 min 
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duration over three weeks (five sessions per week). Symptoms were rated at baseline, at 
the end of the three-week trial and every two weeks thereafter for 12 weeks post 
treatment. The authors found significant differences between the active and sham 
groups at up to 10 weeks post stimulation. However, these differences were lost at 12 
weeks follow up.  
Theta Burst Stimulation – Dorsolateral Prefrontal Cortex  
  Finally, one study has trialled TBS. The single case report conducted by Wu et 
al. (2010) reported on a 33-year old participant with treatment resistant OCD, and 
concomitant MDD. The treatment protocol consisted of two phases targeting different 
regions. In the first phase, they were administered 10 sessions of cTBS targeting the 
right-DLPFC over four-weeks. One week later, they were administered 10 sessions of 
iTBS over the left-DLPFC over two-weeks. At the end of both phases, their symptoms 
reduced from 19 to 8 on the YBOCS (58% reduction). 





Overall, the findings of this systematic review do not clearly demonstrate the 
efficacy of TMS for treating OCD. However, there are enough rTMS trials that can be 
used to inform the development of new treatment protocols. As several reviews have 
been published (Berlim et al., 2013; Blom et al., 2011; Jaafari et al., 2012; Martin et al., 
2003; Trevizol et al., 2016), and in a departure from those reviews, the findings from 
the current systematic review will be interpreted with reference to neuroanatomical 
models of OCD. 
As described in Chapter 3, accepted neuroanatomical models of OCD posit 
primary dysfunctions within the OFC, ACC, and striatum  (Graybiel & Rauch, 2000; 
Saxena & Rauch, 2000). Secondary regions include the DLPFC, and SMA (Aouizerate 
et al., 2004; Huey et al., 2008; Menzies et al., 2008; Milad & Rauch, 2011; Yucel et al., 
2007). As the primary dysfunctions observed in OCD are thought to manifest from the 
overactivity within the OFC, ACC and striatum, these regions would be ideal targets for 
biological interventions such as rTMS. A limitation of TMS, however, is that depth of 
penetration (~20 mm) limits researchers to cortical regions (Rudiak & Marg, 1994) that 
makes targeting deep frontal (i.e., the OFC), and subcortical regions (i.e., ACC, and 
striatum) difficult. Thus, secondary regions such as the DLPFC, and SMA have been 
targeted.  
Stimulation of the Dorsolateral Prefrontal Cortices  
From a neurobiological perspective, if the DLPFC is indeed underactive in 
individuals diagnosed with OCD (Saxena & Rauch, 2000), high frequency rTMS over 
the DLPFC could normalise activity within the region. Although neuroimaging data 
indicate the DLPFC is less responsive in individuals diagnosed with OCD (van den 
Heuvel et al., 2005), this region has not been as consistently implicated in the disorder 
(Aouizerate et al., 2004; Menzies et al., 2008; Saxena & Rauch, 2000). The DLPFC 




thus appears to play a secondary role in the pathogenesis of the OCD and that could 
partly explain why targeting the DLPFC has been met with limited success (Blom et al., 
2011; Jaafari et al., 2012).  For instance, although the results of one open trial targeting 
the DLPFC using high frequency rTMS parameters was promising (Sachdev et al., 
2001b), the negative results from one single blind RCT  (Sarkhel et al., 2010) targeting 
the right-DLPFC, and two double blind RCTs (Mansur et al., 2011; Sachdev et al., 
2007) targeting the right and left, respectively, suggest that the DLPFC may not be a 
suitable region for reducing primary OCD symptoms. Of note, the largest TMS trial to 
date (n = 42) conducted by Sarkhel et al. (2010) demonstrated that high frequency 
rTMS of the right-DLPFC led to significant decreases on two measures of negative 
mood; the Hamilton Rating Scale for Depression (1960) and Hamilton Rating Scale for 
Anxiety (cited in Sarkhel et al., 2010). Thus, high frequency rTMS of the right-DLPFC 
may have confer antidepressant benefits.   
Another potential hypothesis is because the DLPFC has direct projections to the 
striatum (Alexander & Crutcher, 1990; Alexander, DeLong, & Strick, 1986), and the 
striatum has been shown to be overactive in individuals with OCD (Saxena & Rauch, 
2000), low frequency rTMS over the DLPFC may have distal effects on subcortical 
structures not directly accessible with TMS (Alonso et al., 2001; Rudiak & Marg, 
1994). Thus, by modulating the striatum indirectly via stimulation of the DLPFC, it may 
be possible to effect changes within pathological subcortical regions. However, the 
negative results from three double blind RCTs, one targeting the left and two targeting 
the right (Alonso et al., 2001; Kang et al., 2009; Prasko et al., 2006), suggests low 
frequency rTMS over the dorsolateral prefrontal cortices is not effective for reducing 
OCD symptoms. Thus, there is little evidence to support low frequency rTMS over the 
dorsolateral prefrontal cortices for treating OCD (Blom et al., 2011; Jaafari et al., 2012).  
 




Stimulation of the Supplementary Motor Area  
 Similarly, although neuroimaging data indicate the SMA may be hyperactive in 
individuals diagnosed with OCD (Yucel et al., 2007), the SMA does not feature 
prominently in most neurobiological models of OCD (Aouizerate et al., 2004; Graybiel 
& Rauch, 2000; Huey et al., 2008; Menzies et al., 2008; Saxena & Rauch, 2000). 
Nonetheless, the results of two open trials (Kumar & Chadda, 2011; Mantovani et al., 
2006), one case report (Talaei et al., 2009), and two double blind RCTs (Gomes et al., 
2012; Mantovani et al., 2010a) indicates this region may be a viable therapeutic target. 
rTMS protocols targeting the SMA have utilised low frequency rTMS parameters 
(Jaafari et al., 2012) that may normalise the hyperactivity within the SMA. However, 
this conclusion should be made cautiously as although the results of the double blind 
RCT by Gomes et al. (2012) were positive, the other double blind RCT conducted by 
Mantavani et al. (Mantovani et al., 2010a) only found reductions on the self-rated 
version of the YBOCS rather than the clinically rated scales.  
Stimulation of the Orbitofrontal Cortex  
In contrast, the OFC is the only region that has been consistently implicated in 
OCD (Saxena & Rauch, 2000; Whiteside, Port, & Abramowitz, 2004). As such, the 
OFC features more prominently in most neurobiological models of OCD (Aouizerate et 
al., 2004; Graybiel & Rauch, 2000; Huey et al., 2008; Menzies et al., 2008; Milad & 
Rauch, 2011; Saxena & Rauch, 2000). As the OFC has been shown to be overactive in 
OCD, it could be hypothesised that normalisation of this region could be achieved 
through modulatory rTMS. Indeed, the positive findings from one single blind RCT 
conducted by Ruffini et al. (2009) have provided initial support for this hypothesis. In 
their study, the authors demonstrated that low frequency rTMS over the OFC led to a 
reduction in primary OCD symptoms compared to sham (Ruffini et al., 2009). It is 
possible that low frequency rTMS normalises overactivity within the OFC. The findings 




from the Ruffini et al. (2009) study therefore suggest that this region may be a suitable 
target for future interventions.  
Conclusions  
 OCD is a severely debilitating illness with an estimated 40 – 60 % of individuals 
failing to receive adequate symptom relief (Abramowitz et al., 2005; Fineberg & Gale, 
2005; Pallanti et al., 2002). Although several rTMS interventions indicate the technique 
may have therapeutic potential, there is currently only low-to-moderate evidence 
supporting its use for treating OCD. rTMS parameters delivered at varying stimulus 
strengths, frequencies, and target regions have been evaluated with evidence supporting 
the administration of low frequency rTMS over the OFC, or SMA. Administration of 
high frequency rTMS over the DLPFC may confer antidepressant effects. One novel 
approach would be to target multiple regions in the same protocol (Kang et al., 2009; 
Ma et al., 2014). A preliminary step is to evaluate the feasibility, safety, and tolerability 
of a multisite rTMS protocol. To this end, the following chapter reports on the findings 
of the first empirical study (Study 2, Chapter 5) that evaluated the safety, and 
tolerability of a multisite rTMS protocol developed from the combined findings of 
Chapter 2, Chapter 3, and Chapter 4 (Study 1).  




Chapter 5: Study 2: Examining the Feasibility and Tolerability of a Clinically 
Informed Multisite, Repetitive Transcranial Magnetic Stimulation Protocol 
 
Explanatory note 
Collectively, Chapter 3, Chapter 4 (Study 1) and Chapter 5 (Study 2) formed part of the 
first research stream that evaluated the potential of multisite rTMS paradigms for use in 
clinical settings. Chapter 5 presents on the findings of the first empirical study (Study 2) 
that examined the feasibility, safety and tolerability of a multisite rTMS paradigm 
informed from the findings of Chapter 3, and the systematic review presented in 
Chapter 4 (Study 1). The version of the manuscript prior to acceptance and publication 
has been included to maintain consistency with the formatting of this thesis. As a result, 
some of the headings, figures and tables were reformatted. Full citation information 
along with digital online identifier (DOI) is included below. This is followed by an 
Authorship Statement signed by each author of the manuscript. The reference list and 
Appendix associated with the publication has been included at the end of this chapter. 
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• We evaluate the safety and tolerability of multi-site brain stimulation.  
• Low and high frequency rTMS is applied sequentially to three cortical regions.  
• The multi-site protocol is safe and tolerable.  
• Participants receiving active stimulation reported more side effects.  









Background: Repetitive transcranial magnetic stimulation (rTMS) applied to multiple 
cortical regions is finding increased application particularly within the area of clinical 
psychiatry.  
New Method: This study was conducted to systematically evaluate the safety, 
tolerability and neurocognitive effects of rTMS applied to three cortical regions over a 
period of three months.   
New Method: Twenty healthy participants aged 22 – 33 years were randomly allocated 
to receive one session of active or sham stimulation of low and high frequency rTMS 
applied sequentially to the pre-supplementary motor area, right-dorsolateral prefrontal 
cortex and left-orbitofrontal cortex totalling nine minutes. Tolerability and safety was 
evaluated using a standardised safety questionnaire. Neurocognitive functioning was 
examined using the Cambridge Neuropsychological Test Automated Battery and 
measures of verbal fluency from the Delis-Kaplan Executive Functioning TestTM at five 
time points over three months.  
Results: The protocol was safe and tolerable. Frequencies of minor adverse effects were 
higher in active (17 endorsements) than sham (1 endorsement) conditions. No between 
group differences in neurocognitive functioning were identified over three months.  
Comparison with Existing Method(s): This study is the first evaluate the feasibility of 
low and high frequency parameters applied sequentially in a single session to three 
cortical regions whilst providing neurocognitive data.  
Conclusions: rTMS applied sequentially over three cortical regions was found to be safe 
and tolerable in healthy individuals with no major neurocognitive effects over three 
months. Such findings can be used to inform the development of rTMS protocols 
involving multi-site stimulation.  




Keywords: Repetitive transcranial magnetic stimulation; Safety; Tolerability; Multisite; 
Neurocognition.  





Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain 
stimulation technique which uses electromagnetic fields to repetitively stimulate nerve 
cells (Rossi, Hallett, Rossini, & Pascual-Leone, 2009). rTMS applied at different 
frequencies can modulate both cortical excitability and neurocognitive functioning 
(Fitzgerald, Fountain, & Daskalakis, 2006; Guse, Falkai, & Wobrock, 2010). For 
instance, low frequency stimulation (≤ 1Hz ) has been observed to decrease excitability 
(Fitzgerald, Fountain, et al., 2006). In contrast, high frequency stimulation (> 1Hz) has 
been shown to increase cortical excitability (Fitzgerald, Fountain, et al., 2006). With 
regard to neurocognitive functioning, high frequency stimulation has been shown to 
improve memory performance (Wang et al., 2014), processing speed (Pearce et al., 
2014) and reaction time (Pascual-Leone et al., 1993). In one study, low frequency rTMS 
increased participant’s willingness to accept unfair monetary offers (Knoch, Pascual-
Leone, Meyer, Treyer, & Fehr, 2006). 
More recently, researchers have begun to experiment with rTMS protocols 
involving sequential stimulation to multiple cortical regions (Fitzgerald, Benitez, et al., 
2006; Kang, Kim, Namkoong, Lee, & Kim, 2009). The findings from multisite cortical 
stimulation could be used to inform the development of more effective non-invasive 
brain stimulation treatments for psychiatric disorders and to open up new avenues for 
exploring the neurophysiology and underlying neural circuitry of the human brain.  
To add to this area, the current study was conducted to systematically assess the 
tolerability, safety profile and feasibility of sequentially applied, multisite rTMS using a 
novel combination of high and low frequency parameters to three cortical regions using 
a single-blind randomised control trial. A secondary aim was to evaluate any potential 
acute or long term changes to neurocognitive functioning over three months.  




5.1.2 Materials and methods  
5.2.1 Participants 
Twenty participants (15 females, 5 males) aged 22 – 33 years (M= 25.75, SD = 
2.59) completed the study. Participants were 18 years or older, free of neurological, 
psychological and physiological health conditions, right-handed and spoke English as 
their primary language. Participants were renumerated with a $20.00 gift voucher. 
Standard exclusionary criteria were applied (Rossi et al., 2009).  All participants 
provided fully informed, voluntary consent. The study protocol was approved by the 
Deakin University Human Research Ethics Committee.  
5.2.2 Materials  
The tolerability and safety of the rTMS protocol was evaluated using a 
standardised adverse effects questionnaire requiring participants to indicate ‘Yes’ or 
‘No’ to a range of adverse effects (e.g. headaches, neck pain; Rossi et al., 2009). If 
participants answered affirmatively to any of the side effect questions, they were also 
required to indicate the severity of the side effect on a 5-point Likert scale (anchor 
points: 1 ‘mild’; 5 ‘severe’).  
Participants were also administered six tests from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB, 2006) suite. The Reaction 
Time Task (RTI; parallel mode) assesses response speed (milliseconds) requiring 
participants to respond to a visual cue and to select a visual stimulus located in a single 
or multiple (five) locations. The dependent measures were response latencies to a visual 
cue (reaction times) and the time taken to touch the visual object (movement times) for 
single and multiple locations. The Affective Go/No-Go (AGN) assesses affective 
attentional bias and inhibitory response control. Participants are rapidly presented with 
words of either positive (e.g. ‘happy’) or negative (e.g. ‘negative’) valence and respond 
via a touch pad to a target valence (e.g. positive words) whilst ignoring distractors (e.g. 




negative words). The order of presentation was NNPPNNPP. The dependent measures 
were the mean correct response latencies (milliseconds) for negative, positive and 
combined conditions and combined errors of commission and omission.  The Paired 
Associates Learning (PAL; parallel mode) task measures visual learning and memory. 
Participants are presented with two, three, six or eight patterns hidden behind six or 
eight boxes. The location of each pattern is ‘revealed’ in a randomised order then 
‘hidden’. Participants are required to memorise and locate each pattern. The dependent 
measure was the number of patterns located correctly on the first attempt (ranging 
between 0 - 21) with higher values indicating better memory performance.  
 The Intra/Extra Dimensional Set Shift (IED) task measures rule acquisition and 
rule reversal ability. The task requires participants to acquire a rule (and to reverse that 
rule once the contingencies change) in relation to sets of patterns that vary over one 
dimension (intra-dimensional shift), then to acquire (and reverse) a set of rules over a 
second dimension (the extra-dimensional shift). The dependent measure was the number 
of trials undertaken for completed stages. The Stockings of Cambridge (SOC) measures 
forward planning and spatial working memory. The task requires participants to recreate 
coloured ball patterns in as few moves as possible. The dependent measures were the 
number of problems solved using the minimum number of moves. Finally, the Spatial 
Working Memory (SWM) task was included which measures spatial working memory 
and strategic searching. Participants are presented with boxes in sets of four, six and 
eight and are required to locate ‘tokens’ hidden behind the boxes. The dependent 
measure was the search strategy score.    
Verbal fluency was assessed using the Delis-Kaplan Executive Functioning 
TestTM. Participants were administered the Letter (FAS), Category (animals and boy’s 
names) and Switching (fruits and furniture) Fluency tasks. The dependent measure was 
the number of items correctly generated. Intelligence Quotient (IQ) was estimated using 




the Test of Premorbid Functioning (Pearson, 2009) by converting raw scores to 
standardised IQ equivalents.  
5.2.3 Stimulator and Coil  
 Stimulation was administered using the Magstim Rapid2 (Magstim Co., UK). 
The pulse generated by the device was a biphasic waveform with a cycle period of 400 
µs. Stimulation was delivered using a 70 mm air cooled figure of eight coil or identical 
sham coil (Magstim Co., UK) and was held in an anterior-posterior position (electrical 
lead pointing backwards) parallel to the scalp.  
5.2.4 Threshold Determination, Cortical Region Identification and rTMS 
Stimulation Parameters  
Active motor threshold (AMT) was established using the first dorsal 
interosseous muscle of the right hand as the reference muscle following previously 
published protocols (Rossini et al., 1994) procedure. Electromyography activity 
recordings (PowerLab, USA) were amplified (x1000) with bandpass filtering between 
10 Hz and 1 kHz and digitised at 1.5 kHz for 500 ms. Cortical regions were defined 
using the 10-20 electroencephalography system (Jasper, 1958). Neuronavigation was 
not employed. rTMS was applied sequentially to three regions in the following order; 
the pre-supplementary motor (SMA) area defined as 15% of the distance between the 
inion and nasion along the mid-sagittal plane anterior to Cz (vertex)(Kang et al., 2009) 
using low frequency parameters of 1Hz at 80% of AMT for 3 min. The right-
dorsolateral prefrontal cortex (DLPFC) defined as region F4 and stimulated with high 
frequency parameters of 5Hz, 5 s trains, with an inter-train interval of 25 s, for 3 min (6 
trains total). Finally, the left-orbitofrontal cortex (OFC) defined as region Fp1 was 
stimulated using low frequency parameters of 1Hz at 80% AMT for 3 min.  





 Participants were allocated to active or sham stimulation using a randomised 
computer-generated schedule. The neurocognitive battery was administered in the 
following order: RTI, AGN, PAL, IED, SOC, SWM, Letter, Category and Switching 
Fluency and took one hour to administer. The study was conducted in a quiet 
laboratory. In the first session, participants were administered baseline measures, 
followed by motor threshold determination procedures (30 min). They were then 
administered the rTMS protocol (nine min), followed by the safety questionnaire (5 
min). Within 5 min, participants were readministered the neurocognitive battery then 
followed up after 7 days, then an average of 30.30 days and 91.00 days.  
5.2.6 Data Analysis 
 Data were checked for outliers and normality using histograms and 
Kolmogorov-Smirnov statistics. Data transformations (log10) to approximate normality 
were applied, where appropriate. Mixed between-within Analysis of Variance 
(ANOVA) was used to compare participant neurocognitive performance at five time 
points. Where normality could not be assumed, we performed Mann-Whittney U Tests 
for comparing independent groups at the post-stimulation time point. For demographic 
data, we ran independent sample t-tests (parametric data) and Mann-Whittney U Tests 
for comparing independent groups (non-parametric data). All tests were considered 
significant at p < 0.05. Tabulated data are presented as means, standard deviations or 
frequency counts. Analyses were conducted using SPSS version 22. There was no 









5.3.1 Demographics  
Demographic variables and associated statistical tests are presented in Table 6. There 
were no differences between active and sham conditions in mean age, years of 
education (Md [active] = 17.00), Md [sham] = 18.50) or estimated IQ.  





Demographic Variables (Means and Standard Deviations) and Responses to Adverse 
Effects Questionnaire (Frequency Counts) as a Function of Group (Active versus Sham 
Stimulation)  
 Active  (n = 10) 
Sham 
(n = 10)   
Demographics Mean (SD) Mean (SD) Test Statistic  
Age 26.20 (2.66) 25.3 (2.58) t (18) = .77, p = .45, η = .03 
Years of education 17.80 (3.55) 18.70 (1.95) U = 41, z = -.71, p = .48, r = .16 
Estimated IQ 110.70 (11.69) 114.50 (8.03) t (18) = -.85, p = .41, η = .04 
Guess Frequency Frequency  
Active  7 7  
Sham  3 3  
Adverse Side Effects  Frequency Frequency    
Dizziness 0 0  
Ear pain 0 0  
Electrode burns 0 0  
Fainting  0 0  
General discomfort 4 0  
General unease 1 0  
Head pain 1 0  
Headache 3 0  
Bodily pains 0 0  
Migraine 0 0  
Muscle pain 1 0  
Neck pain 1 0  
Nervousness 2 1  
Not feeling quite right 1 0  
Scalp pain  1 0  
Speaking difficulties  1 0  
Thinking difficulties  0 0  
Tooth ache 1 0  
Weepiness  0 0  
Shoulder pain 0 0   
Totals 17 1  
 




5.3.2 Tolerability and Adverse Effects 
 All participants tolerated the stimulation protocol. The results of the adverse 
effects questionnaire (Table 1) indicate that those in the active stimulation group 
experienced a higher number of side effects (17 endorsements) when compared to those 
in the sham group (1 endorsement). The most frequently endorsed items included 
general discomfort (n = 4) followed by headache (n = 3). 
5.3.3 Neurocognitive Battery  
 There were no significant interactions or group effects for any of the 
neurocognitive measures (for brevity, only tasks with significant time effects are 
presented in Appendix A). For the RTI five-choice movement time, there was a main 
effect of time with both groups showing increased reaction times, Wilks Lambda = .54, 
F (4, 15) = 3.25, p = .041, ηp2 = .47.  For the AGN task mean correct latencies in the 
positive valence condition, there was a main effect of time with increased participant 
response latencies, Wilks Lambda = .44, F (4, 15) = 4.87, p = .010, ηp2 = .57. For the 
AGN total number of errors (errors of commission and omission combined) for both 
positive and negative valence conditions, there was a main effect of time with 
participants committing fewer errors, Wilks Lambda = .52, F (4, 15) = 3.44, p = .035, 
ηp2 = .48. Finally, for the FAS Verbal Fluency Task there was a main effect of time with 
participants generating a greater number of words, Wilks Lambda = .24, F (4, 15) = 
11.82, p = < .001, ηp2 = .76.  
5.4. Discussion  
Overall, it was found that rTMS applied using a combination of high and low 
frequency parameters sequentially to the pre-SMA, right-DLPFC and left-OFC in a 
single session was safe and tolerable. Anecdotally, those in the active group reported 
greatest discomfort over the left-OFC, possibly due to direct stimulation of facial 
muscles or nerves. The most commonly reported adverse effects for those receiving 




active stimulation were headaches (30%) and general discomfort (40%) which is 
consistent with previous safety reviews (Rossi et al., 2009).  Additionally, there were no 
discernible differences in neurocognitive functioning between active and sham 
conditions either immediately after stimulation or over three months. Importantly, the 
performance of those in the active group was not impaired. Although improvements 
were found in the verbal fluency task (FAS), verbal fluency is susceptible to practice 
effects (Wilson, Watson, Baddeley, Emslie, & Evans, 2000). Thus, the improvements 
found in this study likely reflect practice effects due to repeated testing with the same 
stimuli rather than true gains.  
Limitations of the study included the relatively low stimulation threshold and the 
time-limited effects of a single session of rTMS (Fitzgerald, Fountain, et al., 2006). As 
there are no guidelines for multisite stimulation for combinations of high and low 
frequency parameters (Rossi et al., 2009; Wassermann, 1998), lower stimulation pulse 
strengths (80% of ATM) were used as a safety margin. Stronger pulse strengths could 
be used in future. Second, the effects of rTMS (albeit, when measured in terms of 
cortical excitability and inhibition) are generally limited to minutes (Fitzgerald, 
Fountain, et al., 2006). Thus, it is possible that subtle neurocognitive effects may not 
have been detected towards the end of the neurocognitive battery. Alternatively, more 
robust effects may not have been induced because participants only underwent a single 
session. Future studies may wish to use more targeted measures or to administer rTMS 
over multiple sessions.  
5.5. Conclusion 
rTMS applied sequentially using a combination of high and low frequency 
parameters applied to three cortical regions in a single session was found to be safe and 
tolerable in a sample of healthy volunteers. Furthermore, we offer evidence on the long 




term safety of rTMS. These preliminary findings can be used to inform the development 
of future rTMS protocols involving sequentially applied, multi-site cortical stimulation.  
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Neurocognitive Performance on the CANTAB and Verbal Fluency Measures Presented as Means (SD ) as a Function of  
Group (Active versus Sham Stimulation)
  Pre-Test Post-Test 7 days  30 days 90 days ANOVA (time) 
Reaction Time Task  
        
Wilks 
λ  F p ηp
2 
5-Choice reaction time             










0.54 3.26 0.041 0.47 










        
Affective Go/No-Go              
Positive latency                 










0.44 4.87 0.01 0.57 










        
Total errors             
Active  9.50     
(6.72) 
6.80       
(4.31) 
8.50     
(4.17) 
7.20      
(4.87) 
6.50       
(4.67) 
0.52 3.44 0.035 0.48 
Sham  9.40      
(6.99) 
11.00     
(7.35) 
6.80      
(5.35) 
5.80      
(6.49) 
5.30      
(4.45) 
        
Verbal Fluency (FAS)           
Active  41.10 
(11.87) 








0.24 11.82 < .001 0.76 








55.30    
(8.59) 
        




Chapter 6 – Theta Burst Stimulation, Meta-Plasticity, Priming Protocols  
Introduction  
 Chapter 3, Chapter 4 (Study 1), and Chapter 5 (Study 2) collectively formed the 
efforts of the first research stream that evaluated the potential of multisite repetitive 
transcranial magnetic stimulation (rTMS) protocols for clinical applications. The 
findings of the first empirical study presented in Study 2 (Chapter 5) provided 
preliminary evidence regarding the safety, and tolerability of a multisite repetitive rTMS 
protocol informed by neuroanatomical models of obsessive-compulsive disorder (OCD) 
presented in Chapter 3, and the findings of the systematic review presented in Chapter 4 
(Study 1). Most notably, Study 2 (Chapter 5) revealed that multisite rTMS was safe, and 
tolerable with no differences in neurocognitive functioning observed over a 3-month 
period between those receiving active or sham stimulation.  
Another important consideration when developing multisite rTMS protocols for 
clinical applications not only involves the identification of potential neuroanatomical 
targets, but also the selection and combination of non-invasive brain stimulation (NIBS) 
paradigms and stimulation parameters. Indeed, there is an emerging body of literature 
showing the protocol and stimulation parameters used to prime or condition the target 
brain region can significantly alter the usual or expected neuroplastic effects induced by 
a single administration of a NIBS neuro-modulatory paradigm (Iyer, Schleper, & 
Wassermann, 2003; Karabanov et al., 2015). With increasing use of priming protocols 
for neurophysiological (Goldsworthy et al., 2012; Hamada et al., 2008; Karabanov et 
al., 2015; Potter-Nerger et al., 2009), cognitive (Murakami et al., 2015), and therapeutic 
applications (Kang et al., 2009; Ma et al., 2014; Prasser et al., 2015), the findings from 
the inter-regional priming NIBS literature has several important implications for the 
selection of appropriate paradigms and stimulation parameters, in addition to 
neuroanatomical targets.   




These considerations led to a shift from the first research stream that evaluated 
the clinical potential of rTMS paradigms for clinical applications, to the second research 
stream that sought to characterise the neurological effects induced by multisite rTMS 
priming protocols. The second research stream is comprised of the work presented in 
Chapter 6, Chapter 7 (Study 3), Chapter 8, and Chapter 9 (Study 4). As mentioned, the 
findings from this area can be used to inform the development and optimisation of 
multisite priming rTMS protocols that target neuroanatomical regions implicated 
disorders including obsessive compulsive disorder (Kang et al., 2009; Ma et al., 2014), 
but also tinnitus (Lehner et al., 2013), major depressive disorder (Prasser et al., 2015), 
and Parkinson’s disease (Boggio et al., 2005). Moreover, inter-regional priming 
protocols may induce more predictable, and robust neuroplastic effects (Goldsworthy, 
Müller-Dahlhaus, Ridding, & Ziemann, 2014b; Goldsworthy et al., 2012), and reduce 
the high levels of inter-individual variability often reported following application of 
neuro-modulatory NIBS techniques (Fitzgerald et al., 2006; Goldsworthy et al., 2012; 
Hamada et al., 2012; Ridding & Ziemann, 2010; Wiethoff et al., 2014).  
With the second research stream in mind, this chapter was thus written with 
several aims. The first was to characterise the effects of a subtype of rTMS referred to 
as theta burst stimulation (TBS) that was used in Study 3 (Chapter 7), and Study 4 
(Chapter 9). TBS has been increasingly adopted as it can induce comparable 
neuroplastic effects to conventional rTMS (Fitzgerald et al., 2006; Huang et al., 2005), 
with the added benefits of short administration times (< 3 min), and greater tolerability 
due to reduced stimulus pulse intensities. This chapter begins with a brief description of 
TBS protocols used to induce neuroplastic effects in animal models that inspired the 
development of TBS protocols used in humans. The second aim was to characterise the 
neurological effects of TBS on the human primary motor cortex (M1). It will be argued 
that although TBS can modulate M1 excitability, these effects can show a high degree 




of variability. In line with the second research stream, the third aim was to characterise 
the neuro-modulatory effects induced by intra- and inter-regional priming protocols. 
Another aim was to identify priming protocols that may induce more consistent, and 
robust neuroplastic effects on M1. The M1 region was selected as it remains the 
prototypical model for priming NIBS. A model that can account for the complex 
neuroplastic effects induced by priming protocols referred to as the Bienenstock, 
Cooper, and Munro (BCM) theory of homeostatic meta-plasticity will be introduced 
(Bienenstock, Cooper, & Munro, 1982). In this latter section, the initial focus will be on 
intra-regional priming of M1, followed by inter-regional multisite priming. The findings 
from this chapter were used to inform the selection of target brain regions and multisite 
rTMS parameters evaluated in the second empirical study (Chapter 7).  
Theta Burst Stimulation - Animal Models 
TBS paradigms used in humans were inspired by electrical stimulation protocols 
involving the delivery of electrical stimuli in the theta range that could induce 
neuroplastic effects in animal models (Huang et al., 2011). In one study, Diamond et al. 
(1988) applied electrical stimulation in the rat using primed stimulation. This involved 
the administration of a single pulse delivered 140-170 ms (i.e., within the theta range) 
prior to a brief train of stimuli delivered at 100 Hz. This protocol induced strong long-
term potentiation (LTP) with a single train of patterned stimulation lasting at least 30 
min with strongest effects occurring within 5 min (200% increase over baseline). They 
applied the same TBS protocol, in vivo, and induced LTP in most samples (78%), and 
recordings (65%), with the effects lasting up to 3 hr. Administration of N-methyl-D-
aspartate receptor (NDMAR) antagonists AP45, and PCP blocked LTP induction.  
In another study, Hess et al. (1996) investigated the effects of TBS (10 trains at 
5 Hz, with 4 pulses at 100 Hz per train), in vitro, in the rat M1 (layers II/III). The 
authors applied TBS using single or bi-electrode arrays, arranged horizontally or 




vertically, with and without infusion of a gamma amino butyric acid receptor (GABAR) 
antagonist (bicuculline methiodide). The authors induced long lasting LTP (> 60 min) 
with single TBS trains delivered in preparations conditioned with bic infusion. More 
robust effects could be achieved using double electrodes arranged horizontally. LTP 
induction was impaired with administration of an N-methyl-d-aspartate receptor 
(NMDAR) antagonist (APV) indicating that the effects were NMDAR dependent.  
Theta Burst Stimulation - Human Studies 
Huang et al. (2005) were the first to adapt TBS protocols used in animals studies 
for use in humans. In their seminal paper, the authors reported on three TBS protocols, 
composed of the same basic stimulation configuration was capable of inducing LTP- 
and long-term depression (LTD)-like effects on M1 excitability (Huang et al., 2005). 
The basic TBS pattern involved the delivery of three pulses at 50 Hz (one pulse every 
20ms), repeated at 5 Hz (i.e., every 200 ms within the theta frequency) with the stimulus 
pulse strength set at 80% AMT due to prior safety concerns (Huang & Rothwell, 2004). 
The following sections focus on the two more commonly applied forms of TBS.  
Continuous Theta Burst Stimulation  
One variant was referred to as continuous theta burst stimulation (cTBS) and 
involved continuous administration of the TBS pattern for 20 s (300 total pulses; 
cTBS300), or 40 s (600 pulses; cTBS600) (Huang et al., 2005). In their original study, 
the authors reported that stimulation of the M1 hand region with cTBS300 or cTBS600 
induced strong suppression of motor evoked potential (MEP) amplitude responses in the 
contralateral first dorsal interosseous (FDI) by approximately 50% for up to 20 and 60 
min, respectively (Huang et al., 2012). Similar inhibitory effects on corticospinal 
excitability have been reported by other groups using comparable parameters (Chung et 
al., 2016; Iezzi et al., 2008; Martin, Gandevia, & Taylor, 2006; Murakami, Sakuma, 
Nomura, Nakashima, & Hashimoto, 2008; Suppa et al., 2008; Zafar, Paulus, & 




Sommer, 2008). cTBS also appears to have distal effects on the unstimulated, 
contralateral M1 (Stefan, Gentner, Zeller, Dang, & Classen, 2008; Suppa et al., 2008). 
Stefan et al. (2008) and Suppa et al. (2008) showed that cTBS (cTBS300 and cTBS600, 
respectively) applied over the M1 hand representation induced facilitation of MEP 
responses measured from the contralateral M1 region.  
Some studies, however, have reported that the effects of cTBS on corticospinal 
excitability are less consistent than those reported in the initial study by Huang et al. 
(2005). In one of the largest studies to date, Hamada et al. (2012) administered a single 
train of cTBS600 at 80% AMT in a sample of 52 participants and found no significant 
changes in corticospinal excitability at the group level. In other words, they were unable 
to replicate the robust LTD-like effects reported by Huang et al. (2005). Hamada et al. 
(2012) also investigated the role of intra-cortical inter-neural networks in contributing to 
the variability in responses. Specifically, they examined whether individual MEP 
latencies could be used to predict neuroplastic responses to cTBS600. They used 
different coil orientations to preferentially recruit intra-cortical inter-neural networks in 
M1 involved with the general of D-waves (latero-medially induced currents), early I-
waves (posterior-anteriorly induced currents), or late I-waves (antero-posteriorly induce 
currents). They found that individuals with longer MEP latencies between the latero-
medial and anterior-posterior induced currents (> 4 ms) showed the usual suppressive 
effects to cTBS600 (59%) on MEP amplitudes. In contrast, those with shorter MEP 
latencies (< 4 ms) showed the opposite facilitatory effects of corticospinal excitability. 
In another set of findings, Goldsworthy et al. (2014a) simulated the effects of muscle 
contraction during AMT determination using  2 min contraction of the target FDI 
muscle just prior to cTBS600 delivered at 70% resting motor threshold (RMT). The 
authors found prior contraction of the target muscle resulted in highly variable 




neuroplastic responses with some participants showing no change (50%), facilitation 
(20%), and inhibition (30%).  
The physiological mechanisms underlying the effects induced by cTBS are not 
fully understood (Huang et al., 2011). There is evidence that cTBS is NMDAR 
dependent (Huang, Chen, Rothwell, & Wen, 2007).  Huang et al. (2007) reported that 
administration of an NMDAR antagonist (memantine) inhibited the usual suppressive 
effects induced by cTBS300. There is also evidence that cTBS preferentially affects 
neural populations involved with the generation of early I-waves (Di Lazzaro et al., 
2005). Di Lazzaro et al (2005) measured responses to spTMS from the high cervical 
spine in patients with chronic pain following administration of cTBS300 at 80% AMT. 
They showed that early I-wave responses were supressed, whereas D- and later I-waves 
were less affected by the protocol.  
Neuroplastic responses to cTBS also appear to be moderated by genetic factors 
(Cheeran, Koch, Stagg, Baig, & Teo, 2010). Cheeran et al. (2008)  showed that the 
single nucleotide polymorphism of brain-derived neurotropic factor (BDNF) Val66Met 
predicts whether individuals exhibit the expected LTD-like effects to cTBS. BDNF is 
neurotrophin that moderates LTP and LTD induction in animal models (Aicardi et al., 
2004), with certain gene variants associated with hippocampal volumes in humans (Lu, 
2003; Pezawas et al., 2004). Individuals with the Val/Val allele variant showed the 
usual suppressive effects on M1 excitability lasting up to 25 min, whereas individuals 
with the non-Val/Val allele showed no sustained changes in M1 excitability. A 
summary of the above findings is presented in Table 8.





Effects of Continuous Theta Burst Stimulation on Corticospinal Excitability 
Author (year) N  Brain 
region 
Condition  Protocol Intensity Target 
muscle/region 
Neurological effects 
Cheeran et al. (2008) 9  M1 Val/Val group cTBS300 80% AMT FDI ↓ MEP  
9  M1 non-Val/Val group cTBS300 80% AMT FDI No change (MEP) 
Di Lazzaro et al. (2005) 4  R-M1 Chronic pain patients  cTBS600 80% AMT L-FDI, cervical  ↓ I1-wave, D-wave (no 
effect), I3-wave (no 
effect) 
Goldsworthy et al. (2014) 10  L-M1  cTBS600 70% RMT R-FDI ↓ MEP 
 10  L-M1 FDI 2 min 
contraction (pre-
cTBS) 
cTBS600 70% RMT R-FDI No change (MEP) 
 36  L-M1  cTBS600 70% RMT R-FDI ↓ MEP 
Hamada et al. (2012) 52  L-M1  cTBS600 80% AMT R-FDI No change (MEP) 
Huang et al. (2005) 9  L-M1 
 
cTBS600 80% AMT R-FDI ↓ (MEP)  
9  L-M1 
 
cTBS300 80% AMT R-FDI ↓ (MEP) 
Huang et al. (2007) 6  L-M1 NMDAR antagonist 
(memantine) 
cTBS300 80% AMT R-FDI No change (MEP) 
 
6  L-M1 Placebo  cTBS300 80% AMT R-FDI No change (MEP)  
5  L-M1 NMDAR antagonist 
(memantine) 
cTBS300 60% AMT R-FDI  No effect 
Huang et al. (2008)  9  L-M1 
 
cTBS300 80% AMT R-FDI ↓ MEP  
9  L-M1 FDI contraction 
during intervention 
cTBS300 80% AMT R-FDI No change (MEP) 
Iezzi et al. (2008)  10  L-M1 
 
cTBS300 80% AMT R-FDI, R-APB ↓ MEP  
Martin et al. (2006) 8  L-M1  
 
cTBS600 80% AMT R-FDI ↓ MEP 
McAllister et al. (2009) 9  M1 
 
cTBS600 70% AMT FDI No change (MEP) 
Murakami et al. (2008) 6  L-M1 
 
cTBS600 80% AMT R-FDI ↓ MEP 
Stefan et al. (2008) 14  L-M1 
 
cTBS300 70% RMT L & R-APB ↓ MEP R-APB; no change 
to MEP L-APB 




 14  R-M1  cTBS300 70% RMT L & R-APB ↓ MEP L-APB; ↑ MEP R-
APB 
Suppa et al. (2008) 15  R-M1 
 
cTBS600 80% AMT L & R-FDI ↓ MEP L-FDI  
10  R-M1 
 
cTBS600 80% AMT R-FDI ↑ MEP R-FDI  
5  R-M1 
 
cTBS600 80% AMT R-FDI ↓ MEP R-FDI  
5  R-M1 AP-PA current  cTBS600 80% AMT L & R-FDI ↓ MEP L-FDI, ↑ MEP R-
FDI  
5  R-M1 PA-AP current  cTBS600 80% AMT L & R-FDI No change  
5  L-M1 AP-PA current  cTBS600 80% AMT L & R-FDI ↓ MEP R-FDI, ↑ MEP L-
FDI  
5  L-M1 PA-AP current  cTBS600 80% AMT L & R-FDI No change (MEP) 
Talelli et al. (2007) 10  L-M1 PA-AP current  cTBS600 80% AMT R-FDI ↓ MEP  
 
10  L-M1 AP-PA current  cTBS600 80% AMT R-FDI No change (MEP) 
 
10  L-M1 AP-PA current  cTBS600 100% AMT R-FDI  ↓ MEP 
Todd et al. (2009) 20  L-M1  cTBS600  80% AMT R-FDI No change (MEP) 
Zafar et al. (2008)  9  L-M1 AP-PA  cTBS600 80% AMT R-ADM  ↓ MEP  
9  L-M1 PA-AP currents  cTBS600 80% AMT R-ADM ↓ MEP  
9  L-M1 Half-sine AP-PA  cTBS600 80% AMT R-ADM ↓ MEP  
9  L-M1 Half-sine PA-PA  cTBS600 80% AMT R-ADM ↓ MEP 
Note. ADM – abductor digiti minimi; AMT – active motor threshold; AP – anterior-posterior; APB – abductor pollicis brevis; cTBS – 
continuous theta burst stimulation; D – direct-wave; FDI – first dorsal interosseous; I – indirect-wave; L – left; MEP – motor evoked 
potential; M1 – primary motor cortex; PA – posterior-anterior; RMT – resting motor threshold; R – right. 




Intermittent Theta Burst Stimulation 
 The other variant was referred to as intermittent theta burst stimulation (iTBS). 
The iTBS protocol comprised 3 pulses at 50 Hz, delivered in bursts of 5 Hz for 2 s, with 
inter-train-intervals of 8 s, repeated for 190 seconds (600 total pulses) (Huang et al., 
2005; Rossi et al., 2009). Although early reports indicated that iTBS could induce 
robust facilitation of M1 excitability (Hoogendam et al., 2010; Huang et al., 2005), 
subsequent studies have also shown the effects of iTBS to be more variable (Hamada et 
al., 2012). In their original study, Huang et al. (2005) showed that iTBS600 (600 total 
pulses) applied to the M1 hand representation induced strong facilitation of MEP 
responses in the contralateral FDI muscle for approximately 20 min after stimulation. 
Other studies have also reported similar facilitatory effects (Chung et al., 2016; Huang 
et al., 2007; Iezzi et al., 2008; Murakami et al., 2008; Swayne, Teo, Greenwood, & 
Rothwell, 2009).  
In contrast, Hamada et al. (Hamada et al., 2012) administered a single round of 
iTBS at 80% AMT over M1, and found highly variable responses in corticospinal 
excitability with participants showing a mixture of inhibitory, and facilitatory changes 
in MEP amplitude. Again, Hamada et al. (2012) were unable to find group level 
facilitation in corticospinal excitability as reported by Huang et al. (2005). Hamada et 
al. (2012) examined whether differences in individual intra-cortical inter-neural network 
activity could be used to account for the variability in responses to iTBS. The authors 
reported that individuals with longer MEP latencies between the latero-medial and 
antero-lateral induced currents (> 4 ms) showed the more usual or expected facilitatory 
response (67%) compared to individuals with shorter latencies (< 4 ms) who showed 
inhibition of MEP amplitude.  
The neurological mechanisms underpinning the effects of iTBS are yet to be 
fully characterised (Huang et al., 2011). The variable effects on M1 excitability 




notwithstanding, there is evidence that the neuro-modulatory effects of iTBS are 
mediated by NMDAR, and cholinergic neurotransmitter systems. Huang et al. (2007) 
showed that administration of an NMDAR antagonist (memantine) interfered with the 
usual facilitation observed following iTBS600. In a complementary study, Teo et al. 
(2007) found administration of D-cycloserine induced reversal of the usual facilitation 
to inhibition, a surprising finding as D-cycloserine at low doses has been shown to be a 
partial NMDAR agonist (Watanabe, Saito, & Abe, 1992). Swayne et al. (2009) reported 
that the administration of a cholinergic agonist (nicotine) enhanced the faciliatory 
effects of iTBS600, particularly in the later phase (10 min after stimulation).  
iTBS also appears to differentially recruit neural populations involved in the 
generation of early- and late I-waves and are mediated by genetic factors. Di Lazzaro 
(2008) showed that iTBS preferentially affects late, rather than early I-waves. They 
studied three individuals with electrodes implanted in the high cervical spine for 
intractable pain and found enhancement of late I-waves, resulting in larger MEP 
amplitude responses. Finally, Cheeran et al. (2008) have shown that the single BDNF 
polymorphism Val66Met mediates the effects of iTBS. Specifically, individuals with 
the Val/Val variant exhibited the expected facilitatory effects on M1 excitability, 
whereas those with the non-Val/Val variant showed no consistent changes in MEP 
responses. Table 9 summarises the above findings.    
 
  





Effects of Intermittent Theta Burst Stimulation on Corticospinal Excitability 
Author (year) N Brain 
Region  
Condition Protocol Intensity Target 
muscle/region 
Neurological effects 
Cheeran et al. (2008) 9 M1 Val/Val iTBS600 80% AMT FDI ↑ MEP  
9 M1 non-Val/Val iTBS600 80% AMT FDI No change (MEP) 
Di Lazzaro et al. (2008) 3 R-M1 Patients (chronic pain)  iTBS600 80% AMT L-FDI, 
ceRvicaL  




iTBS600 80% AMT L-FDI ↑ L-FDI, ↓ R-FDI  
Hamada et al. (2012) 52 M1  iTBS600 80% AMT FDI No change (MEP) 
Huang et al. (2005) 9 L-M1 
 
iTBS600 80% AMT R-FDI ↑ MEP 
Huang et al. (2007) 6 L-M1 NMDAR antagonist 
(memantine)  
iTBS600 80% AMT R-FDI No change (MEP) 
 
6 L-M1 Placebo iTBS600 80% AMT R-FDI ↑ MEP 
Huang et al. (2008)  9 L-M1 
 
iTBS600 80% AMT R-FDI ↑ MEP  
9 L-M1 2 min FDI contraction 
during intervention 
iTBS600 80% AMT R-FDI No change (MEP) 
Iezzi et al. (2008)  10 M1 
 
iTBS600 80% AMT FDI, APB ↑ MEP  
5 M1 
 
iTBS600 80% AMT FDI, APB ↑ MEP 
McAllister et al. (2009) 9 M1 Low intensity iTBS  iTBS600 70% AMT FDI No change (MEP) 
Murakami et al. (2008) 6 L-M1 
 
iTBS600 80% AMT R-FDI ↑ MEP 
Swayne et al. (2009) 10 R-M1 Placebo  iTBS600 80% AMT L-FDI ↑ MEP (early)  
10 R-M1 Nicotine  iTBS600 80% AMT L-FDI ↑ MEP (late) 
Suppa et al. (2008) 10 R-M1 
 
iTBS600 80% AMT L & R-FDI ↑ MEP L-FDI  
10 R-M1 
 
iTBS600 80% AMT R-FDI ↓ MEP R-FDI 
Talelli et al. (2007) 6 L-M1 PA-PA current  iTBS600 80% AMT R-FDI ↑ MEP 
 
7 L-M1 AP-PA current  iTBS600 80% AMT R-FDI No change (MEP) 
 
8 L-M1 AP-PA current  iTBS600 100% AMT R-FDI No change (MEP) 
Teo et al. (2007) 6 M1 d-Cycloserine 
(NMDAR agonist) 
iTBS600 80% AMT ?  ↓ MEP 





6 M1 Placebo iTBS600 80% AMT ? ↑ MEP 
Zafar et al. (2008)  9 L-M1 AP-PA  iTBS600 80% AMT R-ADM ↑ MEP  
9 L-M1 PA-PA  iTBS600 80% AMT R-ADM ↑ MEP  
9 L-M1 Half-sine AP current  iTBS600 80% AMT R-ADM ↑ MEP  
9 L-M1 Half-sine PA current  iTBS600 80% AMT R-ADM ↑ MEP 
Note. ADM – abductor digiti minimi; AMT – active motor threshold; APB – abductor pollicis brevis; AP – anterior-posterior; FDI – first 
dorsal interosseous; iTBS – intermittent theta burst stimulation; L – left; M1 – primary motor cortex; MEP – motor evoked potential 
NMDAR – N-methyl-D-aspartate receptor; PA – posterior-anterior; R – right; RMT – resting motor threshold.  




Effects of Theta Burst Stimulation on Intra-Cortical Inhibition and Facilitation  
 The effects of cTBS on short-interval intra-cortical inhibition (SICI) are 
relatively consistent, with most studies showing a decrease in SICI responses. Both 
cTBS300, and cTBS600 can reduce SICI for up to 20 min (Huang et al., 2005; 
Murakami et al., 2008; Suppa et al., 2008), even during contraction (Huang, Rothwell, 
Edwards, & Chen, 2008), or at low stimulation thresholds (70% AMT) (Loporto, 
McAllister, Williams, Hardwick, & Holmes, 2011; McAllister, Rothwell, & Ridding, 
2009). One study has examined the effect of cTBS on long interval intra-cortical 
inhibition (LICI), and inter-hemispheric inhibition (IHI) (Suppa et al., 2008). In their 
third experiment, Suppa et al. (2008) applied cTBS600 over the right M1, and measured 
LICI at inter-stimulus-intervals (ISI) of 100 and 150 ms from the left M1 and found 
cTBS had no effect on LICI at either ISI. In experiment four, the authors applied 
cTBS600 over the right M1 and elicited IHI from the right FDI but found no changes in 
IHI. The conditioning stimulus was delivered 10 or 40 ms over the right M1 prior to the 
test stimulus applied over the left M1, with responses measured from the right FDI. One 
study has reported that intra-cortical facilitation (ICF) is reduced following cTBS300 
(Huang et al., 2005). The explanation offered by Huang et al. (2005) is that cTBS 
reduces synaptic efficacy in populations modulating SICI and ICF, thus resulting in a 
suppressed response.  
In contrast, several studies have shown that iTBS has a facilitatory effect on 
intra-cortical inhibitory mechanisms leading to enhanced SICI (Table 10) (Huang et al., 
2005; Murakami et al., 2008; Suppa et al., 2008). The effect disappears if there is 
contraction concurrent during the administration of iTBS600 (Huang et al., 2008). 
Huang et al. (2005) suggested that iTBS may induce its effects by increasing synaptic 
activity in neural populations involved in facilitation. Di Lazzaro et al. (2008) measured 
transcallosal inhibition following iTBS600 in the muscle ipsilateral to the stimulated 




hemisphere (right M1), and found no changes to the ipsilateral silent period.  Suppa et 
al. (2008) found that iTBS600 had no effect on LICI or IHI. Table 10 summarises the 
above findings.  





Effects of Theta Burst Stimulation on Intra-Cortical Inhibition and Facilitation  
Author (year) N Region 
targeted 
Condition Protocol % MT Target 
muscle 
Neurological effects 
Continuous theta burst stimulation  
    
Huang et al. (2005) 9 L-M1 
 
cTBS300 80% AMT R-FDI ↓ SICI, ↓ICF  
Huang et al. (2008)  9 L-M1 FDI contraction during 
intervention 
cTBS300 80% AMT R-FDI ↓ SICI  
McAllister et al. 
(2009) 
9 M1 Low intensity cTBS cTBS600 70% AMT FDI ↓ SICI, ICF (no effect) 




cTBS600 80% AMT R-FDI ↓ SICI 
Suppa et al. (2008) 15 R-M1 
 
cTBS600 80% AMT L & R-FDI ↓ SICI R-FDI  
8 R-M1 LICI (ISI 100, 150 ms) cTBS600 80% AMT R-FDI No effect (both ISI)  
8 R-M1 IHI cTBS600 80% AMT R-FDI No effect (IHI)  
5 R-M1 
 
cTBS600 80% AMT R-FDI ↓ SICI, no effect (ICF)  
Talelli et al. (2007) 8 L-M1 Reversed AP-PA current  cTBS600 100% AMT R-FDI ↓ SICI, no effect (ICF) 
Intermittent theta burst stimulation  
    
Di Lazzaro et al. 
(2008) 
10 R-M1 iSP iTBS600 80% AMT R-FDI No effect (iSP) 
Huang et al. (2005) 9 L-M1 
 
iTBS600 80% AMT R-FDI ↑ SICI 
Huang et al.(2008)  9 L-M1 FDI contraction during 
intervention  
iTBS600 80% AMT R-FDI No effect (SICI) 
McAllister et al. 
(2009) 
9 M1 Low intensity iTBS  iTBS600 70% AMT FDI No effect (SICI/ICF) 




iTBS600 80% AMT R-FDI ↑ SICI  
Suppa et al. (2008) 10 R-M1 
 
iTBS600 80% AMT L & R-FDI ↑ SICI (R-FDI)  
8 R-M1 LICI (ISI 100, 150 ms) iTBS600 80% AMT R-FDI No effect (both ISI)  
8 R-M1 IHI  iTBS600 80% AMT R-FDI No effect (IHI) 




Note. AMT – active motor threshold; AP – anterior-posterior; cTBS – continuous theta burst stimulation; FDI – first dorsal interosseous; 
ICF – intra-cortical facilitation; IHI – inter-hemispheric inhibition; ISI – inter-stimulus-interval; iTBS – intermittent theta burst stimulation; 
iSP  - ipsilateral silent period; L- left; LICI – long interval intra-cortical inhibition; M1 – primary motor cortex; MT – motor threshold; PA 
– posterior-anterior; R – right; SICI – short interval intra-cortical inhibition.




Priming Protocols - Homeostatic Meta-Plasticity 
 The studies presented in the preceding have investigated the effects of a single 
administration of cTBS or iTBS over the target M1 region. Under certain experimental 
conditions, however, it has been shown that the prior activation history of a neural 
population conditioned with pharmacological, electrical, electromagnetic, or 
physiological means can modulate the synaptic efficacy of that same neural population 
(Christie & Abraham, 1992; Huang, Colino, Selig, & Malenka, 1992; Karabanov et al., 
2015). The phenomenon whereby synaptic plasticity is itself modifiable is referred to as 
meta-plasticity (Abraham & Bear, 1996). The delineating feature of meta-plasticity is 
that it is the pre-conditioning or priming of a neural population that alters the efficacy of 
subsequent plasticity-inducing paradigms. Within the animal and human literature, 
several pre-conditioning or priming protocols have been shown to alter the usual or 
expected neuroplastic effects of LTD- and LTP-inducing paradigms (Abraham & Bear, 
1996; Karabanov et al., 2015). These alterations in the expected effects have important 
implications for the selection of NIBS parameters and target brain regions used in 
multisite, inter-regional protocols.  
The Bienenstock, Cooper and Munro Theory of Homeostatic Meta-plasticity 
 The effects of priming protocols can be described using the BCM theory of 
homeostatic meta-plasticity (Bienenstock et al., 1982). The BCM model was originally 
developed to account for the complex effects of experience dependent plasticity of 
orientation neurons in the cat visual cortex (Abreu et al., 2012; Bienenstock et al., 
1982). The BCM theory takes into account the prior activation history of a synapse, in 
addition to current pre- and post-synaptic activity, to describe dynamic changes in 
synaptic efficacy (Bienenstock et al., 1982). The theory is predicated on two major 
tenets (Philpot, Bear, & Abraham, 1999). Firstly, the theory proposes that the strength 
of synaptic connections can follow a non-linear function (refer to Figure 3). When low 




levels of uncorrelated pre- and post-synaptic activity are present, this results in a 
weakening of synaptic efficacy or LTD. Conversely, if there are high levels of 
correlated pre- and post-synaptic activity, this increases synaptic efficacy or LTP 
(Bienenstock et al., 1982). The point at which the function crosses over from LTD to 
LTP (or vice versa) is referred to as the modification threshold (ϴm). The second 
component allows the Өm to vary according to the average history of synaptic activity. 
If there are high levels of prior activity, this moves the Өm to the right, consequently 
raising the threshold for LTP induction (i.e., LTP induction becomes more difficult), 
whilst decreasing the threshold for LTD expression (i.e., LTD can be more readily 
induced) (Hulme, Jones, Raymond, Sah, & Abraham, 2014). Conversely, if there are 
low levels of prior activity, the Өm moves further left. Accordingly, the threshold for 
LTP induction decreases (i.e., LTP is easier to induce), whereas the threshold for LTD 
induction is increased (i.e. LTD is more difficult to induce). The outcomes associated 
with different prior levels of activation on LTD and LTP inducing paradigms are 
summarised in Table 11.  






Figure 3. Bienenstock, Cooper and Munro theory of meta-plasticity  illustrating the 
change in synaptic efficacy and modification threshold (Өm) in response to high and low 
levels of postsynaptic activity. Note that high levels of prior activity shift the Өm to the 
right, whereas low levels of activity shift the threshold to the left. Reproduced from 
Hulme et al. (2014). 





Effects of Prior Activity Levels on Long-Term Potentiation (LTP) and Long-Term 
Depression (LTD) Paradigms as Predicted by the Bienenstock, Cooper, and Munro 
Theory of Meta-Plasticity 
  Plasticity Paradigm 
Prior activity levels LTD LTP 
Control Moderate Moderate 
Low  Less effective More effective 
High  More effective Less effective 
 




Homeostatic Meta-plasticity – Animal Models 
There are a wide range of animal, and human data (discussed further below) 
supporting the predictions made by the BCM theory (Abraham, 2008; Bienenstock et 
al., 1982; Karabanov et al., 2015; Philpot et al., 1999).  In one study, Kirkwood et al. 
(1996) provided evidence of a sliding Өm by comparing the efficacy of LTD- and LTP-
inducing paradigms in slices prepared from the visual cortex in light and dark reared 
rats. To induce LTP, the authors applied high frequency stimulation at 10, 20, and 100 
Hz.  For LTD induction, the authors delivered low frequency stimulation at 1 Hz for 
900 pulses. As predicted by the BCM theory, the authors showed that high frequency 
stimulation induced greater levels of LTP in dark versus light reared rats. Conversely, 
low frequency stimulation induced less LTD in dark versus light reared rats.  
Interestingly, the authors showed that exposing dark reared rats to light for two days 
restored LTD responses to levels observed in light reared rats (Philpot et al., 1999). This 
is predicted by the BCM theory; increased levels of experience (i.e., increased exposure 
to light) should shift the Ѳm further to the right facilitating LTD induction.  
Homeostatic Meta-plasticity – Effects on Long Term Potentiation Paradigms 
 Correspondingly, LTP can be inhibited or enhanced depending on the type of 
pre-activity or priming protocol that is employed. In one study, Huang et al. (1992) 
showed that pre-conditioning the CA1 region of the hippocampus with electrical 
stimulation could significantly inhibit the efficacy of a LTP inducing paradigm. They 
applied a weak tetanus (30 Hz for 0.1 to 0.2 s) within region CA1 of the hippocampus 
prior to the administration of a known LTP inducing protocol (stimulation at 100 Hz for 
0.5 s). The authors reported that the level of potentiation was significantly reduced in 
the primed versus non-primed preparation, with the effects lasting 30 min to 1 hr.  
In another study, O’Dell  et al. (1994) applied 5 Hz stimulation for 3 min (900 
pulses), 5 s prior to an LTP-inducing paradigm (two 1 s 100 Hz trains) to the stratum 




radiatum in region CA1 in the guinea pig. They found that the addition of the prime 
strongly reduced the efficacy of the LTP paradigm, with the effect lasting 60 min. 
Similarly, Fuji et al. (1991) applied stimulation to the Shaffer Collaterals in the guinea 
pig, and recorded responses from the stratum radiatum, and pyramidal cells in region 
CA1. They found that 1 Hz stimulation (1000 pulses) inhibited the efficacy of another 
LTP stimulation paradigm (100 Hz stimulation for 100 pulses). In a pharmacological 
study, Cohen et al. (1996) used a metabotropic glutamate receptor agonist (1-amino-
cyclopentane-1S,3R-dicarboxylic acid [ACPD]) to examine its effect on a subsequent 
LTP-inducing paradigm (electrical stimulation at 5 x 100 Hz bursts) within the Schaffer 
collateral pathway in region CA1 in the rat. The authors showed that prior treatment 
with ACPD induced a 50% increase in the level of LTP compared with the control non-
ACPD treated condition, lasting up to 120 min. The window through which LTP could 
be enhanced was approximately 1 hr.  
 Finally, Frey et al. (1995) examined the effect of repeated bouts of high 
frequency stimulation on LTP induction in the dentate gyrus and CA1 in the rat 
hippocampus. They applied high frequency stimulation involving six bursts of 15 pulses 
at 200 Hz with ITI of 10s to the dentate gyus, in vivo. For region CA1, they applied 
three trains of 100 pulses at 100 Hz of 0.2 ms duration at 10 min intervals, in vitro. For 
their secondary tetanisation, they applied stimulation at slightly reduced intensities to 
overcome the issue of LTP saturation. In both the dentate gyrus and CA1, they found 
that a second bout of stimulation can induce short-term (but not long-term) potentiation, 
lasting approximately 30 - 60 min.   
Homeostatic Meta-plasticity - Effects on Long Term Depression Paradigms  
Similarly, the effectiveness of LTD paradigms can be enhanced using specific 
priming procedures. In one study, Christie and Abraham (1992) showed that low 
frequency stimulation can lead to the enhancement of associative LTD. The authors first 




induced associative LTD by interweaving stimulation of the medial performant pathway 
(MPP) with out-of-phase stimulation of the lateral performant pathway (LPP). They 
also induced non-associative LTD by stimulating the MPP without stimulation of the 
LPP. They found that both protocols induced a similar level of depression within the 
LPP. In the priming condition, however, the authors reported that when the LPP was 
primed with 5 Hz stimulation prior to administration of the associative LTD protocol, 
this led to a 50% increase in the level of LTD (Abraham & Bear, 1996).  
In another study, Wexler et al. (1993) showed that prior long- or short-term 
potentiation induction can increase the strength and likelihood of LTD induction. They 
used four trains of 100 Hz stimulation of 0.5 s duration, totalling 200 stimuli for LTP 
induction, 4-8 bursts of 30 Hz .33 s bursts (10 pulses) for STP, and 1 Hz 15 min trains 
for LTD induction. They found that prior LTP induction facilitated the establishment of 
the subsequently applied LTD paradigm. Similarly, the application of short trains of 
high frequency stimulation enhanced the level of LTD induced by low frequency 1 Hz 
stimulation within region CA1 of the rat hippocampus. The level of LTD induced in the 
STP primed condition was 50% greater when compared to the non-primed condition. 
Similarly, Wagner et al. (1995) examined the role of GABAR in LTD in both 
young and old rats. They applied stimulation to region CA1 using different low and 
high frequency parameters. Interestingly, they found that two bouts of high frequency 
stimulation (100 Hz, 1 s) were required before 1 Hz stimulation could induce LTD in 
mature slices. In other words, the low frequency protocol had been previously 
ineffective in inducing LTD but priming with high frequency stimulation facilitated the 
induction of LTD. Similar findings have been reported by Bashir and Collingridge 
(1994).  




Non-Homeostatic Meta-plasticity - Late Phase Long-Term Potentiation 
 In addition to homeostatic meta-plasticity, non-homeostatic forms of meta-
plasticity have been described. A study by Huang and Kandel (1994) examined the 
molecular mechanisms involved in the induction of early- and late-phase LTP. They 
stimulated the Shaffer collaterals of the rat hippocampus with recordings taken from 
CA1. They used three different stimulation protocols, including single trains of 100 Hz 
1 s stimulation (duration of pulses of either 0.1 or 0.2 ms) or three trains of 100 Hz 1 s 
stimulation (duration of 0.2 ms) separated by 10 min. They found three consecutive 
trains induced the strongest level of LTP (increase of 81% after 3 hr).  
 Another study by Nguyen et al. (1994) examined the molecular mechanisms 
involved with late phase LTP in rat hippocampal slices (region CA1). They induced late 
phase LTP using three trains of 1 s 100 Hz trains at 5 min intervals. They applied 
different gene transcription inhibitors, including actinomysin D (ACT D) and 5,6-
dichloro-1B-D-ribo-furanosyl benzimidazole (DRB), at different stages of the LTP 
induction paradigm. They found that administration of ACT D at the beginning of the 
first stimulation protocol, but not the end of the final stimulation, blocked the effect of 
late phase LTP. Likewise, they found that administration of DRB at the beginning of the 
first train blocked induction of late phase LTP.  
 Abraham et al. (1993) examined the effect of repeated bouts of high frequency 
stimulation delivered on one day or over several consecutive days (5 days). They 
examined responses in the dentate hillus, with stimulation applied to the performant 
pathway. They used stimulation parameters of 400 Hz stimulation for 25 ms, with 250 
μs pulse widths, in bursts of 5 trains at 1 Hz, with 1 min between bursts. They found 
higher numbers of trains induced longer lasting LTP. For example, responses to 10 
trains decayed to 63% after 1.54 days, but up to 26.1 days for 30 trains. The rate of LTP 
decay varied among numbers of trains, with the highest rate following a single train. 




The number of trains, however, did not appear to affect the magnitude of the 
potentiation.  
 Another study by Abraham et al. (2002) investigated the molecular mechanisms 
involved with repeated bouts of high frequency stimulation on LTP induction and 
maintenance within the dentate gyrus. They applied high frequency stimulation of 400 
Hz, 25 ms with pulse durations of 250 μs to the perforant pathways. They delivered 
trains in sets of five trains with 1 s between trains with 1 or 10 min in between sets. 
They found that four sets delivered 10 min apart induced longer lasting, stable LTP in 
50% of animals compared to 20 trains, where LTP was only seen in 23%. They reported 
5 trains with 1 min inter-set-intervals induced stable LTP in 67% (8/12) animals.  Fifty 
trains were associated with an increase of pCREB 2 hr after tetanisation. An NMDAR 
antagonist (CPP) blocked the induction of LTP by 50 trains of HFS.  
The Bidirectionality of Synaptic Strength – De-depression and De-potentiation  
 Two other related but distinct neural phenomena are referred to as de-depression 
and de-potentiation. Whereas meta-plasticity involves the modification of plasticity 
threshold of a neural population (Abraham & Bear, 1996), de-depression and de-
potentiation involve reversing the effects induced by plasticity paradigms. In one study, 
Lee et al. (2000) demonstrated that LTD and LTP can  be reversed by applying specific 
stimulation parameters within the CA1 region of the rat hippocampus. In the de-
potentiation condition, the authors first induced LTP in two slices using TBS (10 trains 
at 5 Hz, four pulses per train at 100 Hz). The authors found that subsequent application 
of low frequency stimulation (900 pulses at 1 Hz) reversed the initial level of 
potentiation to baseline levels. Similarly, in the de-depression condition, the authors 
found that the levels of LTD induced by low frequency stimulation could be reversed 
through TBS. Similar de-potentiation and de-depression effects had been demonstrated 




earlier by Dudek and Bear (1993). Thus, different stimulation protocols can be used to 
illustrate bidirectional changes in responsivity and synaptic strength.  
Homeostatic and non-Homeostatic Meta-Plasticity - Human Studies 
  As described, most of our understanding of the neurological mechanisms 
underpinning homestatic- and non-homeostatic meta-plastic effects, and bidirectional 
changes in synaptic strength, are derived from animal models (Abraham & Bear, 1996). 
Although animal models have been crucial in characterising the neural mechanisms 
underpinning meta-plasticity, the degree to which such findings generalise to humans is 
less clear. One way to test whether similar mechanisms may operate within humans, 
albeit indirectly via measurement of corticospinal excitability, is by using NIBS 
techniques including TMS. Indeed, several research groups have examined the effects 
of priming NIBS protocols on cortical motor excitability using TMS (Gentner, Wankerl, 
Reinsberger, Zeller, & Classen, 2008; Goldsworthy et al., 2014b; Huang et al., 2008; 
Karabanov et al., 2015) and other techniques such as transcranial direct current 
stimulation (Siebner et al., 2004). In the following sections, it will be shown that 
different priming protocols can be used to induce homeostatic and non-homeostatic 
meta-plastic effects, as well as bidirectional changes in synaptic strength in the human 
M1. The discussion will begin with studies examining meta-plastic effects through 
intra-regional priming of M1, followed by experiments investigating inter-regional 
priming paradigms.   
Effect of Priming Protocols on Conventional Low Frequency Repetitive 
Transcranial Magnetic Stimulation  
 Relatively few studies have examined the effect of priming on conventional 
rTMS protocols (Table 12). Iyer et al. (2003) conducted one of the earliest studies and 
showed that M1 priming with conventional high frequency rTMS can enhance the 
suppressive effects of conventional low frequency rTMS, consistent with the predictions 




made by the BCM theory (Bienenstock et al., 1982). The authors applied either 6 Hz- or 
variable 6 Hz-rTMS (cycling between 4 - 8 Hz) at 90% RMT over the primary motor 
cortex prior to 1 Hz rTMS (600 pulses at 115% RMT). They found increased 
suppression of MEP responses (50%) in the target abductor pollicis brevis (APB) and 
extensor carpi radialis for up to 1 hr in the primed versus sham conditions.    
 
 





Effect of Priming on Conventional Low Frequency Stimulation on Corticospinal Excitability 
Study (Year)  N Priming protocol  Brain 
region 
Test protocol Brain 
region 
Target muscle Effect on MEP 
(type) 
Iyer et al. (2003) 16 6 Hz-rTMS (90% 
RMT, 600 pulses) 
L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓↓ (homeo) 
 
16 4-8 Hz-rTMS (90% 
RMT, 600 pulses) 
L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓↓ (homeo) 
 
16 (Sham) 6 Hz-rTMS  L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓ (LTD) 
 
9 6 Hz-rTMS (90% 
RMT, 600 pulses) 
L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓↓ (homeo) 
 
9 4-8 Hz-rTMS (90% 
RMT, 600 pulses) 
L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓↓(homeo) 
   9 (Sham) 6 Hz-rTMS  L-M1 1 Hz-rTMS (115% 
RMT, 600 pulses) 
L-M1 R-APB & ECR ↓ (LTD) 
 
Note. AMT – active motor threshold; APB – abductor pollicis brevis; ECR - extensor carpi radialis; homeo – homeostatic; L – left; M1 – 
primary motor cortex; MEP – motor evoked potential; MT – motor threshold; R – right; RMT – resting motor threshold; rTMS – repetitive 
transcranial magnetic stimulation. 









Effect of Priming Protocols on Continuous Theta Burst Stimulation 300  
Most of the literature examining the effects of priming of M1 prior to administration of 
cTBS300 have used physiological priming (i.e., phasic voluntary hand muscle contractions) to 
condition the target motor region (Table 13). Overall, the effects of priming on cTBS300 follow the 
predictions made by the BCM theory. Gentner et al. (2008) examined the effect of isometric 
contraction (1.5 or 5 min) on MEP responses two minutes prior to administration of the test 
cTBS300 protocol, applied at 70% RMT or 80% AMT. If cTBS300 was preceded by short 1.5 min 
contraction or no muscle activity, there was facilitation of the MEP response. In contrast, if cTBS 
was preceded by 5 min of isometric contraction, there was suppression of the MEP response. In 
another study, Iezzi et al (2008) examined the effect of phasic thumbs movements prior to 
application of cTBS300 at 80% AMT. In contrast to the findings by Gentner et al. (2008), Iezzi et 
al. (2008) found that when cTBS300 was preceded by no movements, there was suppression of the 
MEP response. However, if cTBS300 was preceded by 3 min of phasic thumb movements, this 
induced facilitation, again consistent with the BCM model.  





The Effect of Priming on Continuous Theta Burst Stimulation 300 








Effect on MEP 
(type) 
Gentner et al. 
(2008) 
16 ISO contraction R-
APB (1.5 min) 
L-M1 2 cTBS300 (70% RMT) L-M1 R-APB ↑  
 
16 ISO contraction R-
APB (5 min) 
L-M1 2 cTBS300 (70% RMT) L-M1 R-APB ↓ (homeo) 
 
13 AMT L-M1 2 cTBS300 (80% AMT) L-M1 R-FDI ↓ (LTD) 
Iezzi et al. 
(2008)  
10  AMT + R-
finger/thumb 
abduction/adductio
n (3 min) 
L-M1 2 cTBS300 (80% AMT) L-M1 R-FDI ↑ (homeo) 





cTBS300 (70% RMT) L-M1 L & R-
APB 
↓ R-APB, no 
change L-APB  





cTBS300 (70% RMT) R-M1 L & R-
APB 
↑ R-APB, ↓ L-
APB  





cTBS300 (70% RMT) L-M1 L & R-
APB 
↓ R-APB, no 
change L-APB 
 
Note.  AMT – active motor threshold; APB – abductor policis brevis; cTBS – continuous theta burst stimulation; FDI – first dorsal 
interosseous; homeo – homeostatic; IPI – inter-protocol-interval; ISO – isometric; L – left; M1 – primary motor cortex; MEP – motor 
evoked potential; MT – motor threshold; R – right; RMT – resting motor threshold. 




Stefan et al. (2008) examined the effect of 1 min phasic right thumb movements 
prior to application of cTBS300 (70% RMT) over the left- and right-M1. They found 
that a 1 min period of phasic movements before administration of the test cTBS300 
protocol over the right-M1 induced suppression of the MEP response in the 
contralateral left APB, and facilitation in the ipsilateral right APB. In contrast, 
stimulation of the left M1 induced suppression of the MEP response in the contralateral 
right APB, and non-significant facilitation of MEP amplitudes in the ipsilateral left 
APB. These findings illustrate that the right M1 can be distally primed with ipsilateral 
hand movements.  
Effect of Priming Protocols on Continuous Theta Burst Stimulation 600  
Priming M1 prior to the application of a test round of cTBS600 can induce both 
homeostatic- and non-homeostatic meta-plastic effects (Table 14). In one study, priming 
with iTBS was used to enhance the suppressive effects of cTBS600 consistent with the 
BCM model (Bienenstock et al., 1982). Todd et al. (2009) examined the effect of 
priming using either conventional high frequency stimulation or iTBS on corticospinal 
excitability. In the conventional rTMS conditions, the authors used 2 or 6Hz stimulation 
at either 70% AMT or 90% RMT versus a control (non-primed) condition. They found 
no differences in the level of suppression induced in either the primed or non-primed 
conditions. However, when cTBS600 was primed with iTBS600, this induced strong 
suppression of MEP responses of up to 45% from baseline levels for 30 min. 
Interestingly, a single bout of cTBS600 at 80% AMT did not induce suppression of the 
MEP response in their sample that differed to earlier reports by Huang et al (2005).  A 
subsequent study by Doeltgen et al. (2011) confirmed that iTBS600 prior to cTBS600 at 
80% AMT leads to enhanced suppression of the MEP response.  
 





Effect of Priming on Continuous Theta Burst Stimulation 









Effect on MEP 
(notes) 
Todd et al. 
(2009) 
10 2 Hz-rTMS (70% AMT) L-M1 < 2 cTBS600 (80% AMT) L-M1 R-FDI No change 
 
10 6 Hz-rTMS (70% AMT) L-M1 < 2 cTBS600 (80% AMT) L-M1 R-FDI ↓ MEP area   
10 2 Hz-rTMS (90% RMT) L-M1 < 2 cTBS600 (80% AMT) L-M1 R-FDI ↓ MEP area   
10 6 H-rTMS (90% RMT) L-M1 < 2 cTBS600 (80% AMT) L-M1 R-FDI ↓ MEP area   
8 iTBS600 (80% AMT) L-M1 < 2 cTBS600 (80% AMT) L-M1 R-FDI ↓ MEP area 
(homeo) 
Gamboa et al. 
(2010) 
14 cTBS600 (80% AMT) L-M1 0 cTBS600 (80% AMT) L-M1 R-FDI ↑ (homeo) 
Doeltgen et al. 
(2011)  
14 iTBS600 (80% AMT) L-M1 2 cTBS600 (80% AMT) L-M1 R-FDI ↓ (homeo) 
 
9 iTBS600 (80% AMT) L-M1 2 cTBS600 (80% AMT) L-M1 R-FDI ↓  
Goldsworthy 
et al. (2012) 
12 cTBS600 (80% AMT) L-M1 10 cTBS600 (80% AMT) L-M1 R-FDI No change   
 
12 cTBS600 (70% RMT) L-M1 10 cTBS600 (70% RMT) L-M1 R-FDI ↓   
12 ISO contraction FDI (3 
min) + cTBS600 (70% 
RMT) 
L-M1 10 cTBS600 (70% RMT) L-M1 R-FDI No change 
 
6 cTBS600 (65% RMT)  L-M1 10 cTBS600 (65% RMT) L-M1 R-FDI ↓  
9 cTBS600 (70% RMT) L-M1 10 cTBS600 (70% RMT) L-M1 R-FDI ↓  
Goldsworthy 
et al. (2014) 
10 ISO contraction FDI (2 
min) 
L-M1 15 cTBS600 (70% RMT) L-M1 R-FDI No change 
Goldsworthy 
et al. (2014)  
10 cTBS600 (70% RMT) L-M1 10 cTBS600 (70% RMT) L-M1 R-FDI ↓  
 
10 cTBS600 (70% RMT) L-M1 10 cTBS600 (70% RMT) + 
ISO contraction FDI (2 
min) 
L-M1 R-FDI ↓  





8 cTBS600 (70% RMT) L-M1 10 cTBS (sham) + ISO 
contraction FDI (2 min) 
L-M1 R-FDI ↑ (trend) 
Note. AMT – active motor threshold; cTBS – continuous theta burst stimulation; FDI – first dorsal interosseous; homeo – homeostatic; IPI 
– inter-protocol-interval; ISO – isometric; iTBS – intermittent theta burst stimulation; L – left; M1 – primary motor cortex; MEP – motor 
evoked potential; R – right; RMT – resting motor threshold; rTMS – repetitive transcranial magnetic stimulation. 




Two studies have reported differing effects when cTBS600 80% AMT is used as 
the priming protocol that may be due to different inter-protocol-intervals between the 
prime and test protocol. Gamboa et al.  (2010) applied two trains of cTBS600 
continuously (i.e., no time interval between the prime and test protocol) at 80% AMT 
and found the usual suppressive effects reversed into facilitation (50% increase from 
baseline) for approximately 50 min following the second train, again consistent with the 
BCM model. In contrast, Goldsworthy et al. (2012) applied two cTBS600 trains at 80% 
AMT with an inter-protocol-interval of 10 min and found no changes in the MEP 
responses from baseline levels.  
Goldsworthy et al. (2014b; 2012) have provided evidence of non-homeostatic 
meta-plasticity in the human M1. The authors reported that two rounds of cTBS600 
trains 10 min apart at either 65% or 70% RMT induced strong suppression of the MEP 
response (maximal suppression of 50% from baseline levels) lasting one to two hours, 
consistent with non-homeostatic meta-plastic effects. Suppression of M1 excitability 
could be abolished if cTBS600  at 70% RMT was preceded by 2 min isometric 
contraction of the FDI, a finding they confirmed in a subsequent study (Goldsworthy et 
al., 2014a). These latter findings conform to the predictions by the BCM meta-plastic 
framework, and are consistent other studies using physiological priming (Gentner et al., 
2008). Interestingly, engaging in isometric contraction of the target muscle induced 
variable MEP responses, with 50% showing no changes, 30% showing inhibition, and 
the final 20% showing facilitation in corticospinal excitability.   
Effects of Priming on Intermittent Theta Burst Stimulation 
 Overall, priming M1 prior to the application of a test round of iTBS can reverse 
the usual facilitatory effects (Huang et al., 2005) according to the BCM theory of meta-
plasticity (Table 15). Iezzi et al. (2008) showed that priming the motor cortex with 3 
min phasic thumb movements 2 min prior to the application of iTBS600 induced 




suppression of MEP amplitudes for up to 30 min. In a related study, Gamboa et al. 
(2010) compared the effect of one versus two consecutive trains of iTBS600 (80% 
AMT) over M1. They found that one train of iTBS600 induced the usual MEP 
facilitation, however, two trains induced suppression of MEP amplitudes to 
approximately 40% of baseline levels for up to 1 hr consistent with the predictions of 
the BCM theory. Similar meta-plastic effects have been reported using iTBS in young 
(mean age = 22.3. SD = 1.0), but not older (mean age = 70.2, SD = 1.7), participants 
(Opie, Vosnakis, Ridding, Ziemann, & Semmler, 2017). 





Effect of Priming on Intermittent Theta Burst Stimulation 600 








Effect on MEP 
(min) 
Iezzi et al. 
(2008)  
10 AMT + R-finger 
abduction/adduction (3 min) 
L-M1 2 iTBS600 (80% AMT) L-M1 R-FDI ↓ (15) 
 
5 AMT + R-voluntary thumb 
movements (3 min?)  
L-M1 2 iTBS600 (80% AMT) L-M1 R-FDI ↓ (30) 
 
5 AMT + R-Median nerve 
stimulation (30 pulses) 
L-M1 2 iTBS600 (80% AMT) L-M1 R-FDI ↑ (30) 
Gamboa et al. 
(2010) 
14 AMT + control 
 
5 iTBS600 (80% AMT) L-M1 R-FDI  ↑ (20) 
 
14 AMT + iTBS600 (80% AMT) L-M1 0 iTBS600 (80% AMT) L-M1 R-FDI ↓ (60) 
 Note.   AMT – active motor threshold; IPI – inter-protocol-interval; iTBS – intermittent theta burst stimulation; L – left; MEP – motor 
evoked potential; R - right.  




Inter-Regional Priming of the Primary Motor Cortex 
 The preceding studies have examined the priming effects of NIBS applied to a 
single region, namely, M1. Relatively fewer studies have examined the effects of 
multisite inter-regional priming of the human M1. Overall, the effects of inter-regional 
priming generally follow the predictions made by the BCM theory of meta-plasticity 
(Hamada et al., 2009; Potter-Nerger et al., 2009; Ragert et al., 2009). The findings of 
inter-regional priming protocols are summarised in Table 16. 





Effects of Inter-Regional Priming of the Primary Motor Cortex 




Effect on MEP 
Potter-Nerger et al. 
(2009) 
11 1 Hz-rTMS (90% 
MT) 
left-dPMC ? PASN20-5 L-M1 L-FDI ↑P1, ↑P2 (homeo) 
 
11 5 Hz-rTMS (90% 
MT) 
left-dPMC ? PASN20+2 L-M1 L-FDI ↓P1, ↓P2(homeo)  
Hamada et al. 
(2008) 
9 QPS5 SMA 
 
QPS1.5 L-M1 R-FDI No change 
 
9 QPS5 SMA 5 QPS5 L-M1 R-FDI ↓ (homeo)  
9 QPS5 SMA 5 QPS10 L-M1 R-FDI ↓ (homeo)  
9 QPS5 SMA 5 QPS30 L-M1 R-FDI ↓ (non-homeo)  
9 QPS5 SMA 5 QPS50 L-M1 R-FDI ↑ (homeo)  
9 QPS5 SMA 5 QPS100 L-M1 R-FDI ↑ (homeo)  
9 QPS50 SMA 5 QPS5 L-M1 R-FDI ↓ (homeo)  
9 QPS50 SMA 5 QPS10 L-M1 R-FDI No change  
9 QPS50 SMA 5 QPS30 L-M1 R-FDI ↑ (homeo)  
9 QPS50 SMA 5 QPS50 L-M1 R-FDI No change 
Ragert et al. (2009) 8 1 Hz-rTMS (115% 
RMT)  
R-M1 10 iTBS600 (80% 
AMT) 
L-M1 R-FDI ↑P1 (homeo), ↓P2 (trend) 
 
 Note. dPMC – dorsal premotor cortex; homeo – homeostatic; IPI – inter-protocol-interval; L – left; MEP – motor evoked potential; QPS – 
quadripulse stimulation; P1 – post 1; P2 – post 2; PAS – paired associative stimulation; R – right; rTMS – repetitive transcranial magnetic 
stimulation; SMA – supplementary motor area. 




Potter-Nerger et al. (2009) showed that inter-regional priming of M1 via the 
dorsal premotor cortex (dPMC) can induce homeostatic-like effects on corticospinal 
excitability. They primed M1 via the dPMC with either low- or high-frequency rTMS. 
They then administered a test NIBS protocol referred to as paired associated stimulation 
(PAS) over M1. PAS is a neuro-modulatory technique involving carefully timed paired 
delivery of electrical stimuli to the median nerve and TMS over M1 (Cincotta et al., 
2004; Giovannelli et al., 2006; Stefan, Kunesch, Cohen, Benecke, & Classen, 2000; 
Ziemann, Iliać, Pauli, Meintzschel, & Ruge, 2004). When the ISI is set to the latency of 
the N20 (a somatosensory evoked potential elicited through median nerve stimulation 
with a latency of 20 ms) (Wolters et al., 2003), it is referred to as PASN20 (Zimmermann 
et al., 2012). Positive and negative values after PASN20 denotes whether the TMS pulse 
is administered (in milliseconds) after or before the delivery of median nerve 
stimulation, respectively. The authors found that the usual inhibitory effects of PASN20-5 
ms applied over M1 were reversed into facilitation if preceded by priming low frequency 
rTMS applied to the dPMC. In contrast, the usual facilitatory effects of PASN20+2ms 
applied over M1 could be reversed into inhibitory if preceded by high frequency rTMS 
applied over the dPMC.  
 Similarly, Hamada et al. (2009) showed that inter-regional priming of M1 via 
the supplementary motor area (SMA) can also induce homeostatic meta-plastic effects 
in accordance with the BCM theory. They applied quadripulse stimulation (QPS) a 
NIBS technique involving four precisely timed TMS pulses that can induce facilitation, 
or inhibition of M1 corticospinal excitability at different ISIs that are denoted with 
subscripts. Short-latency ISIs of 1.5, 5, or 10 ms (i.e., QPS1.5ms, QPS5ms, and QPS10ms, 
respectively) tends to induce facilitation, whereas long-latency ISIs of 30, 50, and 100 
ms (i.e., QPS30ms, QPS50ms, and QPS100ms, respectively) tends to induce inhibition. The 
authors applied priming QPS over the SMA with either short (i.e., restricted) bursts of 




QPS5ms-prime or QPS10ms-pime that, when delivered alone, did not induce any changes in 
MEP amplitudes measured from the FDI. The authors found that the usual faciliatory 
effects on corticospinal excitability induced by short latency QPS5ms or QPS10ms applied 
to M1 could be reversed into inhibition if primed with QPS5ms-prime applied over the 
SMA. In contrast, the usual inhibitory effects of long-latency QPS50ms and QPS100ms 
applied over M1 could be reversed into inhibition primed with QPS5ms-prime applied over 
the SMA. They also found that the usual facilitatory effects of QPS5ms applied to M1 on 
corticospinal excitability could be reversed into suppression with short priming QPS5ms-
prime. In contrast, the usual suppressive effects of QPS30ms applied over M1 could be 
reversed into facilitation if first primed with short QPS50ms-prime via the SMA. These 
results are largely consistent with the predictions made by the BCM theory of meta-
plasticity.  
 Finally, Ragert  et al. (2009) investigated the effect of inter-hemispheric priming 
by first stimulating the right M1 with 1Hz-rTMS (115% RMT), followed 10 min later 
by stimulation of the contralateral (left) M1 using iTBS600 (80% AMT). The authors 
reasoned that because 1Hz-rTMS of one hemisphere can modulate the excitability in the 
contralateral unstimulated hemisphere (Kobayashi, Hutchinson, Theoret, Schlaug, & 
Pascual-Leone, 2004; Schambra, Sawaki, & Cohen, 2003), it may be possible to prime 
the motor cortex inter-hemispherically. The authors reported that priming the right M1 
with 1 Hz rTMS facilitated MEP amplitudes elicited from the ipsilateral right FDI. The 
authors then applied the test iTBS600 protocol over the left M1 and found non-
significant decreases in MEP amplitude in the right FDI.  Although the results were 
non-significant, there was a reduction in corticospinal excitability consistent with the 
predictions made by the BCM theory of meta-plasticity.  





 TBS protocols were originally developed in animal models and can induce LTD 
and LTP. These protocols were later adapted for application in humans by Huang et al. 
(2005) who developed several TBS variants including cTBS, and iTBS. Although early 
studies indicated that short trains of TBS could induce strong LTD- and LTP-like 
effects in humans, more recent studies indicate that the effects can show a high degree 
of inter-individual variability (Hamada et al., 2012). Researchers have also developed a 
range of priming protocols in animal studies that involve priming a target region prior to 
the application of the test protocol. Priming protocols can induce complex neuroplastic 
effects in humans including homeostatic, and non-homeostatic meta-plastic effects. The 
BCM theory of homeostatic meta-plasticity can account for several of the findings 
within the animal and human literature. Most research to date has focused on the effects 
of priming over a single region, primarily M1. Relatively fewer studies have examined 
the effects of multisite or inter-regional priming. An understanding of the basic 
neuroplastic effects induced by multisite priming protocols are needed as there is 
currently limited data that can be used to inform the development of multisite protocol 
targeting functionally associated regions. Multisite protocols may have the potential to 
induce more robust and predictable neuroplastic effects reducing inter-individual 
variability (Goldsworthy et al., 2014b; Goldsworthy et al., 2012), and to improve 
clinical outcomes (Kang et al., 2009; Ma et al., 2014; Prasser et al., 2015). To extend 
our understanding of the effects of multisite rTMS, the following chapter presents the 
results of the second published empirical study (Study 3, Chapter 7) that evaluated the 
neuroplastic effects of intra- and inter-regional priming over M1 using TBS. 




Chapter 7 - Study 3: Intra- and Inter-Priming of Ipsilateral Human Primary 
Motor Cortex with Continuous Theta Burst Stimulation Does Not Induce 
Consistent Neuroplastic Effects 
 
Explanatory Note 
Chapter 6, Chapter 7 (Study 3), Chapter 8, and Chapter 9 (Study 4) formed part of the 
work that contributed the second research stream that evaluated the neuroplastic effects 
induced by inter-regional priming rTMS protocols. Chapter 6 provided an overview of 
the neuro-modulatory effects induced by theta burst stimulation (TBS), in addition to 
the neuroplastic effects of intra- and inter-regional priming protocols on corticospinal 
excitability. The findings from Chapter 6 directly informed the four protocols evaluated 
in the second published empirical study presented in this chapter (Chapter 7, Study 3). 
The version of the manuscript prior to acceptance and publication has been included to 
maintain consistency with this thesis. As a result, some of the headings, figures, and 
tables have been slightly reformatted. Full citation information along with the digital 
online identifier has been included. An Authorship Statement signed by each author of 
the manuscript has been included. The reference list and appendix associated with this 
publication has been included at the end of this chapter.  
 
Full Citation Information: 
Do., M., Kirkovski, M., Davies, C.B., Bekkali, S., Byrne, L.K., & Enticott, P.G. (2018). 
Intra- and inter-regional priming of ipsilateral human primary motor cortex with 
continuous theta burst stimulation does not induce consistent neuroplastic effects. 
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Human responses to non-invasive brain stimulation (NIBS) techniques can be highly 
variable. Recently, priming protocols involving a conditioning round of NIBS applied to 
a target brain region prior to the application of a test protocol have shown promise in 
inducing more reliable effects. We investigated whether intra- or inter-regional priming 
of the left primary motor cortex (M1) using continuous theta burst stimulation (cTBS) 
can induce consistent, and reliable modulation of corticospinal excitability. Twenty 
healthy adults (6 males) underwent four cTBS protocols. For intra-regional priming, 
cTBS was applied twice to the left M1 (M1-M1). For inter-regional M1 priming, cTBS 
was applied to the ipsilateral (left) dorsal premotor cortex (dPMC-M1), and ipsilateral 
(left) dorsolateral prefrontal cortex (DLPFC-M1). In the control condition, sham 
stimulation was applied to left M1, followed by active cTBS also applied to the left M1 
(sham-M1). Each round of cTBS was separated by 10 mins. Neuroplastic responses 
were indexed using motor evoked potentials (MEPs) elicited from the left M1 hand 
region, and measured from the contralateral first dorsal interosseous (right hand). MEP 
measurements were taken before the first round of cTBS priming, then immediately, 10, 
20, and 30min after the second test round of cTBS. The primary two-way repeated 
measures ANOVA revealed no significant differences in MEP responses across each 
condition (no main effects or interaction). Intra- and inter-regional priming of the left 
M1 using cTBS does not induce consistent neuroplastic effects. Further work is required 
to identify factors which contribute to such variability in human responses to NIBS.  
Keywords: Corticospinal excitability, metaplasticity, motor cortex, neuroplasticity, 
theta burst stimulation, transcranial magnetic stimulation. 
 
 





Neuroplasticity refers to the brain’s capacity for neural restructuring, and 
underlies our capacity to acquire knowledge, retain memories, and to recover from 
injury and trauma (Hebb, 1949; Pascual-Leone et al., 2005). Some of the most well 
characterized forms of neuroplasticity include long-term depression (LTD), and long 
term potentiation (LTP) (Malenka and Bear, 2004). In the human neocortex, similar 
LTD- and LTP-like effects can be induced using non-invasive brain stimulation (NIBS) 
techniques (Chung et al., 2016; Fitzgerald et al., 2006; Ridding and Ziemann, 2010). 
Correspondingly, a large body of work is now dedicated to the application of NIBS for 
investigative, and clinical applications (Daskalakis, 2005; Guse et al., 2010; Jaafari et 
al., 2012; Wassermann and Lisanby, 2001). 
Although NIBS techniques can modulate corticospinal excitability, the 
neuroplastic effects reported in humans are often highly variable, thus limiting their 
potential utility (Goldsworthy et al., 2014a; Hamada et al., 2012; Pell et al., 2011; 
Ridding and Ziemann, 2010). One method that may induce more homogenous and 
predictable effects involves “priming” a target region with a conditioning bout of NIBS 
before administration of the test protocol (Karabanov et al., 2015). Recently, 
Goldsworthy and colleagues (2012; 2014b) have shown that two rounds of continuous 
theta burst stimulation (cTBS; a NIBS technique involving the delivery of very high 
frequency electromagnetic pulse bursts in the theta range) applied intra-regionally to the 
human primary motor cortex (M1) can induce strong, and persistent suppression of 
corticospinal excitability lasting up to two hours. 
Another approach which may yield effective protocols for inducing robust 
neuroplastic effects is through inter-regional priming (Karabanov et al., 2015; Müller-
Dahlhaus and Ziemann, 2015). In general, the effects of intra- and inter-regional 




priming using NIBS techniques can be described using the Bienenstock, Cooper, and 
Munro (BCM) theory of homeostatic metaplasticity (Bienenstock et al., 1982; 
Karabanov et al., 2015). One of the predictions made by the BCM model is the 
inhibitory effects of an LTD-inducing paradigm can be reversed into facilitation if it is 
preceded by low-frequency stimulation (i.e. a LTD paradigm). For example, Potter-
Nerger et al. (2009) found that the usual inhibitory LTD-like effects on M1 
corticospinal excitability induced by paired associative stimulation (PASN20-5ms; a NIBS 
technique involving carefully timed electrical stimulation applied to peripheral nerves 
combined with transcranial magnetic stimulation [TMS]) paradigm can be reversed into 
facilitation if it is first preceded by low-frequency repetitive transcranial magnetic 
stimulation (rTMS1Hz) applied to the ipsilateral dorsal premotor cortex (dPMC). 
Similarly, Hamada et al. (2009) have shown that the usual inhibitory LTD-like effects 
on M1 excitability induced by quadripulse stimulation (QPS30ms; a NIBS technique 
involving the delivery of four precisely timed TMS pulses) can also be reversed into 
facilitation if preceded by low-frequency QPS50ms applied over the supplementary motor 
area (SMA). Similar homeostatic metaplasttic effects have been demonstrated following 
intra-regional priming of M1 (Hamada et al., 2008; Siebner et al., 2004) 
In the current study, we investigated whether priming the left-M1 intra- or inter-
regionally with cTBS can induce more consistent, and robust neuroplastic effects. The 
dPMC and dorsolateral prefrontal cortex (DLPFC) ipsilateral to M1 were selected as 
they comprise a richly interconnected network which subserves motor control (Fang et 
al., 2005; Lu et al., 1994; Kantak et al., 2012; Picard and Strick, 2001). Four protocols 
were evaluated. For intra-regional priming, active cTBS was applied to the left M1 
twice. For inter-regional priming of M1, cTBS was applied to the ipsilateral (left) 
dPMC, and ipsilateral (left) DLPFC. A control condition was included with sham 
stimulation applied to ipsilateral (left) M1. It was hypothesized that intra-regional 




priming of M1 would suppress corticospinal excitability (Goldsworthy et al., 2012; 
Goldsworthy et al., 2014b). In accordance with the BCM model of homeostatic 
metaplasticity, it was anticipated that inter-regional priming of the ipsilateral dPMC, 
and DLPFC with cTBS would facilitate M1 excitability (Hamada et al., 2009; Potter-
Nerger et al., 2009).   
7.2 Material and Methods 
Participants  
Twenty right-handed participants (M = 26.45, SD = 3.07; range = 19 - 33; 6 
males) attended four sessions. Participants had no self-reported history of psychiatric, or 
neurological illness. Participants were screened for contraindications to TMS according 
to standard exclusionary criteria (Rossi et al., 2009). The study was approved by the 
Deakin University Human Ethics Research Committee with all participants providing 
written, and informed consent prior to enrolment. All participants were right-handed 
according to the Edinburgh Handedness Inventory (M = 83.71 SD = 21.35; range = 40 – 
100)(Oldfield, 1971).  
Electromyography Recordings  
Electromyography (EMG) was measured using the Trigno Wireless EMG 
system (Delsys, USA). The electrode sensor was placed over the belly-tendon of the 
first dorsal interosseous (FDI) muscle of the right hand. EMG recordings (PowerLab 
4/35, ADInstruments) were amplified (x1000), bandpass filtered (0.3Hz to 1 kHz), 
digitized (10 kHz), and epoched to the TMS pulse (-100ms to 400ms). Data was 
recorded, saved, and processed offline (Labchart 7, ADInstruments). 
 Single and Paired-Pulse Transcranial Magnetic Stimulation  
Single-pulse transcranial magnetic stimulation (spTMS) was administered using 
a Magstim 2002 unit (Magstim, UK) via a 70mm figure 8 coil which generates a 
monophasic pulse with a 100 µm rise time of 1ms (Magstim, 2011). The coil was held 




tangential to the scalp at a 45-degree angle to the midline, with the lead pointing in a 
postero-lateral direction. The presumed motor hand region location was probed in 
intervals of 10mm over the left M1 to identify the location which produced the strongest 
motor evoked potential (MEP) response (i.e., the hand motor “hot spot”). The test 
stimulus was delivered at the % maximal stimulator output (%MSO) intensity which 
induced an average peak-to-peak MEP of approximately 1mV across 10 trials. Changes 
in corticospinal excitability were quantified as peak-to-peak MEP amplitudes before the 
first (priming), and after the second (test) round of cTBS. The %MSO was left 
unchanged for spTMS. There were five measurement points; pre-intervention 
(baseline), and four post-intervention time points after the second test bout of cTBS (0, 
10, 20 and 30 min). For each block, 10 TMS pulses were delivered manually at a rate of 
4s – 6s to avoid rhythmic delivery. Paired-pulse transcranial magnetic stimulation 
(ppTMS) was used to investigate intra-cortical inhibitory, and facilitatory mechanisms 
but is not reported in this paper. For ppTMS, the conditioning and test pulses were 
delivered with a 70mm figure 8 coil using the Magstim Bistim2 (Magstim, UK) 
connected via the Bistim Module.  
Continuous Theta Burst Stimulation 
cTBS was administered using a Magstim Rapid2 (Magstim, UK) via a 70mm 
figure 8 air cooled coil which induces a biphasic pulse of 0.5ms duration with 80µs rise 
time (Magstim, 2007a).  The coil was held tangential to the scalp at a 45-degree angle to 
the midline for all sites, and held in place by the researcher, supported by a mechanical 
stand. The cTBS protocol comprised three pulses delivered at 50Hz repeated at 5Hz for 
40s for a total of 600 pulses at 70% resting motor threshold 
(cTBS60070%RMT)(Goldsworthy et al., 2012; Huang et al., 2005). RMT for cTBS was 
defined as a discernible MEP of peak-to-peak amplitude greater than 50µV in 3 out of 5 
trials and was established after baseline measurements with the Magstim Rapid2 using a 




non-air cooled figure 8 70mm coil. Sham stimulation was delivered using an identical 
70mm figure 8 air cooled placebo coil which produces a similar discharge sound, but 
does not stimulate the cortex (Magstim, 2007b). The experimental design is illustrated 
in Figure 4. 





Figure 4. Timeline of experimental design. Note. cTBS600 – continuous theta burst stimulation (600 pulses); DLPFC – dorsolateral 
prefrontal cortex; dPMC – dorsal premotor cortex (dPMC); M1 – primary motor cortex; MEP – motor evoked potential; mV – millivolt; 
RMT – resting motor threshold; transcranial magnetic stimulation (TMS).   




Experimental Conditions  
Participants underwent all four experimental conditions with the order of 
conditions determined using a randomized computer-generated sequence. Participants 
attended sessions at approximately the same time of day for each session.  Sessions 
were separated by a minimum of five days to avoid carry over effects (Baumer et al., 
2003). The basic paradigm comprised a conditioning-test protocol with an inter-train-
interval of 10min all applied to the left hemisphere (Figure 4). This interval was 
selected because it has been shown to induce robust neuroplastic effects (Goldsworthy 
et al., 2012), but also to maintain consistency across conditions. M1 was defined 
functionally as the FDI “motor hotspot.” The dPMC was defined as 2.5cm anterior to 
the motor hot spot on the basis of neuroimaging (Picard and Strick, 2001), and previous 
rTMS studies (Rizzo et al., 2004). The DLPFC was defined as 5cm anterior to the M1 
hot spot (Loo et al., 1999; Wassermann et al., 1995).  
Statistical analysis 
Only spTMS MEP data were analyzed. Outliers were defined as values 
exceeding absolute z-scores of 3.29. To reduce the influence of outliers, extreme values 
were replaced with the M + 3 SD (Field, 2009). Less than 1% of the data were 
transformed. Data were checked visually for normality using histograms. To better 
approximate normality and maintain positive integers, log10 + 1 transformations were 
applied to raw spTMS MEP values (Tabachnick and Fidell, 2007). The primary analysis 
was a two-way repeated measures ANOVA with protocol (four levels: M1-M1, sham-
M1, DLPFC-M1, dPMC-M1), and time (five levels: baseline, 0, 10, 20 and 30 min post-
cTBS) as within-subjects factors. One-way repeated measures ANOVA (four levels: 
M1-M1, sham-M1, DLPFC-M1, dPMC-M1) were conducted to test for pre-
conditioning differences in the %MSO 1mV test stimulus, %MSO cTBS RMT, and 
baseline MEP values (transformed data). Mauchley’s test indicated that sphericity could 




be assumed for all analyses. Analyses were conducted offline (SPSS version 22 for 
Windows; SPSS Inc.). For ease of comparison, figures were generated using normalized 
MEP values by dividing spTMS MEP responses at each post-intervention time point (0, 
10, 20 and 30 min) with pre-intervention mean baseline MEP responses. Normalized 
MEP values were not used for any parametric tests.   
For categorical data analysis, nominal 20% post-measurement change from 
baseline levels were used to categorize participants as having an “expected” or 
“unexpected” response according to a priori directions of predicted change. For M1-M1 
and sham-M1 conditions, participants with at least one post-intervention normalized 
MEP response ≤ .8, were classified as “expected”. For the DLPFC-M1 and dPMC-M1 
conditions, participants with at least one post intervention response ≥ 1.2 were classified 
as “expected.” Cochrane’s Q analysis (exact p-value reported) was used to test whether 
the protocols differed in inducing patterns of “expected” versus “unexpected” results. 
Finally, individual response plots were generated for all participant across each 
measurement point, and protocol using normalized values.  
7.3 Results 
Participants completed each session without major complaints, or adverse 
reactions (refer to Supplementary Table 1). Pre-conditioning values for the %MSO 
1mV test stimulus (F [3, 57] = 1.472, p = .232, partial η2 = .072), %MSO cTBS RMT 
(F [3, 57] = 1.728, p = .171, partial η2 = .083), and baseline MEP values (F [3, 57] = 
1.570, p = .207, partial η2 = .076) did not differ across conditions (Table 17). 





Average (SD) 1mV Test Stimulus and Resting Motor Threshold (RMT) for Continuous Theta Burst Stimulation (cTBS) Expressed as a 
Percentage of Maximal Stimulator Output (%MSO), and Mean (SD) Raw Pre-Conditioning Motor Evoked Potential (MEP) values across 
each Protocol.  
    %MSO 1mV   %MSO cTBS RMT   Pre-Conditioning MEP 
  n Mean SD   Mean SD   Mean SD 















dPMC-M1 20 54.00 8.97   57.75 10.22   1.10 0.26 
DLPFC = dorsolateral prefrontal cortex; dPMC – dorsal premotor cortex; M1 – primary motor cortex.   




For the main analysis comparing the effect of all four protocols on MEP 
responses, the two-way repeated measures ANOVA revealed no main effect of time, F 
(4, 76) = .683, p = .606, partial η2 = .035; protocol, F (3, 57) = .235, p = .872, partial η2 
= .012; or time*protocol interaction, F (12, 228) = .930, p = .518, partial η2 = .047. This 
indicates that M1 corticospinal excitability levels did not consistently differ between 
conditions (Figure 5). This was despite an increase in corticospinal excitability in the 
DLPFC-M1 condition from the second (10min) post-measurement time points, and 
suppression in the M1-M1 condition at the first post-measurement time point.  





Figure 5. Normalised motor evoked potential (MEP) amplitudes (standard errors)  across each time point as a function of protocol. Note. 

































Cochrane’s Q showed that the proportion of individuals with an “expected” 
versus “unexpected” response did not differ across conditions, χ2 (3) = 5.866, p = .136. 
This indicates that the protocols did not differ in inducing consistent and predicted 
inhibitory or facilitatory effects (Table 18).  





Proportion of Participants Classified as Having an Expected or Unexpected Response  
as a Function of Protocol.  
 
 Expected 
Protocol N Number Percent 
M1-M1 20 14 70% 
Sham-M1 20 10 50% 
DLPFC-M1 20 10 50% 
dPMC-M1 20 6 30% 
DLFPFC – dorsolateral prefrontal cortex;  
dPMC – dorsal premotor cortex; M1 – primary motor cortex. 




Normalized inter-individual values are presented in Figure 6. As observed, 
individual responses across each post-measurement point and protocol were highly 
variable. 





Figure 6. Individual motor evoked potential (MEP) response plots expressed as normalised MEP amplitudes ; (A, top-left) primary motor 
cortex (M1)-M1 (M1-M1), (B, top-right) sham-M1, (C, bottom-left) dorsolateral prefrontal cortex-M1 (DLPFC-M1), and (D, bottom-
right) dorsal premotor cortex -M1 conditions (dPMC-M1). Bolded lines with triangle markers indicate the mean.  





The current study investigated whether intra- or inter-regional priming of the ipsilateral 
M1 with repeated cTBS60070%RMT trains can induce homogenous, and predictable 
neuroplastic effects on corticospinal excitability compared to a single round of 
cTBS60070%RMT. Overall, it was found that neither intra-regional nor inter-regional 
priming of left-M1 induced robust neuromodulation of M1 corticospinal excitability. 
For the categorical data, the proportion of individuals with an expected inhibitory or 
facilitatory response did not differ across conditions. Finally, individual response plots 
showed that participant responses to each protocol were highly variable.  
cTBS of M1 – Neurological Mechanisms 
The overall null findings indicate that sham-M1 stimulation did not have significant 
inhibitory effects at the group level. Early studies reported that a single administration 
of cTBS80%AMT can induce relatively strong suppression of M1 corticospinal excitability 
(Huang et al., 2005). These effects are described as “LTD-like”, and have been shown 
to be N-methyl-D-aspartate receptor dependent (Huang et al., 2007; Pell et al., 2011). 
More recently, studies with larger samples have shown that the effects of a single 
administration of cTBS60080%AMT can have both LTD-like and LTP-like effects 
(Hamada et al., 2012). Interestingly, individuals for whom TMS can more readily 
recruit late I-wave activity (when elicited with anterior-posteriorly induced currents) 
tend to show the expected suppressive effects, whilst individuals who show early I-
wave recruitment tend to show facilitatory responses (Hamada et al., 2012). Future 
studies could examine whether differences in early- and late-I wave recruitment can be 
used to better predict “expected” and “unexpected” neuroplastic responses to 
cTBS60070%RMT.    
Intra-Regional Priming of M1 – Neurological Mechanisms 




At least four studies have examined the effects of intra-regional priming of M1 with 
cTBS using different inter-train intervals, and stimulation parameters with varying 
results. Gamboa et al. (2011) reported that two bouts of cTBS60080% Active motor threshold 
(AMT) spaced by 20 min enhanced early suppression of M1, whilst Goldsworthy et al. 
(2012; 2014b) showed that two rounds of cTBS60070% RMT spaced by 10min induced 
robust suppression of corticospinal excitability lasting up to two hours.  In contrast, 
Gamboa et al. (2010; 2011) found that double application of cTBS60080% AMT attenuated 
the LTD response at short intervals (0 or 5 min), and Murakami et al. (2012) reported 
that sequential bouts of cTBS60080% AMT at longer intervals (15 min) induced 
facilitation. The differences in findings are likely due to a combination of factors 
including different cTBS parameters (e.g. the time interval between successive bouts, 
the use of AMT versus RMT), and the activation of the target muscle required to 
determine AMT prior to conditioning (Gentner et al., 2008).  
As a whole, these findings indicate that intra-regional priming of M1 can induce 
either homeostatic or non-homeostatic metaplastic effects, depending on the inter-train-
interval. Intra-regional priming of M1 using paired trains of cTBS60070%RMT at 10min 
appears to induce non-homesotatic metaplastic effects. The strong and long lasting 
suppression of M1 excitability for up to 2 hours over and above the inhibitory effects 
following a single round of cTBS70%RMT (Goldsworthy et al., 2012; Goldsworthy et al., 
2014b) may be due to late phase-LTD consolidation as demonstrated in animal models 
(Karabanov et al., 2015; Nguyen et al., 1994). In contrast, paired trains of cTBS 
delivered at short (0 or 5 min) or long intervals (15min) induces facilitatory effects 
(Gamboa et al., 2011; Murakami et al., 2012). The reversal of the expected inhibitory 
effects can be explained with the BCM theory of metaplasticity (Bienenstock et al., 
1982), akin to those observed in the animal literature (Abraham and Bear, 1996). 
Although there was some evidence of suppression of M1 corticospinal excitability in 




the M1-M1 condition (particularly the first post-measurement time point), the analysis 
failed to reach significance. Future investigations could directly compare the effect of 
different inter-train-intervals using a repeated measures design to better control for 
individual, and methodological differences. 
Inter-Regional Priming of M1 – Neurological Mechanisms 
Two studies examining the effects of inter-regional priming of M1 with inhibitory NIBS 
protocols have shown that the expected suppressive effects can be reversed in 
accordance with the predictions made by the BCM theory (Bienenstock et al., 1982). 
Potter-Nerger et al. (2009) reported that priming the dPMC with low frequency 
rTMS1Hz reversed the usual inhibitory effects of paired associative stimulation (PASN20-
5ms) applied over the ipsilateral (left) M1 into facilitation. Similarly, Hamada et al. 
(2009) reported that priming the SMA with low frequency QPS50ms reversed the usual 
inhibitory effects of QPS30ms applied over the left M1 into facilitation. Although visual 
inspection of Figure 2 shows facilitation of corticospinal excitability in the DLPFC-M1 
condition, this failed to reach significance at the group level. Thus, we report that inter-
regional priming of M1 with cTBS60070%RMT via the ipsilateral DLPFC, or dPMC does 
not induce consistent neuroplastic effects.  
As mentioned, the reversal of expected neuroplastic effects in previous studies 
are in line with the predictions made by the BCM theory of metaplasticity (Bienenstock 
et al., 1982; Potter-Nerger et al., 2009; Murakami et al., 2012). Although the precise 
neurological mechanisms that underpin these effects in humans are unknown (Hamada 
et al., 2009; Potter-Nerger et al., 2009), because the SMA and dPMC both have 
connections with M1 (Dum and Strick, 2005; Kantak et al., 2012; Picard and Strick, 
2001) the homeostatic-like effects reported in past studies may involve cortico-cortical 
pathways. A limitation of the current study was MEP responses were not collected 
during the inter-train-interval between each round of cTBS60070%RMT. Furthermore, the 




sham-M1 protocol (i.e. the control condition) failed to induce an inhibitory effect at the 
group level. Nonetheless, the lack of consistent effects at the group level across all 
conditions makes it difficult to draw strong conclusions regarding potential neurological 
mechanisms induced by inter-regional priming of M1 with cTBS60070%RMT. However, 
this does not preclude the use of other protocols (e.g. iTBS), localisation methods (e.g. 
neuroimaging), or parameters (e.g. different inter-train-intervals) in future 
investigations.  
Expected versus Unexpected responses 
The categorical data analysis showed that the proportion of participants with an 
“expected” versus “unexpected” response did not differ across conditions. The findings 
of the current study are largely consistent with the known inter-individual variability in 
responses following NIBS (Hamada et al., 2012). For example, both Hamada et al. 
(2012) and Goldsworthy et al. (2014a) found that one round of cTBS60080% AMT applied 
to the left-M1 inducted the expected inhibitory response in only 25-30% of participants. 
In the current study, inter-regional priming of the DLPFC (DLPFC-M1 condition) and 
dPMC (dPMC-M1 condition) only induced the expected facilitatory response in 50% 
and 30% of participants, respectively. Thus, we report similar variability even with 
inter-regional priming. Goldsworthy et al. (2014a) have shown that cTBS60070% RMT 
induces inhibition in 70% of participants. In the current study, cTBS60070% RMT was 
used for both the conditioning and test bout. We found that M1-M1, and sham-M1 
stimulation induced suppression in 70% and 50% of participants, respectively. The 
differences in reported findings between cTBS60080% AMT and cTBS60070% RMT may be 








Inter- and Intra-Individual Responses  
The overall null findings in the primary analysis is most likely driven by the high degree 
of intra- and inter-individual variability between protocols and across each measurement 
time point. Human responses to NIBS are known to be highly variable (Hamada et al., 
2012; Ridding and Ziemann, 2010; Suppa et al., 2016). In one of the largest single 
studies to date (n = 57), Hamada et al. (2012) showed that a single application of cTBS, 
or intermittent TBS (iTBS) to the left-M1 resulted in highly variable neuroplastic 
responses. So much so, there were no overall differences at the group level. In the 
current study, it was also found that participant responses to intra- and inter-regional 
priming of left M1 using cTBS60070% RMT were highly variable. The factors which 
contribute to such variability remain to be elucidated but may include the prior 
activation history of a target region (Gentner et al., 2008), genetic factors (Cheeran et 
al., 2008), intrinsic fluctuations in corticospinal excitability (Kiers et al., 1993), 
individual differences in inter-neural networks (Hamada et al., 2012), and inherent 
variability in human responses to NIBS (Ridding and Ziemann, 2010).  
7.5 Conclusions 
The current investigation found that neither intra- nor inter-regional priming of the left 
M1 with cTBS60070%RMT did induced consistent, and robust effects on corticospinal 
excitability. A high degree of inter-individual variability was observed regardless of 
whether the prime was applied inter- or intra-regionally. The neural mechanisms 
underpinning these findings are not clear. Potential mechanisms may include LTD-like 
mechanisms, or homeostatic and non-homeostatic metaplasticity. Further work is 
required to better understand the factors contributing to this variability. This in turn can 
be used to better inform research, and clinical parameters involving priming protocols.   
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Supplementary Table 1 
Frequency (n) and proportion (%) of participants who reported experiencing the following adverse events as a function of protocol.  
  M1-M1   Sham-M1   DLPFC-M1   dPMC-M1 
Adverse event Frequency (%)   Frequency (%)   Frequency (%)   Frequency (%) 
Ear Pain 0 (0)  0 (0)  0 (0)  1 (5) 
Face pain 2 (10)  0 (0)  3 (15)   1 (5) 
Fatigue 2 (10)  2 (10)  2 (10)  2 (10) 
Headache 3 (15)  1 (5)  2 (10)  6 (30) 
Migraine 0 (0)  1 (5)  0 (0)  0 (0) 
Neck pain 2 (10)  2 10)  3 (15)  2 (10) 
Nervousness 0 (0)  1 (5)  0 (0)  0 (0) 
Numbness 0 (0)  0 (0)  1 (5)  1 (5) 
Scalp pain 3 (15)  2 (10)  6 (30)  5 (25) 
Shoulder Pain 0 (0)  1 (5)  0 (0)  0 (0) 
Tingly 3 (15)  1 (5)  2 (10)  3 (15) 
Toothache 0 (0)  1 (5)  0 (0)  0 (0) 
Weepiness/crying 0 (0)   0 (0)   1 (5)   1 (5) 
N = 20 for all protocols. One participant experienced a transient, migraine 15min after the end of one session (DLPFC-M1 condition) that 
resolved spontaneously after 30min. DLPFC – dorsolateral prefrontal cortex; dPMC – dorsal premotor cortex; M1 – primary motor 
cortex. 
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Chapter 8 – Concurrent Transcranial Magnetic Stimulation-
Electroencephalography 
 Introduction  
Study 3 (Chapter 7) revealed that intra- and inter-regional priming of the 
primary motor cortex (M1) with continuous theta burst stimulation (cTBS) induces 
highly variable neuroplastic effects on corticospinal excitability. This unexplained 
variability is problematic and limits more widespread adoption of priming protocols, 
and may contribute less optimal outcomes for investigative, and clinical applications 
(Guse et al., 2010; Hamada et al., 2012; Pell et al., 2011; Ridding & Ziemann, 2010). 
One technique that may provide important insights into the variability of neuroplastic 
responses induced by multisite paradigms is by combining transcranial magnetic 
stimulation (TMS) with neuroimaging techniques such as electroencephalography 
(Komssi & Kähkönen, 2006). Combined transcranial magnetic stimulation-
electroencephalography (TMS-EEG) is one measurement approach that can be used to 
index neuroplastic responses to non-invasive brain stimulation (NIBS) protocols 
directly at the scalp (Chung et al., 2018; Farzan et al., 2016). Though initially hampered 
by technical limitations (Cracco, Amassian, Maccabee, & Cracco, 1989), a number of 
solutions have been developed offering researchers new ways to measure the human 
brain’s response to NIBS non-invasively (Ilmoniemi et al., 1997; Rogasch et al., 2017; 
Rogasch et al., 2014).  
 The final empirical study (Study 4, Chapter 9) of this thesis utilises combined 
TMS-EEG to characterise the neuroplastic effects of multisite priming of M1 with 
cTBS directly at the scalp. It will also evaluate the validity of TMS-EEG for examining 
neurological brain responses evoked with TMS applied over central (i.e., the scalp) and 
peripheral regions (e.g., the shoulder). The current chapter, in addition to Chapter 6, 
Chapter 7 (Study 3), and Chapter 9 (Study 4) contributes to the second research stream 
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in this thesis that investigated the neuroplastic effects induced by multisite priming 
protocols. This chapter was thus written with several aims. The first was to provide an 
overview of EEG including foundational neurophysiology and technical information, in 
addition to common EEG measures, specifically, event related potentials (ERPs). The 
second section will provide an overview of some of the technical challenges posed by 
combining TMS with EEG, in addition to some of the major outcome measures, 
specifically, transcranial magnetic stimulation evoked potentials (TEPs). The final 
section will provide an overview of the insights garnered through TMS-EEG including 
the utility of TEPs as unique markers of plasticity induced by NIBS techniques. The 
findings of the review were used to inform the rationale, development, analysis, and 
interpretation of the final empirical study (Study 4, Chapter 9) that utilised TMS-EEG 
to characterise the neuroplastic effects induced by multisite priming cTBS directly at the 
scalp.  
Basic Neurophysiology of Electroencephalography 
EEG is a neuroimaging technique that can non-invasively record electrical brain 
activity directly at the scalp (Teplan, 2002). Since the first demonstrated recording of 
EEG in humans by Hans Berger in 1930 (Millett, 2001), the technique has found a wide 
range of applications in sensory and perceptual (Başar-Eroglu, Başar, Demiralp, & 
Schürmann, 1992; Luck & Hillyard, 1994), cognitive (Bruin & Wijers, 2002; Kutas & 
Hillyard, 1980), and clinical domains (Connell, Oozeer, de Vries, Dubowitz, & 
Dubowitz, 1989; Smith, 2005). The technique offers excellent temporal resolution, 
capable of recording brain activity in the order of milliseconds (Luck, 2014).  
 The accurate recording of brain activity with EEG poses several challenges, with 
certain biological and technical requirements needing to be met before a reliable signal 
can be detected. Electrical signals generated in the brain must be of sufficient magnitude 
to be detected by EEG recording electrodes placed on or near the scalp (Teplan, 2002). 
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Due to the unique structure and organisation of the human neocortex, it is possible to 
detect the activity neural populations below the scalp. The cerebral cortex is comprised 
of large pyramidal cells organised in a columnar fashion that extend through layers II to 
VI (Elston, 2003). Although pyramidal neurons can differ considerably in terms of 
shape and size, their general form is that of a rectangular cell body with a single large 
apical dendrite with tuft, and more numerous, shorter, basal dendrites (Spruston, 2008).  
There is general acceptance that EEG detects and records post-synaptic-
potentials (PSPs) of large clusters of neurons activating synchronously (Kirschstein & 
Köhling, 2009; Teplan, 2002) . Specifically, EEG detects the temporo-geographically 
summated PSPs of large clusters of neurons. When an electrochemical signal is received 
by a neuron, a dipole is created whereby the region of localised activity will show a 
relative change in the electrical charge compared to distal regions along the length of 
the neuron (Jackson & Bolger, 2014). An excitatory postsynaptic potential (EPSP) is 
generated when an excitatory input (e.g., glutamate) is received at the post-synaptic 
neuron that increases the intra-cellular membrane positivity due to influx of positivity 
charged sodium (Na+), or calcium (Ca2+) ions (Kandel, Schwartz, Jessel, Siegelbaum, & 
Hudspeth, 2013; Takagi, 2000). In contrast, an inhibitory postsynaptic potential (IPSP) 
is generated when an inhibitory input (e.g., gamma amino butyric acid; GABA) is 
received at a post-synaptic neuron that increases the intra-cellular negativity due to 
influx of negatively charged chloride (Cl-), or efflux of positively charged potassium 
(K+) ions (Kandel et al., 2013).    
 Unfortunately, it is not possible to differentiate between an EPSP or IPSP with 
EEG alone (Jackson & Bolger, 2014). Whether the EEG trace shows a negative or 
positive deflection depends on several factors including the type of transmitted neural 
signal (e.g., EPSP or IPSP), neural arrangement in relation to the scalp (e.g., neurons 
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orientated perpendicular or horizontally to the scalp), neighbouring neural populations, 
and/or electrode placement (Jackson & Bolger, 2014).  
Assuming a neural population is arranged perpendicularly to the scalp, if an 
EPSP occurs at the dendrites, the extracellular space near the focal region of activity 
will be more negative (and thus more positive near the soma) and will be recorded as a 
negative deflection in the EEG (Jackson & Bolger, 2014). Assuming the same 
arrangement, if an IPSP occurs at the soma, the immediate extracellular space will be 
more positive, whereas the dendrites will be more negative. The IPSP, in this instance, 
will be detected as a negative deflection in the EEG. Thus, an EPSP at the dendrites, or 
an IPSP near the soma will be detected as a negative deflection in the EEG trace 
(Jackson & Bolger, 2014).  
In contrast, if an EPSP occurs at the soma, this will induce a localised negativity 
in the surrounding extracellular space and a relative increase in the positive potential at 
distal dendrites (Jackson & Bolger, 2014). This activity will be reflected as a positive 
deflection the EEG. Similarly, if an IPSP occurs near the dendrites, this will lead to an 
increase in the regional positivity (and relative negativity in the soma) and will be 
reflected as a positive deflection in the EEG. Thus, given these conditions, an IPSP and 
EPSP will both be detected as a positive deflection in the EEG (Jackson & Bolger, 
2014).  
Contributors to the Electroencephalography signal 
 The EEG signal is likely to be comprised primarily of neural activity at the level 
of the cortex. This activity is detectable as a result of thousands of similarly orientated 
and synchronously active pyramidal cells arranged perpendicularly to the scalp (Baillet, 
Mosher, & Leahy, 2001). The activity of a single neuron is too small to detect via scalp 
recordings; thus, the activity represented in the EEG trace is likely the result of the 
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activity of several thousands of neurons summated temporo-spatially (Baillet et al., 
2001; Hämäläinen, Hari, Ilmoniemi, Knuutila, & Lounasmaa, 1993).  
There is also evidence that subcortical regions, particularly the thalamus, 
contribute to the EEG signal measured at the scalp (Buzsaki et al., 1988; Davidson, 
Jackson, & Larson, 2000; Pizzagalli, 2007; Steriade, Deschenes, Domich, & Mulle, 
1985). For instance, Buzsaki et al. (1988) showed that rhythmic high voltage spindle 
activity in the neocortex could be abolished following controlled lesions of the reticular 
thalamus in rats. Similarly, Steriade et al. (1985) showed that transections of the 
reticular thalamus in cats could also supress spindle activity measured with EEG. 
 Thus, at least some of the EEG signal measured at the scalp likely contains 
contributions from distal subcortical structures.  
Electroencephalography Waveforms  
 One of the most recognisable and characteristic measures obtainable through 
EEG are EEG waveforms that were first identified and described by Hans Berger 
(Millett, 2001). EEG waveforms appear as time-varying positive and negative 
deflections in the EEG trace, and have been associated with a wide range of 
psychological, attentional, sleep, and pathological processes (Spehlmann, 1981). The 
waveforms are measured in microvolts (μV) and can range between 0.5 to 100 μV 
(Teplan, 2002). The waves are often grouped into several bands according to their 
frequency.  
Different frequency bands are associated with a wide range of neuro-
psychophysiological states, and processes. Delta waves ranging from 0.5 to 4 Hz are 
associated with arousal states (e.g., sleep), and motivational and cognitive processes 
(Borbély, Baumann, Brandeis, Strauch, & Lehmann, 1981; Dang-Vu et al., 2008; 
Knyazev, 2007). Theta waves oscillate between 4 - 8 Hz and are correlated with sleep 
(Borbély et al., 1981), memory (Klimesch, Schimke, & Schwaiger, 1994), and 
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attentional processes (Buzsáki, 2002). Alpha waves are characterised by oscillations in 
the 8 - 13 Hz range and were initially associated with closing of the eyes, but have more 
recently been linked with inhibitory and attentional processes (Adrian & Matthews, 
1934; Klimesch, 1997, 2012; Sauseng et al., 2005). Beta waves are higher frequency 
oscillations between 13 - 20 Hz and have been found to occur during the processing of 
sensorimotor information contributing to successful task execution , inhibiting 
competing motor patterns on selection of a chosen motor sequence (Engel & Fries, 
2010), and accurate correction of motor movements with visual guidance 
(Androulidakis, Doyle, Gilbertson, & Brown, 2006). Finally, the gamma frequency is 
characterised by oscillations > 30 Hz, and have been associated with perceptual 
processing (e.g., visual and somatosensory) (Fries, 2009; Singer, 1999).  
Event Related Potentials  
 ERPs are a special class of EEG recordings that capture brain responses time-
locked to an event or stimulus (Luck, 2014; Pfurtscheller, Neuper, & Krausz, 2000). 
Due to their high temporal precision (in the order of milliseconds), ERPs can be used to 
measure sensory/perceptual (Davis, 1939; Vogel & Luck, 2000), cognitive (Rohrbaugh, 
Syndulko, & Lindsley, 1976), and behavioural  (Brunia, van Boxtel, & Böcker, 2012) 
processes that occur over a short time frame. One of the earliest descriptions of an ERP 
was reported by Davis (1939). The author played tones of various frequencies to awake 
participants with eyes closed and reported a series of deflections (usually two or three) 
in the EEG trace that began with a negative deflection, peaking at approximately 30 to 
40 ms, following the presentation of the tone.  
 An ERP is a composite EEG trace obtained after averaging over multiple trials, 
and comprises a series of positive and/or negative deflections in response to a time-
locked event or stimulus (Luck, 2014). ERP deflections are measured in μV and usually 
span hundreds of milliseconds (Coles & Rugg, 1995). ERPs are generated by 
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segmenting a continuous EEG recording into epochs of equal temporal length 
demarcated by an event marker (Luck, 2014). Once the trials belonging to a single event 
or stimulus are grouped, the set of common trials are averaged. The averaging process is 
needed to isolate the brain signal of interest. This is because on any given trial, the 
recorded EEG trace represents a mixture of target brain activity, and non-target 
background noise (Delorme, Sejnowski, & Makeig, 2007). The target brain signal is any 
neurological process elicited directly in response to the stimulus or event (e.g., sensory 
or cognitive processes involved with identifying, and responding to a target) (Coles & 
Rugg, 1995). Non-target activity refers to any biological or non-biological on-going, 
coincidental, or random activity unrelated to the stimulus or event (e.g., electrical 
activity due to eye movements, muscle activity, or line noise) (Chaumon, Bishop, & 
Busch, 2015; Fitzgibbon et al., 2016; Hoffmann & Falkenstein, 2008). If the evoked 
target brain signal is consistent and the non-target activity occurs randomly, averaging 
over multiple trials can extract the brain signal of interest whilst reducing background 
noise (Luck, 2014).  
 ERPs are characterised by a series of positive and/or negative deflections (Coles 
& Rugg, 1995). These deflections can be referred to as peaks, waves or components 
(Luck, 2014). There are several ways to refer to the deflections in an ERP trace. A 
common scheme is to assign the peak with the letter P or N depending on whether it is 
positive or negative deflection, respectively. Single digit numerals can be assigned to 
each peak according to their rank order (Luck, 2014). For example, if there are two 
positive and two negative peaks, they may be referred to as the P1, P2, N1, and N2. 
Another scheme is to assign each peak of interest a number depending on their 
approximate latency (Luck, 2014). For instance, a positive peak occurring at 100 
milliseconds (ms) can be referred to as the P100, whereas a negative peak occurring at 
200 ms can be referred to as the N200.  
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 ERPs can be described in terms of their latency and amplitude. The latency 
describes the time point that a peak reaches its local maxima or minima usually within a 
pre-defined window (Luck, 2014). For example, a negative peak may reach its local 
minima at 160 ms between the time window 150 - 200 ms. Similarly, a positive peak 
may reach its local maxima at 180 ms between the time window 150 - 200 ms. ERP 
peaks can also be described in terms of their amplitude that refers to the magnitude of 
the peak measured in μV (Coles & Rugg, 1995).  Before analysing ERPs (and indeed, 
any EEG data), it is first necessary to remove unwanted artefacts present in the EEG 
recording.  
Common Electroencephalography Artefacts  
 Artefacts in EEG refer to any electrical activity that is not the target signal of 
interest that can lead to distortion of the recorded neural activity (Tatum, Dworetzky, & 
Schomer, 2011). Artefacts are almost universally present and must be dealt with in 
some form to reduce their influence on the underlying neural signal. Common artefacts 
include eye artefacts (e.g., eye blinks, eye rotation, lateral eye movement) (Hoffmann & 
Falkenstein, 2008; Joyce, Gorodnitsky, & Kutas, 2004; Plöchl, Ossandón, & König, 
2012; Vigário, 1997), muscle activity (Fitzgibbon et al., 2016; Goncharova, McFarland, 
Vaughan, & Wolpaw, 2003; Whitham et al., 2008; Whitham et al., 2007), and electrode 
noise (Chaumon et al., 2015; Delorme, Palmer, Onton, Oostenveld, & Makeig, 2012; 
Rogasch et al., 2014). As several excellent resources have been developed to correct for 
common artefacts (Luck, 2014), this chapter will focus on characterising artefacts 
unique to TMS-EEG.  
 Recovering the Transcranial Magnetic Stimulation-Electroencephalography 
Signal 
 In concurrent TMS-EEG, a TMS pulse is delivered over the target brain region 
during simultaneous recording of the EEG signal (Rogasch, Thomson, Daskalakis, & 
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Fitzgerald, 2013). Due to the nature and magnitude of the TMS pulse, this results in 
several unique artefacts that severely distorts the EEG trace (Epstein, 1995; Rogasch et 
al., 2013). One of the more clearly identifiable and problematic artefacts is the 
electromagnetic TMS pulse itself (Paus, Sipila, & Strafella, 2001; Rogasch et al., 2013). 
The nature, severity, and magnitude of the TMS pulse essentially destroys the 
underlying neural signal in the EEG trace, so several solutions have been developed to 
mitigate its effects. One solution involves the use of specialised recording equipment 
such as sample and hold circuits  that ‘pins’ the EEG recording equipment (i.e., stops 
recording the electrical signal) prior to the delivery of the TMS pulse and resumes 
recording once the TMS pulse has passed (Ilmoniemi et al., 1997). Recording can begin 
as early as 1 - 2.5 ms after the onset of the pulse (Iramina, Maeno, Nonaka, & Ueno, 
2003; Virtanen, Ruohonen, Näätänen, & Ilmoniemi, 1999).  
Another approach, that does not require specialised equipment, is to correct for 
the TMS pulse offline using custom processing software (Rogasch et al., 2017). One 
such package has been developed by Dr Nigel Rogasch (Monash University, Australia), 
and is referred to as TMS-EEG Signal Analyser (TESA). TESA is a library of open 
source functions and customs scripts implemented through EEGALB (Delorme & 
Makeig, 2004) in the MATLAB programming environment made specifically for the 
removal and correction of the TMS pulse, allowing for the recovery and subsequent 
analysis of the EEG signal (Rogasch et al., 2017; Rogasch et al., 2013). TESA has been 
successfully used to measure transcranial magnetic evoked responses from the primary 
motor cortex (M1) (Biabani, Fornito, Mutanen, Morrow, & Rogasch, 2018; Rogasch et 
al., 2014), and dorsolateral prefrontal cortex (DLPFC) (Chung et al., 2017; Chung et al., 
2018).   
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Transcranial Magnetic Pulse Artefact  
 The TMS pulse induces an electrical artefact several magnitudes larger than the 
neural signal of interest (Rogasch et al., 2017; Rogasch et al., 2013). Higher sampling 
rates (i.e., ≥ 10 kHz) can be used to clearly characterise and delineate the TMS pulse for 
offline correction (Rogasch et al., 2017; Rogasch et al., 2013). Although the precise 
shape and latency of the TMS pulse depends upon the stimulator, the TMS pulse is 
generally characterised by high frequency, and large amplitude deflections on the EEG 
trace, and can last anywhere from ~6ms (Magstim 200) to up to 400ms (MagPro R30) 
(Rogasch et al., 2013).  An elegant solution to correct for the distortion introduced by 
the TMS pulse is to remove data contaminated by the artefact and to interpolate the 
missing values by fitting with a function (i.e., linear or cubic interpolation) (Rogasch et 
al., 2017). Removing the high frequency, and high amplitude TMS pulse permits down 
sampling of the data file saving processing time, and the application of filters without 
introducing distortion artefacts (Rogasch et al., 2017).  
Transcranial Magnetic Evoked Muscle Activity  
 Another major artefact associated with the pulse is the activation of muscles 
distributed across the scalp, particularly the frontalis, and temporalis muscles, referred 
to as TMS-evoked muscle activity (Tortora & Gabrowski, 2003). Ideally, this type of 
artefact ought to be avoided by stimulating scalp locations less densely covered by 
muscle (i.e., closer to the central midline), however, this may not always be possible if 
the target region lies directly below scalp muscles (i.e., the frontal or lateral regions) 
(Mutanen, Mäki, & Ilmoniemi, 2013; Rogasch et al., 2014). TMS-evoked muscle 
activity is characterised by a series of time-locked positive and negative deflections in 
the EEG lasting up to 50 ms, with peak amplitudes up to ~10,000 µV occurring within 
the first 10 ms (Rogasch et al., 2014). Two major peaks appear at approximately 5 and 8 
ms.  
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Decay Artefacts  
 Another artefact associated with the TMS pulse is a long latency artefact with an 
exponential decay that can last up to 200 ms with amplitudes of up to 30 µV (Rogasch et 
al., 2014). The long latency artefact precludes complete removal of the trace thus other 
methods (e.g., independent component analysis [ICA]) are required to remove or supress 
the artefact (Rogasch et al., 2017; Rogasch et al., 2014). The source of the artefact may 
be residual TMS-evoked muscle activity, as described earlier, and/or on-going electrical 
activity induced by the TMS-pulse. The topography is often near the area of stimulation 
and time-locked to the TMS pulse, supporting the supposition that the artefact is indeed 
related to the TMS pulse.  
Correcting Artefacts - Independent Component Analysis  
 ICA is a mathematical technique that can be used to identify latent (i.e., 
unobserved) sources contributing to a signal (Hyvärinen, Karhunen, & Oja, 2001). The 
technique has found many applications in the biological (Viola et al., 2009), 
technological (Draper, Baek, Bartlett, & Beveridge, 2003), and neuroimaging fields 
including EEG (Delorme & Makeig, 2004) and functional magnetic resonance imaging 
(Calhoun, Liu, & Adalı, 2009).  
As comprehensively described by Hyvärinen et al. (2001) ICA can be used to 
solve the problem of blind source separation . The blind source problem involves 
identifying each unique contributor to a recorded signal whilst having little to no prior 
knowledge of those sources. This is referred to as the cocktail party problem. The 
commonly used example is that of a party where there are several sources that generate 
auditory stimuli (e.g., a singer on stage, conversations between attendees, and the 
waiters carrying serving trays). Placed around the room at different locations are 
microphones that detect the combined auditory signals from each source. The problem 
is to uncover each unique source with only the recorded signals. In ICA, the 
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combination of signals from each source is referred to as the mixing matrix, and by 
estimating the unmixing matrix it becomes possible to recover each unique source 
(Hyvärinen et al., 2001).  
ICA requires that the sources be temporally and spatially independent. In 
general, these assumptions can be met by EEG, although in TMS-EEG there is the issue 
of time-locked events (e.g., blinks elicited by a TMS pulse) (Rogasch et al., 2017). In 
EEG analysis, ICA can be used identify and characterise potential neural generators 
contributing to an EEG signal, as well as correcting for unwanted biological and non-
biological artefacts (Delorme et al., 2007; Joyce et al., 2004; Plöchl et al., 2012; 
Rogasch et al., 2017; Viola et al., 2009). The application of ICA for artefact 
identification and correction is an active area of research, and can be used to recover 
EEG signals that would otherwise be lost due to excessive noise, large artefacts, or 
contamination caused by the TMS pulse (Biabani et al., 2018; Delorme et al., 2007; 
Farzan et al., 2016; Rogasch et al., 2017).   
Transcranial Magnetic Stimulation Evoked Potentials Elicited from the Primary 
Motor Cortex 
When a TMS pulse is administered directly over M1 during EEG recording, it 
can elicit a sequence of highly reproducible deflections in the EEG trace of varying 
latencies, and amplitudes (Lioumis, Kičić, Savolainen, Mäkelä, & Kähkönen, 2009). 
These event-locked EEG traces (the event being the TMS pulse) are referred to as TEPs 
and are a subclass of ERP (Cracco et al., 1989). Specifically, the M1 TEP is 
characterised by up to 8 peaks, including the N15, P14, N18, P30, N45, P60, N100, and 
P200 (Bonato, Miniussi, & Rossini, 2006; Ferreri et al., 2011; Ilmoniemi & Kičić, 2010; 
Lioumis et al., 2009; Rogasch et al., 2014). An example of the M1 TEP is presented in 
Figure 7. 




Figure 7. Transcranial magnetic stimulation evoked potential (TEP) elicited from the primary motor cortex . Note the generation of the 
P30, N45, P60, N100, and P200. The trace is the mean of electrodes C1, C3, and C5. 
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The M1 TEP can be elicited with pulses delivered either above or below motor 
threshold (MT) (Komssi, Kähkönen, & Ilmoniemi, 2004; Lioumis et al., 2009; Tiitinen et al., 
1999). The neurological sources contributing to each component are highly complex and 
likely comprise a mixture of proximal and distal excitatory and inhibitory neural populations, 
but also artefacts including muscle, somatosensory, electrical, and auditory (Schürmann et al., 
2001; Tiitinen et al., 1999). The following sections will examine potential contributors to the 
M1 TEP and will draw from directly related and concomitant literature to delineate potential 
source contributors. It will also be shown that TMS-EEG can be used as a marker of 
neuroplastic responses to neuro-modulatory NIBS techniques.  
N10 
The N10 is a negative deflection occurring 7 - 10 ms after the TMS pulse (Bonato et 
al., 2006; Ferreri et al., 2011). Topography maps indicate a strong localised negativity 
slightly anterior to the target M1 region (Bonato et al., 2006; Ferreri et al., 2011). Due to the 
short latency of the N10, it is difficult to isolate the precise sources contributing to the early 
component. The topography may indicate contributions from ipsilateral regions anterior to 
M1, including the dorsal premotor cortex (dPMC) or DLPFC (Bäumer et al., 2009; Civardi, 
Cantello, Asselman, & Rothwell, 2001; Groppa et al., 2012b). The time frame and large 
amplitude of the N10 (Bonato et al., 2006; Ferreri et al., 2011) may be partially contaminated 
by short latency artefacts including the TMS pulse, and muscle contraction (Bonato et al., 
2006; Rogasch et al., 2013).   
P14 
The P14 is a positive deflection occurring 13 - 14 ms after the TMS pulse (Bonato et 
al., 2006; Ferreri et al., 2011). Topography maps indicate the TEP P14 is a widely distributed 
positivity over fronto-central regions contralateral to the target M1 region (Bonato et al., 
2006; Ferreri et al., 2011). Potential sources of the positivity include the dPMC (Mochizuki, 
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Huang, & Rothwell, 2004; Ni et al., 2009) or contralateral M1 (Ferbert et al., 1992; Ni et al., 
2009). The P14 response can be modulated using paired-pulse transcranial magnetic 
stimulation (ppTMS) and shows similar fronto-central distribution to single pulse transcranial 
magnetic stimulation (spTMS). Ferreri et al. (2011) found that the P14 response is augmented 
when elicited with intra-cortical facilitation (inter-stimulus-interval [ISI] of 11 ms) and larger 
still with short-interval intra-cortical inhibition (SICI; ISI of 3 ms). As ICF have been shown 
to be mediated by glutamate (Ziemann et al., 1998), and SICI is dependent on GABARA (Di 
Lazzaro et al., 2000), the P14 may partially reflect both neurotransmitter systems. The P14 
can also be elicited with sham stimulation; thus, part of the component is likely contaminated 
by artefacts (e.g., muscle and/or auditory) (Bonato et al., 2006).  
N18 
The N18 appears as a negative deflection 14 – 18 ms after the TMS pulse (Bonato et 
al., 2006; Ferreri et al., 2011; Komssi et al., 2004). Topography maps indicate localised 
negativity slightly posterior to the target M1 location (Bonato et al., 2006; Ferreri et al., 
2011). One potential source of the negativity is the posterior parietal cortex (PPC). The PPC 
is known to have direct connections with M1 (Johnson, Ferraina, Bianchi, & Caminiti, 1996; 
Wise, Boussaoud, Johnson, & Caminiti, 1997). More direct evidence of the potential 
contributions from the PPC comes from dual-site transcranial magnetic stimulation where the 
conditioning stimulus (CS) and test stimulus (TS) are administered over functionally related 
but distinct anatomical regions. Koch et al. (2007) showed that a subthreshold CS (90% 
RMT) delivered 2 - 20 ms over the PPC prior the TS applied over M1 facilitates the 
conditioned TS response at ISI of 4 and 15 ms, consistent with the latency of the N18 
(Bonato et al., 2006; Ferreri et al., 2011). The N18 can also be modulated by ppTMS with 
SICI, and ICF attenuating the N18 response (Ferreri et al., 2011).  




The P30 appears as a positive deflection appearing 30 ms after the TMS pulse 
(Bonato et al., 2006; Ferreri et al., 2011; Komssi et al., 2004). Topography maps indicate a 
wide-ranging positivity over fronto-central (Bonato et al., 2006; Komssi et al., 2004), or 
fronto-lateral distribution contralateral to the target M1 (Ferreri et al., 2011). The P30 is 
likely to be a complex component, with several potential sources contributing to its genesis. 
The fronto-lateral distribution over the contralateral hemisphere may indicate 
interhemispheric contributions from the contralateral primary or non-primary motor regions 
(e.g., dPMC), and/or the DLPFC (Ferbert et al., 1992; Ni et al., 2009).  Using an inter-
hemespheric dual-site TMS paradigm, Ni et al. (2009) have shown that a CS delivered over 
the M1, dPMC, or DLPFC 30 ms prior to a TS delivered over the contralateral M1 can inibit 
the conditioned TS response. Ni et al. (2009) suggested the comparable timeframe across the 
three regions may indicate a shared common pathway possibly through the corpus callosum.  
The P30 is likely to be cortical in origin. Bonato et al. (2006) compared short latency TEP 
components elicited with TMS using optimal orientations for M1 (i.e., TMS coil angled 45° 
away from the midline that induces current flow in a posterior-anterior direction), sub-
optimal orientations (i.e., TMS coil angled 135° along the mid-line that induces current flow 
in an anterior-posterior direction), or sham TMS. The authors found that optimal, and sub-
optimal orientations elicicted the P30 response, but not sham TMS.  
The P30 has also been shown to be modulated by cTBS, and may serve as a marker of 
plasticity induced by patterened rTMS. Vernet et al. (2013) applied a modified cTBS protocol 
(triplets delivered at ISI of 240 ms rather than the standard 200 ms) over left-M1. Using 
suprathreshold TMS test pulses, they found dynamic time-varying changes across different 
components, with the P30 showing decreased amplitudes at the 5- and 20-min time points.  




  The N45 is a negative deflection appearing at a latency of 45 ms when elicited from 
M1. Topography maps indicate that the N45 is located directly under the area of stimulation 
(Bonato et al., 2006; Paus et al., 2001; Premoli et al., 2014). The N45 amplitude increases 
with increasing TMS pulse intensities (Bonato et al., 2006; Kähkönen, Wilenius, Komssi, & 
Ilmoniemi, 2004; Komssi et al., 2004; Paus et al., 2001). The N45 is unlikely to be related to 
proprioceptive/somatosensory feedback as TMS delivered at suboptimal orientations that 
does not elicit a muscle contraction evokes an attenuated N45 response (Bonato et al., 2006). 
Similarly, stimulation of peripheral regions such as the shoulder does not elicit a discernible 
N45 (Biabani et al., 2018).  
In addition to topography maps, several other lines of evidence indicate the N45 may 
reflect neural activity intrinsic to M1. Data from an individual with myoclonus of the leg has 
shown that electrical stimulation of the M1 leg area induces early, and late positive potentials 
in adjacent regions in the cortex (Ashby, Chen, Wennberg, Lozano, & Lang, 1999). The late 
phase positive potential peaks at approximately 43 ms, consistent with the N45 elicited 
through TEP (Ferreri et al., 2011; Paus et al., 2001). Moreover, paired electrical stimuli 
delivered at ISI of 10 ms in the patient abolished the cortical positivity at 43 ms (Ashby et al., 
1999). In healthy controls, ICF delivered at ISI of 11 ms also attenuates the N45 response 
(Ferreri et al., 2011).  
The N45 is also mediated by GABA-ergic transmission. Premoli et al. (2014) 
investigated the involvement of GABAA-mediated neural systems with administration of 
alprazolam, diazepam, and zolpidem on TEP. They found administration of alprazolam, 
zolpidem, and diazepam facilitated the N45 response, implicating GABAA-mediated systems, 
specifically the GABA α1 subunit. In contrast, administration of the GABARB agonist 
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baclofen had no effect on the N45, indicating that the effects on the N45 are unlikely to be 
related to GABARB activity.  
The N45 can be used as a marker of neuro-modulation induced by conventional rTMS 
(Esser et al., 2006; Van Der Werf & Paus, 2006, though see Casula et al. 2014 for evidence 
against), and cTBS (Vernet et al., 2013) Van der Werf  (2006) applied low-frequency 
repetitive transcranial magnetic stimulation (low frequency rTMS) (0.6 Hz, 90% RMT, 560 
total pulses) over the left M1 and found reductions in the N45 lasting 40 min. In contrast, 
Esser et al. (2006) applied high frequency rTMS (5Hz, 90% RMT, 1500 pulses) over the left 
M1 and found increases in the early components (< 50ms), including the P2, P3, and P4, 
using global mean field averages. The authors argued that the increased amplitudes are 
analogous to the facilitation observed in LTP identified in animal models (Malenka & Nicoll, 
1999). In contrast, Casula et al. (2014) applied low frequency rTMS (1Hz, 90% RMT, 1200 
pulses total) over the M1 hand region, but found no differences in the N45 amplitude in the 
post-stimulation condition. Using cTBS600, Vernet et al. (2013) showed the N45 follows a 
relatively complex pattern of change with decreases in the N45 amplitude at 5, 20, and 30 
min, but an increase at the 10 min time point.  
P60 
 The P60 is a positive deflection appearing 60 ms after the TMS pulse. Topography 
maps indicate widespread positivity over, or slightly posterior, to the target M1 region 
(Bonato et al., 2006; Ferreri et al., 2011). The precise origin, and functional significance of 
the P60 is not well understood. There is indirect evidence the P60 may be mediated by 
GABARB (Rogasch, Daskalakis, & Fitzgerald, 2012). Firstly, the latency of the P60 
coincides with the time interval of activation for GABARB in the neocortex (Tamás, Lőrincz, 
Simon, & Szabadics, 2003). Secondly, LICI can be elicited at intervals of 60 ms (Valls-Solé 
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et al., 1992), that has been shown to be mediated by GABARB (Werhahn, Kunesch, Noachtar, 
Benecke, & Classen, 1999a).  
The P60 can be modulated using spTMS and ppTMS. Rogasch et al. (Rogasch et al., 
2012) showed the P60 amplitude increases incrementally with larger spTMS stimulus pulse 
strengths, whilst leaving the latency unaffected. Ferrier et al. (2011), using ppTMS, found 
ICF delivered at an ISI of 11 ms induced strong facilitation of the P60 amplitude, with no 
such changes observed following delivery of SICI at 3 ms, with similar topography to 
spTMS. The authors noted, however, that despite change in the P60 amplitude, topography 
maps indicated a reversal of the polarity to a negativity over the stimulated region.  
The P60 can also be modulated using conventional and patterned rTMS and may 
reflect neuroplastic responses. Casula et al. (2014) found low frequency rTMS applied over 
M1 increases the P60 amplitude. The authors suggested that the increase in the P60 may 
reflect enhanced GABARB activity, with corresponding evidence that similar low frequency 
rTMS protocols can induce lengthening of the cortical spinal period (Lang et al., 2006). 
Vernet et al. (2013) showed that cTBS600 has dynamic time varying effects on the P60. The 
authors found small amplitude decreases in the P60 at short latencies (5 min), and larger 
amplitude reductions at longer latencies (20 and 30 min). There was some facilitation of the 
P60 at the 10 min post-measurement time point.   
N100 and N200  
The N100 is a relatively large and reliable component appearing 100 ms after the 
TMS pulse (Bonato et al., 2006; Paus et al., 2001; Premoli et al., 2014). The N100 likely 
comprises a mixture of activity from the target neurological response of interest (Bonato et 
al., 2006; Ferreri et al., 2011; Premoli et al., 2014), but also multisensory artefacts 
(Nikouline, Ruohonen, & Ilmoniemi, 1999; Tiitinen et al., 1999). Topography maps indicate 
a widespread negativity over central regions, or over the target scalp location (Ferreri et al., 
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2011). Suboptimal TMS coil-orientations (135°) applied over M1 do not elicit an N100 
response, with topography maps indicating the generation of positive, and negative dipoles 
with fronto-lateral and contralateral distribution, respectively (Bonato et al., 2006). Thus, the 
N100 partly reflects activity within the cortex elicited by the TMS pulse. 
The N100 also partially reflect sensory artefacts including auditory evoked potentials 
(Tiitinen et al., 1999), somatosensory artefacts caused by coil vibration (Nikouline et al., 
1999), and multisensory afferent inputs (Biabani et al., 2018; Conde et al., 2019). Tiitinen et 
al. (1999) compared differences in the N100 and P200 elicited with sub- and suprathreshold 
TMS intensities, coil elevations (10 or 50 mm above the scalp), and with or without a tone 
pip. The largest N1-P2 complex could be elicited with a tone pip alone, followed by 
simultaneous delivery of the tone pip and TMS pulse. Increased TMS pulse intensities 
induced a larger N1-P2 response, whereas coil elevation had little impact. Nikouline et al. 
(1999) examined auditory evoked potentials conducted via air and bone following delivery of 
subthreshold TMS over M1. TMS was delivered tangentially to the scalp, or 20 mm above 
the scalp with or without a 20 mm plastic spacer. They found the N1-P2 complex across all 
conditions, with some attenuation of the response with 20 mm spacer. Regarding sensory 
afferents, Conde et al. (2019) used realistic TMS sham by combining non-stimulating TMS 
with electrical stimulation over the target scalp locations (frontal and parietal regions). They 
found that N100, and P200 responses were attenuated in the realistic TMS sham condition 
compared to active TMS applied over frontal, and parietal regions. Biabani et al. (2018) 
conducted a unique study by comparing TMS-EEG responses evoked from M1 scalp, and 
shoulder. They found strong N100 and P200 components could be elicited from the scalp, 
and shoulder with significant temporo-spatial correlations in the EEG trace between 
components > 60 ms suggesting shared underlying mechanisms between the N100 and P200. 
Their findings indicate that part of the N100, and P200 is contaminated by multisensory 
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afferents. Given the N100, and P200 can be elicited under a range of conditions involving 
stimulating and non-stimulating TMS, it is imperative to incorporate active controls to isolate 
the target brain response.   
Several lines of evidence suggest the N100 may also reflect a generalised, inhibitory 
cortical response. Du et al. (2017) showed that the N100 is invariant when elicited from a 
range of anatomical locations including the DLPFC, M1, primary auditory cortex, vertex, and 
vermis. They found an N100 response of similar amplitude and topography (wide, centralised 
distribution) across all five conditions. Sham stimulation failed to elicit a strong N100 
response. Similarly, Kahkhonen et al. (2005) and Rogasch et al. (2014) have identified a N1-
P2 complex following TMS applied over the DLPFC. In a pharmacological challenge study, 
Premoli et al. (2014) showed that administration of the GABARB agonist baclofen facilitated 
the N100, but attenuated the N100 after ingestion of alprazolam, diazepam, and zolpidem. 
Finally, the latency of N100 also coincides with the interval of LICI elicited with ppTMS 
(Valls-Solé et al., 1992). 
The M1 N100 can also be modulated by ppTMS, and rTMS. Ferreri et al. (2011) 
examined the effect of ppTMS delivered at ISI of 3 and 11 ms on TEP elicited from M1. The 
authors showed the N100 was attenuated in both conditions, with the greatest reduction 
observed following pulses delivered at latency of 3 ms. In contrast, Casula et al. (2014) 
examined the effect of low frequency rTMS delivered at 90% RMT for a total of 1200 pulses 
over the M1. The authors found an increased N100 response post-stimulation. The authors 
suggested that GABARB may mediate the potentiated N100 response.   
Conclusions 
 EEG is a neuroimaging technique that can measure brain activity non-invasively. 
Brain signals measured with EEG are characterised by a series of waves that can be separated 
according to different frequency bands. A specialised form of EEG that can measure brain 
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signals time-locked to an event or stimulus is referred to as an ERP. ERPs are characterised 
by positive and/or negative deflections that can be described based on their sign (i.e., positive 
or negative deflections), latency, and amplitude. A novel way to record brain responses 
evoked by TMS is by combining TMS with EEG. Although there are technical challenges 
associated with TMS-EEG, it is possible to recover the underlying neural signal using on- 
and off-line solutions. When a TMS pulse is delivered over M1, this can result in the 
generation of a TEP. The M1 TEP is characterised by several deflections in the EEG trace 
including the N10, P15, P30, N45, P60, N100, and P200. These peaks likely comprise a 
mixture of target neurological mechanisms induced by TMS, but also TMS-induced artefacts 
(i.e., auditory, somatosensory, TMS-evoked muscle activity). The M1 N45, P60, and N100 
TEP can be used as markers of neuroplasticity induced by conventional, and patterened forms 
of rTMS. However, the M1 N100, and P200 are partially contaminated by multisensory 
confounds including auditory, and somatosensory afferents. Incorporating active control 
conditions will help isolate the target brain response. In the final empirical study (Chapter 9), 
TMS-EEG will be used to characterise the neuroplastic effects of intra- and inter-regional 
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Chapter 9 - Study 4: Standard, and Inter-Regional Continuous Theta Burst Priming of 




As signposted throughout this thesis, Chapter 6, Chapter 7 (Study 3), Chapter 8 and Chapter 9 
(Study 4) contributed to the second research stream of this thesis. That is, to evaluate the 
neurophysiological effects induced by inter-regional priming protocols, but also the use of 
multi-modal techniques for characterising the neuroplastic effects induced by inter-regional 
rTMS protocols. Chapter 8 provided an overview of the utility of combining transcranial-
magnetic stimulation with electroencephalography (TMS-EEG) for measuring neuroplastic 
responses induced by NIBS techniques directly at the scalp. The findings of Study 3 (Chapter 
7) directly informed the selection of the inter-regional continuous theta burst stimulation 
(cTBS) priming protocol evaluated in the fourth and study empirical study presented in this 
chapter. Study 4 (the current chapter) was written and formatted in a similar style to the 
published empirical, Study 2 and Study 3 to maintain consistency. This chapter has also been 
prepared for publication. The reference list and appendices associated with this study are 
presented at the end of the chapter.  
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Background: Standard and priming continuous theta burst stimulation (cTBS) administered 
over the primary motor cortex (M1) can induce neuroplastic- and metaplastic-like effects on 
corticospinal excitability. No studies have characterised and compared the neuro-modulatory 
effects of standard and priming cTBS protocols using combined transcranial magnetic 
stimulation-electroencephalography (TMS-EEG).      
Objective/s: The neuroplastic effects of standard and inter-regional cTBS priming of M1 
were measured with TMS-evoked potentials (TEPs) elicited from the first dorsal interosseous 
left M1 representation. Shoulder evoked-potentials (SEPs) elicited with TMS were included 
to control for multisensory M1 TEP contamination. 
Methods: Twenty participants (mean age = 24.70 years, SD = 6.05) received standard cTBS 
and inter-regional cTBS priming of M1 (cTBS over the left-DLPFC, then ipsilateral M1 with 
a 10 min inter-train-interval) separated by a minimum of 7 days. M1 TEPs were measured at 
baseline (Time 1), after the first cTBS round (Time 2), and after the second cTBS round 
(Time 3).  
Results: Short latency (< 60 ms) M1 TEP peaks were larger compared to homologous SEPs. 
In contrast, latency (> 60 ms) M1 TEP and SEP components were of comparable amplitude. 
Despite amplitude and topography differences in early components, standard cTBS 
modulated the M1 N45 TEP and N45 SEP over left frontal and right posterior regions. 
However, no correlations in M1 N45 TEP and N45 SEP change values (Time 1 to time 3) 
after cTBS administration were identified. Inter-regional cTBS M1 priming modulated the 
M1 N100 TEP (increased positivity over central regions), but not the N100 SEP.  
Conclusion/s: M1 TEPs comprise a mixture of target and non-target TMS-evoked neural 
activity. The M1 N45 TEP and M1 N100 TEP partially reflect cTBS induced M1 
neuroplastic- and metaplastic-like effects, and multisensory confounds. Incorporating active 
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control conditions into TMS-EEG protocols can help isolate the target TMS-evoked neural 
response of interest.  
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 The capacity of the human brain for structural reorganisation allows for the 
expression of a vast range of flexible, dynamic, and adaptive behaviours (Pascual-Leone et 
al., 2005). This propensity for modification is referred to as neuroplasticity, of which changes 
in synaptic efficacy through mechanisms such as long-term potentiation (LTP) and long-term 
depression (LTD) are the best understood (Malenka & Bear, 2004). Left unabated, 
continuous LTP and LTD expression would lead to system oversaturation (Tsumoto, 1992); 
thus, homeostatic mechanisms exist to maintain neuroplastic processes within biologically 
optimal ranges (Abraham, 2008; Karabanov et al., 2015). Metaplasticity is one homeostatic 
process whereby the threshold for LTD and LTP induction can be shifted depending on the 
prior activation history of a target neural population (Abraham & Bear, 1996).  Several non-
invasive brain stimulation (NIBS) techniques can induce neuroplastic- and metaplastic-like 
effects, in vivo, including conventional repetitive transcranial magnetic stimulation (rTMS) 
(Fitzgerald et al., 2006; Iyer et al., 2003), patterned rTMS protocols such as theta burst 
stimulation (Gamboa et al., 2010; Goldsworthy et al., 2012; Huang et al., 2005), paired 
associative stimulation (PAS) (Potter-Nerger et al., 2009; Stefan et al., 2000), and 
transcranial direct current stimulation (tDCS)(Nitsche & Paulus, 2000; Siebner et al., 2004).  
Our understanding of the neuroplastic- and metaplastic-like effects induced by NIBS 
techniques is derived primarily from studies examining corticospinal responses in the primary 
motor cortex (M1) (Fitzgerald et al., 2006; Karabanov et al., 2015; Ridding & Ziemann, 
2010). Specifically, changes in the size of motor evoked potentials (MEPs) can quantify the 
neuro-modulatory effects of NIBS protocols (Hoogendam et al., 2010). For instance, 
continuous theta burst stimulation (cTBS), which involves delivering high-frequency (50 Hz) 
pulse triplets in the theta range, can supress MEPs for up to 40 min, and is presumably 
underpinned by LTD-like mechanisms (Huang et al., 2005). In priming protocols, wherein a 
target brain region is conditioned prior to the application of the test protocol, the direction of 
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MEP amplitude change is dependent on the inter-train-interval, stimulation parameters, and 
target conditioning regions (Do et al., 2018; Gamboa et al., 2011; Gamboa et al., 2010; 
Goldsworthy et al., 2012; Hamada et al., 2009; Potter-Nerger et al., 2009; Tse et al., 2018).  
For example, intra-regional priming of M1 with two rounds of cTBS applied 10 minutes apart 
can potentiate MEP suppression, possibly reflecting non-homeostatic metaplastic processes 
(Goldsworthy et al., 2014b; Goldsworthy et al., 2012). Conversely, if shorter inter-train-
intervals are used (< 2 minutes), the expected cTBS suppression reverses into facilitation 
(Gamboa et al., 2011; Gamboa et al., 2010) consistent with the Bienenstock, Cooper, and 
Munro (BCM) theory of homeostatic metaplasticity (Bienenstock et al., 1982). Similar 
homeostatic metaplastic effects can be induced with intra-regional priming of M1 with tDCS 
(Siebner et al., 2004), or inter-regional priming of M1 via the supplementary motor cortex 
(Hamada et al., 2009) and premotor cortex (Potter-Nerger et al., 2009).  
 The neuroplastic- and metaplastic-like effects induced by NIBS techniques, however, 
can extend beyond the corticospinal pathway, which are difficult to measure and quantify 
with MEPs alone (Chung et al., 2018; Seewoo, Etherington, Feindel, & Rodger, 2018). 
Characterising the proximal and distal effects of neuro-modulatory paradigms are crucial for 
understanding the reactivity of structurally and functionally connected regions which, in turn, 
can be used to optimise established protocols (Chung et al., 2018; Farzan et al., 2016; Hill, 
Rogasch, Fitzgerald, & Hoy, 2016; Komssi & Kähkönen, 2006). One multi-modal technique 
that can capture the network wide neuro-modulatory effects of NIBS protocols is by 
combining transcranial magnetic stimulation with electroencephalography (TMS-EEG) 
(Bonato et al., 2006; Farzan et al., 2016). TMS-EEG can elicit brain responses termed TMS-
evoked potentials (TEPs) which are a series of highly reproducible deflections in the EEG 
trace (Farzan et al., 2016; Ilmoniemi & Kičić, 2010; Lioumis et al., 2009). TEPs are not only 
thought to represent neural activity evoked directly by the TMS pulse (Bonato et al., 2006; 
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Farzan et al., 2016), but have been postulated as unique markers of neuroplastic responses 
induced by NIBS protocols (Casula et al., 2014; Chung et al., 2018; Esser et al., 2006). For 
example, cTBS applied over M1 induces complex, time sensitive modulation of several TEP 
components including the P30, N45, P60, and N100 (Huang & Mouraux, 2015; Vernet et al., 
2013). Similarly, low frequency rTMS can modulate the N45 (Van Der Werf & Paus, 2006), 
whereas high frequency rTMS facilitates short latency components (< 50 ms) (Esser et al., 
2006). In non-motor regions, intermittent theta burst stimulation (iTBS) administered over 
the DLPFC can modulate the P60, N100, and P200 (Chung et al., 2017; Chung et al., 2018).  
Although several TMS-EEG studies have characterised the neuroplastic effects 
induced by conventional rTMS (Casula et al., 2014; Esser et al., 2006; Van Der Werf & Paus, 
2006), and TBS (Chung et al., 2017; Vernet et al., 2013), no studies have investigated the 
effects of priming plasticity protocols on TEPs. Previously, we found that inter-regional 
cTBS priming of M1 via the ipsilateral DLPFC induced non-significant facilitation of MEP 
amplitudes consistent with a homeostatic metaplastic response (Bienenstock et al., 1982; Do 
et al., 2018; Karabanov et al., 2015). We therefore sought to systematically examine and 
compare the neuro-modulatory effects of standard and inter-regional cTBS M1 priming 
directly at the scalp with TMS-EEG. The primary outcome measure were TEPs elicited from 
M1. An active control condition involving TMS administered over the shoulder was included 
to account for generalised sensory contamination resulting from the coil click and sensation 
of stimulation on the scalp, as these responses likely contribute to the TEP (Biabani et al., 
2018; Conde et al., 2019). Based on the reviewed literature, it was anticipated that standard 
and inter-regional cTBS M1 priming would differentially modulate M1 TEPs including the 
P30, N45, P60, and N100. It was further hypothesised that shoulder-evoked potentials (SEPs) 
would not be modulated by cTBS, indicating that changes in M1 TEPs would reflect 
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The study was a randomised (determined by coin flip), repeated measures, design 
involving two sessions separated by a minimum of seven days (Baumer et al., 2003). Twenty-
six right-handed participants were initially recruited for the study. Five did not complete all 
sessions due to TMS induced headache (n = 1), discomfort (n = 2), fatigue (n = 1), and 
disinterest (n = 1). Data loss occurred for one participant in one session due to a technical 
error. The final sample thus comprised 20 participants (mean age = 24.70 years, SD = 6.05; 
male = 9). Participants were screened for TMS contraindications using standard exclusionary 
criteria (Rossi et al., 2009). Participants did not self-report any physiological, psychological, 
or neurological conditions. All participants were right-handed according to the Edinburgh 
Handedness Inventory (mean laterality quotient = 95.97, SD = 8.05, min = 70, max = 100) 
(Oldfield, 1971). The study was approved by the Deakin University Research Ethics 
Committee. All participants provided fully informed and written consent prior to study 
commencement, and received reimbursement valued at $20.00 AUD for each session.  
Electromyography Recordings  
 Electromyography (EMG) activity was recorded using a belly-tendon montage over 
the first dorsal interosseous (FDI) muscle of the right hand, with the ground electrode placed 
over the styloid process of the ulna. EMG signals were recorded with a PowerLab data 
acquisition system (ADInstruments; Dunedin, New Zealand) and were amplified (x1000), 
filtered (low pass = 0.3, high pass = 1 kHz), and digitised (10 kHz). Trials were epoched 
around the TMS pulse (-200 ms to 500 ms).  
Single Pulse Transcranial Magnetic Stimulation  
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Single TMS pulses were administered with a figure 8 coil with a 70 mm diameter 
(model: 3190-00) connected to a single Magstim 2002 unit (Device A; model: 3010-00) 
(Magstim, UK). The induced pulse shape was monophasic with a 100 µs rise time and 1 ms 
duration. The coil was held tangential to the scalp at a 45-degree angle from the midline with 
the handle positioned postero-laterally. All TMS pulses were delivered over the EEG cap (see 
EEG protocol for details). The presumed M1 hand region was probed in intervals of ~10 mm 
to locate the scalp region that evoked the largest MEP amplitude response in the contralateral 
FDI of the right hand. Commercially available tape (~1 cm2) was used to mark the location of 
the FDI “hot spot”. An adjustable mechanical stand was used to secure the TMS coil in place 
and was continuously monitored during measurement blocks to ensure accurate positioning.  
The test M1 TEP pulse intensity was set to 90% resting motor threshold (RMT) 
(Rossini et al., 1994). A subthreshold intensity was chosen to avoid contamination from 
sensory afferents associated with twitches in the target FDI muscle commonly elicited with 
suprathreshold stimulation (Fecchio et al., 2017). Subthreshold TMS pulses can reliably elicit 
TEP in the absence of a discernible MEP response (Komssi et al., 2004; Lioumis et al., 2009; 
Tiitinen et al., 1999). RMT was established by adjusting the TMS pulse strength in steps of 
5%, then 1% to identify the minimal % of maximum stimulator output (MSO) that elicited 
MEPs > 50 μV in at least 5 of 10 consecutive trials (Rossini et al., 1994). Test pulses were 
delivered at an average of 5 s (±1 s) for the individual Magstim 2002 unit to recharge, and 
avoid predictable, rhythmic delivery. Foam padding (~2 mm) was secured to the flat plane of 
the Magstim figure 8 TMS coil to dampen vibrations generated during discharge (Tiitinen et 
al., 1999). White noise was played through earphone inserts (< 90 decibels; Earphone insert 
10Ω 1/4 Stereo with Etymotic Research foam ear inserts; Compumedics Ltd., Melbourne, 
Australia) during measurement blocks to attenuate the audible click generated by the coil 
(Tiitinen et al., 1999). M1 TEPs were measured at three time points: at baseline (Time 1), 
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after the first round of cTBS (Time 2), and after the second test round of cTBS (Time 3) 
(Figure 1). At Time 1 and Time 3, 120 trials were delivered in each block. At Time 2, only an 
upper limit of 100 trials could be attained due to the 10 min inter-cTBS-train interval.  
 




Figure 8. Prime-conditioning protocols (rounded squares) transcranial magnetic stimulation-evoked potentials (TEP) (white circles) and 
shoulder-evoked potentials (SEP) (grey circles) measurement blocks (number of trials per block indicated in parentheses), determination of 
resting motor threshold (RMT) (white square), and establishment of percentage of maximal stimulator output (MSO) for SEP (grey square). Nb.: 













































Recent studies have demonstrated that part of the TEP response can be accounted for 
by general multisensory afferents resulting from residual audition of the TMS click and 
sensation of the TMS pulse on the scalp, despite masking measures such as white noise and 
foam padding (Biabani et al., 2018; Conde et al., 2019; Gordon, Desideri, Belardinelli, 
Zrenner, & Ziemann, 2018). To determine whether changes in M1 TEP amplitude resulted 
from TMS-evoked cortical activity or from a general multisensory response, we also recorded 
SEPs elicited with TMS applied over the shoulder (Biabani et al., 2018; Herring, Thut, 
Jensen, & Bergmann, 2015). Although this active, peripheral control site provides 
comparable auditory and general somatosensory input to scalp stimulation, the precise 
somatotopic organisation of the somatosensory response to sensory stimulation may differ 
slightly from scalp activation elicited with TMS (Herring et al., 2015). To maintain 
comparability across the two conditions, participants subjectively rated the similarity of the 
sensation of TMS applied over the shoulder to the scalp on an eight-point scale from 0 (not at 
all similar) to 7 (identical). Shoulder stimulation was delivered with a 70 mm figure 8 coil 
centred dorsally over the left acromion process of the scapula (lead pointing posteriorly) in 
blocks of five (0.2 Hz inter-stimulus interval, ±1 Hz jitter) starting at 25% MSO of the 
Magstim 2002 unit. The stimulus output level was adjusted in steps of 5% until participants 
rated the similarity level at 4 (“somewhat similar”), reported discomfort, or there was visible 
shoulder muscle contraction. SEPs were collected in blocks of 120 trials at Time 1 and Time 
3 only as time constraints precluded measurement of SEPs at Time 2 (i.e., between the first 
and second round of cTBS).  
Continuous Theta Burst Stimulation  
 cTBS was administered using a Magstim Rapid2 (model: 3576-23-09) (Magstim, UK) 
via a 70 mm air cooled figure 8 coil (model: 3910-23-00) supported by a mechanical stand. 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 252 of 414 
 
 
The coil was angled 45-degrees from the mid-line for all stimulation sites (M1 and DLPFC). 
This configuration induces a biphasic cosine pulse with ~80 µs rise time, and 0.5 ms 
duration. The cTBS protocol consisted of three pulses delivered at 50 Hz, repeated at 5 Hz 
continuously for 40 s totalling 600 pulses, at 70% RMT (Goldsworthy et al., 2014b; Huang et 
al., 2005). RMT was re-established with the Magstim Rapid over the FDI “hotspot” 
immediately prior to cTBS and was defined as the MSO which induced an MEP response > 
50µV in at least 5 of 10 consecutive trials (Rossini et al., 1994). The target left-M1 region 
was defined as the FDI “hotspot.” The target left-DLPFC was defined as the region 
corresponding to electrode F3 and was selected on the basis of neuroimaging studies showing 
it to be a reliable indicator of the DLPFC (Fitzgerald, Maller, Hoy, Thomson, & Daskalakis, 
2009). Sham cTBS was delivered using a sham 70 mm figure 8 coil (model: 3950-23-00), 
which appears visually and acoustically identical to the active coil but delivers an attenuated 
pulse using specialised winding configurations.  
Electroencephalography Protocol  
EEG responses were recorded using a 64-channel TMS-EEG compatible cap based on 
the 10-20 EEG system (EASYCAP, Germany). The Ag/AgCl electrodes are low profile  
(~10 mm), with c-slits to reduce Eddy current build up. The EEG recording montage is 
presented in Figure 2. Six additional electrodes were included to measure eye movements (2 
horizontal and 2 vertical electrode), and mastoids (2). The mastoid (2), eye (4), and electrodes 
TP9 and TP10 were removed and not included in the final analysis. EEG signals were 
recorded with a SynAmps RT (Compumedics Ltd., Melbourne, Australia). Signals were low 
pass filtered (8 kHz), recorded in DC, and digitised (20 kHz). This setup allows for short 
latency recovery of the EEG signal (<10 ms) despite system saturation caused by the 
electromagnetic TMS pulse artefact (Rogasch et al., 2017; Rogasch et al., 2013). The 
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reference electrode was placed over FCz, and ground electrode over AFz. Impedances were 
kept below 5 kΩ. 




Figure 9. Electroencephalography electrode recording montage. 
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Electroencephalograph Pre-processing, Data Cleaning and Artefact Removal  
 EEG data were recorded in Curry 7 (Compumedics Ltd, Melbourne, Australia) and 
analysed offline. Pre-processing and data analysis were conducted using customs scripts 
implemented in Matlab (version R2015b). Pre-processing was performed using TMS-EEG 
Signal Analyser (TESA) (Rogasch et al., 2017), a set of open source custom scripts for 
analysing TMS-EEG data implemented in EEGLAB (Delorme & Makeig, 2004). The full 
analysis pipeline is available online (http://bit.ly/2ZIQXa8. Data can be requested from the 
corresponding author). Electrodes with poor signals were removed. Trials were epoched to 
the TMS pulse (-1000 ms to 1000 ms), and baseline removed (-1000 ms pre-TMS period). 
The time interval (-2 ms to 10 ms) containing the large electromagnetic TMS pulse artefact 
was removed and zero padded. The removed data were interpolated with a cubic function, 
then downsampled to 1000 Hz. Manual trial rejection was performed to identify trials 
contaminated with large eye blinks, or drift artefacts. The interpolated data were removed (-2 
ms to 10 ms). An initial round of independent component analysis (ICA; FastICA version 
2.5) was performed to remove TMS related artefacts including TMS-evoked muscle activity. 
Standard thresholds in the auto-component removal function (tesa_compselect) were used as 
this method reliably removes artefacts with similar performance to manual removal and is 
less prone to bias (Rogasch et al., 2017). Data removal around the TMS pulse was extended 
from -2 ms to 15 ms to mitigate residual muscle artefacts. The removed data were 
interpolated with a cubic function (5 ms before and after the remove interval), then bandpass 
(low pass = 100 Hz, high pass = 1 Hz), and bandstop (48 Hz to 52 Hz) filtered. A second 
round of fast ICA was implemented to remove standard EEG artefacts including eye 
movements (i.e., blinks, and lateral eye movement), persistent muscle activity, and electrode 
noise. These artefacts were removed again by using standard auto-component thresholds 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 256 of 414 
 
 
(tesa_compselect) (Rogasch et al., 2017). All removed data and electrodes were interpolated. 
Data were re-referenced to the common average.  
Transcranial Magnetic Stimulation-Evoked Potentials  
 M1 TEPs were elicited from the left-M1 FDI “hotspot” (approximately electrode C3). 
Previous studies have shown that M1 TEPs comprise several robust peaks including the N18, 
P30, N45, P60, N100, and P200 (Bonato et al., 2006; Du et al., 2017; Ferreri et al., 2011; 
Ilmoniemi & Kičić, 2010; Komssi et al., 2004). For this study, we focused on the P30, N45, 
P60 and N100, as these have shown to be amenable to modulation using low- (Van Der Werf 
& Paus, 2006) and high-frequency rTMS (Esser et al., 2006), and cTBS (Vernet et al., 2013). 
The P200 was included for topography maps and source localisation only. The average over a 
±5 ms time interval for each component was selected based on studies that have isolated the 
P30 (30 ms), N45 (45 ms), P60 (60 ms), N100 (100 ms), P200 (180 ms). We used electrodes 
C1, C3, and C5 (i.e., M1) to define the region of interest (ROI).   
Shoulder-Evoked Potentials     
 Comparability between the M1 TEP and SEP conditions was maintained by analysing 
the same ROI, event related components (the P30, N45, P60, N100, and P200), and averaging 
over identical time intervals for the M1 TEP analysis detailed in the preceding paragraph.  
Source Localisation 
 Source localisation was performed using Brainstorm (Tadel et al., 2011), a 
documented and freely available open source software under the GNU general public license 
(http://neuroimage.usc.edu/brainstorm). We used the open source OpenMEEG BEM head 
model template calculated using the forward model (Gramfort, Papadopoulo, Olivi, & Clerc, 
2010; Kybic et al., 2005). Sources were estimated using minimum norm estimates 
constrained to the cortex.  
 Data Analysis 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 257 of 414 
 
 
 Average RMT MSO values for M1 TEPs and cTBS, MSO values for SEPs, and 
subjective shoulder ratings were compared between sessions using paired samples t-tests 
performed in Matlab (version R2015b). For the main EEG analyses, non-parametric cluster-
based permutation, repeated measures t-tests implemented in Fieldtrip (Oostenveld, Fries, 
Maris, & Schoffelen, 2011) were performed for M1 TEPs (within time and between 
protocols) and SEPs (within time only). Electrode clusters were defined using Fieldtrip’s 
default templates (easycap_braincap_60) for reproducibility with the minimum number of 
channels considered as part of a cluster set at two (cluster alpha level p < .05).  The Monte-
Carlo permutation distribution was generated with 5,000 draws of the observed data. For all 
EEG analyses, clusters with summed t-values greater than the cluster level statistic alpha = 
.0125 (two-tailed, corrected for multiple corrections over four component peaks) were 
considered significant. Within (time) M1 TEP comparisons were performed between Time 1 
and Time 2 (Time 1 subtracted from Time 2), Time 2 and Time 3 (Time 2 subtracted from 
Time 3), and Time 1 and Time 3 (Time 1 subtracted from Time 3). Similarly, within (time) 
SEP comparisons were performed between Time 1 and Time 3 (Time 1 subtracted from Time 
3). The M1 TEP analysis comparing standard cTBS to inter-regional priming cTBS was 
performed on difference values generated between Time 1 and Time 2 (Time 1 subtracted 
from Time 2), Time 2 and Time 3 (Time 2 subtracted from Time 3), and Time 1 and Time 3 
(Time 1 subtracted from Time 3), also corrected for multiple comparisons (p < .0125, two-
tailed).    
Results 
Side Effect Profile, Descriptive and Inferential Statistics 
 All participants underwent each protocol without serious, or incident (Appendix A).  
RMT Threshold and Shoulder MSO 
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 Repeated measures t-tests did not reveal differences in average MSO intensity values 
for RMT or cTBS RMT between sessions (Table 1). Similarly, no differences in mean MSO 
values for SEPs were found between sessions. The average MSO intensity for SEPs was 
approximately 63% of the mean MSO value for RMT which was likely due to lower stimulus 
strengths required to elicit comparable responses between the scalp and shoulder, slight 
differences in sensory afferents, and comfort.  There were no differences in subjective 
similarity ratings comparing shoulder and scalp sensations between sessions. 




Descriptive and Inferential Statistics  






Paired T-Tests     
Dependent measure n M SD   M SD   T-value df p-value SEM Cohen's D 




0.00 19.00 1.00 0.64 0.00 




0.00 19.00 1.00 1.00 0.00 
SEP MSO 20 32.75 5.73   32.50 7.52   -0.16 19.00 0.87 1.52 -0.04 
Shoulder ratings 20 4.30 1.26  4.45 1.10  0.36 19.00 0.72 0.41 0.08 
Nb.:  cTBS – continuous theta burst stimulation; DLPFC – dorsolateral prefrontal cortex; M1 – primary motor cortex; MSO – maximal 
stimulator output; SEP – shoulder evoked potential; TEP – transcranial magnetic stimulation evoked potential. 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 260 of 414 
 
 
Baseline Responses to TEPs and SEPs 
 Butterfly plots, topography maps, and source localisation for M1 TEPs at Time 1 for 
standard (sham-M1), and priming cTBS (DLPFC-M1) are presented in Figure 3. The ROI 
analysis revealed several prominent early and late M1 TEP components elicited from the site 
of stimulation including the P30, N45, P60, N100, and P200 confirming findings from 
previous studies. Topography maps and source localisation indicate localised activity over the 
left hemisphere at short latencies (< 50 ms) developing into diffuse, centralised activity 
across both hemispheres at longer latencies (> 50 ms).  
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Figure 10. Group M1 transcranial magnetic evoked potentials  (TEPs). Butterfly plots (upper 
row), topography maps (middle row), and source localisation (lowest row) for TEPs elicited 
from the primary motor cortex (M1) at Time 1 for A) standard continuous theta burst 
stimulation (cTBS; sham-M1), and B) priming cTBS (DLPFC-M1). Note the generation and 
amplitudes of the P30, N45, P60, N100, and P200 across the region of interest waveform 
(mean of electrodes C1, C3, and C5; bolded red line). Nb.: DLPFC: dorsolateral prefrontal 
cortex; M1: primary motor cortex.  
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 Butterfly plots, topography maps, and source localisation for SEPs at Time 1 are 
presented for standard cTBS (sham-M1), and priming cTBS (DLPFC-M1) (Figure 4). The 
SEP ROI analysis revealed similar component peaks to M1 TEPs including the P30, N45, 
P60, N100 and P200. Notably, early SEP components (< 60 ms) were of considerably smaller 
amplitude compared to homologous M1 TEP components. In contrast, late SEP components 
(> 60 ms) were of similar magnitude to M1 TEPs. Topography maps and source localisation 
indicate more diffuse, centralised activity across early and late time points.  
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Figure 11. Group shoulder evoked potentials (SEPs) elicited with transcranial magnetic 
stimulation. Butterfly plots (upper row), topography maps (middle row), and source 
localisation (lowest row) for SEPs at Time 1 for A) standard continuous theta burst 
stimulation (cTBS) (sham-M1), and B) priming cTBS (DLPFC-M1). Note the attenuated 
P30, N45, and P60 amplitudes, and larger magnitude N100 and P200 peaks across the region 
of interest waveform (mean of electrodes C1, C3, and C5; bolded red line). Nb.: DLPFC: 
dorsolateral prefrontal cortex; M1: primary motor cortex. 
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The Effects of Standard and Priming cTBS on TEPs across Time  
  Within (i.e., time) M1 TEP comparisons were performed between Time 1 and Time 2 
(after the first round of cTBS), Time 2 and Time 3 (after the second round of cTBS), and 
Time 1 and Time 3 (baseline versus post-intervention responses) are presented in Figure 5. 
Standard cTBS (sham-M1) modulated the M1 N45 TEP from Time 1 to Time 3 over left 
anterior (increased negativity; p = .012), right-posterior regions (increase positivity; p = 
.012). There was an increased positivity in the M1 N100 TEP over central regions from Time 
1 to Time 2, and Time 1 to Time 3. However, these failed to reach significance after 
controlling for multiple comparisons (p = .029 and p = .09, respectively). No other M1 TEP 
components were modulated.  




Figure 12.  Group transcranial- magnetic stimulation evoked potential (TEP) responses to 
standard cTBS across time. Comparisons of TEPs elicited from the primary motor cortex for 
standard continuous theta burst stimulation (sham-M1). A) Region of interest waveforms 
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(mean of C1, C3, and C5), and B) t-value topography maps between Time 1 and Time 2 (first 
row), Time 2 and Time 3 (second row), and Time 1 and Time 3 (third row).  
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For priming cTBS (DLPFC-M1), no changes in M1 TEPs were detected from Time 1 
to Time 2 (the first priming round of active cTBS over the DLPFC), or from Time 2 to Time 
3 (after the second active round of cTBS over M1) (Figure 6). The M1 N100 TEP was 
modulated from Time 1 to Time 3 over central regions (increased positivity; p = .001).  No 
changes in any other M1 TEP components were found.  




Figure 13. Group transcranial- magnetic stimulation evoked potentials (TEPs) responses to 
priming cTBS across time. Comparisons of TEPs elicited from the primary motor cortex for 
priming cTBS (DLPFC-M1). A) Region of interest waveforms plots (mean of C1, C3, and 
C5) between Time 1 and Time 2 (top-left), Time 2 and Time 3 (top-right), and Time 1 and 
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Time 3 (bottom-left). B) T-value topography maps Time 1 and Time 2 (top row), Time 2 and 
Time 3 (middle row), and Time 1 and Time 3 (lowest row). Nb.: DLPFC: dorsolateral 
prefrontal cortex. 
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 Effects of Standard and Priming cTBS on SEPs across Time 
Within SEP comparisons were performed between Time 1 and Time 3 (i.e., pre- 
versus post-intervention responses). For standard cTBS (sham-M1), there was modulation of 
the N45 SEP over left-frontal electrodes (increased negativity, p < .001), and right-posterior 
electrodes (increased positivity, p < .001) (Figure 7). No changes in any other SEP 
components were found.  




Figure 14. Group shoulder evoked potential (SEP) responses to standard cTBS across time. 
SEP comparisons across Time 1 and Time 3 for standard continuous theta burst stimulation 
(sham-M1). A) Region of interest waveforms (mean of electrodes C1, C3, and C5) for Time 1 
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For priming cTBS (DLPFC-M1), no modulation of any SEP component was detected 
between Time 1 and Time 3 (i.e., pre- versus post-intervention) (Figure 8).  




Figure 15. Group shoulder evoked potential  (SEP) responses to standard cTBS across time.  
SEP across Time 1 and Time 3 for priming continuous theta burst stimulation (DLPFC-M1). 
A) Region of interest waveforms (mean of C1, C3, and C5) between Time 1 and Time 3. B) 
T-value topography maps from Time 1 and Time 3. Nb.: DLPFC: dorsolateral prefrontal 
cortex; M1: primary motor cortex. 
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Effects of priming and standard cTBS on M1 N45 TEP and N45 SEP change values 
 To investigate whether modulation of the M1 N45 TEP and N45 SEP after 
administration of standard (sham-M1), and priming cTBS (DLPFC-M1) were associated, 
exploratory Pearson’s correlations were performed on change values from Time 1 to Time 3 
over regions with significant clusters identified from time comparisons within protocols. For 
the left-central cluster (left-M1), 6 electrodes were selected including C1, C3, C5, FC1, FC3, 
and FC5. For the right-posterior cluster (right-parietal cortex), nine electrodes were selected 
including P2, P4, P8, O2, PO4, POz, Pz, TP8, and Oz. The average was taken across all 
electrodes for each cluster over the pre-defined N45 time interval (5 ± 45 ms). The results are 
presented in Figure 9. The analysis did not reveal significant correlations in change values 
between the M1 N45 TEP and N45 SEP response across regions or protocols. 
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Figure 16. Group level change values for transcranial- and shoulder-evoked potentials. Scatterplots of change values for the M1 N45 
transcranial magnetic stimulation evoked-potential (TEP) and N45 shoulder evoked-potential (SEP) responses across significant clusters 
identified from within protocol comparisons for (A) standard continuous theta burst stimulation (cTBS; sham-M1), and (B) priming cTBS 
(DLPFC-M1). Pearson correlation coefficients (r) and p-values included as insets. The line of best fit is represented as a bolded red line. Nb.: 
DLPFC: dorsolateral prefrontal cortex; M1: primary motor cortex. 
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Comparing the neuroplastic effects of Standard and \Priming cTBS on TEPs 
Comparisons between standard cTBS (sham-M1) and priming cTBS (DLPFC-M1) 
were performed on M1 TEP difference values generated between Time 1 and Time 2, Time 2 
and Time 3, and Time 1 and Time 3. No changes were detected at any measurement time 
point across any components. There was a non-significant decrease in the M1 TEP N100 
(medial-anterior cluster) from Time 1 to Time 2 (p = .106) (Figure 10). 
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Figure 17. Group level comparisons between standard and priming cTBS on transcranial 
magnetic stimulation-evoked potential potentials  (TEP). TEP difference traces for region of 
interest (means of C1, C3, and C5; upper panels) and t-value topography maps (lower panels) 
for standard (sham-M1) and priming continuous theta burst stimulation (cTBS) (DLPFC-M1) 
at A) Time 1 to Time 2, B) Time 2 to Time 3, and C) Time 1 to Time 3. Nb.: DLPFC: 
dorsolateral prefrontal cortex; M1: primary motor cortex. 
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Individual M1 N45 TEP and M1 N100 TEP Change Values after Standard and Priming 
cTBS 
To examine inter-individual variability in modulatory responses to standard cTBS 
(sham-M1) and priming cTBS (DLPFC-M1), individual peak component M1 TEP change 
values from Time 1 to Time 2, Time 2 to Time 3, and Time 1 to Time 3 were extracted across 
the M1 ROI (mean of electrodes C1, C3, and C5). To maintain consistency with earlier 
analyses, the average time interval (± 5 ms) was extracted for the N45 (45 ms), and N100 
(100 ms). Individual responses are presented in Figure 11. In the standard cTBS condition, 
there was a tendency for increased difference values in the M1 N45 TEP from Time 1 to 
Time 3, and Time 2 to Time 3. In contrast, M1 N100 TEP difference values remained 











Figure 18. Individual change value responses to standard and priming cTBS. Individual transcranial magnetic stimulation evoked-potential 
(TEP) N45 and N100 change values for standard (sham-M1; red crosses) and priming (DLPFC-M1; black circles) cTBS at A) Time 1 to Time 
2, B) Time 2 to Time 3, and C) Time 1 to Time 3. Averages indicated with dotted black line. Region of interest electrodes are C1, C3 and C5.  




We investigated the neuro-modulatory effects of standard cTBS and inter-
regional cTBS priming of M1 with TMS-EEG. We also evaluated the regional 
specificity of M1 TEPs by comparing EEG responses evoked with TMS applied over 
the scalp and shoulder. Overall, there was partial support for the hypotheses. Firstly, 
although long latency (> 60 ms) M1 TEP and SEP components were of similar 
magnitude, short latency (< 60 ms) component peaks evoked from M1 of larger 
magnitude compared to those elicited from the shoulder. Source localisation indicated 
more localised activity for short latency M1 TEP components including the P30, N45, 
and P60 over the stimulated region compared to the equivalent SEP peaks. More diffuse 
and generalised activity were found for the M1 TEP/SEP N100 and P200. Despite 
differences in peak amplitudes between scalp and shoulder stimulation, within time 
comparisons revealed cTBS modulated the M1 N45 TEP and N45 SEP over left frontal 
and right posterior regions. In contrast, inter-regional cTBS priming of M1 modulated 
the M1 N100 TEP inducing an increased positivity over central regions but did not 
modulate any SEP component peaks. Comparisons performed on TEP change values 
between standard and priming cTBS failed to detect modulation of any component 
across all time points. There was a tendency for DLPFC priming to “block” modulation 
of the M1 TEP N45.  
Effects of standard cTBS  
The M1 N45 TEP is a relatively robust component that can be reliably elicited 
with TMS. The peak likely reflects intrinsic activity within M1 and may also serve as a 
unique marker of M1 plasticity (Esser et al., 2006; Van Der Werf & Paus, 2006). For 
example, Vernet et al. (2013) reported that cTBS applied to M1 induces dynamic, time 
sensitive modulation of the M1 N45 TEP with attenuation of the response at 5, 20 and 
30 minutes, but potentiation at 10 minutes. Another study showed that low frequency 
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rTMS over M1 also attenuated the N45 response (Van Der Werf & Paus, 2006), 
although this finding was not replicated in a subsequent study using a similar 1 Hz  
rTMS protocol (Casula et al., 2014). Finally, high frequency rTMS over M1 facilitated 
early components (< 50 ms) (Esser et al., 2006).  The M1 N45 TEP thus appears to be 
sensitive to the neuroplastic effects of conventional rTMS and TBS applied to M1, with 
cTBS and low-frequency rTMS inducing LTD-like effects and high frequency rTMS 
inducing LTP-like changes.  
Despite evidence for the M1 N45 TEP reflecting TMS-evoked cortical activity, 
recent studies comparing TEPs to sensory-evoked potentials have cast doubt on the 
origin of this peak. Conde et al. (Conde et al., 2019) found that realistic sham TMS over 
frontal and parietal regions also induces diffuse widespread activity at ~40 ms. This 
N40 sensory-evoked peak showed moderate correlations with comparable frontal and 
parietal N40 TEPs, despite measures taken to minimise sensory input, such as playing 
white noise and placing foam under the coil. The authors controlled for acoustic and 
somatosensory confounds via delivery of TMS with a spacer (thus, reducing the 
effective TMS depth of penetration) combined with concurrent real cutaneous electrical 
stimulation over the scalp (Conde et al., 2019). Gordon et al. (Gordon et al., 2018)  used 
a similar sensory control condition involving electrical stimulation of the scalp during 
non-stimulating subthreshold M1 stimulation at 90% RMT, comparable to the 
stimulation intensity used in our study. They found that while both the TEP and sensory 
evoked peak contained an N45 peak, the amplitude and distribution were different 
between conditions, suggesting a partially overlapping, but dissociable origin of the 
N45. Finally, Biabani et al. (2018) also applied TMS over the shoulder and reported that 
the SEP N45 had a different topographical distribution and peak amplitudes compared 
to the M1 N45 TEP. 
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We found that standard cTBS modulated the M1 N45 TEP and N45 SEP, 
suggesting that changes in the N45 may reflect alteration of sensory processing rather 
than TMS-evoked activity. However, we could not identify correlations between M1 
N45 TEP and N45 SEP change values, suggesting that these components may reflect 
partially separable mechanisms. In line with this, scalp distribution maps and source 
localisation indicated that the M1 N45 TEP response was strongest over the stimulated 
motor area (see Figure 3), whereas the N45 SEP showed more widespread, diffuse 
activity over central regions. It is important to note, however, that the somatosensory 
input from the scalp differs to that from the shoulder, so it is unclear how dissociable 
the M1 N45 TEP and N45 SEP are. Taken together, there is some uncertainty in the 
available evidence as to whether the M1 N45 TEP and N45 SEP reflect the same or 
overlapping, but dissociable components. Modulation of the M1 N45 TEP may partially 
reflect plasticity originating in M1, whereas modulation of the N45 SEP may reflect 
changes in somatosensory mapping or reorganisation. However, this finding does 
demonstrate that neuroplastic NIBS paradigms can alter sensory processing, and 
therefore underscores the importance of integrating sensory control conditions into 
TMS-EEG protocols. 
Neuroplastic Effects of priming cTBS 
 The N100 is a robust component that can be elicited with stimulating (Ilmoniemi 
& Kičić, 2010; Komssi et al., 2004; Rogasch et al., 2014), and non-stimulating TMS 
(Biabani et al., 2018; Conde et al., 2019; Nikouline et al., 1999; Tiitinen et al., 1999). 
The ubiquity of the N100 response and the multitude of conditions under which it can 
be evoked indicates the N100 likely reflects several concurrent processes including a 
mixture of the target TMS-evoked neural response (e.g., inhibitory or neuroplastic 
processes), and non-target TMS-evoked confounds (e.g., somatosensory, and auditory 
artefacts). For instance, the N100 TEP can be reliably elicited from several scalp 
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regions including M1 (Biabani et al., 2018; Bonato et al., 2006), the DLPFC (Chung et 
al., 2017), vermis, cerebellum, vertex, and parietal cortex (Du et al., 2017). The N100 
TEP also be modulated with NIBS (Chung et al., 2018; Harrington & Hammond-Tooke, 
2015; Vernet et al., 2013), and pharmacological intervention (Premoli et al., 2014). 
However, a similar N100 response can also be evoked with the sound of the discharging 
TMS coil (Nikouline et al., 1999; Tiitinen et al., 1999), realistic somatosensory-auditory 
sham TMS (i.e., cutaneous electrical stimulation applied over the scalp during non-
stimulating TMS) (Conde et al., 2019), and TMS applied to the shoulder (Biabani et al., 
2018). Although the contributors to the N100 are unknown, topography and source 
estimates suggest common or overlapping underlying neural substrates. For example, 
topography maps indicate the N100 TEP is a widespread, diffuse negativity over vertex 
when elicited from several brain regions including M1 (Conde et al., 2019; Du et al., 
2017; Ferreri et al., 2011; Paus et al., 2001). Source localisation estimates confirm the 
centrality of the N100 TEP response  (Chung et al., 2018; Rogasch et al., 2014), but also 
the SEP N100 (Biabani et al., 2018). Although the non-specific nature of the N100 
poses interpretative challenges, including active control conditions can help to 
differentiate the target TMS-evoked response of interest. 
These issues notwithstanding, the findings from several authors support the 
proposal that the N100 TEP partly reflects target TMS-evoked neural responses. 
Specifically, the N100 TEP may be a partially unique marker of cortical plasticity that 
cannot be accounted for by sensory confounds alone (Biabani et al., 2018; Chung et al., 
2018; Premoli et al., 2014; Vernet et al., 2013). Although we found that scalp and 
shoulder TMS evoked a strong N100 response (and indeed, a strong P200 deflection) 
(Biabani et al., 2018), inter-regional M1 cTBS priming only modulated the N100 TEP 
but not the N100 SEP. In the priming condition, the first conditioning round of active 
cTBS over the DLPFC (Time 1 to Time 2) and second round of cTBS over M1 (Time 2 
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to Time 3) did not modulate any components across the scalp or shoulder conditions. 
However, we found an increased positivity in the N100 TEP from Time 1 and Time 3 
over central regions (i.e., modulation of the N100 was observed after cTBS over the 
DLPFC then M1).  
The findings of the current study are consistent with reports that TEPs can 
measure TBS induced plasticity in motor and non-motor regions. Vernet et al. (Vernet 
et al., 2013) showed cTBS applied over M1 decreased the M1 N100 TEP. Harrington et 
al. (Harrington & Hammond-Tooke, 2015) found that cerebellar cTBS decreased the 
M1 N100 TEP. Chung et al. (Chung et al., 2017) reported that iTBS potentiated the 
DLPFC N100 TEP over central regions (although standard cTBS failed to modulate the 
DLPFC TEP N100). In a subsequent study, Chung et al. (Chung et al., 2018) reported 
that individualised iTBS (individually determined peak theta and gamma frequencies) 
applied over the DLPFC decreased the DLPFC N100 TEP amplitude over central 
regions. In this study, we found that priming cTBS applied over the DLPFC, followed 
by cTBS over ipsilateral M1 reduced the amplitude of the M1 TEP N100 over central 
regions with no corresponding reduction in the M1 N45 TEP or N45 SEP found in the 
standard cTBS condition. The reduction of the M1 N100 TEP amplitude and “blocking” 
of the M1 N45 TEP and N45 SEP modulation could be interpreted as evidence of a 
homeostatic metaplastic response whereby low levels of prior activity can inhibit or 
even reverse the expected inhibitory effects of a subsequently applied LTD-inducing 
paradigm (Bienenstock et al., 1982; Gamboa et al., 2011; Gamboa et al., 2010; Hamada 
et al., 2008; Potter-Nerger et al., 2009; Siebner et al., 2004). It should be noted, 
however, that there were non-significant reductions in the M1 N100 TEP in the standard 
cTBS condition after active cTBS (Time 2 to Time 3), which tempers this hypothesis. 
Nonetheless, we add that inter-regional cTBS priming of M1 via the DLPFC modulated 
the M1 N100 TEP.  




 We did not collect or analyse MEPs to measure changes in corticospinal 
excitability. This decision was made because we were primarily interested in 
modulation of M1 TEPs and aimed for a high signal-to-noise ratio to capture the target 
neurological response of interest and to maintain participant alertness throughout each 
session. We also did not include an active scalp control condition (i.e., measuring TEPs 
from a non-M1 brain region), which would have helped to differentiate whether the TEP 
components and neuroplastic effects observed from M1 are regionally specific (Du et 
al., 2017). The shoulder was selected as the active control site as it provides an 
approximation of general sensory responses to TMS located in the periphery. However, 
muscle activation in the scalp is somatotopically different to the shoulder and so the 
somatosensory responds elicited in the SEP condition are likely to be underestimates of 
true confounding responses at the scalp (Biabani et al., 2018; Conde et al., 2019). 
Finally, although previous TMS-EEG studies have shown that the neuro-modulatory 
effects of NIBS can be detected with small to moderate samples (n < 20), there was 
some inter-individual variability in responses which may have contributed to non-
significant results in some analyses.  
Implications  
 There are several implications stemming from this body of work. Firstly, rTMS 
may be an effective treatment modality for OCD. Future studies could investigate 
targeting multiple regions involved in the pathogenesis of the disorder using multisite 
paradigms. Second, clinically informed multisite studies are safe and tolerable. Such 
protocols could be evaluated for efficacy in a large RCT in patients diagnosed with 
OCD. The effects of rTMS and TBS are highly heterogeneous. Additional studies using 
different multisite priming protocols could be investigated including iTBS or combining 
different stimulation techniques (e.g., tDCS and TBS). TMS-EEG is a viable technique 
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for characterising the neuro-modulatory effects of rTMS. However, additional work is 
needed to understand the sources of the ERP. Further, these techniques could be 
combined to explore non-motor regions involved with specific disorders. This could 
lead to the development of individualised and more effective protocols.  
Conclusions 
Overall, the current study contributes additional evidence on the utility of TEPs 
as a putative marker of TBS induced plasticity. The results also highlight the 
importance of incorporating active sensory control conditions when using TMS-EEG to 
measure TMS-evoked EEG responses directly at the scalp. We found partially 
overlapping TMS-evoked responses elicited from M1 and the shoulder. Short latency 
peaks (< 60 ms) including the P30, N45 and P60 were more prominent following TMS 
applied to M1 compared to the shoulder. In contrast, long latency components (> 60 ms) 
such as the N100 and P200 were reliably evoked from the scalp and shoulder. 
Topography maps and source localisation revealed localised activity around the target 
region for early M1 TEP components compared to more diffuse centralised activity for 
the equivalent SEP peaks. Despite shared commonalities in some components 
(particularly long latency peaks), the results from this and previous studies suggest that 
M1 TEPs cannot be solely accounted for by sensory confounds. Standard cTBS 
modulated both the M1 N45 TEP and N45 SEP over left frontal and right posterior 
regions, which may reflect TMS induced plasticity, and/or sensory remapping. Inter-
regional cTBS priming of M1 via the ipsilateral DLPFC modulated the M1 N100 TEP 
and blocked the modulation of the M1 N45 TEP, perhaps representing a homeostatic 
metaplastic response. Future studies using TMS-EEG ought to consider the inclusion of 
active control sites located centrally (e.g., over non-target brain regions) or peripherally 
(e.g., shoulder) to clarify the degree to which TEPs reflect the target neurological 
response of interest.  
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Frequency and Proportion of Reported Post-Stimulation Side Effects following 
Standard (Sham-M1) and Priming (DLPFC-M1) cTBS. 
 Sham-M1  DLPFC-M1 
Adverse event Frequency Percent  Frequency Percent 
Headache 2 10%  1 5% 
Migraine 0 0%  0 0% 
Scalp pain 2 10%  1 5% 
Face pain 1 5%  2 10% 
Ear pain 1 5%  0 0% 
Neck pain 1 5%  1 5% 
Shoulder pain 0 0%  0 0% 
Body pain 0 0%  0 0% 
Pins and needles 0 0%  4 20% 
Toothache 0 0%  0 0% 
Nausea 0 0%  1 5% 
Vision problems 1 5%  0 0% 
Weepiness/crying 0 0%  0 0% 
Nervousness/anxiety 0 0%  0 0% 
Fatigue 7 35%  4 20% 
Dizziness 1 5%  1 5% 
Faint 0 0%  1 5% 
Skin rash/burn 0 0%  0 0% 
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Thinking difficulties 0 0%  0 0% 
Speaking difficulties 0 0%  0 0% 
Hearing difficulties 0 0%  0 0% 
Nb. N = 20  
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Chapter 10 – General Discussion, Implications, Limitations, and Conclusions 
Introduction 
This program of research sought to investigate several aspects of multisite 
priming repetitive transcranial magnetic stimulation (rTMS). Broadly, this thesis 
examined the safety, development, implementation, measurement, and neuro-
modulatory effects of multisite rTMS across two research streams. The first stream of 
research investigated the potential of multisite rTMS protocol to be used in clinical 
applications, informed by neurobiological models of obsessive-compulsive disorder 
(OCD) pathology and clinical intervention outcomes from rTMS and OCD literature. 
Chapter 3, Chapter 4 (Study 1), and Chapter 5 (Study 2) contributed to the first research 
stream. The second research stream evaluated the basic neurophysiological effects 
induced by inter-regional rTMS priming protocols, and the utility of novel multimodal 
approaches for measuring neuroplastic effects induced by standard and inter-regional 
cTBS priming paradigms. Chapter 6, Chapter 7 (Study 3), Chapter 8, and Chapter 9 
(Study 4) were included to address the aims of the second stream of research. The 
following section provides a summary of the major aims and rationale for each program 
of research in conjunction with a description of how each chapter contributed to the 
accomplishment of those objectives. Following from this, an integrated and 
consolidated summary of the major findings of each study included in this thesis will be 
presented. The final section will outline the major implications and limitations 
stemming from this program of research, and close with final concluding remarks.  
Aims and Rationales 
As mentioned, the first stream of research investigated the potential of multisite 
rTMS paradigms for clinical applications. This led to the generation of two aims. The 
first aim was to evaluate the utility of neuroanatomical models of OCD pathology, 
combined with clinical intervention outcomes from the TMS and OCD treatment 
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literature, for guiding the selection of neuroanatomical targets and stimulation 
parameters for multisite rTMS. This aim was addressed in Chapter 3 and the systematic 
review presented in Chapter 4 (Study 1). OCD was selected as the clinical focus of this 
thesis for several reasons. As argued in Chapter 3 and Chapter 4, although several 
treatments have been developed for OCD, a sizable proportion of individuals do not 
respond adequately to first order treatments including pharmacological, or cognitive-
behavioural treatments (Abramowitz et al., 2005; Pallanti et al., 2002). Other 
therapeutic options such as ablative psychosurgery (Greenberg et al., 2010b), and deep 
brain stimulation (Greenberg et al., 2010a) are available, however, these treatments are 
reserved for the most debilitating and treatment resistant cases. Moreover, surgical 
techniques used in OCD are associated with a higher degree of serious risks including 
changes in mood, destruction of brain tissue, and haemorrhaging (Greenberg et al., 
2006). Thus, alternative novel treatments with higher tolerability, safety, and 
effectiveness are needed. 
The second aim was to evaluate the feasibility, safety, tolerability, and long-term 
neurocognitive effects of a clinically informed multisite rTMS paradigm. This was 
addressed in the first empirical investigation (Study 2, Chapter 5). The multisite 
paradigm was developed based on the combined findings of Chapter 2, Chapter 3, and 
the systematic review presented in Chapter 4 (Study 1). In Chapter 2, the neuro-
modulatory effects of conventional rTMS were reviewed, in addition to the safety 
profile of TMS. The safety of TMS was extensively examined as the participants 
recruited for the first empirical study (Study 2, Chapter 5) were healthy volunteers. It 
was therefore a major imperative of this thesis to provide a comprehensive and detailed 
evaluation of the safety of TMS before administration of the multisite rTMS protocol. 
As there was limited safety data on multisite rTMS protocols, the thesis implemented a 
conservative approach when administering the multisite protocol in Study 2 by utilising 
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short rTMS trains (i.e., less than 3 min), and reduced stimulus intensities (i.e., 
subthreshold pulses). Comprehensive safety and adverse events data were 
systematically collected.  
After some further investigation, the research focus of the thesis shifted from 
clinical applications of multisite rTMS to the second research stream that sought to 
characterise the neurophysiological effects induced by inter-regional priming rTMS 
protocols. This change was implemented for several reasons. Firstly, it was identified 
that there was limited data on the neuro-modulatory effects of multisite paradigms 
(Karabanov et al., 2015). This is an important consideration as priming protocols 
applied intra- or inter-regionally can induce complex neuroplastic effects such as 
homeostatic and non-homeostatic meta-plasticity (Goldsworthy et al., 2012; Hamada et 
al., 2009; Karabanov et al., 2015; Potter-Nerger et al., 2009; Ragert et al., 2009). 
Second, there were relatively few studies examining the neurophysiological effects of 
multisite inter-regional priming protocols that could be used to guide the selection of 
appropriate neuroanatomical targets and rTMS parameters for clinical applications 
(Kang et al., 2009; Ma et al., 2014; Potter-Nerger et al., 2009). A third major reason was 
that the neuroplastic effects induced by neuro-modulatory NIBS techniques can be 
highly variable (Hamada et al., 2012; Ridding & Ziemann, 2010; Wiethoff et al., 2014). 
This unexplained variability hinders the utility and application of NIBS techniques in 
the areas of neurophysiological (Hamada et al., 2012; Ridding & Ziemann, 2010), 
cognitive neuropsychology (Guse et al., 2010), and clinical neuropsychiatry (Jaafari et 
al., 2012). Thus, there was not only a need to characterise the neuroplastic effects 
induced by inter-regional priming protocols, but also a rationale for developing more 
reliable rTMS protocols, perhaps through multisite rTMS designs.  
With this change in research focus in mind, the first two aims relating to the 
second research stream were to characterise the neuroplastic effects induced by inter-
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regional rTMS protocols, and to evaluate whether more consistent neuro-modulatory 
effects could be achieved with multisite rTMS paradigms. These aims were addressed in 
Chapter 6, and the second empirical study (Study 3, Chapter 7). In Chapter 6, the neuro-
modulatory effects of theta burst stimulation (TBS) and priming protocols were 
evaluated. The findings of Chapter 6 revealed that the neuroplastic effects of TBS on 
corticospinal excitability can be highly variable. It was also revealed that intra- and 
inter-regional priming protocols can induce more complex forms of plasticity including 
homeostatic and non-homeostatic meta-plasticity (Karabanov et al., 2015). Added to 
this, only a small number of studies could be identified (n = 3) that evaluated the 
neurophysiological effects of inter-regional priming applied over M1. One major 
finding from Chapter 6 was the identification of an intra-regional priming developed by 
Goldsworthy et al.  (2014b; 2012) that could induce consistent, and robust effects on 
corticospinal excitability. Thus, Study 3 (Chapter 7) was conducted to evaluate the 
neurological effects induced by inter-regional priming protocols, and to determine 
whether more consistent robust neuro-modulatory effects could also be achieved 
through inter-regional priming of M1.   
The findings of Study 3 (Chapter 7), however, revealed that intra- and inter-
regional priming of M1 induced highly variable neuroplastic effects on corticospinal 
excitability.  This led to the conception of the final aim related to the second stream of 
research, which was to characterise the neuro-modulatory effects of standard and inter-
regional priming cTBS paradigms on M1 using a novel multi-modal approach that 
combined transcranial magnetic stimulation with electroencephalography (TMS-EEG). 
The collective findings of Chapter 6, Chapter 7 (Study 3), and Chapter 8 contributed to 
the design, implementation, and analysis of the final empirical study (Study 4, Chapter 
9). In Study 3 (Chapter 7), it was found that the neuro-modulatory effects induced by 
both standard continuous theta burst stimulation (cTBS) and priming of M1 intra- or 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 297 of 414 
 
 
inter-regionally induced highly variable neuro-modulatory effects on corticospinal 
excitability. Although some variability had been expected, the high degree of 
heterogeneity in responses observed in the third study (Chapter 7) prompted the final 
investigation. Thus, Study 4 (Chapter 9) sought to characterise the neuro-modulatory 
effects induced by standard and inter-regional priming cTBS priming protocols applied 
to M1 directly at the scalp using combined TMS-EEG.  
Summary and Consolidation of Major Findings 
The findings of the first study presented in the form of a systematic review in 
Chapter 4 led to several conclusions. Firstly, it was revealed that, overall, there was 
only weak-to-moderate evidence that rTMS is effective for treating OCD. Although the 
results of an initial open trial were promising (Greenberg et al., 1997), later trials failed 
to replicate these early reports (Jaafari et al., 2012). However, when the effectiveness of 
rTMS for treating OCD was considered on a regional anatomical basis, the findings 
were more nuanced. For example, most trials to date targeting the dorsolateral prefrontal 
cortices have been met with limited success. Studies that have targeted the left 
dorsolateral prefrontal cortex (DLPFC) include an open trial (Sachdev et al., 2001a), 
two RCTs using low frequency rTMS (Prasko et al., 2006), and one study using high-
frequency rTMS (Sachdev et al., 2007). Several studies have targeted the right DLPFC 
and also found no clinical improvements in primary OCD symptoms including one open 
trial (Sachdev et al., 2001a), and three RCTs (Alonso et al., 2001; Mansur et al., 2011; 
Sarkhel et al., 2010). Only one RCT targeting the DLPFC bilaterally with individualised 
high frequency rTMS reported improvements in primary OCD symptoms (Ma et al., 
2014). In one trial, it was reported that high frequency rTMS over the right DLPFC 
improved secondary anxiety symptoms in individuals diagnosed with OCD (Sarkhel et 
al., 2010). 
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Two other neuroanatomical targets and rTMS parameters were identified that 
showed therapeutic potential including low frequency rTMS applied over the 
supplementary motor area (SMA) or orbitofrontal cortex (OCF). With regard to the 
SMA, several trials have shown that low frequency rTMS over the SMA reduced OCD 
symptoms including one case study (Talaei et al., 2009), one open trial (Mantovani et 
al., 2006), and two RCTs (Gomes et al., 2012; Mantovani, Simpson, Fallon, Rossi, & 
Lisanby, 2010b). In relation to the OCF, low frequency rTMS over the left OFC appears 
to improve OCD symptoms for up to 10 weeks (Ruffini et al., 2009). Thus, low 
frequency rTMS over the SMA or OFC appear to be promising avenues of 
investigation.  
The findings of Chapter 3, and the first study (Chapter 4) led to the development 
and implementation of the first empirical study presented in Chapter 5. Study 2 
(Chapter 5) evaluated the feasibility, safety, tolerability, and neurocognitive effects of a 
clinically informed multisite rTMS protocol. Specifically, the safety profile of a 
multisite rTMS protocol targeting the left OFC and SMA with low frequency rTMS, 
and the left-DLPFC with high frequency rTMS was evaluated. These regions and rTMS 
parameters were selected based on the findings of Chapter 2, Chapter 3, and Chapter 4 
(Study 1). As mentioned, because the multisite protocol was administered in a sample of 
healthy participants, an extensive review on the safety of rTMS had been performed in 
Chapter 2. Although it was found that TMS is a safe technique, there was relatively less 
safety data on multisite designs. To address these issues, it was decided that the 
multisite protocol would involve the administration of reduced stimulation trains and 
lower stimulation intensities, Furthermore, a comprehensive and systematic evaluation 
of the safety and tolerability of the multisite paradigm employed in Study 2 was 
conducted.  
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Overall, it was found that the multisite protocol was safe and tolerable. Although 
there was a higher frequency of adverse effects in the group receiving active rTMS 
immediately after receiving the protocol, there were no differences in neurocognitive 
performance between those receiving active or sham rTMS over a 3-month period. 
Participants who received active rTMS reported a higher frequency of commonly 
reported side effects including headaches, general discomfort, and nervousness 
consistent with several other major publications on the safety of TMS (Machii et al., 
2006; Rossi et al., 2009; Wasserman, 2002). Performance on the neurocognitive battery 
did not differ between groups as evaluated on tasks that measured reaction time, verbal 
fluency, executive functioning, and inhibition. The results of Study 2, therefore, 
provided additional evidence that multisite paradigms informed by clinical findings can 
be safe and tolerable.  
Although the findings of Study 2 revealed that multisite paradigms are tenable, 
as mentioned, it was identified that there were very sparse information on the neuro-
modulatory effects induced by multisite inter-regional protocols (Karabanov et al., 
2015). Further, there was only a limited number of studies utilising inter-regional 
priming protocols that could be used to inform the selection of neuroanatomical targets 
and rTMS parameters for clinically informed multisite protocols (Hamada et al., 2009; 
Potter-Nerger et al., 2009; Ragert et al., 2009). 
This led to development of the second stream of research. The third empirical 
study (Chapter 7) sought to address this gap in knowledge by investigating the neuro-
modulatory effects of standard, and intra- and inter-regional priming of M1 with cTBS. 
Four protocols were evaluated including standard cTBS (Sham-M1), and three priming 
protocols. One priming protocol involved intra-regional priming of M1 (i.e., cTBS was 
applied to M1 twice; M1-M1). The other two priming protocols involved inter-regional 
priming of M1 via the DLPFC (DLPFC-M1), and dorsal premotor cortex (dPMC; 
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dPMC-M1). Each round was separated by 10 min. This interval was selected as 
previous studies involving intra-regional priming of M1 separated by 10 min could 
induce strong and robust suppression of corticospinal excitability reflective of non-
homeostatic meta-plasticity (Goldsworthy et al., 2014b; Goldsworthy et al., 2012). 
Study 2 sought to extend the application of spaced rounds of intra-regional cTBS using 
an inter-regional design. Again, adverse events were systematically recorded following 
administration of each protocol.  
Although the standard and priming cTBS protocols were well-tolerated, the 
neuroplastic effects induced on corticospinal excitability across the four protocols were 
highly variable. With regards to safety, the adverse events data revealed that all 
protocols were safe and tolerable. There was a slightly higher frequency of adverse 
events reported following administration of the DLPFC-M1 (n = 20), and dPMC-M1 (n 
= 22) protocols, followed by M1-M1 (n = 15), and Sham-M1 (n = 12). In relation to the 
primary outcome measure, the main analysis failed to show consistent group level 
effects on corticospinal excitability across each paradigm. Neither standard nor priming 
cTBS induced consistent neuro-modulatory effects. The responder/non-responder 
analysis revealed a large degree of variation in the proportion of individuals showing 
‘expected’ responses. For example, in the M1-M1 condition, 70% showed the expected 
inhibitory response in corticospinal excitability, however, only 30% showed the 
expected facilitatory effect in the dPMC-M1 condition. Individual response plots were 
generated to investigate the lack of group level effects and showed large disparities in 
responses between participants. The large heterogeneity in neuroplastic responses across 
the four protocols was consistent with reports of Hamada et al. (2012) who also failed to 
find group level changes in corticospinal excitability following single administrations of 
standard cTBS or intermittent theta burst stimulation (iTBS).  
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The high degree of variability in neuroplastic responses deserved closer 
attention. This led to the development and implementation of the fourth and final 
empirical study. Study 4 (Chapter 9) investigated the neuro-modulatory effects induced 
by standard and inter-regional priming of M1 with a novel multimodal approach that 
combined TMS with EEG. Specifically, Study 4 sought to index the neuroplastic effects 
of standard and priming cTBS protocols measured directly from the scalp using 
transcranial magnetic stimulation evoked potentials (TEPs). The DLPFC was selected 
as the inter-regional priming target as the results of Study 3 (Chapter 7) showed that the 
DLPFC-M1 protocol induced facilitation of MEP responses, albeit, non-significantly. 
Based on the findings of Chapter 8, an active control condition involving TMS applied 
over the shoulder (i.e., shoulder evoked potentials [SEPs]) was included to control for 
multi-sensory contamination. 
The first major finding was that short latency TEP components (< 60 ms) were 
more prominent compared to the equivalent SEP components. However, similar long 
latency components (> 60 ms) were elicited in both the TEP and SEP conditions. This 
suggests that early components may involve partly dissociable mechanisms, but late 
components may have a shared neurological underpinnings (Biabani et al., 2018; Conde 
et al., 2019). The second major finding was TEPs can be used as partial indicators of 
neuro-modulatory responses to standard and inter-regional cTBS priming of M1. 
Standard cTBS modulated both the N45 TEP and N45 SEP over left frontal and right 
posterior regions. Correlational analysis, however, failed to identify significant 
association between the N45 TEP and N45 SEP difference values over the stimulated 
M1 or right-posterior regions. This suggests that modulation of the TEP and SEP N45 
induced by standard cTBS involves, at least in part, separable neurological mechanisms. 
Inter-regional cTBS priming of M1 over the DLPFC modulated the N100 TEP but 
failed to modulate any SEP component. Specifically, there was a reduction in the N100 
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amplitude over central regions (increased positivity). It should be noted that a similar 
reduction in the N100 TEP was observed in the standard cTBS protocol after active 
stimulation, however, the reduction was not significant. These findings provide some 
evidence that the N100 TEP may be a partially unique marker of priming cTBS. Study 4 
thus extends the TMS-EEG literature by illustrating that the technique has utility in 
measuring neuroplastic effects induced by standard and inter-regional cTBS priming 
protocols (Chung et al., 2018; Farzan et al., 2016; Komssi & Kähkönen, 2006).  
Implications 
 There are several implications that stem from this program of research. The first 
implication is that neuroanatomical models of pathology (Saxena & Rauch, 2000) can 
be combined with clinical outcome data (Jaafari et al., 2012; Trevizol et al., 2016) to 
identify neuroanatomical targets for neurobiological treatments such as TMS 
(Greenberg et al., 2010a; Greenberg et al., 2010b). Although the current thesis did not 
evaluate the effectiveness of the multisite paradigm in a sample of individuals 
diagnosed with OCD, it did provide preliminary evidence that neurobiological models 
of clinical disorders can not only be used to assist with the identification of potential 
therapeutic targets, but can provide a conceptual framework for analysing, 
contextualising, and accounting for the clinical outcomes of neurobiological treatments.  
 The second implication is that multisite paradigms can be continually evaluated 
for investigative, and research purposes. One major consideration throughout this thesis 
was the safety of multisite rTMS paradigms. Although a large body of research over the 
last 30 years has shown TMS to be a safe technique (Rossi et al., 2009; Wasserman, 
2002), due to the inherent risks associated with TMS (Green et al., 1997), it is 
imperative that the safety profile of the technique be continually monitored and updated. 
In the current thesis, detailed and comprehensive safety data was collected after the 
administration of each multisite protocol across each empirical study. By and large, the 
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adverse effects identified in this thesis were consistent with those reported in the extant 
literature (Di Iorio & Rossini, 2017; Machii et al., 2006; Rossi et al., 2009). TMS 
applied over frontal regions, particularly the DLPFC and dPMC tended to induce a 
higher frequency of adverse events compared to stimulation applied over M1. It appears 
that multisite inter-regional priming protocols are safe and well tolerated, at least with 
the stimulation parameters used in the current study.  
 There is a small but growing literature investigating the utility of inter-regional 
priming protocols for investigative, and clinical applications. For example, Murakami et 
al. (2015) successfully applied multisite cTBS over the dPMC and posterior inferior 
frontal gyrus to examine language processes associated with speech production and 
errors. In terms of neurophysiological processes, three papers have reported on the use 
of inter-regional priming protocols to examine homeostatic meta-plastic processes that 
occur over networked regions including the dPMC and M1 (Potter-Nerger et al., 2009), 
the SMA and M1 (Hamada et al., 2009), and bilateral M1 regions (Ragert et al., 2009). 
In the clinical domain, a small number of studies have examined multisite paradigms for 
treating several disorders including OCD (Kang et al., 2009; Ma et al., 2014), tinnitus 
(Lehner et al., 2013), and major depressive disorder (Prasser et al., 2015). Although the 
current program of research did not provide evidence that intra- or inter-regional 
priming protocols induces consistent modulation of corticospinal excitability, the 
findings of the final empirical study that utilised TMS-EEG provided promising 
findings that standard and priming cTBS may induce group level neuroplastic changes.  
  Another implication is because the effects of the intra- and inter-regional 
priming protocols are not always predictable (Dodakian et al., 2013; Hamada et al., 
2009), particularly when indexed as changes in corticospinal excitability, further work 
is needed not only identify factors that contribute to the observe variability, but also 
how to mitigate their influence (Hamada et al., 2012; Pell et al., 2011; Ridding & 
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Ziemann, 2010; Wiethoff et al., 2014). Factors that have been shown to contribute to 
variability in neuroplastic responses include on-going fluctuations in corticospinal 
excitability (Kiers, Cros, Chiappa, & Fang, 1993b), genetic factors (Cheeran et al., 
2008), the prior activation history of the target neural population (Goldsworthy et al., 
2014a; Iezzi et al., 2008), movement planning (Izumi et al., 1995), and attentional 
processes (Antonelli & Luchettl, 2007; Badre, 2007; Churchland & Shenoy, 2007; 
Committee, 2007; Conte et al., 2007; Lenzi et al., 2007; Linden, 2007; Nowak et al., 
2009). The variability in responses to NIBS techniques makes the selection, 
development, and implementation of rTMS protocols difficult. Ultimately, if the neuro-
modulatory effects induced by rTMS are difficult to reproduce or replicate at a basic 
neurophysiological level, this makes it challenging to develop explanatory models that 
can account for the neurological effects induced by NIBS techniques.  
The task of selecting appropriate rTMS parameters becomes more difficult when 
trying to enhance or improve cognitive function. This is reflected in the number of 
reviews reporting mixed findings on whether rTMS can improve cognitive functions. 
For example, a systematic review by Guse et al. (2010) revealed that high frequency 
rTMS did not improve performance over a range of domains including working 
memory, cognitive flexibility, verbal fluency or psychomotor speed. Another review by 
Iimori et al. (2019) examined the effects of rTMS on cognitive ability in clinical 
populations. Overall, the authors found some benefit in attention for individuals 
diagnosed with depression, but mixed results for individuals diagnosed with 
schizophrenia and Alzheimer’s disease. A review by Martin et al. (2017) showed that 
rTMS over the DLPFC can improve a limited number of cognitive abilities in 
individuals with major depression including psychomotor speed, visual, set-shifting. 
Finally, a systematic review by Lage et al. (2016) examined the effects of low frequency 
rTMS on cognitive performance in clinical and healthy populations. Although the 
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authors reported that low frequency rTMS was safe, there were no overall effects on 
several cognitive domains including attention, executive functioning, spatial reasoning, 
and memory. Further work is needed to understand the mechanisms underpinning the 
neuroplastic effects of NIBS to optimise and improve current protocols.  
A final implication is that multi-modal techniques may provide an alternative 
avenue for measuring neuroplastic responses to NIBS directly at the scalp. The large 
degree of variability in corticospinal responses identified in Study 3 contributed to the 
non-significant group level findings (Chapter 7). However, the results of Study 4 
(Chapter 9) showed that TMS-EEG can be used to index neuroplastic responses to 
standard and inter-regional priming protocols at the group level. The findings of Study 4 
contribute to a unique and emerging body of work illustrating the utility of multimodal 
techniques such as TMS-EEG for providing insights into the neurological effects 
induced by NIBS (Farzan et al., 2016; Ilmoniemi & Kičić, 2010; Komssi & Kähkönen, 
2006). A benefit of TMS-EEG is that the technique it is not limited to motor regions 
(Chung et al., 2017; Chung et al., 2018; Du et al., 2017). The technique could not only 
be used to measure neuroplastic responses to NIBS in non-motor regions, but also be 
used to optimise current protocols. For example, there is some early pioneering work 
showing that TMS-EEG can be used to develop individualised stimulation parameters 
that can induce more consistent and robust neuroplastic effects over the DLPFC (Chung 
et al., 2018). These advancements could lead to the development of individualised 
protocols that could improve investigative and clinical outcomes.  
As an extension of this, it may also be possible to use TMS-EEG to evaluate the 
neuro-modulatory effects of priming rTMS in non-motor regions directly implicated in 
conditions such as OCD (Saxena & Rauch, 2000). For instance, the neuro-modulatory 
effects of priming protocols could be evaluated in frontal, and non-primary motor areas 
such as the SMA to assess whether the hypothesised directions of change can be 
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achieved. Further, it may also be possible to individualise treatment parameters based 
on intrinsic frequencies in regions shown to be involved in the disorder including the 
OFC, ACC, SMA, and DLPFC (Chung et al., 2018). This may not only reduce the 
variability in responses observed in current protocols (Hamada et al., 2012; Ridding & 
Ziemann, 2010), but improve treatment response outcomes (Trevizol et al., 2016). 
Limitations 
 There were several limitations associated with this thesis. One limitation was an 
evaluation of the safety, tolerability, and effectiveness of the clinically informed 
multisite paradigm in a clinical population, specifically, OCD, was not obtained. 
Although this was one of the original aims of this thesis associated with the first stream 
of research, it was identified that there was little data examining the neuroplastic effects 
induced by multisite inter-regional priming protocols. It was therefore decided that a 
thorough examination of the neuroplastic effects induced by multisite protocols was 
warranted. To this end, regions with known structural and functional connections with 
M1 were selected to provide a higher degree of control over the potential neuroplastic 
effects induced by inter-regional priming protocols as evaluated in Study 3 and Study 4 
(Fang, Stepniewska, & Kaas, 2005; Kantak et al., 2012; Lu, Preston, & Strick, 1994; 
Picard & Strick, 2001).  
 A second limitation was there was a delay between the time systematic review 
presented in Chapter 4 (Study 1) was conducted and the subsequent submission of this 
thesis. Although an update of the literature review was considered, there were two 
primary reasons why this was decided against. Firstly, the multisite protocol evaluated 
in the first empirical study (Study 2, Chapter 5) had been developed directly because of 
the findings of the systematic review. Updating the literature review would not have 
resulted in a major change to the multisite protocol. A second more important reason 
was because a recent meta-analytic article had been published by Trevizol et al. (2016) 
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in the intervening time. The authors used a quantitative method to evaluate the efficacy 
of rTMS for treating OCD. Quantitative methods are superior to qualitative methods as 
they are less prone to bias, and so an update of the systematic review included in this 
thesis would not have contributed substantially to the existing literature.  
 A third limitation was that neuro-navigation was not used to target non-motor 
regions, specifically, the SMA, OFC, DLPFC and dPMC. Studies have shown that 
neuronavigation techniques can improve the localisation and targeting of motor and 
non-motor regions (Fox, Liu, & Pascual-Leone, 2013; Moisa, Pohmann, Ewald, & 
Thielscher, 2009; Sack et al., 2009). However, the targeting methods used in the current 
thesis were selected on the basis on previous studies that had used similar methods for 
identifying target regions in clinical interventions (Mantovani et al., 2010a; Ruffini et 
al., 2009), or neurophysiological studies (Chuang, Huang, Lu, & Chen, 2014; Huang et 
al., 2009; Ortu, Ruge, Deriu, & Rothwell, 2009; Potter-Nerger et al., 2009). 
Nonetheless, localisation techniques with greater spatial precision may enhance the 
neurophysiological, and potentially cognitive, effects induced by rTMS paradigms.   
 A final limitation was the lack of active control conditions involving TMS 
applied to non-motor regions in the TMS-EEG study. Additionally, MEPs were not 
measured to re-examine the neuroplastic effects of standard and multisite priming with 
cTBS over M1 on corticospinal excitability. An active non-motor control site measured 
with TMS-EEG was not included in Study 3 (Chapter 9) due to pragmatic constraints. 
Each TEP and SEP block comprised 100 – 120 trials. Although this increased the 
signal-to-noise ratio, each block lasted approximately 10 min. The large numbers of 
trials within each block made the inclusion of a third active control condition difficult as 
this needed to be balanced with maintaining participant attention throughout each 
session. Relatedly, the primary outcome measure of the final study was TEP responses 
measured with TMS-EEG, rather changes in corticospinal excitability. Although MEPs 
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would have provided additional data to compliment the TEP results and analysis, high 
quality EEG data was prioritised over secondary measures such as changes in MEPs.  
Overall Conclusions and Summary 
 There are several major conclusions stemming from the two streams of research 
presented in this thesis. Firstly, neuroanatomical models of pathology and disease can 
be combined with the therapeutic rTMS literature to identify potential neuroanatomical 
targets and rTMS stimulation parameters. However, due to the limited number of 
studies examining the neuroplastic effects induced by multisite rTMS protocols, and the 
highly complex neuro-modulatory effects induced by intra- and inter-regional priming 
rTMS protocols, further work is needed to understand and characterise the effects 
induced by multisite paradigms. The unexplained variability in neurological responses 
induced by NIBS paradigms hinders more widespread adoption and implementation of 
techniques such as rTMS and TBS across a wide range of fields including 
neurophysiology, cognitive-neuropsychology, and clinical neuro-psychiatry. Continued 
refinement, optimisation, and innovation will lead to the development of NIBS 
protocols that can induce more robust, and predictable effects. These innovations can be 
combined with newly developed multimodal measurement techniques that may provide 
new avenues for investigating, characterising, and understanding the effects induced by 
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DUHREC – 2012-107 
 
PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participants  
 
 
Plain Language Statement  
Date:___________________________________ 
Full Project Title: The long term neurocognitive effects of a single session of multisite, 
sequential, repetitive transcranial magnetic stimulation: A randomised, single blind 
controlled trial   
Principal Researcher: Dr. Linda Byrne 
Student Researcher: Michael Do 
Associate Researcher(s): Dr. Alan Pearce 
 
 
This Plain Language Statement and Consent Form is 8 pages long. Please ensure that 
you have read the document in full.  
 
1. Your Consent  
 
You are invited to take part in this research project.  
 
 Thank you for taking the time to read the information outlined in this Information 
Sheet.  
 
This Plain Language Statement contains detailed information about this research 
project. Its purpose is to explain to you as clearly as possible the purpose of the project 
and all the procedures involved with the project so that you can make an informed 
decision as to whether you would like to take part in the project or not.  
 
Please take as much time as you need to read the Plain Language Statement. We 
encourage you to ask any questions about any aspect of the research project at any time. 
We would also encourage you to speak to a friend or family member about the project 
before making any decisions. You are free to do this at any time.   
 
Once you have understood what this project is about and if you would still like to take 
part in this project, we will ask you to sign the Consent Form. By signing the Consent 
Form, you are indicating that you have understood the information provided in this 
Plain Language Statement. You will also be indicating that you have given your consent 
to take part in the project.  
 
You will be provided with a copy of the Plain Language Statement to keep.  
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We would like to emphasise that your participation is completely voluntary. You are 
not obliged to take part in this study. This means that you are free to withdraw from the 
project at any time and you do not have to provide a reason. If you decide to withdraw 
your participation, there will not be any consequences and your decision to withdraw 
will not impact on your relationship with the investigators or Deakin University.  
 
2. Purpose and background  
 
The purpose of this project is to investigate the long term effects of a technique called 
repetitive transcranial magnetic stimulation (rTMS). rTMS is a non-invasive, relatively 
painless technique which uses magnetic pulses to activate brain areas beneath the scalp. 
The technique has been used for well over 20 years and is used routinely in different 
clinics around the world. The effects of rTMS are temporary and the risks associated 
with the technique are extremely low. In order to ensure your safety at all stages of this 
project, the researcher has been specifically trained in first aid and has a current first aid 
certificate. 
 
This project has been designed to assess whether stimulation over three different parts 
of your brain in a single session has any effects that last longer than 1 hour. This study 
will assess whether these effects can improve or decrease a healthy person’s ability to 
think. It is expected that any effects from rTMS will be extremely temporary (less than 
1 hour).  
 
This research is being conducted as part of a PhD (Psychology) thesis.  
 
A maximum of 20 people will participate in this project.    
 
You have been asked to participate in this study because: 
• You are healthy 
• You are between the ages of 18 and 55  
• You are right handed 
• You do not have a current or a past history of neurological, psychological or 
severe physical illnesses  
• You are not have any metal implants/shrapnel inside your head  
• You do not have any surgically implanted devices including pace-makers, 
neurostimulator devices (deep-brain stimulation, vagus nerve stimulator), 
cochlear implants or other surgically implanted device  
• You are not pregnant  
 
3. Procedures  
 
This study will be conducted at the Burwood campus of Deakin University and will be 
conducted over three months. You will be asked to visit the university grounds for a 
total of four times. The first session will take two and a half hours. Each session 
thereafter will take one hour. In total, you will be asked to volunteer five and a half 
hours of your time over three months.  
 
You will come into the clinic and meet the researcher. The researcher will then tell you 
about rTMS and answer any questions that you have. You will then fill out a safety 
questionnaire to ensure that you are eligible to participate. Please answer the safety 
questionnaire as accurately as possible. This is to ensure your safety. You will then be 
randomly allocated to one of two groups. One group will receive magnetic pulses at 
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strengths that will activate the brain. The other group will undergo identical procedures, 
but will be administered a completely inactive coil that produces the same sensations as 
an active coil, but does not stimulate the brain. This random allocation process is 
necessary to ensure that the results of this study are accurate. During the entirety of the 
study you will not be told which group you are in. However, at the conclusion of the 
study, you will be fully informed of which group you were allocated to.    
 
Following from this, the researcher will begin to set up the rTMS equipment. We ask 
that you do not wear any products in your hair. You will be asked to wear a cap and it is 
extremely important that the cap fits on your head. It is perfectly acceptable to wear 
make-up or to have facial hair. You will be seated in a comfortable chair with your head 
supported by a headrest. During the set-up, the researcher will measure your head using 
a measuring tape and will place electrodes on both your hands. To ensure that we get 
the correct readings, it will be necessary to clean the area around your hand quite firmly 
with alcohol wipes and to place a small amount of conductive gel on your hands. You 
will be asked to remain as still as possible throughout the duration of the set-up and 
pulse phases. The researcher will then administer a number of pulses to determine the 
minimum strength that will be needed to get a response from your brain. You may feel a 
light tap on your head when the pulses are given. Although the pulses are not painful, 
they may feel a little uncomfortable. Following from this, the rTMS pulses will be 
applied by either the active or inactive coil. 
 
In the rTMS pulse trials, three parts of your brain will be located. Once located, pulses 
will be applied to each region for three minutes each. Ear plugs will also be provided in 
order to prevent any audible clicking sounds that the machine generates. You will be 
given pulses for a maximum of nine minutes. This will be the one and only time that 
the pulses will be applied. It will not be necessary to give you any more pulses after the 
initial session. After a short break, you will then complete a short pen and paper 
questionnaire that will ask if you experienced any discomfort. Following from this, you 
will complete some tasks that assess your thinking and speaking ability. To evaluate 
your thinking ability, you will be asked to complete some tasks using a computer 
program. At the end of each completed task, the computer program will record and save 
your responses. To evaluate your speaking ability, a short number of speaking tasks will 
be used and your responses will be recorded with a pen and paper by the researcher. The 
first session will take approximately two and a half hours in total.  
 
You will then be invited back after one week, one month and three months following 
from your first session. Each session after the first will be almost identical. However, it 
is important to emphasise that you will not be given any further pulses. In each new 
session, you will complete similar or slight variations of the same tasks used in the first 
session to assess your thinking and speaking ability. These visits are expected to last a 
total of one hour each. At the conclusion of the study, you will be informed of which 
group you have been allocated to. It is anticipated that you will visit Deakin on a total of 
four occasions. It is also anticipated that you will volunteer five and a half hours of your 
time for the entirety of the study.  
 
4. Possible Benefits  
 
The possible benefits of this project include being able to design new procedures to help 
understand how the brain functions. Furthermore, this project provides a unique 
opportunity to understand if rTMS can be used to understand how healthy people think 
and whether this information can be used to develop treatments for individuals who 
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suffer from psychological/neurological illnesses. It is hoped that this project will open 
up new research avenues for future research. We do not expect this research to benefit 
you directly.  
 
5. Possible Risks  
 
Although rTMS is non-invasive and has been shown to be a safe technique for studying 
the brain, there are potential risks to this research. The more common risk that you 
might experience includes some minor discomfort during the stimulation. Other 
reported but minor risks include mild headache, neck pain, general discomfort, tooth 
pain, slight changes in mood and muscle pains around the shoulders. These minor risks 
are temporary and usually resolve within a few hours.  
 
In very rare instances, seizures have been reported following from rTMS exposure. The 
risk of a seizure, however, is extremely low and has been estimated to be 1% around the 
world. Prior to any exposure, you will undertake the safety screen to ensure your safety. 
If you have circumstances that increase your risk of harm, it will not be appropriate for 
you to take part in this project. To ensure your safety at all times, the researcher has 
been specifically trained to provide first-aid. It is important to emphasise at this point 
that your participation is completely voluntary and you are free to withdraw at any 
time. You do not have to give a reason if you do not wish to participate and there will 
be no consequences if you wish to withdraw.  
 
6. Provision of Services  
 
In the unlikely event of a seizure, the researcher will immediately attend to your health 
and wellbeing. Your health and safety is our highest priority. All testing will be 
immediately terminated and the researcher will administer first aid if necessary. You 
will then be carefully monitored until the situation has been judged to pass. Following 
from this, a report will be filled and the relevant Ethics Review Board will be notified 
immediately. Even if you experience a seizure there has been no evidence from multiple 
studies over the past 20 years that you are susceptible to develop seizures at other times. 
In other words epilepsy (recurrent seizures) has not been seen to develop following this 
procedure even in the unlikely event that you experience a seizure. A detailed report 
substantiating this claim has been written as part of the research student’s thesis and can 
be provided to any relevant individuals, if required.  
 
Your involvement in this project will not expose you to any risk of emotional or 
physical harm which is greater than that encountered in your normal daily life. 
However, in the unlikely event that participation in this study causes you some distress, 
you can receive free counselling from Lifeline (phone number: 131114), or if you are a 
Deakin student you can use the Deakin University Counselling Service located at 
Student Life, Melbourne Campus at Burwood, Level 2 Building B. 
 
Furthermore, if you feel that you need further assistance following from any negative 
events, and with your permission, we can refer you onto your family doctor or general 
health practitioner (GP). We can also provide your GP with any information that they 
require regarding rTMS and its safety.   
 
7. Privacy, Confidentiality and Disclosure of Information 
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The data in this study you provide will be identifiable so that your responses to the 
questionnaires and tests will be matched to your rTMS responses. However, you will 
not be identifiable by name on each of the questionnaires or tests. We will use subject 
numbers to put your information together. A password protected participant list will be 
used to connect your subject number with your name. The list will also be stored 
electronically in a computer that requires a password to be accessed. This will provide 
two levels of security for your electronic data. As it will be possible to connect your 
information together, this will enable us to remove your data should you wish to 
withdraw from the study. Thereafter, only aggregated data (or group data) will be 
reported in a thesis and published in a psychological journal.  
 
The information collected during this project will be stored in hard-copy and electronic-
copy form. Data collected in hard-copy will be locked away in a filing cabinet. The 
filing cabinet will be kept in a locked room. Again, this will provide two levels of 
security for your hard-copy data. Your data will be kept in a secure location for a 
minimum of six years, which is in accordance with Deakin University guidelines. After 
a period of six years, the hard-copy files of your data will be destroyed and the 
electronic-files will be deleted. A report of the study may be submitted for publication 
in a psychological journal. However, individual participants will not be identifiable as 
only aggregated data (or group data) will be reported.  
8. Results of the Project  
 
You are encouraged to contact the researcher at the conclusion of the study to be 
informed of the aggregate research findings. If requested, we will provide you with the 
aggregate findings of this study by mail or e-mail. Aggregate results will be published 
in a thesis and published in a psychological journal.  
 
9. How the Research will be Monitored 
 
The principal researchers will meet with the associate researchers throughout the 
duration of the project to monitor its progress and to reflect on any issues that arise.  
 
10. Financial Support 
 
This study is funded by the School of Psychology at Deakin University.  
 
11. Participation is Voluntary  
 
It is important to reemphasise that you participation is completely voluntary. If you do 
not wish to be part of the study, you are not obliged to. You do not have to take part in 
this project. You are free to withdraw from this project at any time. Any information 
that you have provided will not be used and will be destroyed.  
 
If you decide to withdraw from this project, your relationship with the investigators or 
Deakin University will not be affected. In other words, there will be no consequences if 
you do not wish to participate.  
 
At every stage of the project, you are encouraged to ask questions from the researchers. 
The research members will be available to answer any questions that you may have 
about the research project. You may ask about any aspect of the project that you would 
like to know about. Please feel free to do so. We ask that you sign the Consent Form if 
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and only if you have had a chance to ask your questions and you have received 
satisfactory answers.  
 
If you do not wish to participate in this project, please do not sign the Consent Form.  
 
12. Ethical Guidelines  
 
This project has been developed in accordance with the National Statement on Ethical 
Conduct in Human Research (2007) that is produced by the National Health and 
Medical Research Council of Australia.  
 
13. Complaints  
 
If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you may 
contact:   
 
The Manager, Research Integrity, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au 
 
Please quote project number [2012-107]. 
 
 
14. Reimbursement for Your Costs  
 
To ensure that you do not incur any monetary losses, parking vouchers will be provided 
for every visit you make to the Deakin University grounds on the Burwood Campus. 
Each parking voucher will be provided on the day you arrive and each voucher is priced 
at $6.00 per day.  
 
15. The Researchers Responsible for this Project Include: 
 
Michael Do (student researcher).  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: domichae@deakin.edu.au  
Phone: 03 9251 7234 
 
Dr. Linda Byrne (principal researcher).  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: linda.byrne@deakin.edu.au  
Phone: 03 9244 6424 International: +61 3 9244 6424 
Fax: 03 9244 6858 International: +61 3 9244 6858 
 
Dr. Alan Pearce (associate researcher). 
Cognitive and Exercise Neuroscience Unit 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: alan.pearce@deakin.edu.au 
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 PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 




Full Project Title: The long term neurocognitive effects of a single session of multisite 




I have read and I understand the attached Plain Language Statement. 
I freely agree to participate in this project according to the conditions in the Plain 
Language Statement.  
I have been given a copy of the Plain Language Statement and Consent Form to keep.  
The researcher has agreed not to reveal my identity and personal details, including 
where information about this project is published, or presented in any public form.   
 
Participant’s Name (printed) 
…………………………………………………………………… 
Signature ……………………………………………………… Date  
………………………… 
  




DUHREC – 2015-296 
 
PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  The Participant  
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date: 
Full Project Title: The long term neurocognitive effects of a single session of multisite 





I hereby wish to WITHDRAW my consent to participate in the above research project 
and understand that such withdrawal WILL NOT jeopardise my relationship with 




Participant’s Name (printed) ……………………………………………………. 
 
 





Please mail or fax this form to: 
 
Dr. Linda Byrne 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Phone: 03 9244 6424 International: +61 3 9244 6424 









PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participants  
 
 
Plain Language Statement  
Date: 
Full Project Title: The Neurophysiological Effects of Sequentially Applied 
Transcranial Magnetic Stimulation:  A Theta Burst Stimulation Investigation 
Principal Researcher: Dr. Linda Byrne, Associate Professor Peter Enticott  
Student Researcher(s): Ms Soukayna Bekkali, Michael Do   
Associate Researcher(s): Dr. Melissa Kirkovski, Miss Charlotte Davies  
 
 
Thank you for taking the time to read this Information Statement. This Participant 
Information Statement contains detailed information about the research project. Its 
purpose is to explain to you as clearly as possible all the procedures involved in the 
project before you decide whether or not to take part in it.  
 
Please read this information carefully. Feel free to ask questions about anything in the 
document. You may also wish to discuss the project with a relative or friend. Please feel 
free to do this.  
 
Once you understand what is involved in the project and if you agree to take part in it, 
you will be asked to sign the Consent Form. By signing the Consent Form, you indicate 
that you understand the information and that you give your consent to participate in the 
project. 
 
Participation in this study is voluntary. If you do not wish to take part you are not 
obliged to. If you decide to take part and later change your mind, you are free to 
withdraw from the project during the data collection stage. It should be noted that it will 
not be possible to withdraw your data once it has been published. Your decision 
whether or not to participate will not affect your relationship with Deakin University.  
 
You will be given a copy of this Participant Information Sheet and Consent Form to 
keep as a record. 
 
1. What is the reason for this project  
The purpose of this project is to investigate the effects of a non-invasive brain 
stimulation technique applied to two regions of the brain. The technique is referred to as 
repetitive transcranial magnetic stimulation (rTMS) and has been used for well over two 
decades. rTMS is used routinely in healthy individuals in laboratories all over the world. 
The technique induces very short term effects on the brain. There are risks associated 
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with the technique. In order to ensure your safety, the researcher administering rTMS 
(the associate researcher or student researcher) will be present in each session and holds 
a current first aid certificate. At all times there will be two researchers present in the 
laboratory, one of which holds a first aid certificate.  
 
The project has been designed to examine how different parts of your brain 
communicate. The study will involve stimulating two brain regions and then measuring 
a hand muscle to determine your brain’s response. The project will help us to better 
understand how rTMS applied to different regions affects the brains ability to 
communicate. This information can be used to help develop future neuroscience and 
clinical protocols involving multisite stimulation.  
 
This research is being conducted as part of a PhD (psychology) thesis.  
 
A maximum of 30 participants will participate in this project.  
 
You have been asked to participate in this study because:  
• You are healthy  
• You are between the ages 18 and 35  
• You are right handed  
 
If you have or suspect that you have any of these conditions, it is important for your 
safety that you do not participate in this study:  
• If you have a current or past history of neurological, psychological or severe 
physical illness  
• If you have metal implants/shrapnel in your head  
• If you have any surgically implanted devices including pace-makers, 
neurostimulator devices (including deep-brain stimulation, vagus nerve 
stimulator), cochlear implants or other surgically implanted device  
• If you are pregnant or breastfeeding 
• If you are a professional driver or machine operator 
 
2. What is involved with this project  
This study will be conducted in the Cognitive Neuroscience Laboratories at the Deakin 
University Burwood campus. You will be asked to visit the university grounds four 
times, with five days in between each session. Each session will last 1 hour 15 minutes.   
 
In the first session, you will come into the laboratory and meet the researcher. The 
researcher will tell you about rTMS and answer any questions that you have. You will 
then fill out a safety questionnaire to ensure that you are eligible to participate. You will 
answer the same safety questionnaire in each session. Please answer the safety 
questionnaire as accurately as possible. You will also be asked to complete a 
questionnaire which determines whether you right or left handed.  
 
The researcher will then set up the study protocol. You will sit in a comfortable chair. 
You will be asked to wear a specialised cap with a snug fit. Tape measures will be used 
to locate the centre of your head. The researcher will then clean a hand muscle on your 
right hand with alcohol wipes. Electrodes will be placed on your hand muscle. The 
researcher will then administer TMS pulses to determine the minimal strength required 
to elicit a response from your brain. The area that elicits the strongest response will be 
indicated with a small dot using a marker. The TMS pulses may feel like some light taps 
on your head. You will feel some light taps under the area that is being stimulated. 
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Although the pulses are not painful, they may feel a little uncomfortable. You will be 
able to provide feedback about how you are feeling throughout the entire procedure. 
The researcher will then take baseline measures to establish your brain’s initial 
responsiveness.  
 
In each session, the rTMS will be administered using one of four protocols. For ease of 
understanding, we will refer to them as Region 1 (premotor cortex), Region 2 (primary 
motor cortex) and Region 3 (dorsolateral prefrontal cortex). For an explanation of these 
regions, please don’t hesitate to ask the researcher:  
1. Region 1  Region 2 
2. Region 2 stimulated twice  
3. Region 3  Region 2  
4. Region 1 with sham (inactive) coil  Region 2 
 
Stimulation will be delivered using a variant of rTMS referred to as continuous theta 
burst stimulation (cTBS). cTBS involves very quick, but low intensity stimulation. The 
total delivery time for cTBS will be 80 seconds.  
 
After a short break, the researcher will then deliver additional TMS pulses to measure 
your brain’s response to the protocol at four time points: immediately after the protocol, 
then at 10 minutes, 20 minutes and 30 minutes. At the end of each session, you will be 
asked to report any adverse side affects you may have experienced. You will also be 
asked to indicate which areas of your brain you think were stimulated and whether it 
involved active or sham (inactive) stimulation. 
 
3. Possible benefits  
The possible benefits of this project include being able to design new TMS procedures 
to help understand how the brain functions. It also provides a unique opportunity to 
understand how different regions of the brain communicate. It is hoped that this project 
will open up new research avenues for future research in cognitive neuroscience and 
clinical neuropsychology. We do not expect this research to benefit you directly.  
 
4. Possible risks  
Although rTMS is non-invasive and has been shown to be a relatively safe technique in 
some populations and used extensively in healthy people, there are potential risks to this 
research. The more common risk that you might experience includes some minor 
discomfort during the stimulation. Other reported but minor risks include mild 
headache, neck pain, general discomfort, tooth pain, slight changes in mood and muscle 
pains around the shoulders. These minor risks are temporary and usually resolve within 
a few hours.  
 
In some instances, seizures have been reported following from rTMS exposure. The risk 
of a seizure, however, is low and has been estimated to be less than 1% in healthy 
individuals (Rossi et al., 2009). Prior to any TMS, you will undertake a safety screen to 
ensure your safety. If you have circumstances that increase your risk, it will not be 
appropriate for you to take part in this project. To ensure your safety at all times, one of 
the researchers (associate or student researcher) has been specifically trained to provide 
first-aid. Please note that there will be two researchers present in all sessions of which 
one of the researchers will hold a current first aid certificate.  
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It is important to emphasise at this point that your participation is completely voluntary 
and you are free to withdraw at any time. You do not have to give a reason if you do not 
wish to participate and there will be no consequences if you wish to withdraw.  
 
5. Provision of services  
In the unlikely event of a seizure, the researcher will immediately attend to your health 
and wellbeing. Your health and safety is our highest priority. All testing will be 
immediately terminated and the researcher will administer first aid, where necessary. 
You will then be carefully monitored until the situation has been judged to pass. 
Following from this, a report will be filled and the relevant Ethics Review Board will be 
notified immediately. Even if you experience a seizure there has been no evidence from 
multiple studies over the past 30 years to indicate that you are more susceptible to 
developing seizures at another stage. In other words epilepsy (a condition involving 
recurrent seizures) has not been seen to develop following administration of TMS, even 
in the unlikely event that you experience a seizure. A detailed report substantiating this 
claim has been written as part of the research student’s thesis and can be provided to 
any relevant individuals, if required.  
 
It is possible that some participants may feel mild discomfort when answering certain 
questions on some of the questionnaires. If you feel any discomfort at any time, you are 
free to withdraw from the study by completing the Withdrawal of Consent Form (found 
at the end of this information sheet) and sending it to the researchers. If you feel distress 
resulting from participating in this project, it is strongly advised that you contact your 
general health practitioner (GP) or other relevant health care worker. You can also 
receive free counselling from Lifeline (phone number: 131 114).  
 
6. Privacy, confidentiality and disclosure of information  
The data in this study you provide will be stored with a code so that your responses to 
the questionnaires and tests will be matched to your TMS responses. However, you will 
not be identifiable by name on any of the questionnaires or tests. A password protected 
participant list will be used to connect your ID number with your name. The list will 
also be stored electronically in a computer that requires a password to be accessed. This 
will provide two levels of security for your electronic data. As it will be possible to 
connect your information together, this will enable us to remove your data should you 
wish to withdraw from the study. Thereafter, only aggregated data (or group data) will 
be reported in a thesis and published in a psychological journal.  
 
The information collected during this project will be stored in hard-copy and electronic-
copy form. Data collected in hard-copy will be locked away in a filing cabinet. Your 
data will be kept in a secure location for a minimum of six years, which is in accordance 
with Deakin University guidelines. After a period of six years, the hard-copy files of 
your data will be destroyed and the electronic-files will be deleted. A report of the study 
may be submitted for publication in a psychological journal. However, individual 
participants will not be identifiable as only aggregated data (or group data) will be 
reported.  
 
With respect to the short survey regarding your experience of non-invasive brain 
stimulation (which will be administered at the end of each session), if you give us your 
permission by signing the consent form and not withdrawing from the study, your data 
will form part of the group data (i.e., from a number of different studies) to be analysed 
and reported in scientific papers and/or conferences.. Data will be presented as group 
data, and/or individual response plots. All presented data will be de-identified meaning 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 398 of 414 
 
 
that your sensitive personal information will not be associated with the data. As a result, 
any published or presented data cannot be used to identify you individually.  
 
The data obtained from this research will be re-identifiable (coded so your data can only 
be linked to your personal information by the research team). The re-identifiable 
information will be stored in password-protected files on a secure web-based server. 
 
7. Results of the Project  
You are encouraged to contact the researcher at the conclusion of the study to be 
informed of the aggregate research findings. If requested, we will provide you with the 
aggregate findings of this study by mail or e-mail. Aggregate results will be presented in 
a thesis and published in a psychological journal.  
 
8. How the research will be monitored  
The principal researchers will meet with the associate researchers throughout the 
duration of the project to monitor its progress and to discuss any issues that arise.  
 
9. Reimbursement for your costs  
To ensure that you do not incur any monetary loses, you will be provided with parking 
vouchers for every visit you make to the university grounds. Each parking voucher is 
valued at $6. You will also receive a $20 gift voucher after you complete the fourth and 
final session.  
 
10. Financial support  
This study is fully funded by the School of Psychology at Deakin University.  
 
11. Participation is voluntary  
It is important to reemphasise that your participation is completely voluntary. If you do 
not wish to be part of the study, you are not obliged to. You do not have to take part in 
this project. You are free to withdraw from this project at any time. Any information 
that you have provided will not be used and can be destroyed at your request.  
 
If you decide to withdraw from this project, your relationship with the investigators or 
Deakin University will not be affected. In other words, there are no consequences if you 
do not wish to participate.  
 
At every stage of the project, you are encouraged to ask questions from the researchers. 
The research members will be available to answer any questions that you may have 
about the research project. You may ask about any aspect of the project that you would 
like to know about. Please feel free to do so. We ask that you sign the Consent Form if 
and only if you have had a chance to ask your questions and you have received 
satisfactory answers.  
 
If you do not wish to participate in this project, please do not sign the Consent Form.  
 
12. Ethical guidelines  
This project has been developed in accordance with the National Statement on Ethical 
Conduct in Human Research (2007) that is produced by the National Health and 
Medical Research Council of Australia.  
 




If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you may 
contact:   
 
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, 
Burwood Victoria 3125, Telephone: 9251 7129, research-ethics@deakin.edu.au 
 
Please quote project number [2015-296]. 
 
14. Researchers responsible for the project  
Dr. Linda Byrne (Principal researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: linda.byrne@deakin.edu.au  
Phone: 03 9244 6424 International: +61 3 9244 6424 
Fax: 03 9244 6858 International: +61 3 9244 6858 
 
Associate Professor Peter Enticott (Principal researcher)  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia.  
Email: peter.enticott@deakin.edu.au  
Phone: 03 9244 5504 
 
Dr. Melissa Kirkovski (Associate Researcher)  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
melissa.kirkovski@deakin.edu.au 
Phone: 03 9251 7795 
 
Charlotte Davies (Research Assistant)  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia.  
Email: charlotte.davies@deakin.edu.au  
Phone: 03 9256 8273 
Soukayna Bekkali (student researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia.  
Email: soukayna.bekkali@deakin.edu.au 
Phone: 03 9244 5250 
 
Michael Do (student researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: domichae@deakin.edu.au  
Phone: 03 9251 7234 
 
 





 PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 




Full Project Title: The Neurophysiological Effects of Sequentially Applied 




I have read and I understand the attached Plain Language Statement. 
I freely agree to participate in this project according to the conditions in the Plain 
Language Statement.  
 
I have been given a copy of the Plain Language Statement and Consent Form to keep.  
 
The researcher has agreed not to reveal my identity and personal details, including 
where information about this project is published, or presented in any public form.   
 
I understand that my re-identifiable data on my experience of non-invasive brain 
stimulation will be recorded and stored, but only group data will be reported in 
scientific papers and/or conferences. 
 




Signature ……………………………………………………… Date  
………………………… 
 
☐ Please tick this box if you wish to receive a one page summary of results explained in 
non-technical language at the conclusion of the study, and include your email address 
below. 
 










PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO: The Participant  
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date: 
Full Project Title: The Neurophysiological Effects of Sequentially Applied 





I hereby wish to WITHDRAW my consent to participate in the above research project 





Participant’s Name (printed) ……………………………………………………. 
 
 





Please mail or fax this form to: 
 
Dr. Linda Byrne 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Phone: 03 9244 6424 International: +61 3 9244 6424 
Fax: 03 9244 6858 International: +61 3 9244 6858 
 




Study 4 – DUHREC – 2017-050 
PLAIN LANGUAGE STATEMENT AND 





DU Human Research Ethics number: 2017-050 
Full Project Title: Priming the motor cortex -  A combined transcranial magnetic 
stimulation-electroencephalography study 
Principal Researcher: Dr Linda Byrne, Associate Professor Peter Enticott  
Associate Researcher/s: Dr Melissa Kirkovski, Dr Nigel Rogasch,  




Thank you for taking the time to read this Information Statement. 
 
This Participant Information Statement contains detailed information about the 
research project. Its purpose is to explain to you as clearly as possible all the 
procedures involved in the project before you decide whether or not to take part in 
it. 
 
Please read this information carefully. Feel free to ask questions about anything in 
the document. You may also wish to discuss the project with a relative or friend. 
Please feel free to do this. 
 
Once you understand what is involved in the project and if you agree to take part in 
it, you will be asked to sign the Consent Form.  By signing the Consent Form, you 
indicate that you understand the information and that you give your consent to 
participate in the project. 
 
Participation in this study is voluntary. If you do not wish to take part you are 
not obliged to. If you decide to take part and later change your mind, you are free 
to withdraw from the project at any stage. Your decision whether or not to 
participate will not affect your relationship with Deakin University. 
 
You will be given a copy of this Participant Information Sheet and Consent Form to keep 
as a record. 
 
1. What is the reason for this project? 
 
Plain Language Statement 
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The primary reason for this project is to develop non-invasive brain stimulation 
protocols to better understand how the brain functions in healthy individuals.  A 
secondary aim is to develop new ways to measure brain activity non-invasively. 
Additionally, transcutaneous magnetic peripheral nerve stimulation (tMPNS) of the 
shoulder will be used to better understand brain responses to non-invasive brain 
stimulation applied to the scalp.  
 
2. What will I be asked to do? 
You will be asked to attend 2 sessions at the Cognitive Neuroscience Unit (CNU) 
laboratories located at Deakin University in Burwood, Victoria. Each session will last 
approximately 2 hours to 2 hours 30 minutes 
 
You will sit in a comfortable chair. A specialized cap used for electroencephalography 
(EEG) will be placed on your head. A cotton bud prepared with a mild exfoliant and 
alcohol will be used to very gently clean the area above and below your right eye. 
Electrodes will be attached to the cap, and also above and below your eye. Conductive 
gel will be injected into wells positioned inside the cap using a blunted syringe. At no 
stage will your skin be broken. Some muscles on your right hand will be cleaned with 
alcohol wipes. Three electrodes will be placed on your hand. The electrodes will be 
secured with easily removable tape. We will apply some pulses to your scalp using a 
technique known as transcranial magnetic stimulation (TMS) to measure the initial 
responsive of your brain. We will then apply a technique known as transcutaneous 
magnetic peripheral nerve stimulation (tMPNS) to your shoulder and measure your 
brain’s response.  
 
Two rounds of continuous theta burst stimulation (cTBS)(a subtype of TMS) will be 
applied to your scalp. Each round will be separated by 10 minutes. To measure your 
brain’s response to cTBS, TMS pulses will be applied to your scalp in between the first 
and second rounds of cTBS. TMS will also be applied over your scalp immediately after 
the second round of cTBS, then after 30 minutes. tMPNS will be applied once after the 
second round of cTBS. Shower facilities, clean towels, and commercially available 
shampoo will be made available to wash your hair.  
 
If you agree to participate in this study, you will be screened by one of the 
investigators to make sure that you meet all the criteria for TMS as a participant in 
this study. You will not be able to take part in this study if: 
 
• You have ever had a seizure or seizure disorder (e.g., epilepsy) 
• You have previously undergone electroencephalography (EEG) for 
clinical/medical reasons, and the presence of seizure activity has not 
been excluded 
• You are a professional driver or machine operator 
• You have had brain surgery, a brain injury, or neurological condition 
• You have any metal in your head (outside the mouth) 
• If you have any metal in your body 
• You have an implanted medical device 
• You have a serious and/or unstable illness or medical condition 
• You are pregnant, or there is a chance that you might be pregnant 
• You are breastfeeding 
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• You have consumed alcohol in the 12 hours prior to TMS, or have had 
more than 3 standard drinks in the 24 hours prior to TMS 
• You have consumed any recreational drugs in the past 7 days 
• You are taking psychotropic medication 
• You have recently experienced insomnia or another form of sleep deprivation 
 
You may not be able to take part in this study if: 
 
• You are taking certain types of medication 
• You have had a recent change in your sleeping, smoking, or drinking habits, or 
caffeine intake 
• You get frequent headaches or migraines 
• You are prone to fainting 
• You have had an adverse reaction to brain stimulation 
 
TMS Methodology 
You will then undergo TMS. This is a safe and non-invasive technique commonly 
used in neuroscience research. TMS involves the application of brief magnetic 
pulses through a plastic-coated metal coil that is held against the scalp. Each 
magnetic pulse is able to temporarily induce a small amount of electricity in your 
brain and cause some brain cells to briefly activate or “fire.” 
 
You will feel the TMS coil positioned against your scalp and shoulder, and you 
will hear a “tapping” or a “clicking” sound each time a pulse in delivered 
(typically every 3-5 seconds). You will also most likely feel a tapping sensation 
on your head and shoulder. In this study we will first stimulate the region of your 
brain that controls the right hand muscles. Immediately after each pulse you may 
feel a slight twitch in your hand and wrist. We will attach small electrodes to your 
right hand to measure muscle activity in the hand and wrist; this is a technique 
called electromyography (EMG). You will not feel or experience anything from 
these hand electrodes, they simply record muscle activity. 
 
This study also involves theta burst stimulation (TBS), which is a form of repetitive 
transcranial magnetic stimulation, or rTMS. rTMS involves the administration of 
TMS in a repeated fashion to temporarily and subtly change activity within a 
particular part of the brain. During TBS, participants are administered a large 
number of pulses in very quick succession (e.g., 15 pulses per second), but at a 
low intensity (i.e., the “tapping” sensation on the head will not feel as strong). 
 
TBS is typically delivered in one of two ways. Continuous TBS, or cTBS, involves 
a series of very quick pulses delivered continuously for 40 seconds. This tends to 
inhibit or reduce brain activity. 
Intermittent TBS, or iTBS, involves a series of very quick pulses lasting 2 
seconds, delivered every 10 seconds for around 3 minutes. This tends to excite or 
enhance brain activity. These effects on the brain are very subtle, and are unlikely 
to be noticed by the person undergoing TBS. Below is an image of a person 
receiving TMS.  
 
tMPNS Methodology 
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You will then undergo tMPNS. This is a safe and non-invasive technique 
commonly used in neuroscience research. tMPNS involves the application of brief 
magnetic pulses through a plastic-coated metal coil that is held against your 
shoulder. Each magnetic pulse temporarily induces a small amount of electricity in 
the area under your skin and cause some muscle fibers and nerve cells to briefly 
activate or “fire.” 
 
You will feel the coil positioned against your shoulder, and you will hear a 
“tapping” or a “clicking” sound each time a pulse in delivered (typically every 3-5 
seconds). You will also most likely feel a tapping sensation on your skin. You 




EEG is a safe, non-invasive way to measure brain activity and is common used in 
neuroscience. It is very safe and is completely harmless. It involves placing 
sensitive electrodes on the scalp. The can electrodes detect very faint electrical 
activity in the brain. This information is transmitted and stored on a computer. 







3. What will I gain by participating? 
 
We do not expect you to benefit directly from the study.  
 
4. Are there any risks involved? 
 
The main concern with TMS is its potential to induce a fit or seizure. These are 
extremely rare, and have occurred when people have been given many TMS 
pulses very close together at a high intensity, or in those with a pre-existing 
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neurological abnormality. As of the most recently safety guidelines for TMS 
(Rossi et al., 2009), there were 16 seizures reported since TMS began in 1985. 
Most of these were in individuals taking medication that increased the likelihood 
of seizure, or that had a pre-existing seizure disorder. However, all participants 
should be aware that events such as a seizure may have adverse consequences for 
future employment and insurance, and this should be considered when choosing 
to take part in the study. 
 
Less serious side effects of TMS are also uncommon, but can include: 
 
• Local pain or discomfort at site of stimulation 
• Tingling or contraction of muscles of the scalp, jaw or face during stimulation 
• Mild headache during or immediately following stimulation 
• Minor tooth pain 
• Minor muscle pain around the shoulders 
• Syncope (fainting) 
• Nausea 
• Insomnia or other sleep disturbance 
• Slight change in mood 
• Ear pain or ringing in the ears 
 
There may be as yet other unknown adverse effects from TMS. 
 
Transcutaneous magnetic stimulation is a very safe technique. It does not carry a 
seizure risk. Side effects are uncommon, but can include:  
 
• Local pain or discomfort at the site of stimulation 
• Tingling or contraction of muscles near the area of stimulation 
• Ear pain for ringing in the ears 
 
There may be as yet other unknown adverse side effects from transcutaneous 
magnetic stimulation.  
 
If you experience pain resulting from cTBS, it will typically resolve within a short 
period of time. If desired, you can take regular pain medication such as 
paracetamol, ibuprofen, or aspirin. 
 
You will be provided with ear-plugs to reduce any risk of damage to your ears 
or hearing. If you experience any abnormalities in your hearing following the 
procedure, please notify one of the researchers so you can be referred to a 
hearing specialist. 
 
As with many standard medical procedures, it is also possible that you may 
experience syncope (fainting) during the TMS session. Although this is 
considered very unlikely, you may wish to inform t h e  researchers if you have a 
history of syncope or feeling faint during medical procedures. We will be able to 
communicate with you throughout the testing. If you become uncomfortable at any 
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point, you can ask us to stop. At least one researcher with first aid training will be 
present during the TMS procedure. 
 
It is important that you inform the researchers of any side effects experienced either 
during or after stimulation. You will be asked more specific questions about this at 
the end of each session. 
 
 
5. Expected benefits to the wider community 
 
The results of this study will help to inform the development of new techniques for 
investigating brain functioning in healthy individuals. It will also provide information 
which can be translated in clinical investigations.  
 
6. Privacy and confidentiality 
 
Participation in this study will be confidential. Your data will not contain your 
name or any identifying information, and it will only be accessible to members of 
the research team listed above.  Data will be presented in the form of group data 
(e.g. means, percentages) and individual response plots (e.g. as a figure or values). 
It should be emphasized that only de-identified data will be presented. It will not 
be possible to identify who you are based on the group data or your individual 
responses.  
 
The data collected in this study will be used as a component of the student 
researcher’s thesis.   
It is expected that the results of this research will be published in a scientific 
journal.  Upon conclusion of the study, a non-identifiable data set could be made 
publically available via a data repository. This data will be completely anonymous. It 
will not contain any identifying information (e.g. your name, address, contact details, 
date of birth). It will not be possible to identify you personally based on any 
publically available data relating to this study. 
If you would like to be informed of the results at the conclusion of the study, 
please tick the box beneath the consent form and provide your email address. 
 
With respect to the short survey regarding your experience of non-invasive brain 
stimulation, if you give us your permission by signing the consent form and not 
withdrawing from the study, your data will form part of the group data (i.e., from 
a number of different studies) to be analysed and reported in scientific papers 
and/or conferences. Only group data will be reported. The data obtained from this 
research will be re-identifiable (coded so your data can only be linked to your 
personal information by the research team). The re-identifiable information will be 
stored in password-protected files on a secure web-based server. 
 
7. Reimbursement and funding 
You will receive a $20 Coles-Myers gift voucher to cover travel expenses, as well as 
food and beverage costs for each session you attend.  
 
STANDARD AND PRIMING CTBS: TMS-EEG   Page 408 of 414 
 
 
8. What if I decide to stop participation during the study? 
 
If you wish to withdraw from the study at any stage, your decision will not be 
questioned and any information that you have provided to that point will not be 
used. 
 
9. Who can I contact for further information? 
 
If you require further information or if you have any problems concerning this 
project you can contact one of the principal researchers. The researchers 
responsible for this project are: 
 
Dr Linda Byrne (Principal researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: linda.byrne@deakin.edu.au  
Phone: 03 9244 6424 International: +61 3 9244 6424 
Fax: 03 9244 6858 International: +61 3 9244 6858 
 
Associate Professor Peter Enticott (Principal researcher)  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia.  
Email: peter.enticott@deakin.edu.au  
Phone: 03 9244 5504 
 
Dr Melissa Kirkovski (Associate Researcher)  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology. 
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: melissa.kirkovski@deakin.edu.au 
Phone: 03 9251 7795 
 
Dr Nigel Rogasch (Associate Researcher)  
Monash Biomedical Imaging  
Monash University, 770 Blackburn Road, Clayton Victoria 3800 Australia. 
 
Ms Soukayna Bekalli  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: soukayna.bekkali@deakin.edu.au 
Phone: 03 9244 5250 
 
Mr Michael Do (student researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: m.do@deakin.edu.au  
Phone: 03 9251 7234 
 
Mr Jason He  
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of Psychology.  
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Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 




If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you 
may contact: 
 















































DU Human Research Ethics number: 2017-050 
Full Project Title: Priming the motor cortex - A combined transcranial magnetic 
stimulation-electroencephalography study 
Principal Researcher: Dr Linda Byrne, Associate Professor Peter Enticott  
Associate Researcher/s: Dr Melissa Kirkovski, Dr Nigel Rogasch 




I have read and I understand the attached Plain Language Statement. 
 
I freely agree to participate in this project according to the conditions in the Plain 
Language Statement. 
 
I have been given a copy of the Plain Language Statement and Consent Form to keep. 
 
The researcher has agreed not to reveal my identity and personal details, including 
where information about this project is published, or presented in any public form. 
 
I understand that my re-identifiable data on my experience of non-invasive brain 
stimulation will be recorded and stored, but only group data will be reported in 
scientific papers and/or conferences. 
 
I have been made aware of the exclusion criteria for this study, and I declare that I 
do not meet any of those criteria. 
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□ Please tick this box if you wish to receive a summary of results at the 




Email …………………………………………………… @ 
………………………………………………………………………….. 












 (To be used for participants who wish to withdraw from the project) 
 
DU Human Research Ethics number: 2017-050 
Full Project Title: Priming the motor cortex - A combined transcranial magnetic 
stimulation-electroencephalography study 
Principal Researcher: Dr Linda Byrne, Associate Professor Peter Enticott  
Associate Researcher/s: Dr Melissa Kirkovski, Dr Nigel Rogasch  





I hereby wish to WITHDRAW my consent to participate in the above research 
project and understand that such withdrawal WILL NOT jeopardise my 









Please mail or fax this form to: 
 
Dr. Linda Byrne (Principal researcher) 
Faculty of Health, Medicine, Nursing and Behavioural Sciences, School of 
Psychology.  
Deakin University, 221 Burwood Highway, Burwood Victoria 3125 Australia. 
Email: linda.byrne@deakin.edu.au  
Phone: 03 9244 6424 International: +61 3 9244 6424 
Fax: 03 9244 6858 International: +61 3 9244 6858 
 
 
Withdrawal of Consent Form 
